User login
Complications cluster in inflammatory arthritis patients after total knee replacement
CHICAGO – Patients with an inflammatory arthritis had significantly higher rates of infections, transfusions, and readmissions following total knee replacement than did patients without inflammatory arthritis in a study of more than 137,000 Americans who underwent this surgery.
A sampling of U.S. patients who underwent total knee arthroplasty (TKA) during 2007-2016 showed that among the small percentage of these patients who had an inflammatory arthritis (IA), the rate of periprosthetic joint or wound infection while hospitalized or out to 30 days after surgery was a statistically significant 64% higher relative to patients without inflammatory arthritis, after adjustment for several demographic and clinical confounders, including recent glucocorticoid treatment, Susan M. Goodman, MD, said at the annual meeting of the American College of Rheumatology. The analysis also showed a statistically significant 46% higher relative rate of hospital readmission for any cause during the 90 days after surgery, and a significant 39% relative increase in blood transfusions during the 30 days after TKA in the IA patients.
“These results have important implications for evolving bundled payment models” for TKA, said Dr. Goodman, a rheumatologist at the Hospital for Special Surgery in New York. “Hospitals should receive commensurate resources to maintain access to total TKA for patients with IA.”
For this analysis, Dr. Goodman and her associates classified IA as a patient with a recorded diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus if the patient had also received treatment during the year before surgery with a disease-modifying antirheumatic drug, a biologic agent, or a drug that treats systemic lupus erythematosus.
Complications following TKA became a particular concern to hospitals starting in 2013 when the Centers for Medicare & Medicaid Services began a program that penalized hospitals for outcomes such as excessive readmissions following selected types of hospitalizations and also with recent steps to bundle TKA reimbursement with related 90-day outcomes.
“My concern is to ensure that patients with IA aren’t penalized and can maintain access” to TKA despite recent policy moves by the CMS. Faced with potential disincentives to treat patients with an IA, “hospitals might cherry pick patients,” Dr. Goodman said in an interview. The new findings “are a reason for administrators to argue for patients with IA to come out of the cost bundle.”
Dr. Goodman expressed hope that future policies will better reflect the higher levels of risk faced by patients with an IA undergoing TKA. CMS “is pretty responsive,” she said.
The study used data collected by Humana for about 25 million American health insurance beneficiaries during 2007-2016, which included 137,550 people who underwent a TKA. Of these, 3,067 (2%) met the study’s definition for IA, and 134,483 did not. Most of those who did not meet the definition likely had osteoarthritis, Dr. Goodman said. This low percentage of U.S. TKA patients with IA was consistent with numbers in prior reports.
The researchers calculated the relative risk of the IA patients, compared with all the others, for nine potential complications, including acute MI, pneumonia, sepsis, pulmonary embolism, and death. The complications with significantly higher rates among the IA patients after confounder adjustment were 30-day infections, 30-day transfusions, and 90-day readmissions.
Dr. Goodman had no relevant disclosures.
SOURCE: Richardson S et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1932.
CHICAGO – Patients with an inflammatory arthritis had significantly higher rates of infections, transfusions, and readmissions following total knee replacement than did patients without inflammatory arthritis in a study of more than 137,000 Americans who underwent this surgery.
A sampling of U.S. patients who underwent total knee arthroplasty (TKA) during 2007-2016 showed that among the small percentage of these patients who had an inflammatory arthritis (IA), the rate of periprosthetic joint or wound infection while hospitalized or out to 30 days after surgery was a statistically significant 64% higher relative to patients without inflammatory arthritis, after adjustment for several demographic and clinical confounders, including recent glucocorticoid treatment, Susan M. Goodman, MD, said at the annual meeting of the American College of Rheumatology. The analysis also showed a statistically significant 46% higher relative rate of hospital readmission for any cause during the 90 days after surgery, and a significant 39% relative increase in blood transfusions during the 30 days after TKA in the IA patients.
“These results have important implications for evolving bundled payment models” for TKA, said Dr. Goodman, a rheumatologist at the Hospital for Special Surgery in New York. “Hospitals should receive commensurate resources to maintain access to total TKA for patients with IA.”
For this analysis, Dr. Goodman and her associates classified IA as a patient with a recorded diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus if the patient had also received treatment during the year before surgery with a disease-modifying antirheumatic drug, a biologic agent, or a drug that treats systemic lupus erythematosus.
Complications following TKA became a particular concern to hospitals starting in 2013 when the Centers for Medicare & Medicaid Services began a program that penalized hospitals for outcomes such as excessive readmissions following selected types of hospitalizations and also with recent steps to bundle TKA reimbursement with related 90-day outcomes.
“My concern is to ensure that patients with IA aren’t penalized and can maintain access” to TKA despite recent policy moves by the CMS. Faced with potential disincentives to treat patients with an IA, “hospitals might cherry pick patients,” Dr. Goodman said in an interview. The new findings “are a reason for administrators to argue for patients with IA to come out of the cost bundle.”
Dr. Goodman expressed hope that future policies will better reflect the higher levels of risk faced by patients with an IA undergoing TKA. CMS “is pretty responsive,” she said.
The study used data collected by Humana for about 25 million American health insurance beneficiaries during 2007-2016, which included 137,550 people who underwent a TKA. Of these, 3,067 (2%) met the study’s definition for IA, and 134,483 did not. Most of those who did not meet the definition likely had osteoarthritis, Dr. Goodman said. This low percentage of U.S. TKA patients with IA was consistent with numbers in prior reports.
The researchers calculated the relative risk of the IA patients, compared with all the others, for nine potential complications, including acute MI, pneumonia, sepsis, pulmonary embolism, and death. The complications with significantly higher rates among the IA patients after confounder adjustment were 30-day infections, 30-day transfusions, and 90-day readmissions.
Dr. Goodman had no relevant disclosures.
SOURCE: Richardson S et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1932.
CHICAGO – Patients with an inflammatory arthritis had significantly higher rates of infections, transfusions, and readmissions following total knee replacement than did patients without inflammatory arthritis in a study of more than 137,000 Americans who underwent this surgery.
A sampling of U.S. patients who underwent total knee arthroplasty (TKA) during 2007-2016 showed that among the small percentage of these patients who had an inflammatory arthritis (IA), the rate of periprosthetic joint or wound infection while hospitalized or out to 30 days after surgery was a statistically significant 64% higher relative to patients without inflammatory arthritis, after adjustment for several demographic and clinical confounders, including recent glucocorticoid treatment, Susan M. Goodman, MD, said at the annual meeting of the American College of Rheumatology. The analysis also showed a statistically significant 46% higher relative rate of hospital readmission for any cause during the 90 days after surgery, and a significant 39% relative increase in blood transfusions during the 30 days after TKA in the IA patients.
“These results have important implications for evolving bundled payment models” for TKA, said Dr. Goodman, a rheumatologist at the Hospital for Special Surgery in New York. “Hospitals should receive commensurate resources to maintain access to total TKA for patients with IA.”
For this analysis, Dr. Goodman and her associates classified IA as a patient with a recorded diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus if the patient had also received treatment during the year before surgery with a disease-modifying antirheumatic drug, a biologic agent, or a drug that treats systemic lupus erythematosus.
Complications following TKA became a particular concern to hospitals starting in 2013 when the Centers for Medicare & Medicaid Services began a program that penalized hospitals for outcomes such as excessive readmissions following selected types of hospitalizations and also with recent steps to bundle TKA reimbursement with related 90-day outcomes.
“My concern is to ensure that patients with IA aren’t penalized and can maintain access” to TKA despite recent policy moves by the CMS. Faced with potential disincentives to treat patients with an IA, “hospitals might cherry pick patients,” Dr. Goodman said in an interview. The new findings “are a reason for administrators to argue for patients with IA to come out of the cost bundle.”
Dr. Goodman expressed hope that future policies will better reflect the higher levels of risk faced by patients with an IA undergoing TKA. CMS “is pretty responsive,” she said.
The study used data collected by Humana for about 25 million American health insurance beneficiaries during 2007-2016, which included 137,550 people who underwent a TKA. Of these, 3,067 (2%) met the study’s definition for IA, and 134,483 did not. Most of those who did not meet the definition likely had osteoarthritis, Dr. Goodman said. This low percentage of U.S. TKA patients with IA was consistent with numbers in prior reports.
The researchers calculated the relative risk of the IA patients, compared with all the others, for nine potential complications, including acute MI, pneumonia, sepsis, pulmonary embolism, and death. The complications with significantly higher rates among the IA patients after confounder adjustment were 30-day infections, 30-day transfusions, and 90-day readmissions.
Dr. Goodman had no relevant disclosures.
SOURCE: Richardson S et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1932.
REPORTING FROM THE ACR ANNUAL MEETING
Key clinical point: Complications were more common after total knee arthroplasty in patients with an inflammatory arthritis.
Major finding: Inflammatory arthritis patients had a 64% higher rate of infections after total knee arthroplasty, compared with patients without inflammatory arthritis.
Study details: Data analysis for 137,550 Americans who underwent total knee arthroplasty during 2007-2016.
Disclosures: Dr. Goodman had no relevant disclosures.
Source: Richardson S et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1932.
Ultrasound excels for assessing shoulder dislocation
SAN DIEGO – Point-of-care ultrasound should be the go-to approach for the routine assessment of suspected shoulder dislocations in the ED, based on data from a prospective, multicenter study presented at the annual meeting of the American College of Emergency Physicians.
In the observational study, the average time needed to diagnose shoulder dislocation using ultrasound was 18 seconds, far faster than time from triage to x-ray, according to Michael Secko, MD, director of the emergency ultrasound division at Stony Brook University (NY).
The results from this study, called MUDDS (Musculoskeletal Ultrasound to Diagnose Dislocated Shoulders), support point-of-care ultrasound as a faster and more readily performed alternative to x-ray. Of the 46 adult patients enrolled so far in the ongoing study, ultrasound’s sensitivity has been 96% and its specificity 100% when validated by x-ray findings.
In the study, adults presenting to the ED are evaluated with point-of-care ultrasound from a posterior approach using either a curvilinear or linear transducer in the transverse plane. About half of the patients enrolled so far had injuries caused by falls, and many of the others had a shoulder complaint related to being pulled. Slightly more than one-third had a previous shoulder dislocation.
When evaluated with point-of-care ultrasound and x-ray, 23 of the 42 evaluable patients had a dislocation. The time from triage to ultrasound evaluation averaged 60 minutes, 40 minutes faster than the average of 100 minutes from triage to x-ray. Both tests were ordered at the same time.
Ultrasound performed less well for the diagnosis of a fracture, with a sensitivity of only 53%. Dr. Secko said the anterior approach would not be expected to provide a comprehensive assessment for fracture. He noted, for example, that there was no attempt in this study to evaluate patients for the presence of Bankart lesions. However, in those found to have a fracture on point-of-care ultrasound, the specificity of this imaging tool was 96%.
Ultimately, a major goal of this study was to determine whether a posterior point-of-care ultrasound could provide a quick answer to the question, “is it in or out?” Although patients are still being enrolled, Dr. Secko believed there is already good evidence that ultrasound is fast and effective for diagnosing dislocations.
Others have addressed this same question. Citing a meta-analysis published last year, Dr. Secko reported that all but one of four studies evaluating ultrasound for shoulder dislocations found a sensitivity and specificity of 100% (Gottlieb M et al. West J Emerg Med. 2017 Aug;18[5]:937-942).
Many centers have already switched to ultrasound for the evaluation of shoulder dislocations, according to Andrew S. Liteplo, MD, who moderated the ACEP session in which Dr. Secko presented his data. “If you are not already doing this for suspected shoulder dislocation, start right away because it is easy and awesome,” said Dr. Liteplo, who is chief of the division of ultrasound in emergency medicine at Massachusetts General Hospital, Boston. He also advised that ultrasound can also can be performed after reduction to confirm the efficacy of treatment.
Dr. Secko reported no financial relationships relevant to this study.
SAN DIEGO – Point-of-care ultrasound should be the go-to approach for the routine assessment of suspected shoulder dislocations in the ED, based on data from a prospective, multicenter study presented at the annual meeting of the American College of Emergency Physicians.
In the observational study, the average time needed to diagnose shoulder dislocation using ultrasound was 18 seconds, far faster than time from triage to x-ray, according to Michael Secko, MD, director of the emergency ultrasound division at Stony Brook University (NY).
The results from this study, called MUDDS (Musculoskeletal Ultrasound to Diagnose Dislocated Shoulders), support point-of-care ultrasound as a faster and more readily performed alternative to x-ray. Of the 46 adult patients enrolled so far in the ongoing study, ultrasound’s sensitivity has been 96% and its specificity 100% when validated by x-ray findings.
In the study, adults presenting to the ED are evaluated with point-of-care ultrasound from a posterior approach using either a curvilinear or linear transducer in the transverse plane. About half of the patients enrolled so far had injuries caused by falls, and many of the others had a shoulder complaint related to being pulled. Slightly more than one-third had a previous shoulder dislocation.
When evaluated with point-of-care ultrasound and x-ray, 23 of the 42 evaluable patients had a dislocation. The time from triage to ultrasound evaluation averaged 60 minutes, 40 minutes faster than the average of 100 minutes from triage to x-ray. Both tests were ordered at the same time.
Ultrasound performed less well for the diagnosis of a fracture, with a sensitivity of only 53%. Dr. Secko said the anterior approach would not be expected to provide a comprehensive assessment for fracture. He noted, for example, that there was no attempt in this study to evaluate patients for the presence of Bankart lesions. However, in those found to have a fracture on point-of-care ultrasound, the specificity of this imaging tool was 96%.
Ultimately, a major goal of this study was to determine whether a posterior point-of-care ultrasound could provide a quick answer to the question, “is it in or out?” Although patients are still being enrolled, Dr. Secko believed there is already good evidence that ultrasound is fast and effective for diagnosing dislocations.
Others have addressed this same question. Citing a meta-analysis published last year, Dr. Secko reported that all but one of four studies evaluating ultrasound for shoulder dislocations found a sensitivity and specificity of 100% (Gottlieb M et al. West J Emerg Med. 2017 Aug;18[5]:937-942).
Many centers have already switched to ultrasound for the evaluation of shoulder dislocations, according to Andrew S. Liteplo, MD, who moderated the ACEP session in which Dr. Secko presented his data. “If you are not already doing this for suspected shoulder dislocation, start right away because it is easy and awesome,” said Dr. Liteplo, who is chief of the division of ultrasound in emergency medicine at Massachusetts General Hospital, Boston. He also advised that ultrasound can also can be performed after reduction to confirm the efficacy of treatment.
Dr. Secko reported no financial relationships relevant to this study.
SAN DIEGO – Point-of-care ultrasound should be the go-to approach for the routine assessment of suspected shoulder dislocations in the ED, based on data from a prospective, multicenter study presented at the annual meeting of the American College of Emergency Physicians.
In the observational study, the average time needed to diagnose shoulder dislocation using ultrasound was 18 seconds, far faster than time from triage to x-ray, according to Michael Secko, MD, director of the emergency ultrasound division at Stony Brook University (NY).
The results from this study, called MUDDS (Musculoskeletal Ultrasound to Diagnose Dislocated Shoulders), support point-of-care ultrasound as a faster and more readily performed alternative to x-ray. Of the 46 adult patients enrolled so far in the ongoing study, ultrasound’s sensitivity has been 96% and its specificity 100% when validated by x-ray findings.
In the study, adults presenting to the ED are evaluated with point-of-care ultrasound from a posterior approach using either a curvilinear or linear transducer in the transverse plane. About half of the patients enrolled so far had injuries caused by falls, and many of the others had a shoulder complaint related to being pulled. Slightly more than one-third had a previous shoulder dislocation.
When evaluated with point-of-care ultrasound and x-ray, 23 of the 42 evaluable patients had a dislocation. The time from triage to ultrasound evaluation averaged 60 minutes, 40 minutes faster than the average of 100 minutes from triage to x-ray. Both tests were ordered at the same time.
Ultrasound performed less well for the diagnosis of a fracture, with a sensitivity of only 53%. Dr. Secko said the anterior approach would not be expected to provide a comprehensive assessment for fracture. He noted, for example, that there was no attempt in this study to evaluate patients for the presence of Bankart lesions. However, in those found to have a fracture on point-of-care ultrasound, the specificity of this imaging tool was 96%.
Ultimately, a major goal of this study was to determine whether a posterior point-of-care ultrasound could provide a quick answer to the question, “is it in or out?” Although patients are still being enrolled, Dr. Secko believed there is already good evidence that ultrasound is fast and effective for diagnosing dislocations.
Others have addressed this same question. Citing a meta-analysis published last year, Dr. Secko reported that all but one of four studies evaluating ultrasound for shoulder dislocations found a sensitivity and specificity of 100% (Gottlieb M et al. West J Emerg Med. 2017 Aug;18[5]:937-942).
Many centers have already switched to ultrasound for the evaluation of shoulder dislocations, according to Andrew S. Liteplo, MD, who moderated the ACEP session in which Dr. Secko presented his data. “If you are not already doing this for suspected shoulder dislocation, start right away because it is easy and awesome,” said Dr. Liteplo, who is chief of the division of ultrasound in emergency medicine at Massachusetts General Hospital, Boston. He also advised that ultrasound can also can be performed after reduction to confirm the efficacy of treatment.
Dr. Secko reported no financial relationships relevant to this study.
REPORTING FROM ACEP18
Key clinical point: Point-of-care ultrasound is accurate, simple, and fast, relative to x-ray, for the evaluation of shoulder dislocation.
Major finding: Based on results from 42 patients, time from triage to ultrasound, which had a sensitivity of 96% and specificity of 100%, was 60 minutes versus 100 minutes for x-ray.
Study details: An ongoing prospective, multicenter, observational study.
Disclosures: Dr. Secko reported no financial relationships relevant to this study.
Brisk walking may decrease TKR risk in OA
CHICAGO – according to a new analysis of data from the National Institutes of Health-sponsored Osteoarthritis Initiative.

Whether walking increases or decreases the risk of structural deterioration and total knee replacement (TKR) in patients with knee osteoarthritis has been a controversial topic marked by conflicting data. That’s probably because prior studies haven’t taken into account walking intensity, Hiral Master said at the annual meeting of the American College of Rheumatology.
Ms. Master, a PhD candidate in physical therapy at the University of Delaware, Newark, presented a study of 1,854 patients with knee osteoarthritis who participated in the Osteoarthritis Initiative, all of whom had worn an accelerometer. This permitted calculation of time spent walking at various intensities. Subjects spent an average of 459 minutes per day not walking and 8 minutes walking at moderate to vigorous intensity, defined as a cadence of more than 100 steps per minute.
During 5 years of follow-up, the incidence of TKR was 6%. In this video interview, Ms. Master explains that patients who replaced 5 minutes of not walking with 5 minutes of brisk walking daily had an adjusted 14% reduction in the risk of TKR. A dose-response was evident, with more minutes of moderate to vigorous walking being associated with progressively larger reductions in the risk of this major surgery. Walking at a cadence of less than 100 steps per minute, regardless of duration, was nonprotective.
SOURCE: Master H et al. Arthritis Rheumatol. 2018;70(Suppl 10), Abstract 1166.
CHICAGO – according to a new analysis of data from the National Institutes of Health-sponsored Osteoarthritis Initiative.

Whether walking increases or decreases the risk of structural deterioration and total knee replacement (TKR) in patients with knee osteoarthritis has been a controversial topic marked by conflicting data. That’s probably because prior studies haven’t taken into account walking intensity, Hiral Master said at the annual meeting of the American College of Rheumatology.
Ms. Master, a PhD candidate in physical therapy at the University of Delaware, Newark, presented a study of 1,854 patients with knee osteoarthritis who participated in the Osteoarthritis Initiative, all of whom had worn an accelerometer. This permitted calculation of time spent walking at various intensities. Subjects spent an average of 459 minutes per day not walking and 8 minutes walking at moderate to vigorous intensity, defined as a cadence of more than 100 steps per minute.
During 5 years of follow-up, the incidence of TKR was 6%. In this video interview, Ms. Master explains that patients who replaced 5 minutes of not walking with 5 minutes of brisk walking daily had an adjusted 14% reduction in the risk of TKR. A dose-response was evident, with more minutes of moderate to vigorous walking being associated with progressively larger reductions in the risk of this major surgery. Walking at a cadence of less than 100 steps per minute, regardless of duration, was nonprotective.
SOURCE: Master H et al. Arthritis Rheumatol. 2018;70(Suppl 10), Abstract 1166.
CHICAGO – according to a new analysis of data from the National Institutes of Health-sponsored Osteoarthritis Initiative.

Whether walking increases or decreases the risk of structural deterioration and total knee replacement (TKR) in patients with knee osteoarthritis has been a controversial topic marked by conflicting data. That’s probably because prior studies haven’t taken into account walking intensity, Hiral Master said at the annual meeting of the American College of Rheumatology.
Ms. Master, a PhD candidate in physical therapy at the University of Delaware, Newark, presented a study of 1,854 patients with knee osteoarthritis who participated in the Osteoarthritis Initiative, all of whom had worn an accelerometer. This permitted calculation of time spent walking at various intensities. Subjects spent an average of 459 minutes per day not walking and 8 minutes walking at moderate to vigorous intensity, defined as a cadence of more than 100 steps per minute.
During 5 years of follow-up, the incidence of TKR was 6%. In this video interview, Ms. Master explains that patients who replaced 5 minutes of not walking with 5 minutes of brisk walking daily had an adjusted 14% reduction in the risk of TKR. A dose-response was evident, with more minutes of moderate to vigorous walking being associated with progressively larger reductions in the risk of this major surgery. Walking at a cadence of less than 100 steps per minute, regardless of duration, was nonprotective.
SOURCE: Master H et al. Arthritis Rheumatol. 2018;70(Suppl 10), Abstract 1166.
REPORTING FROM THE ACR ANNUAL MEETING
Geniculate Artery Injury During Primary Total Knee Arthroplasty
ABSTRACT
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. However, the rate of injury to smaller periarticular vessels and the clinical significance of such an injury have not been well investigated. The purpose of this study is to describe the rate and outcomes of geniculate artery (GA) injury, the time at which injury occurs, and any associations with tourniquet use.
From November 2015 to February 2016, 3 surgeons at a single institution performed 100 consecutive primary TKAs and documented the presence or absence and the timing of GA injury. The data were then retrospectively reviewed. All TKAs had no prior surgery on the operative extremity. Other variables collected included tourniquet use, tranexamic acid (TXA) administration, intraoperative blood loss, postoperative drain output, and blood transfusion.
The overall rate of GA injury was 38%, with lateral inferior and middle GA injury in 31% and 15% of TKAs, respectively. Most of the injuries were visualized during bone cuts or meniscectomy. The rate of overall or isolated GA injury was not significantly different (P > .05) with either use of intravenous (84 patients) or topical (14 patients) TXA administration. Comparing selective tourniquet use (only during cementation) vs routine use showed no differences in GA injury rate (P = .37), blood loss (P = .07), or drain output (P = .46).
There is a relatively high rate of GA injury, with injury to the lateral GA occurring more often than the middle GA. Routine or selective tourniquet use does not affect the rate of injury.
Continue to: Major arterial injury...
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. The majority of literature in this context consists of case reports, small case series, and large retrospective studies that have examined the type, location, and mechanism of injury present in these cases.1-13 Reported arterial injuries include occlusion, laceration, aneurysm, pseudoaneurysm, and arteriovenous fistula formation in the femoral (believed to be due to the tourniquet around the proximal thigh) and popliteal arteries causing combinations of ischemia and hemorrhage necessitating treatment ranging from endovascular arterial intervention to amputation.4,5,9-11,13-17 In addition, several studies have asserted that the risk of major arterial injury may be increased with tourniquet use, suggesting that tourniquet use should be minimized for routine primary TKAs.3,6
There are very few cases in the literature specifically addressing injury to the more commonly encountered geniculate arteries (GAs). The medial GAs are typically visualized and coagulated during the standard medial parapatellar approach. In addition, if performed, a lateral release can damage the lateral superior and inferior GAs and the middle GA can be cut with posterior cruciate ligament resection. However, the middle and lateral inferior GAs are anecdotally the most difficult to detect and treat intraoperatively, especially after implantation of TKA and deflation of the tourniquet. The potential lack of recognition of such GA injury can result in harmful sequelae, including ischemia of the patella, hemorrhage, and painful pseudoaneurysms.2,18-29 Currently, there are only 2 case reports of lateral inferior GA injury, 2 cases of medial inferior GA injury, and no reports of middle GA injury.2,23,24,29
The rate, the timing within surgery, the risk factors, including tourniquet use, and the clinical effects of GA injury are largely unknown. If these factors were better understood, prophylactic measures and/or awareness could be better applied to prevent adverse outcomes, especially in cases of the middle and lateral inferior GAs. The aims of this study are to elucidate the rate and timing of middle and lateral inferior GA injury during primary TKA; determine the factors related to injury, including intraoperative blood loss, postoperative drain output, and tranexamic (TXA) acid use; and investigate any differences in the rate of injury with and without the use of a tourniquet.
MATERIALS AND METHODS
PATIENT DEMOGRAPHICS AND SURGICAL TECHNIQUE
From November 2015 to February 2016, 3 surgeons (MJT, TMM, and RTT) at a single institution performed 100 consecutive unilateral primary TKAs and documented the presence or absence and the timing of GA injury. After obtaining approval from our Institutional Review Board, a retrospective study was performed to investigate the prospectively recorded rate of middle and lateral inferior GA injuries occurring during primary TKAs. Patients with a diagnosis of isolated osteoarthritis were included, and those with any previous surgery on the operative knee were excluded. The average age of patients at the time of surgery was 67 years (range, 25-91 years), the average body mass index was 33 kg/m2 (range, 18-54 kg/m2), and there were 63 (63%) female patients.
All TKAs were performed through a medial parapatellar approach with a posterior-stabilized, cemented design, and each patient received a postoperative surgical drain. One of the 3 lead surgeons (TMM) in this study used a tourniquet from the time of incision until the completion of cementation, and the other 2 (MJT and RTT) predominantly used the tourniquet only during cementation. To elucidate any differences in GA injury between these 2 methods of tourniquet use, the patients were categorized into 2 groups base d on tourniquet use. Group 1 included patients in whom a tourniquet was used to maintain a bloodless surgical field from the time of incision until the completion of cementation, and Group 2 included patients in whom tourniquet use was more selective (ie, applied only during cementation). Group 1 comprised 31% (31/100) of patients, while Group 2 comprised 67% (67/100) of patients; no tourniquet was used in 2% (2/100) of cases. In addition, TXA was used in 98% (98/100) of patients: 84 patients received intravenous (IV) and 14 received topical TXA administration.
Continue to: ANALYSIS OF GENICULATE ARTERY INJURY
ANALYSIS OF GENICULATE ARTERY INJURY
The senior authors critically evaluated the GA during the primary TKAs and documented the presence or absence of injury in the operative reports. GA injury was reported if there was intraoperative visualization of pulsatile bleeding or visualization of arterial lumen in the anatomic areas of the middle and lateral inferior GAs. At 3 separate occasions during the operation, the surgeon looked specifically for pulsatile bleeding or arterial lumen in the areas of the middle and lateral inferior GAs, including after all the femoral and tibial bone cuts were completed, immediately before preparing to cement (before the tourniquet was inflated if there was not one inflated from the start of the procedure), and immediately after the tourniquet was deflated (Figure 1). All bleeding GAs that were visualized were effectively coagulated by cautery. Details regarding the use of TXA (topical or IV), intraoperative blood loss, postsurgical drain output for 24 hours after surgery, and blood transfusion were collected from the patients’ medical records (Table 1).
| Table 1. Operative Variables | |
Variable | Value |
Total number | 100 (100%) |
Intraoperative blood loss (mL) | 160 (25-500) |
Drain output 1st 24 hours (mL) | 488 (75-1980) |
Total output (mL) | 618 (75-2130) |
Use of TXA | 98 (98%) |
Topical TXA | 84 (84%) |
IV TXA | 14 (14%) |
Tourniquet entire procedure | 31 (31%) |
Operative variables other than geniculate artery injury. Data presented as mean (range) or n (%). TXA = tranexamic acid.
STATISTICAL METHODS
Statistical analysis was performed using the JMP software version 10.0.0 (SAS Institute, Inc). The overall rate of GA injury was determined, including the rates of GA injury based on location, time point, and method of diagnosis (pulsatile bleeding or arterial lumen visualization). If >1 GA injury occurred in the same knee, only 1 GA injury was calculated for the overall rate; however, each injury was specified separately when calculating the injury rate for the specific GA. Intraoperative blood loss, postoperative drain output, and the use of TXA were compared between cases in which a GA injury was detected and those in which it was not detected. Before conducting the retrospective review, a power analysis determined that we would require 100 patients to detect a difference in GA injury between Groups 1 and 2 (33 in Group 1 and 67 in Group 2), assuming a 30% rate in Group 1 and a 5% rate of GA injury in Group 2 using Fisher’s exact test. The Fisher’s exact test was used to compare categorical variables, and the Wilcoxon rank sum test was used to compare continuous variables. An alpha value of .05 was considered as statistically significant.
RESULTS
RATE OF GENICULATE ARTERY INJURY
The overall rate of any GA injury was 38% (38/100). Lateral inferior GA injury was more frequently detected than middle GA injury (31% vs 15% of TKAs, respectively; Table 2). Among the 31 lateral inferior GA injuries, 14 were identified as pulsatile bleeding, 7 as lumen visualizations, and 6 as both pulsatile bleeding and lumen visualization; 4 were detected by methods not recorded in the operative report. Of the lateral inferior GA injuries, 11 were identified after the bone cuts, 7 during meniscus removal, 3 during exposure, 1 after tourniquet deflation, and 9 at a time not recorded in the operative report. Of the 15 middle GA injuries, 9 were identified as pulsatile bleeding, 2 as lumen visualizations, and 4 as both pulsatile bleeding and lumen visualization. In addition, 7 of these GA injuries were identified after the bone cuts, 3 during cruciate removal, 1 after meniscus removal, 1 during exposure, and 3 at a time not recorded in the operative report (Table 3).
| Table 2. Rates of Geniculate Artery Injury Based on Location and Method | ||||
Location | Pulsatile Bleeding | Arterial Lumen | Both | Overall Rate |
Lateral inferior GA | 14 (14%) | 7 (7%) | 6 (6%) | 31 (31%) |
Middle GA | 9 (9%) | 2 (2%) | 4 (4%) | 15 (15%) |
Rates of geniculate artery injury based on location and method of diagnosis. Data presented as n (%). There were 4 additional lateral inferior and 9 middle GA injuries identified by a method not specified in the operative report. GA = geniculate artery.
Table 3. Rates of Geniculate Artery Injury Based on Time Point | ||
Time | Lateral Inferior GA | Middle GA |
After bone cuts | 11 (11%) | 7 (7%) |
During meniscus removal | 7 (7%) | 1 (1%) |
During exposure | 3 (3%) | 1 (1%) |
After tourniquet deflation | 1 (1%) | 0 (0%) |
During cruciate removal | 0 (0%) | 3 (3%) |
Not reported | 9 (9%) | 3 (3%) |
Rates of geniculate artery injury based on time point and method of diagnosis. GA = geniculate artery. Data presented as n (%).
FACTORS ASSOCIATED WITH GENICULATE ARTERY INJURY
Mean intraoperative estimated blood loss was 186 mL (standard deviation [SD], 111; range 50–500 mL) in those with a GA injury versus 147 mL (range, 82.25–400 mL) in those without injury (P = .14). Postoperative drain output in the 24 hours after surgery was 467 mL (SD 253, range 100–1105 mL) versus 502 mL (SD 378, range 75–1980 mL) in TKAs with and without GA injury, respectively (P = .82). Total estimated blood loss (combined intraoperative blood loss and 24-hour postoperative drain output) was 613 mL (SD 252, range 150–1105 mL) in TKAs with GA injury versus 620 mL (SD 393, range 75–2130 mL) without injury (P = .44) (Table 4). Overall, there was no statistical difference in blood loss, drain output, or combined output when analyzed according to lateral inferior or middle GA injury (P = .24–.82) (Table 5 and Table 6). No patients required blood transfusion postoperatively after TKA.
| Table 4. Factors Associated with GA Injury | |||
Outcome | GA Injury | No GA Injury | P Value |
Blood loss (mL) | 186 (50-500) | 147 (25-400) | .1366 |
24-Hour drain output (mL) | 467 (100-1105) | 502 (75-1980) | .8240 |
Total output (mL) | 613 (150-1105) | 620 (75-2130) | .4368 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
| Table 5. Factors Associated with LIGA Injury | |||
Outcome | LIGA Injury | No LIGA Injury | P Value |
Blood loss (mL) | 178 (50-400) | 153 (25-500) | .2401 |
24-Hour drain output (mL) | 461 (100-890) | 501 (75-1980) | .8187 |
Total output (mL) | 610 (150-1080) | 621 (75-2130) | .4165 |
Differences in outcomes based on presence or absence of LIGA injury. Note that there were no significant differences. Values are reported as average (range). LIGA = lateral inferior geniculate artery.
| Table 6. Factors Associated with MGA Injury | |||
Outcome | MGA Injury | No MGA Injury | P Value |
Blood loss (mL) | 190 (75-500) | 156 (25-400) | .6225 |
24-Hour drain output (mL) | 455 (125-1105) | 494 (75-1980) | .6428 |
Total output (mL) | 582 (200-1105) | 624 (75-2130) | .6535 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as average (range). MGA = middle geniculate artery.
IV administration of TXA was associated with a 37% (31/84) rate of GA injury, whereas topical TXA administration was associated with a 43% (6/14) rate of GA injury (P = .77). The rate of overall or isolated GA injury was not significantly different (P = .35–1.0) between IV and topical TXA administration (Table 7). In addition, total combined output was not significantly different (P = .1032) when comparing GA injury and noninjury in the subgroup analysis based on TXA use (IV or topical); however, topical administration was associated with lower intraoperative blood loss than IV administration (P = .0489), whereas IV administration was associated with lower 24-hour postoperative drain output than topical administration (P = .0169). There was no difference in blood loss, 24-hour drain output, or total output between those who did and did not sustain a GA injury in the group of patients who received IV TXA administration (Table 8, P = .2118–.7091). The same was true for those receiving topical TXA administration (Table 9, P = .0912–.9485).
Table 7. Factors Associated with TXA Injury | |||
Outcome | IV TXA (n = 84) | Topical TXA (n = 14) | P Value |
Any GA injury | 31 (37%) | 6 (43%) | .7683 |
LIGA injury | 24 (29%) | 6 (43%) | .3498 |
MGA injury | 13 (15%) | 2 (14%) | 1.0 |
Blood loss (mL) | 170 (25-500) | 113 (40-240) | .0489* |
24-Hour drain output (mL) | 454 (75-1980) | 662 (75-1800) | .0169* |
Total output (mL) | 592 (75-2130) | 751 (75-2130) | .1032 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as n (%) or average (range). TXA = tranexamic acid, GA = geniculate artery, LIGA = lateral inferior geniculate artery, MGA = middle geniculate artery. *denotes statistical significance (P < .05).
| Table 8. Factors Associated with GA Injury Given IV TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 195 (50-500) | 157 (25-400) | 38 | .2118 |
24-Hour drain output (mL) | 436 (100-1105) | 464 (75-1980) | 28 | .7091 |
Total output (mL) | 594 (150-1105) | 592 (75-2130) | 2 | .6982 |
Differences in outcomes of those patients who received IV TXA based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery, TXA = tranexamic acid.
| Table 9. Factors Associated with GA Injury Given Topical TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 163 (100-250) | 84 (40-150) | 79 | .0912 |
24-Hour drain output (mL) | 610 (205-890) | 701 (415-1800) | 91 | .9485 |
Total output (mL) | 719 (405-960) | 775 (455-1900) | 56 | .6982 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
Continue to: TOURNIQUET USE
TOURNIQUET USE
Comparison between Groups 1 (tourniquet use) and 2 (selective tourniquet use) revealed similar rates of overall and specific GA injury, intraoperative blood loss, and 24-hour postoperative drain output (Table 10). Group 1 demonstrated a 29% (9/31) rate of any GA injury versus 40% (27/67) in Group 2 (P = .37). For the specific lateral inferior GA injury, there was an equivalent rate of injury at 29% (9/31 in Group 1, 20/67 in Group 2; P = 1.0). Similarly, Group 1 patients had a 10% (3/31) rate of middle GA injury compared to 16% (11/67) in Group 2 patients (P = .53). Intraoperative estimated blood loss was lower in Group 1 (140 mL; range 25–400 mL) than in Group 2 (171 mL; range 40–500 mL) (P = .07), whereas the average 24-hour postoperative drain output was similar for Groups 1 (484 mL; range 75–1800 mL) and 2 (488 mL; range 100–1980 mL) (P = .46). Total estimated output was slightly less for Group 1 (593 mL; range 75–1900 mL) than for Group 2 (626 mL; range 125–2130 mL) (P = .38). A post hoc power analysis showed that with these rates of GA injury in Groups 1 and 2 and given a 2:1 ratio of the number of patients in Group 2 versus Group 1, a total of 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistically significant difference (P < .05) with a power of 80%.
| Table 10. Factors Associated with Tourniquet Use | ||||
Injury | Group 1 (n = 31) | Group 2 (n = 67) | Difference | P Value |
Overall GA injury | 9 (29%) | 27 (40%) | 11% | .3687 |
Lateral inferior GA | 9 (29%) | 20 (29%) | 0% | 1.0 |
Middle GA | 3 (10%) | 11 (16%) | 6% | .5382 |
Blood loss (mL) | 140 (25-400) | 171 (40-500) | 31 | .0661 |
24-Hour drain output (mL) | 484 (75-1800) | 488 (100-1980) | 4 | .4580 |
Total output (mL) | 593 (75-1900) | 626 (125-2130) | 33 | .3776 |
Differences in outcomes separated based on use of a tourniquet for the entire case (Group 1) vs use of a tourniquet only during cementation (Group 2). Note that there were no significant differences. Values are reported as n (%) or average (range). GA = geniculate artery.
DISCUSSION
Major arterial injury associated with TKA is a well-known, rare, and potentially devastating complication.1-13 However, the rate of injury to smaller periarticular vessels and the clinical significance of such injury have not been studied. The present study found a high rate of GA injury but no clinically significant difference in intraoperative blood loss or postoperative drain output between patients with GA injury (which was identified and managed with cautery) and those without GA injury. In addition, tourniquet use did not affect the rate of injury or the associated blood loss. To our knowledge, this is the first study that has critically evaluated the rate of GA injury occurring during TKA.
The overall rate of GA injury occurring during primary TKA was 38% with a higher predominance of lateral inferior than middle GA injury (31% vs 15%). Anatomically, it would follow that the lateral GA could be injured at a higher rate as it courses on top of the lateral meniscus, thus being susceptible to injury during cutting of the tibial plateau and meniscectomy. In addition, because the meniscectomy is performed longitudinally along the course of the artery, it may also be potentially lacerated in multiple locations and lengthwise. In theory, there should be a 100% rate of middle GA injury during posterior-stabilized TKA as this artery runs through the cruciate ligaments, which are resected during these cases. However, vessel injury was defined in this study as the visualization of pulsatile bleeding or vessel lumen. It is probable that in the cases in which injury to the middle GA was not visualized, it was cut but simultaneously cauterized. Thus, a lower rate (15%) of injury was detected. Nonetheless, these results still suggest that these periarticular arteries are injured at a higher rate; therefore, it is important for surgeons to specifically identify these injuries intraoperatively and adequately cauterize these vessels. As long as these arteries are cauterized, additional blood loss and potential vascular pseudoaneurysms should be prevented.
The effect of GA injury on intraoperative blood loss, 24-hour postoperative drain output, and total estimated blood loss showed no significant clinical findings in the present study cohort. In addition, examining the injury rate and blood loss based on TXA use also revealed no detrimental clinical associations. Although GA injury could inherently be associated with higher levels of blood loss and drain output, it is important to note that all GA injuries were also effectively coagulated, thus explaining the indifferent results. Accordingly, it should be recommended to surgeons performing primary TKAs to carefully evaluate for GA injury to prevent excessive blood loss or painful pseudoaneurysms. However, there is also a potential for beta error in this study in which a true difference did exist but no statistical difference was found due to the study being underpowered.
Full or selective tourniquet use during TKA did not appear to have any effect on the rate of GA injury, intraoperative blood loss, or 24-hour postoperative drain output. The similarity between GA injury rates perhaps further indicates an equivalent ability to detect these injuries between these two methods because of operative inspection for such injuries. With regard to intraoperative blood loss and drain output, the present findings are similar to previous studies demonstrating equivocal results despite variable tourniquet utilization in TKA.15,30 However, these results differ from those of Harvey and colleagues31, who demonstrated that blood loss inversely correlated with intraoperative tourniquet time. There are risks and benefits related to the use of both full and selective tourniquet methods, but either method does not appear to be advantageous in decreasing the rate of GA injury.
Continue to: Although this is the first study...
Although this is the first study to investigate the rates of GA injury and the potential clinical effects, there are limitations to this research. First, the study was retrospective in nature despite the fact that the data were collected prospectively. Only acute perioperative follow-up was performed, and thus, we were unable to evaluate longer term effects of GA injury on TKA outcomes. Furthermore, this study is potentially prone to beta error. As discussed above, 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistical difference in the rate of GA injury based on the rates found in this study. This study could also have been underpowered to identify differences in other aspects, such as differences in blood loss and drain. Furthermore, the data collected regarding intraoperative blood loss are estimated data and can be variable. Finally, visualization of vessel lumen and pulsatile bleeding is not a validated method to diagnose GA injuries, and potential injuries may have been missed. Despite such disadvantages, the strengths of this study include the concise results in consecutive patients, the generalizability of the data as multiple surgeons participated, and its first report of nonmajor periarticular artery injury.
CONCLUSIONS
There is a relatively high rate of GA injury, with injury to the lateral GA being visualized more often than injury to the middle GA. The majority of GA injuries occur around the time of bone cuts and meniscectomy, and tourniquet use does not affect the rate of injury. To reduce intraoperative blood loss and postoperative drain output, surgeons should identify and coagulate GA injuries routinely during primary TKA.
1. Calligaro KD, Dougherty MJ, Ryan S, Booth RE. Acute arterial complications associated with total hip and knee arthroplasty. J Vasc Surg. 2003;38(6):1170-1177. doi: 10.1016/S0741-5214(03)00918-2.
2. Dennis DA, Neumann RD, Toma P, Rosenberg G, Mallory TH. Arteriovenous fistula with false aneurysm of the inferior medial geniculate artery. A complication of total knee arthroplasty. Clin Orthop Relat Res. 1987(222):255-260.
3. Hagan PF, Kaufman EE. Vascular complication of knee arthroplasty under tourniquet. A case report. Clin Orthop Relat Res. 1990(257):159-161.
4. Holmberg A, Milbrink J, Bergqvist D. Arterial complications after knee arthroplasty: 4 cases and a review of the literature. Acta Orthop Scand. 1996;67(1):75-78. doi: 10.3109/17453679608995616.
5. Hozack WJ, Cole PA, Gardner R, Corces A. Popliteal aneurysm after total knee arthroplasty. Case reports and review of the literature. J Arthroplasty. 1990;5(4):301-305. doi: 10.1016/S0883-5403(08)80087-3.
6. Jeyaseelan S, Stevenson TM, Pfitzner J. Tourniquet failure and arterial calcification. Case report and theoretical dangers. Anaesthesia. 1981;36(1):48-50. doi: 10.1111/j.1365-2044.1981.tb08599.x
7. Mureebe L, Gahtan V, Kahn MB, Kerstein MD, Roberts AB. Popliteal artery injury after total knee arthroplasty. Am Surg. 1996;62(5):366-368.
8. O'Connor JV, Stocks G, Crabtree JD, Jr., Galasso P, Wallsh E. Popliteal pseudoaneurysm following total knee arthroplasty. J Arthroplasty. 1998;13(7):830-832. doi: 10.1016/S0883-5403(98)90039-0.
9. Ohira T, Fujimoto T, Taniwaki K. Acute popliteal artery occlusion after total knee arthroplasty. Arch Orthop Trauma Surg. 1997;116(6-7):429-430. doi: 10.1007/BF00434007.
10. Parfenchuck TA, Young TR. Intraoperative arterial occlusion in total joint arthroplasty. J Arthroplasty. 1994;9(2):217-220. doi: 10.1016/0883-5403(94)90071-X.
11. Rush JH, Vidovich JD, Johnson MA. Arterial complications of total knee replacement. The Australian experience. J Bone Joint Surg Br. 1987;69(3):400-402. doi: 10.1302/0301-620X.69B3.3584193.
12. Smith DE, McGraw RW, Taylor DC, Masri BA. Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg. 2001;9(4):253-257.
13. Zahrani HA, Cuschieri RJ. Vascular complications after total knee replacement. J Cardiovasc Surg (Torino). 1989;30(6):951-952.
14. Isiklar ZU, Landon GC, Tullos HS. Amputation after failed total knee arthroplasty. Clin Orthop Relat Res. 1994(299):173-178.
15. Wakankar HM, Nicholl JE, Koka R, D'Arcy JC. The tourniquet in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 1999;81(1):30-33. doi: 10.1302/0301-620X.81B1.0810030.
16. Kumar SN, Chapman JA, Rawlins I. Vascular injuries in total knee arthroplasty. A review of the problem with special reference to the possible effects of the tourniquet. J Arthroplasty. 1998;13(2):211-216. doi: 10.1016/S0883-5403(98)90102-4.
17. DeLaurentis DA, Levitsky KA, Booth RE, et al. Arterial and ischemic aspects of total knee arthroplasty. Am J Surg. 1992;164(3):237-240. doi: 10.1016/S0002-9610(05)81078-5.
18. Langkamer VG. Local vascular complications after knee replacement: a review with illustrative case reports. Knee. 2001;8(4):259-264. doi: 10.1016/S0968-0160(01)00103-X.
19. Moran M, Hodgkinson J, Tait W. False aneurysm of the superior lateral geniculate artery following Total Knee Replacement. Knee. 2002;9(4):349-351. doi: 10.1016/S0968-0160(02)00061-3.
20. Pritsch T, Parnes N, Menachem A. A bleeding pseudoaneurysm of the lateral genicular artery after total knee arthroplasty--a case report. Acta Orthop. 2005;76(1):138-140. doi: 10.1080/00016470510030463.
21. Gaheer RS, Chirputkar K, Sarungi M. Spontaneous resolution of superior medial geniculate artery pseudoaneurysm following total knee arthroplasty. Knee. 2014;21(2):586-588. doi: 10.1016/j.knee.2012.10.021.
22. Law KY, Cheung KW, Chiu KH, Antonio GE. Pseudoaneurysm of the geniculate artery following total knee arthroplasty: a report of two cases. J Orthop Surg (Hong Kong). 2007;15(3):386-389. /doi: 10.1177/230949900701500331.
23. Noorpuri BS, Maxwell-Armstrong CA, Lamerton AJ. Pseudo-aneurysm of a geniculate collateral artery complicating total knee replacement. Eur J Vasc Endovasc Surg. 1999;18(6):534-535.
24. Pai VS. Traumatic aneurysm of the inferior lateral geniculate artery after total knee replacement. J Arthroplasty. 1999;14(5):633-634. doi: 10.1016/S0883-5403(99)90089-X.
25. Julien TP, Gravereaux E, Martin S. Superior medial geniculate artery pseudoaneurysm after primary total knee arthroplasty. J Arthroplasty. 2012;27(2):323 e313-326. doi: 10.1016/j.arth.2011.02.009.
26. Kalsi PS, Carrington RJ, Skinner JS. Therapeutic embolization for the treatment of recurrent hemarthrosis after total knee arthroplasty due to an arteriovenous fistula. J Arthroplasty. 2007;22(8):1223-1225. /doi: 10.1016/j.arth.2006.11.012.
27. Ritter MA, Herbst SA, Keating EM, Faris PM, Meding JB. Patellofemoral complications following total knee arthroplasty. Effect of a lateral release and sacrifice of the superior lateral geniculate artery. J Arthroplasty. 1996;11(4):368-372. doi: 10.1016/S0883-5403(96)80024-6.
28. Aldrich D, Anschuetz R, LoPresti C, Fumich M, Pitluk H, O'Brien W. Pseudoaneurysm complicating knee arthroscopy. Arthroscopy. 1995;11(2):229-230. doi: 10.1016/0749-8063(95)90073-X.
29. Sharma H, Singh GK, Cavanagh SP, Kay D. Pseudoaneurysm of the inferior medial geniculate artery following primary total knee arthroplasty: delayed presentation with recurrent haemorrhagic episodes. Knee Surg Sports Traumatol Arthrosc. 2006;14(2):153-155. doi: 10.1007/s00167-005-0639-4.
30. Abdel-Salam A, Eyres KS. Effects of tourniquet during total knee arthroplasty. A prospective randomised study. J Bone Joint Surg Br. 1995;77(2):250-253. doi: 10.1302/0301-620X.77B2.7706340.
31. Harvey EJ, Leclerc J, Brooks CE, Burke DL. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. J Arthroplasty. 1997;12(3):291-296. doi: 10.1016/S0883-5403(97)90025-5.
ABSTRACT
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. However, the rate of injury to smaller periarticular vessels and the clinical significance of such an injury have not been well investigated. The purpose of this study is to describe the rate and outcomes of geniculate artery (GA) injury, the time at which injury occurs, and any associations with tourniquet use.
From November 2015 to February 2016, 3 surgeons at a single institution performed 100 consecutive primary TKAs and documented the presence or absence and the timing of GA injury. The data were then retrospectively reviewed. All TKAs had no prior surgery on the operative extremity. Other variables collected included tourniquet use, tranexamic acid (TXA) administration, intraoperative blood loss, postoperative drain output, and blood transfusion.
The overall rate of GA injury was 38%, with lateral inferior and middle GA injury in 31% and 15% of TKAs, respectively. Most of the injuries were visualized during bone cuts or meniscectomy. The rate of overall or isolated GA injury was not significantly different (P > .05) with either use of intravenous (84 patients) or topical (14 patients) TXA administration. Comparing selective tourniquet use (only during cementation) vs routine use showed no differences in GA injury rate (P = .37), blood loss (P = .07), or drain output (P = .46).
There is a relatively high rate of GA injury, with injury to the lateral GA occurring more often than the middle GA. Routine or selective tourniquet use does not affect the rate of injury.
Continue to: Major arterial injury...
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. The majority of literature in this context consists of case reports, small case series, and large retrospective studies that have examined the type, location, and mechanism of injury present in these cases.1-13 Reported arterial injuries include occlusion, laceration, aneurysm, pseudoaneurysm, and arteriovenous fistula formation in the femoral (believed to be due to the tourniquet around the proximal thigh) and popliteal arteries causing combinations of ischemia and hemorrhage necessitating treatment ranging from endovascular arterial intervention to amputation.4,5,9-11,13-17 In addition, several studies have asserted that the risk of major arterial injury may be increased with tourniquet use, suggesting that tourniquet use should be minimized for routine primary TKAs.3,6
There are very few cases in the literature specifically addressing injury to the more commonly encountered geniculate arteries (GAs). The medial GAs are typically visualized and coagulated during the standard medial parapatellar approach. In addition, if performed, a lateral release can damage the lateral superior and inferior GAs and the middle GA can be cut with posterior cruciate ligament resection. However, the middle and lateral inferior GAs are anecdotally the most difficult to detect and treat intraoperatively, especially after implantation of TKA and deflation of the tourniquet. The potential lack of recognition of such GA injury can result in harmful sequelae, including ischemia of the patella, hemorrhage, and painful pseudoaneurysms.2,18-29 Currently, there are only 2 case reports of lateral inferior GA injury, 2 cases of medial inferior GA injury, and no reports of middle GA injury.2,23,24,29
The rate, the timing within surgery, the risk factors, including tourniquet use, and the clinical effects of GA injury are largely unknown. If these factors were better understood, prophylactic measures and/or awareness could be better applied to prevent adverse outcomes, especially in cases of the middle and lateral inferior GAs. The aims of this study are to elucidate the rate and timing of middle and lateral inferior GA injury during primary TKA; determine the factors related to injury, including intraoperative blood loss, postoperative drain output, and tranexamic (TXA) acid use; and investigate any differences in the rate of injury with and without the use of a tourniquet.
MATERIALS AND METHODS
PATIENT DEMOGRAPHICS AND SURGICAL TECHNIQUE
From November 2015 to February 2016, 3 surgeons (MJT, TMM, and RTT) at a single institution performed 100 consecutive unilateral primary TKAs and documented the presence or absence and the timing of GA injury. After obtaining approval from our Institutional Review Board, a retrospective study was performed to investigate the prospectively recorded rate of middle and lateral inferior GA injuries occurring during primary TKAs. Patients with a diagnosis of isolated osteoarthritis were included, and those with any previous surgery on the operative knee were excluded. The average age of patients at the time of surgery was 67 years (range, 25-91 years), the average body mass index was 33 kg/m2 (range, 18-54 kg/m2), and there were 63 (63%) female patients.
All TKAs were performed through a medial parapatellar approach with a posterior-stabilized, cemented design, and each patient received a postoperative surgical drain. One of the 3 lead surgeons (TMM) in this study used a tourniquet from the time of incision until the completion of cementation, and the other 2 (MJT and RTT) predominantly used the tourniquet only during cementation. To elucidate any differences in GA injury between these 2 methods of tourniquet use, the patients were categorized into 2 groups base d on tourniquet use. Group 1 included patients in whom a tourniquet was used to maintain a bloodless surgical field from the time of incision until the completion of cementation, and Group 2 included patients in whom tourniquet use was more selective (ie, applied only during cementation). Group 1 comprised 31% (31/100) of patients, while Group 2 comprised 67% (67/100) of patients; no tourniquet was used in 2% (2/100) of cases. In addition, TXA was used in 98% (98/100) of patients: 84 patients received intravenous (IV) and 14 received topical TXA administration.
Continue to: ANALYSIS OF GENICULATE ARTERY INJURY
ANALYSIS OF GENICULATE ARTERY INJURY
The senior authors critically evaluated the GA during the primary TKAs and documented the presence or absence of injury in the operative reports. GA injury was reported if there was intraoperative visualization of pulsatile bleeding or visualization of arterial lumen in the anatomic areas of the middle and lateral inferior GAs. At 3 separate occasions during the operation, the surgeon looked specifically for pulsatile bleeding or arterial lumen in the areas of the middle and lateral inferior GAs, including after all the femoral and tibial bone cuts were completed, immediately before preparing to cement (before the tourniquet was inflated if there was not one inflated from the start of the procedure), and immediately after the tourniquet was deflated (Figure 1). All bleeding GAs that were visualized were effectively coagulated by cautery. Details regarding the use of TXA (topical or IV), intraoperative blood loss, postsurgical drain output for 24 hours after surgery, and blood transfusion were collected from the patients’ medical records (Table 1).
| Table 1. Operative Variables | |
Variable | Value |
Total number | 100 (100%) |
Intraoperative blood loss (mL) | 160 (25-500) |
Drain output 1st 24 hours (mL) | 488 (75-1980) |
Total output (mL) | 618 (75-2130) |
Use of TXA | 98 (98%) |
Topical TXA | 84 (84%) |
IV TXA | 14 (14%) |
Tourniquet entire procedure | 31 (31%) |
Operative variables other than geniculate artery injury. Data presented as mean (range) or n (%). TXA = tranexamic acid.
STATISTICAL METHODS
Statistical analysis was performed using the JMP software version 10.0.0 (SAS Institute, Inc). The overall rate of GA injury was determined, including the rates of GA injury based on location, time point, and method of diagnosis (pulsatile bleeding or arterial lumen visualization). If >1 GA injury occurred in the same knee, only 1 GA injury was calculated for the overall rate; however, each injury was specified separately when calculating the injury rate for the specific GA. Intraoperative blood loss, postoperative drain output, and the use of TXA were compared between cases in which a GA injury was detected and those in which it was not detected. Before conducting the retrospective review, a power analysis determined that we would require 100 patients to detect a difference in GA injury between Groups 1 and 2 (33 in Group 1 and 67 in Group 2), assuming a 30% rate in Group 1 and a 5% rate of GA injury in Group 2 using Fisher’s exact test. The Fisher’s exact test was used to compare categorical variables, and the Wilcoxon rank sum test was used to compare continuous variables. An alpha value of .05 was considered as statistically significant.
RESULTS
RATE OF GENICULATE ARTERY INJURY
The overall rate of any GA injury was 38% (38/100). Lateral inferior GA injury was more frequently detected than middle GA injury (31% vs 15% of TKAs, respectively; Table 2). Among the 31 lateral inferior GA injuries, 14 were identified as pulsatile bleeding, 7 as lumen visualizations, and 6 as both pulsatile bleeding and lumen visualization; 4 were detected by methods not recorded in the operative report. Of the lateral inferior GA injuries, 11 were identified after the bone cuts, 7 during meniscus removal, 3 during exposure, 1 after tourniquet deflation, and 9 at a time not recorded in the operative report. Of the 15 middle GA injuries, 9 were identified as pulsatile bleeding, 2 as lumen visualizations, and 4 as both pulsatile bleeding and lumen visualization. In addition, 7 of these GA injuries were identified after the bone cuts, 3 during cruciate removal, 1 after meniscus removal, 1 during exposure, and 3 at a time not recorded in the operative report (Table 3).
| Table 2. Rates of Geniculate Artery Injury Based on Location and Method | ||||
Location | Pulsatile Bleeding | Arterial Lumen | Both | Overall Rate |
Lateral inferior GA | 14 (14%) | 7 (7%) | 6 (6%) | 31 (31%) |
Middle GA | 9 (9%) | 2 (2%) | 4 (4%) | 15 (15%) |
Rates of geniculate artery injury based on location and method of diagnosis. Data presented as n (%). There were 4 additional lateral inferior and 9 middle GA injuries identified by a method not specified in the operative report. GA = geniculate artery.
Table 3. Rates of Geniculate Artery Injury Based on Time Point | ||
Time | Lateral Inferior GA | Middle GA |
After bone cuts | 11 (11%) | 7 (7%) |
During meniscus removal | 7 (7%) | 1 (1%) |
During exposure | 3 (3%) | 1 (1%) |
After tourniquet deflation | 1 (1%) | 0 (0%) |
During cruciate removal | 0 (0%) | 3 (3%) |
Not reported | 9 (9%) | 3 (3%) |
Rates of geniculate artery injury based on time point and method of diagnosis. GA = geniculate artery. Data presented as n (%).
FACTORS ASSOCIATED WITH GENICULATE ARTERY INJURY
Mean intraoperative estimated blood loss was 186 mL (standard deviation [SD], 111; range 50–500 mL) in those with a GA injury versus 147 mL (range, 82.25–400 mL) in those without injury (P = .14). Postoperative drain output in the 24 hours after surgery was 467 mL (SD 253, range 100–1105 mL) versus 502 mL (SD 378, range 75–1980 mL) in TKAs with and without GA injury, respectively (P = .82). Total estimated blood loss (combined intraoperative blood loss and 24-hour postoperative drain output) was 613 mL (SD 252, range 150–1105 mL) in TKAs with GA injury versus 620 mL (SD 393, range 75–2130 mL) without injury (P = .44) (Table 4). Overall, there was no statistical difference in blood loss, drain output, or combined output when analyzed according to lateral inferior or middle GA injury (P = .24–.82) (Table 5 and Table 6). No patients required blood transfusion postoperatively after TKA.
| Table 4. Factors Associated with GA Injury | |||
Outcome | GA Injury | No GA Injury | P Value |
Blood loss (mL) | 186 (50-500) | 147 (25-400) | .1366 |
24-Hour drain output (mL) | 467 (100-1105) | 502 (75-1980) | .8240 |
Total output (mL) | 613 (150-1105) | 620 (75-2130) | .4368 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
| Table 5. Factors Associated with LIGA Injury | |||
Outcome | LIGA Injury | No LIGA Injury | P Value |
Blood loss (mL) | 178 (50-400) | 153 (25-500) | .2401 |
24-Hour drain output (mL) | 461 (100-890) | 501 (75-1980) | .8187 |
Total output (mL) | 610 (150-1080) | 621 (75-2130) | .4165 |
Differences in outcomes based on presence or absence of LIGA injury. Note that there were no significant differences. Values are reported as average (range). LIGA = lateral inferior geniculate artery.
| Table 6. Factors Associated with MGA Injury | |||
Outcome | MGA Injury | No MGA Injury | P Value |
Blood loss (mL) | 190 (75-500) | 156 (25-400) | .6225 |
24-Hour drain output (mL) | 455 (125-1105) | 494 (75-1980) | .6428 |
Total output (mL) | 582 (200-1105) | 624 (75-2130) | .6535 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as average (range). MGA = middle geniculate artery.
IV administration of TXA was associated with a 37% (31/84) rate of GA injury, whereas topical TXA administration was associated with a 43% (6/14) rate of GA injury (P = .77). The rate of overall or isolated GA injury was not significantly different (P = .35–1.0) between IV and topical TXA administration (Table 7). In addition, total combined output was not significantly different (P = .1032) when comparing GA injury and noninjury in the subgroup analysis based on TXA use (IV or topical); however, topical administration was associated with lower intraoperative blood loss than IV administration (P = .0489), whereas IV administration was associated with lower 24-hour postoperative drain output than topical administration (P = .0169). There was no difference in blood loss, 24-hour drain output, or total output between those who did and did not sustain a GA injury in the group of patients who received IV TXA administration (Table 8, P = .2118–.7091). The same was true for those receiving topical TXA administration (Table 9, P = .0912–.9485).
Table 7. Factors Associated with TXA Injury | |||
Outcome | IV TXA (n = 84) | Topical TXA (n = 14) | P Value |
Any GA injury | 31 (37%) | 6 (43%) | .7683 |
LIGA injury | 24 (29%) | 6 (43%) | .3498 |
MGA injury | 13 (15%) | 2 (14%) | 1.0 |
Blood loss (mL) | 170 (25-500) | 113 (40-240) | .0489* |
24-Hour drain output (mL) | 454 (75-1980) | 662 (75-1800) | .0169* |
Total output (mL) | 592 (75-2130) | 751 (75-2130) | .1032 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as n (%) or average (range). TXA = tranexamic acid, GA = geniculate artery, LIGA = lateral inferior geniculate artery, MGA = middle geniculate artery. *denotes statistical significance (P < .05).
| Table 8. Factors Associated with GA Injury Given IV TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 195 (50-500) | 157 (25-400) | 38 | .2118 |
24-Hour drain output (mL) | 436 (100-1105) | 464 (75-1980) | 28 | .7091 |
Total output (mL) | 594 (150-1105) | 592 (75-2130) | 2 | .6982 |
Differences in outcomes of those patients who received IV TXA based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery, TXA = tranexamic acid.
| Table 9. Factors Associated with GA Injury Given Topical TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 163 (100-250) | 84 (40-150) | 79 | .0912 |
24-Hour drain output (mL) | 610 (205-890) | 701 (415-1800) | 91 | .9485 |
Total output (mL) | 719 (405-960) | 775 (455-1900) | 56 | .6982 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
Continue to: TOURNIQUET USE
TOURNIQUET USE
Comparison between Groups 1 (tourniquet use) and 2 (selective tourniquet use) revealed similar rates of overall and specific GA injury, intraoperative blood loss, and 24-hour postoperative drain output (Table 10). Group 1 demonstrated a 29% (9/31) rate of any GA injury versus 40% (27/67) in Group 2 (P = .37). For the specific lateral inferior GA injury, there was an equivalent rate of injury at 29% (9/31 in Group 1, 20/67 in Group 2; P = 1.0). Similarly, Group 1 patients had a 10% (3/31) rate of middle GA injury compared to 16% (11/67) in Group 2 patients (P = .53). Intraoperative estimated blood loss was lower in Group 1 (140 mL; range 25–400 mL) than in Group 2 (171 mL; range 40–500 mL) (P = .07), whereas the average 24-hour postoperative drain output was similar for Groups 1 (484 mL; range 75–1800 mL) and 2 (488 mL; range 100–1980 mL) (P = .46). Total estimated output was slightly less for Group 1 (593 mL; range 75–1900 mL) than for Group 2 (626 mL; range 125–2130 mL) (P = .38). A post hoc power analysis showed that with these rates of GA injury in Groups 1 and 2 and given a 2:1 ratio of the number of patients in Group 2 versus Group 1, a total of 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistically significant difference (P < .05) with a power of 80%.
| Table 10. Factors Associated with Tourniquet Use | ||||
Injury | Group 1 (n = 31) | Group 2 (n = 67) | Difference | P Value |
Overall GA injury | 9 (29%) | 27 (40%) | 11% | .3687 |
Lateral inferior GA | 9 (29%) | 20 (29%) | 0% | 1.0 |
Middle GA | 3 (10%) | 11 (16%) | 6% | .5382 |
Blood loss (mL) | 140 (25-400) | 171 (40-500) | 31 | .0661 |
24-Hour drain output (mL) | 484 (75-1800) | 488 (100-1980) | 4 | .4580 |
Total output (mL) | 593 (75-1900) | 626 (125-2130) | 33 | .3776 |
Differences in outcomes separated based on use of a tourniquet for the entire case (Group 1) vs use of a tourniquet only during cementation (Group 2). Note that there were no significant differences. Values are reported as n (%) or average (range). GA = geniculate artery.
DISCUSSION
Major arterial injury associated with TKA is a well-known, rare, and potentially devastating complication.1-13 However, the rate of injury to smaller periarticular vessels and the clinical significance of such injury have not been studied. The present study found a high rate of GA injury but no clinically significant difference in intraoperative blood loss or postoperative drain output between patients with GA injury (which was identified and managed with cautery) and those without GA injury. In addition, tourniquet use did not affect the rate of injury or the associated blood loss. To our knowledge, this is the first study that has critically evaluated the rate of GA injury occurring during TKA.
The overall rate of GA injury occurring during primary TKA was 38% with a higher predominance of lateral inferior than middle GA injury (31% vs 15%). Anatomically, it would follow that the lateral GA could be injured at a higher rate as it courses on top of the lateral meniscus, thus being susceptible to injury during cutting of the tibial plateau and meniscectomy. In addition, because the meniscectomy is performed longitudinally along the course of the artery, it may also be potentially lacerated in multiple locations and lengthwise. In theory, there should be a 100% rate of middle GA injury during posterior-stabilized TKA as this artery runs through the cruciate ligaments, which are resected during these cases. However, vessel injury was defined in this study as the visualization of pulsatile bleeding or vessel lumen. It is probable that in the cases in which injury to the middle GA was not visualized, it was cut but simultaneously cauterized. Thus, a lower rate (15%) of injury was detected. Nonetheless, these results still suggest that these periarticular arteries are injured at a higher rate; therefore, it is important for surgeons to specifically identify these injuries intraoperatively and adequately cauterize these vessels. As long as these arteries are cauterized, additional blood loss and potential vascular pseudoaneurysms should be prevented.
The effect of GA injury on intraoperative blood loss, 24-hour postoperative drain output, and total estimated blood loss showed no significant clinical findings in the present study cohort. In addition, examining the injury rate and blood loss based on TXA use also revealed no detrimental clinical associations. Although GA injury could inherently be associated with higher levels of blood loss and drain output, it is important to note that all GA injuries were also effectively coagulated, thus explaining the indifferent results. Accordingly, it should be recommended to surgeons performing primary TKAs to carefully evaluate for GA injury to prevent excessive blood loss or painful pseudoaneurysms. However, there is also a potential for beta error in this study in which a true difference did exist but no statistical difference was found due to the study being underpowered.
Full or selective tourniquet use during TKA did not appear to have any effect on the rate of GA injury, intraoperative blood loss, or 24-hour postoperative drain output. The similarity between GA injury rates perhaps further indicates an equivalent ability to detect these injuries between these two methods because of operative inspection for such injuries. With regard to intraoperative blood loss and drain output, the present findings are similar to previous studies demonstrating equivocal results despite variable tourniquet utilization in TKA.15,30 However, these results differ from those of Harvey and colleagues31, who demonstrated that blood loss inversely correlated with intraoperative tourniquet time. There are risks and benefits related to the use of both full and selective tourniquet methods, but either method does not appear to be advantageous in decreasing the rate of GA injury.
Continue to: Although this is the first study...
Although this is the first study to investigate the rates of GA injury and the potential clinical effects, there are limitations to this research. First, the study was retrospective in nature despite the fact that the data were collected prospectively. Only acute perioperative follow-up was performed, and thus, we were unable to evaluate longer term effects of GA injury on TKA outcomes. Furthermore, this study is potentially prone to beta error. As discussed above, 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistical difference in the rate of GA injury based on the rates found in this study. This study could also have been underpowered to identify differences in other aspects, such as differences in blood loss and drain. Furthermore, the data collected regarding intraoperative blood loss are estimated data and can be variable. Finally, visualization of vessel lumen and pulsatile bleeding is not a validated method to diagnose GA injuries, and potential injuries may have been missed. Despite such disadvantages, the strengths of this study include the concise results in consecutive patients, the generalizability of the data as multiple surgeons participated, and its first report of nonmajor periarticular artery injury.
CONCLUSIONS
There is a relatively high rate of GA injury, with injury to the lateral GA being visualized more often than injury to the middle GA. The majority of GA injuries occur around the time of bone cuts and meniscectomy, and tourniquet use does not affect the rate of injury. To reduce intraoperative blood loss and postoperative drain output, surgeons should identify and coagulate GA injuries routinely during primary TKA.
ABSTRACT
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. However, the rate of injury to smaller periarticular vessels and the clinical significance of such an injury have not been well investigated. The purpose of this study is to describe the rate and outcomes of geniculate artery (GA) injury, the time at which injury occurs, and any associations with tourniquet use.
From November 2015 to February 2016, 3 surgeons at a single institution performed 100 consecutive primary TKAs and documented the presence or absence and the timing of GA injury. The data were then retrospectively reviewed. All TKAs had no prior surgery on the operative extremity. Other variables collected included tourniquet use, tranexamic acid (TXA) administration, intraoperative blood loss, postoperative drain output, and blood transfusion.
The overall rate of GA injury was 38%, with lateral inferior and middle GA injury in 31% and 15% of TKAs, respectively. Most of the injuries were visualized during bone cuts or meniscectomy. The rate of overall or isolated GA injury was not significantly different (P > .05) with either use of intravenous (84 patients) or topical (14 patients) TXA administration. Comparing selective tourniquet use (only during cementation) vs routine use showed no differences in GA injury rate (P = .37), blood loss (P = .07), or drain output (P = .46).
There is a relatively high rate of GA injury, with injury to the lateral GA occurring more often than the middle GA. Routine or selective tourniquet use does not affect the rate of injury.
Continue to: Major arterial injury...
Major arterial injury associated with total knee arthroplasty (TKA) is a rare and potentially devastating complication. The majority of literature in this context consists of case reports, small case series, and large retrospective studies that have examined the type, location, and mechanism of injury present in these cases.1-13 Reported arterial injuries include occlusion, laceration, aneurysm, pseudoaneurysm, and arteriovenous fistula formation in the femoral (believed to be due to the tourniquet around the proximal thigh) and popliteal arteries causing combinations of ischemia and hemorrhage necessitating treatment ranging from endovascular arterial intervention to amputation.4,5,9-11,13-17 In addition, several studies have asserted that the risk of major arterial injury may be increased with tourniquet use, suggesting that tourniquet use should be minimized for routine primary TKAs.3,6
There are very few cases in the literature specifically addressing injury to the more commonly encountered geniculate arteries (GAs). The medial GAs are typically visualized and coagulated during the standard medial parapatellar approach. In addition, if performed, a lateral release can damage the lateral superior and inferior GAs and the middle GA can be cut with posterior cruciate ligament resection. However, the middle and lateral inferior GAs are anecdotally the most difficult to detect and treat intraoperatively, especially after implantation of TKA and deflation of the tourniquet. The potential lack of recognition of such GA injury can result in harmful sequelae, including ischemia of the patella, hemorrhage, and painful pseudoaneurysms.2,18-29 Currently, there are only 2 case reports of lateral inferior GA injury, 2 cases of medial inferior GA injury, and no reports of middle GA injury.2,23,24,29
The rate, the timing within surgery, the risk factors, including tourniquet use, and the clinical effects of GA injury are largely unknown. If these factors were better understood, prophylactic measures and/or awareness could be better applied to prevent adverse outcomes, especially in cases of the middle and lateral inferior GAs. The aims of this study are to elucidate the rate and timing of middle and lateral inferior GA injury during primary TKA; determine the factors related to injury, including intraoperative blood loss, postoperative drain output, and tranexamic (TXA) acid use; and investigate any differences in the rate of injury with and without the use of a tourniquet.
MATERIALS AND METHODS
PATIENT DEMOGRAPHICS AND SURGICAL TECHNIQUE
From November 2015 to February 2016, 3 surgeons (MJT, TMM, and RTT) at a single institution performed 100 consecutive unilateral primary TKAs and documented the presence or absence and the timing of GA injury. After obtaining approval from our Institutional Review Board, a retrospective study was performed to investigate the prospectively recorded rate of middle and lateral inferior GA injuries occurring during primary TKAs. Patients with a diagnosis of isolated osteoarthritis were included, and those with any previous surgery on the operative knee were excluded. The average age of patients at the time of surgery was 67 years (range, 25-91 years), the average body mass index was 33 kg/m2 (range, 18-54 kg/m2), and there were 63 (63%) female patients.
All TKAs were performed through a medial parapatellar approach with a posterior-stabilized, cemented design, and each patient received a postoperative surgical drain. One of the 3 lead surgeons (TMM) in this study used a tourniquet from the time of incision until the completion of cementation, and the other 2 (MJT and RTT) predominantly used the tourniquet only during cementation. To elucidate any differences in GA injury between these 2 methods of tourniquet use, the patients were categorized into 2 groups base d on tourniquet use. Group 1 included patients in whom a tourniquet was used to maintain a bloodless surgical field from the time of incision until the completion of cementation, and Group 2 included patients in whom tourniquet use was more selective (ie, applied only during cementation). Group 1 comprised 31% (31/100) of patients, while Group 2 comprised 67% (67/100) of patients; no tourniquet was used in 2% (2/100) of cases. In addition, TXA was used in 98% (98/100) of patients: 84 patients received intravenous (IV) and 14 received topical TXA administration.
Continue to: ANALYSIS OF GENICULATE ARTERY INJURY
ANALYSIS OF GENICULATE ARTERY INJURY
The senior authors critically evaluated the GA during the primary TKAs and documented the presence or absence of injury in the operative reports. GA injury was reported if there was intraoperative visualization of pulsatile bleeding or visualization of arterial lumen in the anatomic areas of the middle and lateral inferior GAs. At 3 separate occasions during the operation, the surgeon looked specifically for pulsatile bleeding or arterial lumen in the areas of the middle and lateral inferior GAs, including after all the femoral and tibial bone cuts were completed, immediately before preparing to cement (before the tourniquet was inflated if there was not one inflated from the start of the procedure), and immediately after the tourniquet was deflated (Figure 1). All bleeding GAs that were visualized were effectively coagulated by cautery. Details regarding the use of TXA (topical or IV), intraoperative blood loss, postsurgical drain output for 24 hours after surgery, and blood transfusion were collected from the patients’ medical records (Table 1).
| Table 1. Operative Variables | |
Variable | Value |
Total number | 100 (100%) |
Intraoperative blood loss (mL) | 160 (25-500) |
Drain output 1st 24 hours (mL) | 488 (75-1980) |
Total output (mL) | 618 (75-2130) |
Use of TXA | 98 (98%) |
Topical TXA | 84 (84%) |
IV TXA | 14 (14%) |
Tourniquet entire procedure | 31 (31%) |
Operative variables other than geniculate artery injury. Data presented as mean (range) or n (%). TXA = tranexamic acid.
STATISTICAL METHODS
Statistical analysis was performed using the JMP software version 10.0.0 (SAS Institute, Inc). The overall rate of GA injury was determined, including the rates of GA injury based on location, time point, and method of diagnosis (pulsatile bleeding or arterial lumen visualization). If >1 GA injury occurred in the same knee, only 1 GA injury was calculated for the overall rate; however, each injury was specified separately when calculating the injury rate for the specific GA. Intraoperative blood loss, postoperative drain output, and the use of TXA were compared between cases in which a GA injury was detected and those in which it was not detected. Before conducting the retrospective review, a power analysis determined that we would require 100 patients to detect a difference in GA injury between Groups 1 and 2 (33 in Group 1 and 67 in Group 2), assuming a 30% rate in Group 1 and a 5% rate of GA injury in Group 2 using Fisher’s exact test. The Fisher’s exact test was used to compare categorical variables, and the Wilcoxon rank sum test was used to compare continuous variables. An alpha value of .05 was considered as statistically significant.
RESULTS
RATE OF GENICULATE ARTERY INJURY
The overall rate of any GA injury was 38% (38/100). Lateral inferior GA injury was more frequently detected than middle GA injury (31% vs 15% of TKAs, respectively; Table 2). Among the 31 lateral inferior GA injuries, 14 were identified as pulsatile bleeding, 7 as lumen visualizations, and 6 as both pulsatile bleeding and lumen visualization; 4 were detected by methods not recorded in the operative report. Of the lateral inferior GA injuries, 11 were identified after the bone cuts, 7 during meniscus removal, 3 during exposure, 1 after tourniquet deflation, and 9 at a time not recorded in the operative report. Of the 15 middle GA injuries, 9 were identified as pulsatile bleeding, 2 as lumen visualizations, and 4 as both pulsatile bleeding and lumen visualization. In addition, 7 of these GA injuries were identified after the bone cuts, 3 during cruciate removal, 1 after meniscus removal, 1 during exposure, and 3 at a time not recorded in the operative report (Table 3).
| Table 2. Rates of Geniculate Artery Injury Based on Location and Method | ||||
Location | Pulsatile Bleeding | Arterial Lumen | Both | Overall Rate |
Lateral inferior GA | 14 (14%) | 7 (7%) | 6 (6%) | 31 (31%) |
Middle GA | 9 (9%) | 2 (2%) | 4 (4%) | 15 (15%) |
Rates of geniculate artery injury based on location and method of diagnosis. Data presented as n (%). There were 4 additional lateral inferior and 9 middle GA injuries identified by a method not specified in the operative report. GA = geniculate artery.
Table 3. Rates of Geniculate Artery Injury Based on Time Point | ||
Time | Lateral Inferior GA | Middle GA |
After bone cuts | 11 (11%) | 7 (7%) |
During meniscus removal | 7 (7%) | 1 (1%) |
During exposure | 3 (3%) | 1 (1%) |
After tourniquet deflation | 1 (1%) | 0 (0%) |
During cruciate removal | 0 (0%) | 3 (3%) |
Not reported | 9 (9%) | 3 (3%) |
Rates of geniculate artery injury based on time point and method of diagnosis. GA = geniculate artery. Data presented as n (%).
FACTORS ASSOCIATED WITH GENICULATE ARTERY INJURY
Mean intraoperative estimated blood loss was 186 mL (standard deviation [SD], 111; range 50–500 mL) in those with a GA injury versus 147 mL (range, 82.25–400 mL) in those without injury (P = .14). Postoperative drain output in the 24 hours after surgery was 467 mL (SD 253, range 100–1105 mL) versus 502 mL (SD 378, range 75–1980 mL) in TKAs with and without GA injury, respectively (P = .82). Total estimated blood loss (combined intraoperative blood loss and 24-hour postoperative drain output) was 613 mL (SD 252, range 150–1105 mL) in TKAs with GA injury versus 620 mL (SD 393, range 75–2130 mL) without injury (P = .44) (Table 4). Overall, there was no statistical difference in blood loss, drain output, or combined output when analyzed according to lateral inferior or middle GA injury (P = .24–.82) (Table 5 and Table 6). No patients required blood transfusion postoperatively after TKA.
| Table 4. Factors Associated with GA Injury | |||
Outcome | GA Injury | No GA Injury | P Value |
Blood loss (mL) | 186 (50-500) | 147 (25-400) | .1366 |
24-Hour drain output (mL) | 467 (100-1105) | 502 (75-1980) | .8240 |
Total output (mL) | 613 (150-1105) | 620 (75-2130) | .4368 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
| Table 5. Factors Associated with LIGA Injury | |||
Outcome | LIGA Injury | No LIGA Injury | P Value |
Blood loss (mL) | 178 (50-400) | 153 (25-500) | .2401 |
24-Hour drain output (mL) | 461 (100-890) | 501 (75-1980) | .8187 |
Total output (mL) | 610 (150-1080) | 621 (75-2130) | .4165 |
Differences in outcomes based on presence or absence of LIGA injury. Note that there were no significant differences. Values are reported as average (range). LIGA = lateral inferior geniculate artery.
| Table 6. Factors Associated with MGA Injury | |||
Outcome | MGA Injury | No MGA Injury | P Value |
Blood loss (mL) | 190 (75-500) | 156 (25-400) | .6225 |
24-Hour drain output (mL) | 455 (125-1105) | 494 (75-1980) | .6428 |
Total output (mL) | 582 (200-1105) | 624 (75-2130) | .6535 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as average (range). MGA = middle geniculate artery.
IV administration of TXA was associated with a 37% (31/84) rate of GA injury, whereas topical TXA administration was associated with a 43% (6/14) rate of GA injury (P = .77). The rate of overall or isolated GA injury was not significantly different (P = .35–1.0) between IV and topical TXA administration (Table 7). In addition, total combined output was not significantly different (P = .1032) when comparing GA injury and noninjury in the subgroup analysis based on TXA use (IV or topical); however, topical administration was associated with lower intraoperative blood loss than IV administration (P = .0489), whereas IV administration was associated with lower 24-hour postoperative drain output than topical administration (P = .0169). There was no difference in blood loss, 24-hour drain output, or total output between those who did and did not sustain a GA injury in the group of patients who received IV TXA administration (Table 8, P = .2118–.7091). The same was true for those receiving topical TXA administration (Table 9, P = .0912–.9485).
Table 7. Factors Associated with TXA Injury | |||
Outcome | IV TXA (n = 84) | Topical TXA (n = 14) | P Value |
Any GA injury | 31 (37%) | 6 (43%) | .7683 |
LIGA injury | 24 (29%) | 6 (43%) | .3498 |
MGA injury | 13 (15%) | 2 (14%) | 1.0 |
Blood loss (mL) | 170 (25-500) | 113 (40-240) | .0489* |
24-Hour drain output (mL) | 454 (75-1980) | 662 (75-1800) | .0169* |
Total output (mL) | 592 (75-2130) | 751 (75-2130) | .1032 |
Differences in outcomes based on presence or absence of MGA injury. Note that there were no significant differences. Values are reported as n (%) or average (range). TXA = tranexamic acid, GA = geniculate artery, LIGA = lateral inferior geniculate artery, MGA = middle geniculate artery. *denotes statistical significance (P < .05).
| Table 8. Factors Associated with GA Injury Given IV TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 195 (50-500) | 157 (25-400) | 38 | .2118 |
24-Hour drain output (mL) | 436 (100-1105) | 464 (75-1980) | 28 | .7091 |
Total output (mL) | 594 (150-1105) | 592 (75-2130) | 2 | .6982 |
Differences in outcomes of those patients who received IV TXA based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery, TXA = tranexamic acid.
| Table 9. Factors Associated with GA Injury Given Topical TXA Use | ||||
Outcome | GA Injury | No GA Injury | Difference | P Value |
Blood loss (mL) | 163 (100-250) | 84 (40-150) | 79 | .0912 |
24-Hour drain output (mL) | 610 (205-890) | 701 (415-1800) | 91 | .9485 |
Total output (mL) | 719 (405-960) | 775 (455-1900) | 56 | .6982 |
Differences in outcomes based on presence or absence of GA injury. Note that there were no significant differences. Values are reported as average (range). GA = geniculate artery.
Continue to: TOURNIQUET USE
TOURNIQUET USE
Comparison between Groups 1 (tourniquet use) and 2 (selective tourniquet use) revealed similar rates of overall and specific GA injury, intraoperative blood loss, and 24-hour postoperative drain output (Table 10). Group 1 demonstrated a 29% (9/31) rate of any GA injury versus 40% (27/67) in Group 2 (P = .37). For the specific lateral inferior GA injury, there was an equivalent rate of injury at 29% (9/31 in Group 1, 20/67 in Group 2; P = 1.0). Similarly, Group 1 patients had a 10% (3/31) rate of middle GA injury compared to 16% (11/67) in Group 2 patients (P = .53). Intraoperative estimated blood loss was lower in Group 1 (140 mL; range 25–400 mL) than in Group 2 (171 mL; range 40–500 mL) (P = .07), whereas the average 24-hour postoperative drain output was similar for Groups 1 (484 mL; range 75–1800 mL) and 2 (488 mL; range 100–1980 mL) (P = .46). Total estimated output was slightly less for Group 1 (593 mL; range 75–1900 mL) than for Group 2 (626 mL; range 125–2130 mL) (P = .38). A post hoc power analysis showed that with these rates of GA injury in Groups 1 and 2 and given a 2:1 ratio of the number of patients in Group 2 versus Group 1, a total of 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistically significant difference (P < .05) with a power of 80%.
| Table 10. Factors Associated with Tourniquet Use | ||||
Injury | Group 1 (n = 31) | Group 2 (n = 67) | Difference | P Value |
Overall GA injury | 9 (29%) | 27 (40%) | 11% | .3687 |
Lateral inferior GA | 9 (29%) | 20 (29%) | 0% | 1.0 |
Middle GA | 3 (10%) | 11 (16%) | 6% | .5382 |
Blood loss (mL) | 140 (25-400) | 171 (40-500) | 31 | .0661 |
24-Hour drain output (mL) | 484 (75-1800) | 488 (100-1980) | 4 | .4580 |
Total output (mL) | 593 (75-1900) | 626 (125-2130) | 33 | .3776 |
Differences in outcomes separated based on use of a tourniquet for the entire case (Group 1) vs use of a tourniquet only during cementation (Group 2). Note that there were no significant differences. Values are reported as n (%) or average (range). GA = geniculate artery.
DISCUSSION
Major arterial injury associated with TKA is a well-known, rare, and potentially devastating complication.1-13 However, the rate of injury to smaller periarticular vessels and the clinical significance of such injury have not been studied. The present study found a high rate of GA injury but no clinically significant difference in intraoperative blood loss or postoperative drain output between patients with GA injury (which was identified and managed with cautery) and those without GA injury. In addition, tourniquet use did not affect the rate of injury or the associated blood loss. To our knowledge, this is the first study that has critically evaluated the rate of GA injury occurring during TKA.
The overall rate of GA injury occurring during primary TKA was 38% with a higher predominance of lateral inferior than middle GA injury (31% vs 15%). Anatomically, it would follow that the lateral GA could be injured at a higher rate as it courses on top of the lateral meniscus, thus being susceptible to injury during cutting of the tibial plateau and meniscectomy. In addition, because the meniscectomy is performed longitudinally along the course of the artery, it may also be potentially lacerated in multiple locations and lengthwise. In theory, there should be a 100% rate of middle GA injury during posterior-stabilized TKA as this artery runs through the cruciate ligaments, which are resected during these cases. However, vessel injury was defined in this study as the visualization of pulsatile bleeding or vessel lumen. It is probable that in the cases in which injury to the middle GA was not visualized, it was cut but simultaneously cauterized. Thus, a lower rate (15%) of injury was detected. Nonetheless, these results still suggest that these periarticular arteries are injured at a higher rate; therefore, it is important for surgeons to specifically identify these injuries intraoperatively and adequately cauterize these vessels. As long as these arteries are cauterized, additional blood loss and potential vascular pseudoaneurysms should be prevented.
The effect of GA injury on intraoperative blood loss, 24-hour postoperative drain output, and total estimated blood loss showed no significant clinical findings in the present study cohort. In addition, examining the injury rate and blood loss based on TXA use also revealed no detrimental clinical associations. Although GA injury could inherently be associated with higher levels of blood loss and drain output, it is important to note that all GA injuries were also effectively coagulated, thus explaining the indifferent results. Accordingly, it should be recommended to surgeons performing primary TKAs to carefully evaluate for GA injury to prevent excessive blood loss or painful pseudoaneurysms. However, there is also a potential for beta error in this study in which a true difference did exist but no statistical difference was found due to the study being underpowered.
Full or selective tourniquet use during TKA did not appear to have any effect on the rate of GA injury, intraoperative blood loss, or 24-hour postoperative drain output. The similarity between GA injury rates perhaps further indicates an equivalent ability to detect these injuries between these two methods because of operative inspection for such injuries. With regard to intraoperative blood loss and drain output, the present findings are similar to previous studies demonstrating equivocal results despite variable tourniquet utilization in TKA.15,30 However, these results differ from those of Harvey and colleagues31, who demonstrated that blood loss inversely correlated with intraoperative tourniquet time. There are risks and benefits related to the use of both full and selective tourniquet methods, but either method does not appear to be advantageous in decreasing the rate of GA injury.
Continue to: Although this is the first study...
Although this is the first study to investigate the rates of GA injury and the potential clinical effects, there are limitations to this research. First, the study was retrospective in nature despite the fact that the data were collected prospectively. Only acute perioperative follow-up was performed, and thus, we were unable to evaluate longer term effects of GA injury on TKA outcomes. Furthermore, this study is potentially prone to beta error. As discussed above, 185 patients in Group 1 and 370 patients in Group 2 would be needed to detect a statistical difference in the rate of GA injury based on the rates found in this study. This study could also have been underpowered to identify differences in other aspects, such as differences in blood loss and drain. Furthermore, the data collected regarding intraoperative blood loss are estimated data and can be variable. Finally, visualization of vessel lumen and pulsatile bleeding is not a validated method to diagnose GA injuries, and potential injuries may have been missed. Despite such disadvantages, the strengths of this study include the concise results in consecutive patients, the generalizability of the data as multiple surgeons participated, and its first report of nonmajor periarticular artery injury.
CONCLUSIONS
There is a relatively high rate of GA injury, with injury to the lateral GA being visualized more often than injury to the middle GA. The majority of GA injuries occur around the time of bone cuts and meniscectomy, and tourniquet use does not affect the rate of injury. To reduce intraoperative blood loss and postoperative drain output, surgeons should identify and coagulate GA injuries routinely during primary TKA.
1. Calligaro KD, Dougherty MJ, Ryan S, Booth RE. Acute arterial complications associated with total hip and knee arthroplasty. J Vasc Surg. 2003;38(6):1170-1177. doi: 10.1016/S0741-5214(03)00918-2.
2. Dennis DA, Neumann RD, Toma P, Rosenberg G, Mallory TH. Arteriovenous fistula with false aneurysm of the inferior medial geniculate artery. A complication of total knee arthroplasty. Clin Orthop Relat Res. 1987(222):255-260.
3. Hagan PF, Kaufman EE. Vascular complication of knee arthroplasty under tourniquet. A case report. Clin Orthop Relat Res. 1990(257):159-161.
4. Holmberg A, Milbrink J, Bergqvist D. Arterial complications after knee arthroplasty: 4 cases and a review of the literature. Acta Orthop Scand. 1996;67(1):75-78. doi: 10.3109/17453679608995616.
5. Hozack WJ, Cole PA, Gardner R, Corces A. Popliteal aneurysm after total knee arthroplasty. Case reports and review of the literature. J Arthroplasty. 1990;5(4):301-305. doi: 10.1016/S0883-5403(08)80087-3.
6. Jeyaseelan S, Stevenson TM, Pfitzner J. Tourniquet failure and arterial calcification. Case report and theoretical dangers. Anaesthesia. 1981;36(1):48-50. doi: 10.1111/j.1365-2044.1981.tb08599.x
7. Mureebe L, Gahtan V, Kahn MB, Kerstein MD, Roberts AB. Popliteal artery injury after total knee arthroplasty. Am Surg. 1996;62(5):366-368.
8. O'Connor JV, Stocks G, Crabtree JD, Jr., Galasso P, Wallsh E. Popliteal pseudoaneurysm following total knee arthroplasty. J Arthroplasty. 1998;13(7):830-832. doi: 10.1016/S0883-5403(98)90039-0.
9. Ohira T, Fujimoto T, Taniwaki K. Acute popliteal artery occlusion after total knee arthroplasty. Arch Orthop Trauma Surg. 1997;116(6-7):429-430. doi: 10.1007/BF00434007.
10. Parfenchuck TA, Young TR. Intraoperative arterial occlusion in total joint arthroplasty. J Arthroplasty. 1994;9(2):217-220. doi: 10.1016/0883-5403(94)90071-X.
11. Rush JH, Vidovich JD, Johnson MA. Arterial complications of total knee replacement. The Australian experience. J Bone Joint Surg Br. 1987;69(3):400-402. doi: 10.1302/0301-620X.69B3.3584193.
12. Smith DE, McGraw RW, Taylor DC, Masri BA. Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg. 2001;9(4):253-257.
13. Zahrani HA, Cuschieri RJ. Vascular complications after total knee replacement. J Cardiovasc Surg (Torino). 1989;30(6):951-952.
14. Isiklar ZU, Landon GC, Tullos HS. Amputation after failed total knee arthroplasty. Clin Orthop Relat Res. 1994(299):173-178.
15. Wakankar HM, Nicholl JE, Koka R, D'Arcy JC. The tourniquet in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 1999;81(1):30-33. doi: 10.1302/0301-620X.81B1.0810030.
16. Kumar SN, Chapman JA, Rawlins I. Vascular injuries in total knee arthroplasty. A review of the problem with special reference to the possible effects of the tourniquet. J Arthroplasty. 1998;13(2):211-216. doi: 10.1016/S0883-5403(98)90102-4.
17. DeLaurentis DA, Levitsky KA, Booth RE, et al. Arterial and ischemic aspects of total knee arthroplasty. Am J Surg. 1992;164(3):237-240. doi: 10.1016/S0002-9610(05)81078-5.
18. Langkamer VG. Local vascular complications after knee replacement: a review with illustrative case reports. Knee. 2001;8(4):259-264. doi: 10.1016/S0968-0160(01)00103-X.
19. Moran M, Hodgkinson J, Tait W. False aneurysm of the superior lateral geniculate artery following Total Knee Replacement. Knee. 2002;9(4):349-351. doi: 10.1016/S0968-0160(02)00061-3.
20. Pritsch T, Parnes N, Menachem A. A bleeding pseudoaneurysm of the lateral genicular artery after total knee arthroplasty--a case report. Acta Orthop. 2005;76(1):138-140. doi: 10.1080/00016470510030463.
21. Gaheer RS, Chirputkar K, Sarungi M. Spontaneous resolution of superior medial geniculate artery pseudoaneurysm following total knee arthroplasty. Knee. 2014;21(2):586-588. doi: 10.1016/j.knee.2012.10.021.
22. Law KY, Cheung KW, Chiu KH, Antonio GE. Pseudoaneurysm of the geniculate artery following total knee arthroplasty: a report of two cases. J Orthop Surg (Hong Kong). 2007;15(3):386-389. /doi: 10.1177/230949900701500331.
23. Noorpuri BS, Maxwell-Armstrong CA, Lamerton AJ. Pseudo-aneurysm of a geniculate collateral artery complicating total knee replacement. Eur J Vasc Endovasc Surg. 1999;18(6):534-535.
24. Pai VS. Traumatic aneurysm of the inferior lateral geniculate artery after total knee replacement. J Arthroplasty. 1999;14(5):633-634. doi: 10.1016/S0883-5403(99)90089-X.
25. Julien TP, Gravereaux E, Martin S. Superior medial geniculate artery pseudoaneurysm after primary total knee arthroplasty. J Arthroplasty. 2012;27(2):323 e313-326. doi: 10.1016/j.arth.2011.02.009.
26. Kalsi PS, Carrington RJ, Skinner JS. Therapeutic embolization for the treatment of recurrent hemarthrosis after total knee arthroplasty due to an arteriovenous fistula. J Arthroplasty. 2007;22(8):1223-1225. /doi: 10.1016/j.arth.2006.11.012.
27. Ritter MA, Herbst SA, Keating EM, Faris PM, Meding JB. Patellofemoral complications following total knee arthroplasty. Effect of a lateral release and sacrifice of the superior lateral geniculate artery. J Arthroplasty. 1996;11(4):368-372. doi: 10.1016/S0883-5403(96)80024-6.
28. Aldrich D, Anschuetz R, LoPresti C, Fumich M, Pitluk H, O'Brien W. Pseudoaneurysm complicating knee arthroscopy. Arthroscopy. 1995;11(2):229-230. doi: 10.1016/0749-8063(95)90073-X.
29. Sharma H, Singh GK, Cavanagh SP, Kay D. Pseudoaneurysm of the inferior medial geniculate artery following primary total knee arthroplasty: delayed presentation with recurrent haemorrhagic episodes. Knee Surg Sports Traumatol Arthrosc. 2006;14(2):153-155. doi: 10.1007/s00167-005-0639-4.
30. Abdel-Salam A, Eyres KS. Effects of tourniquet during total knee arthroplasty. A prospective randomised study. J Bone Joint Surg Br. 1995;77(2):250-253. doi: 10.1302/0301-620X.77B2.7706340.
31. Harvey EJ, Leclerc J, Brooks CE, Burke DL. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. J Arthroplasty. 1997;12(3):291-296. doi: 10.1016/S0883-5403(97)90025-5.
1. Calligaro KD, Dougherty MJ, Ryan S, Booth RE. Acute arterial complications associated with total hip and knee arthroplasty. J Vasc Surg. 2003;38(6):1170-1177. doi: 10.1016/S0741-5214(03)00918-2.
2. Dennis DA, Neumann RD, Toma P, Rosenberg G, Mallory TH. Arteriovenous fistula with false aneurysm of the inferior medial geniculate artery. A complication of total knee arthroplasty. Clin Orthop Relat Res. 1987(222):255-260.
3. Hagan PF, Kaufman EE. Vascular complication of knee arthroplasty under tourniquet. A case report. Clin Orthop Relat Res. 1990(257):159-161.
4. Holmberg A, Milbrink J, Bergqvist D. Arterial complications after knee arthroplasty: 4 cases and a review of the literature. Acta Orthop Scand. 1996;67(1):75-78. doi: 10.3109/17453679608995616.
5. Hozack WJ, Cole PA, Gardner R, Corces A. Popliteal aneurysm after total knee arthroplasty. Case reports and review of the literature. J Arthroplasty. 1990;5(4):301-305. doi: 10.1016/S0883-5403(08)80087-3.
6. Jeyaseelan S, Stevenson TM, Pfitzner J. Tourniquet failure and arterial calcification. Case report and theoretical dangers. Anaesthesia. 1981;36(1):48-50. doi: 10.1111/j.1365-2044.1981.tb08599.x
7. Mureebe L, Gahtan V, Kahn MB, Kerstein MD, Roberts AB. Popliteal artery injury after total knee arthroplasty. Am Surg. 1996;62(5):366-368.
8. O'Connor JV, Stocks G, Crabtree JD, Jr., Galasso P, Wallsh E. Popliteal pseudoaneurysm following total knee arthroplasty. J Arthroplasty. 1998;13(7):830-832. doi: 10.1016/S0883-5403(98)90039-0.
9. Ohira T, Fujimoto T, Taniwaki K. Acute popliteal artery occlusion after total knee arthroplasty. Arch Orthop Trauma Surg. 1997;116(6-7):429-430. doi: 10.1007/BF00434007.
10. Parfenchuck TA, Young TR. Intraoperative arterial occlusion in total joint arthroplasty. J Arthroplasty. 1994;9(2):217-220. doi: 10.1016/0883-5403(94)90071-X.
11. Rush JH, Vidovich JD, Johnson MA. Arterial complications of total knee replacement. The Australian experience. J Bone Joint Surg Br. 1987;69(3):400-402. doi: 10.1302/0301-620X.69B3.3584193.
12. Smith DE, McGraw RW, Taylor DC, Masri BA. Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg. 2001;9(4):253-257.
13. Zahrani HA, Cuschieri RJ. Vascular complications after total knee replacement. J Cardiovasc Surg (Torino). 1989;30(6):951-952.
14. Isiklar ZU, Landon GC, Tullos HS. Amputation after failed total knee arthroplasty. Clin Orthop Relat Res. 1994(299):173-178.
15. Wakankar HM, Nicholl JE, Koka R, D'Arcy JC. The tourniquet in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 1999;81(1):30-33. doi: 10.1302/0301-620X.81B1.0810030.
16. Kumar SN, Chapman JA, Rawlins I. Vascular injuries in total knee arthroplasty. A review of the problem with special reference to the possible effects of the tourniquet. J Arthroplasty. 1998;13(2):211-216. doi: 10.1016/S0883-5403(98)90102-4.
17. DeLaurentis DA, Levitsky KA, Booth RE, et al. Arterial and ischemic aspects of total knee arthroplasty. Am J Surg. 1992;164(3):237-240. doi: 10.1016/S0002-9610(05)81078-5.
18. Langkamer VG. Local vascular complications after knee replacement: a review with illustrative case reports. Knee. 2001;8(4):259-264. doi: 10.1016/S0968-0160(01)00103-X.
19. Moran M, Hodgkinson J, Tait W. False aneurysm of the superior lateral geniculate artery following Total Knee Replacement. Knee. 2002;9(4):349-351. doi: 10.1016/S0968-0160(02)00061-3.
20. Pritsch T, Parnes N, Menachem A. A bleeding pseudoaneurysm of the lateral genicular artery after total knee arthroplasty--a case report. Acta Orthop. 2005;76(1):138-140. doi: 10.1080/00016470510030463.
21. Gaheer RS, Chirputkar K, Sarungi M. Spontaneous resolution of superior medial geniculate artery pseudoaneurysm following total knee arthroplasty. Knee. 2014;21(2):586-588. doi: 10.1016/j.knee.2012.10.021.
22. Law KY, Cheung KW, Chiu KH, Antonio GE. Pseudoaneurysm of the geniculate artery following total knee arthroplasty: a report of two cases. J Orthop Surg (Hong Kong). 2007;15(3):386-389. /doi: 10.1177/230949900701500331.
23. Noorpuri BS, Maxwell-Armstrong CA, Lamerton AJ. Pseudo-aneurysm of a geniculate collateral artery complicating total knee replacement. Eur J Vasc Endovasc Surg. 1999;18(6):534-535.
24. Pai VS. Traumatic aneurysm of the inferior lateral geniculate artery after total knee replacement. J Arthroplasty. 1999;14(5):633-634. doi: 10.1016/S0883-5403(99)90089-X.
25. Julien TP, Gravereaux E, Martin S. Superior medial geniculate artery pseudoaneurysm after primary total knee arthroplasty. J Arthroplasty. 2012;27(2):323 e313-326. doi: 10.1016/j.arth.2011.02.009.
26. Kalsi PS, Carrington RJ, Skinner JS. Therapeutic embolization for the treatment of recurrent hemarthrosis after total knee arthroplasty due to an arteriovenous fistula. J Arthroplasty. 2007;22(8):1223-1225. /doi: 10.1016/j.arth.2006.11.012.
27. Ritter MA, Herbst SA, Keating EM, Faris PM, Meding JB. Patellofemoral complications following total knee arthroplasty. Effect of a lateral release and sacrifice of the superior lateral geniculate artery. J Arthroplasty. 1996;11(4):368-372. doi: 10.1016/S0883-5403(96)80024-6.
28. Aldrich D, Anschuetz R, LoPresti C, Fumich M, Pitluk H, O'Brien W. Pseudoaneurysm complicating knee arthroscopy. Arthroscopy. 1995;11(2):229-230. doi: 10.1016/0749-8063(95)90073-X.
29. Sharma H, Singh GK, Cavanagh SP, Kay D. Pseudoaneurysm of the inferior medial geniculate artery following primary total knee arthroplasty: delayed presentation with recurrent haemorrhagic episodes. Knee Surg Sports Traumatol Arthrosc. 2006;14(2):153-155. doi: 10.1007/s00167-005-0639-4.
30. Abdel-Salam A, Eyres KS. Effects of tourniquet during total knee arthroplasty. A prospective randomised study. J Bone Joint Surg Br. 1995;77(2):250-253. doi: 10.1302/0301-620X.77B2.7706340.
31. Harvey EJ, Leclerc J, Brooks CE, Burke DL. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. J Arthroplasty. 1997;12(3):291-296. doi: 10.1016/S0883-5403(97)90025-5.
TAKE-HOME POINTS
- During total knee arthroscopy (TKA), 38% of patients will have an injury of a geniculate artery.
- The lateral inferior geniculate artery is most commonly injured, with a rate of injury of 31%.
- The middle geniculate artery is injured 15% of the time.
- The most common time of geniculate artery injury is during bone cutting or removal of the meniscus.
- There is no difference in rate of geniculate artery injury identification with or without the use of a tourniquet.
Foot and Ankle Injuries in Soccer
ABSTRACT
The ankle is one of the most commonly injured joints in soccer and represents a significant cost to the healthcare system. The ligaments that stabilize the ankle joint determine its biomechanics—alterations of which result from various soccer-related injuries. Acute sprains are among the most common injury in soccer players and are generally treated conservatively, with emphasis placed on secondary prevention to reduce the risk for future sprains and progression to chronic ankle instability. Repetitive ankle injuries in soccer players may cause chronic ankle instability, which includes both mechanical ligamentous laxity and functional changes. Chronic ankle pathology often requires surgery to repair ligamentous damage and remove soft-tissue or osseous impingement. Proper initial treatment, rehabilitation, and secondary prevention of ankle injuries can limit the amount of time lost from play and avoid negative long-term sequelae (eg, osteochondral lesions, arthritis). On the other hand, high ankle sprains portend a poorer prognosis and a longer recovery. These injuries will typically require surgical stabilization. Impingement-like syndromes of the ankle can undergo an initial trial of conservative treatment; when this fails, however, soccer players respond favorably to arthroscopic debridement of the lesions causing impingement. Finally, other pathologies (eg, stress fractures) are highly encouraged to be treated with surgical stabilization in elite soccer players.
Continue to: EPIDEMIOLOGY
EPIDEMIOLOGY
With roughly 200,000 professional and around 240 million amateur soccer players, soccer has been recognized as the most popular sport worldwide. Nevertheless, given its rising popularity in society, one must also consider the increasing incidence of injuries as a result. Elite soccer players sustain between 10 and 35 injuries per 1000 competitive playing hours.1 Approximately 80% are traumatic, and 20% are overuse injuries.2 Soccer injuries are more frequent with increasing age of the participants, whereas the incidence of injuries in preadolescent players is low. The incidence of injuries has been found to be higher during competition when compared with practice/training sessions, with some studies showing that 59% of injuries occurred during games.2 Amateur or recreational soccer players sustain fewer injuries than professional soccer players, as one would expect, given both the higher intensity of training and match schedule in professionals.
The ankle is one of the most commonly injured joints in soccer, with some studies suggesting it comprises one-fifth of all injuries sustained during soccer, which is only second to those of the knee.2 Ankle sprains specifically are quite a common occurrence in soccer.3-9 A recent study of an English premier league club showed that over a 4-season period, 20% of injuries were of the foot and ankle with a mean return to sport time of 54 days.10 Of all foot and ankle related injuries, ankle sprains are the most common, followed by bruises/contusions, and tendon lesions. Fractures are very rare (1%) in soccer, but when they do occur they impart a much more extended recovery. During the 2010 Fédération Internationale de Football Association (FIFA) World Cup, ankle sprains were among the most common injuries and approximately half lead to players missing training or competitive matches.5
ANATOMY
Knowledge of the biomechanics of both the foot and ankle joints is essential to understand soccer injuries. The ankle joint (talocrural articulation) consists of the distal ends of the tibia and fibula, which form the mortise, and the superior aspect of the talar dome.11 As a hinge joint, the ankle provides 20° of dorsiflexion and 50° of plantar flexion,12 with stability provided by the lateral, medial, and superior ligamentous complexes. The superior articular surface of the talus is narrower posteriorly, which creates a looser fit within the mortise during plantar flexion.11 This decreased stability could help explain why the most common injury in soccer involves a plantar flexion mechanism.13,14 Inferiorly, the talus articulates with the calcaneus to form the subtalar joint. It is at this site that the majority of both foot inversion and eversion occurs. The transverse tarsal joints (Chopart’s joints) separate the hindfoot from the midfoot. Movement of this joint depends on the relative alignment of its 2 articulations: the talonavicular and calcaneocuboid joints. During foot eversion, these 2 joints are parallel to each other allowing supple motion and aiding in shock absorption during the heel strike phase of the gait cycle. With foot inversion, the joints become nonparallel and thus lock the transverse tarsal joints providing a rigid lever needed for push-off.11,12
LATERAL LIGAMENTS
The ankle joint is stabilized laterally by a ligament complex consisting of 3 individual ligaments, all originating from the lateral malleolus: the anterior talofibular ligament (ATFL), the posterior talofibular ligament (PTFL), and the calcaneofibular ligament (CFL) (Figure 1).11,12,15 The ATFL is the primary restraint to inversion in plantar flexion, and it helps resist anterolateral translation of the talus in the mortise. However, it is the weakest and therefore the most frequently injured of the lateral ligaments. The PTFL plays only a supplementary role in ankle stability when the lateral ligament complex is intact. It is under the greatest strain in ankle dorsiflexion and acts to limit posterior talar displacement within the mortise as well as talar external rotation.13,16 The CFL is the primary restraint to inversion in the neutral or dorsiflexed position. It restrains subtalar inversion, thereby limiting talar tilt within the mortise.
DELTOID LIGAMENT
The deltoid ligament complex consists of 6 continuous adjacent superficial and deep ligaments that function synergistically to resist valgus and pronation forces, as well as external rotation of the talus in the mortise.11-13,17 The superficial layer crosses both ankle and subtalar joints. It originates from the anterior colliculus and fans out to insert into the navicular, neck of the talus, sustentaculum tali, and posteromedial talar tubercle. The tibiocalcaneal (sustentaculum tali) portion is the strongest component in the superficial layer and resists calcaneal eversion. The deep layer crosses the ankle joint only. It functions as the primary stabilizer of the medial ankle and prevents both lateral displacement and external rotation of the talus. It originates from the inferior and posterior aspects of the medial malleolus and inserts on the medial and posteromedial aspects of the talus.12,17,18
Continue to: SYNDESMOSIS
SYNDESMOSIS
The ankle syndesmosis, or inferior tibiofibular joint, is the distal articulation between the tibia and fibula. The syndesmosis contributes to ankle mortise integrity through its firm fixation of the lateral malleolus against the lateral surface of the talus. Ligaments comprising the ankle syndesmosis include the anterior inferior tibiofibular ligament (AITFL), the posterior inferior tibiofibular ligament (PITFL), the inferior transverse ligament, and the interosseous ligament (IOL).12
ANKLE SPRAINS
Ankle sprains are the most common pathology encountered amongst soccer players, representing from one-half to two-thirds of all ankle related injuries. Most sprains occur outside of player contact.
LATERAL ANKLE SPRAINS AND INSTABILITY
Injury to the lateral ligaments of the ankle represents 77% to 91% of all ankle sprains in soccer.6,19 The greatest risk factor for an ankle sprain in a soccer player is a history of prior sprain.20 Other risk factors include increasing age, player-to-player contact, condition of the pitch, weight-bearing status of the injured limb at the time of injury, and joint instability or laxity.21,22
The evaluation of an ankle sprain to determine its severity is best done after the acute phase, approximately 4 to 7 days after the initial injury when both pain and swelling have subsided.23 The anterior drawer (ATFL instability) and talar tilt (CFL instability) tests are useful in evaluating ankle instability in the delayed or chronic setting; however, both have been shown to have limited sensitivity and significant variability amongst different examiners.24
Clinical examination will direct further diagnostic tests including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT). The Ottawa ankle rules are generally helpful in determining whether plain X-rays are indicated in the acute setting.25,26 (Figure 2) According to these rules, ankle radiographs should be obtained if ankle pain is reported near the malleoli and 1 or more of the following is seen during examination: inability to bear weight immediately after injury and for 4 steps in the emergency department, and bony tenderness at the posterior edge or tip of the malleolus. Stress X-rays are generally not indicated in acute injuries but may be useful in chronic ankle instability cases.23
Continue to: Ankle sprains cover...
Ankle sprains cover a broad spectrum of injuries; therefore, a grading system was devised to aid in guiding treatment. Grade I (mild) sprains are those with minimal swelling and tenderness but have the ligaments still intact. Grade II (moderate) sprains occur when there are partial ligament tears associated with moderate pain, swelling, and tenderness. Finally, Grade III (severe) sprains are complete ligament tears with marked swelling, hemorrhage, tenderness, loss of function, and abnormal joint motion and instability.23, 24
Initial treatment for all ankle sprains is nonoperative and involves the RICE (rest, ice, compression, elevation) protocol with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during the acute phase (first 4-5 days) with a short period (no >2 weeks) of immobilization.27 Most authors agree that early mobilization followed by phased rehabilitation is warranted to minimize time away from sports.28-31 Prolonged immobilization (>2 weeks) has detrimental effects and may lead to a longer return to play.28-31 The rehabilitation protocol is divided into stages: (1) pain and edema control, (2) range of motion (ROM) and strengthening exercises, (3) soccer specific functional training, and (4) prophylactic intervention with balance and proprioception exercises. Surgical intervention is rarely indicated for acute ankle sprains. There are exceptions, however, such as when ankle sprains are associated with other injuries that require acute intervention (eg, fracture, osteochondral lesion). Surgery is indicated in the setting of chronic, recurrent mechanical instability. Anatomical repairs (modified Brostrom) seem to produce better outcomes than non-anatomical reconstructions (eg, Chrisman-Snook). Surgical outcomes are good, and most athletes are able to return to their pre-injury level of function.32
In athletes, prevention of recurrent sprains is key. Braces may help prevent ankle sprains and bracing has been shown to be superior to taping, as tape loses its restrictive properties within 20 to 30 minutes of initiating activity.33,34 Application of an orthosis (lace-up ankle orthosis) has been shown to reduce the incidence of ankle re-injury in soccer players with previous ankle sprains. Several studies have found minimal, if any, effect of orthoses on athletic performance.20,35,36 Low-profile braces for soccer have been developed which allow for minimal disruption of the player’s boot and space proximally to insert the shin guard. Another essential component of prevention is prophylactic intervention with balance and proprioceptive exercises. A study looking at first division men’s league football (soccer) players in Iran showed a significant decrease in re-injury rates with proprioceptive training.37 In 2003, FIFA introduced a comprehensive warm-up program (FIFA 11+), which has since been shown in several studies to decrease the risk of injury in amateur soccer players.38-40
MEDIAL ANKLE SPRAINS AND INSTABILITY
Soccer places an unusually high demand on both the medial foot and ankle structures when compared with other sports. For instance, striking the ball requires the player to abduct and externally rotate the foot, which preloads medial structures.9 Hintermann18 looked at 54 cases of medial ankle instability and found that injury commonly occurred during landing on an uneven surface, which applies to soccer players when landing after heading the ball or jumping over a tackle. Pronation with eversion and extreme rotational injuries are well known to cause deltoid ligament injury. However, complete rupture of the deltoid ligament is rare and is more often associated with ankle fractures.41 Due to its close proximity and similarly shared function in medial plantar arch stabilization with the tibiospring and spring ligaments, posterior tibialis tendon dysfunction is also frequently seen in medial ankle instability.17 After an acute injury, patients can present with a medial ankle hematoma and pain along the deltoid ligament. Although chronic insufficiency is diagnosed based on the feeling of “giving way,” pain in the medial gutter of the ankle and a valgus and pronation deformity of the foot can be corrected by activating the peroneus tertius muscle. Arthroscopy is the most specific way to confirm clinically suspected instability of the medial ankle; however, MRI can demonstrate loss of organized medial fibers (Figures 3A, 3B).18 Primary surgical repair of deltoid ligament tears yield good to excellent results and should be considered in the soccer player to prevent problems associated with chronic non-repaired tears such as instability, osteoarthritis, and impingement syndromes.18 After surgical repair, players will undergo extensive physical therapy that progresses to sport-specific exercises with the ultimate goal of returning to competitive play around 4-6 months post-operatively.
HIGH ANKLE SPRAINS (SYNDESMOSIS)
High ankle sprains are much less common than low ankle sprains; however, when they do occur they portend a lengthier rehabilitation and a poorer prognosis, especially if undiagnosed. Lubberts and colleagues42 studied the epidemiology of isolated syndesmotic injuries in professional football players. They pooled data from 15 consecutive seasons of European professional football between 2001 and 2016. They examined a total of 3677 players from 61 teams across 17 countries. There were 1320 ankle ligament injuries registered during 15 seasons, of which 94 (7%) were isolated syndesmotic injuries. The incidence of these injuries increased annually between 2001 and 2016. Injuries were 74% contact-related, and isolated syndesmotic injuries were followed by a mean of a 39-day absence.42 Moreover, football players may have an increased risk of syndesmotic sprains due to foot planting and cutting action.41
Continue to: These injuriesa are typically...
These injuries are typically identified with pain over the AITFL and interosseous membrane. Physical examination tests that help identify syndesmotic injuries include the squeeze test, external rotation test, and crossed-leg test.41 The diagnosis can be made on plain X-ray when there is clear diastasis between the distal tibia and fibula. Two critical measurements on plain films are made 1 cm above the tibial plafond and are used to evaluate the integrity of the syndesmosis: tibiofibular clear space >6 mm, and tibiofibular overlap <1 mm, which indicate disruption of the syndesmosis.43 More subtle injuries can be diagnosed with better sensitivity and specificity using MRI, which can also reveal secondary findings such as bone bruises, ATFL injury, osteochondral lesions, and tibiofibular incongruity.44,45 Arthroscopy is an invaluable diagnostic tool for syndesmotic injuries with a characteristic triad finding of PITFL scarring, disrupted interosseous ligament, and posterolateral tibial plafond chondral damage.46
Classification of the ligaments involved can aid in the selection of appropriate treatment. Grade I injuries involve AITFL tears. Grade IIa injuries involve AITFL and IOL tears. Grade IIb injuries include AITFL, PITFL, and IOL tears. Grade III injuries involve injury to all 3 ligaments, as well as a fibular fracture. Conservative treatment is recommended for Grades I and IIa, while surgical intervention is necessary for Grades IIb and III (Figures 4A, 4B). Compared with other ankle sprains, syndesmotic injuries typically require a more prolonged recovery/rehabilitation. Some studies suggest that these injuries require twice as long to heal.47 Hopkinson and colleagues48 reported a mean recovery time of 55 days following syndesmotic injuries in cadets at the United States Military Academy at West Point. Some surgeons advocate surgical intervention in professional athletes with mild sprains to expedite return to play.49
Surgery has been well established as necessary in more severe injuries where there is clear diastasis or instability of the syndesmosis. Traditionally, screws were used for surgical fixation; however, they often required a second surgery for subsequent removal. There is no general consensus on the optimal screw size, level of placement, or timing of removal.50,51 More recently, non-absorbable suture button fixation (eg, TightRope; Arthrex) has become more popular and provides certain advantages over screw fixation, such as avoiding the need for hardware removal. TightRope has been shown to provide more accurate stabilization of the syndesmosis as compared with screw fixation.52 Since malreduction is the most important indicator of poor long-term functional outcome, suture button fixation should be considered in the treatment of the football player.53 Finally, Colcuc and colleagues54 reported a lower complication rate and earlier return to sports in patients treated with knotless suture button devices compared with screw fixation.
OSTEOCHONDRAL LESIONS
Osteochondral lesions (OCLs) are cartilage-bone defects that are usually located in the talus. They can be caused by an acute traumatic event or repetitive microtrauma with no apparent history of trauma (eg, ankle instability). Acute OCLs can occur in soccer secondary to an ankle sprain or ankle fracture. Symptoms of OCLs include pain, swelling, and mechanical symptoms such as catching or locking, and on physical examination, one might see an effusion. The initial imaging modality of choice is radiographing; however, in ankle sprains with continued pain and swelling MRI may be indicated to rule out an underlying OCL. Missed acute lesions have a tendency not to heal and become chronic lesions, which can cause pain and playing disability. It is well established that chronic ankle instability is an important etiologic factor for OCLs. With the normal hydrostatic pressure within the ankle joint, synovial fluid gets pushed into cartilage/bone fissures, which can then lead to cystic degeneration of the subchondral bone.55-57
Surgical repair of an OCL is dependent on both the size and location of the lesion. Acute lesions can be managed by arthroscopic débridement, microfracture, or fixation of the lesion if enough bone remains attached to the chondral lesion. Return to play is based on development and maturation of fibrocartilage over the lesion (debridement/microfracture) or healing and incorporation of the new graft (chondral repair procedures). Meanwhile, chronic lesions can be managed in 1-stage (microfracture, osteochondral autograft transfer or 2-stage (autologous chondrocyte implantation [ACI]) procedures.56-57 Additional biologic healing augmentation with platelet-rich plasma has been described as well.58 Newer techniques in treating chronic talus OCLs, including ones that have failed to respond to bone marrow stimulation techniques, have been developed more recently such as the use of particulated juvenile articular cartilage allograft (DeNovo NT Natural Tissue Graft®; Zimmer Biomet).59 These newer techniques avoid the need for a 2-stage procedure, as is the case with ACI.
Continue to: Further studies are needed...
Further studies are needed to both investigate long-term outcomes and determine the superiority of the arthroscopic juvenile cartilage procedure compared with microfracture and other cartilage resurfacing procedures. When surgically treating OCLs, one must also restore normal ankle joint biomechanics for the lesion to heal. For instance, in the presence of ankle instability, ligament reconstruction must be performed. Also, one should also consider addressing any hindfoot malalignment with an osteotomy (calcaneus, supramalleolar). In a recent retrospective study, van Eekeren and colleagues60 showed that approximately 76% of patients were able to return to sports at long-term follow-up after arthroscopic débridement and bone marrow stimulation of talar OCLs. However, the activity level decreased at long-term follow-up and never attained the pre-injury level.60
ANKLE IMPINGEMENT
ANTERIOR ANKLE IMPINGEMENT (FOOTBALLER'S ANKLE)
Anterior ankle impingement is caused by anterior osteophytes on both the distal tibia and talar neck. It is thought to be related to repetitive microtrauma to the anteromedial aspect of the ankle from recurrent ball impact.61 It is very common amongst soccer players with some studies suggesting that 60% of soccer players have this syndrome. Ankle impingement is characterized by anterior pain with ankle dorsiflexion, decreased dorsiflexion, and swelling. It is primarily diagnosed with lateral ankle X-rays, which will show the osteophytes. An oblique anteromedial X-ray may increase detection of osteophytes (Figure 5). The early stages of anterior impingement can be treated successfully with injections and heel lifts. Treatment of lesions that fail to respond to conservative management involves arthroscopic or open excision of osteophytes. Most patients with no preexisting osteoarthritis treated arthroscopically will experience pain relief and return to full activity, though recurrent osteophyte formation has been noted at long-term follow-up.62
Anterior ankle impingement is most often caused by acute ankle sprains with an inversion type of mechanism.62 The subsequent reactive inflammation can cause fibrosis leading to distal fascicle enlargement of the AITFL. Impingement in the anterolateral gutter of this enlarged fascicle can also cause both chronic reactive synovitis and chondromalacia of the lateral talar dome.63 MRI can identify abnormal areas of pathology; however, 50% of cases are diagnosed based on clinical examination alone.63 Patients generally present with a history of anterolateral ankle pain and swelling with an occasional popping or snapping sensation.
Soccer players commonly develop anterior bony impingement due to repetitive loading of the anterior ankle from striking the ball. This repetition can lead to osteophyte formation of the anterior distal tibia and talar neck. After the osteophytes form, decreased dorsiflexion can occur due to a mechanical stop and inflammation of the interposed capsule.
The patient will exhibit tenderness to palpation along the anterolateral aspect of the ankle, with pain elicited at extreme passive dorsiflexion.62 Initially, an injection with local anesthetic and corticosteroid can serve both a diagnostic and therapeutic purpose; however, patients who fail conservative treatment can be treated with arthroscopy and resection of the involved scar tissue and osteophytes. The best results are seen in those patients with no concurrent intra-articular lesions or ankle osteoarthritis (Figure 5).62 When treated non-operatively, a player may return to play when pain resolves; however, if treated surgically with arthroscopic debridement/resection, a player must wait until his surgical scars have healed prior to attempting return to play.
Continue to: ANTEROMEDIAL ANKLE IMPINGEMENT
ANTEROMEDIAL ANKLE IMPINGEMENT
Anteromedial ankle impingement is a less common ankle impingement syndrome. It is associated with eversion injuries or following medial malleolar or talar fractures.64,65 Previous injury to the anterior tibiotalar fascicle of the deltoid complex leads to ligament thickening and subsequent impingement in the anteromedial corner of the talus. Adjacent fibrosis and synovitis are common consequences of impingement; however, osteophyte formation and chondral stripping along the anteromedial talus can also be seen. Patients typically complain of pain along the anteromedial joint line that is worse with activity, clicking or popping sensations, and painful, limited dorsiflexion. On examination, impingement can be detected through palpation over the anterior tibiotalar fascicle of the deltoid ligament and eversion or extreme passive dorsiflexion of the foot, all of which will elicit medial ankle tenderness.17,62 Initial treatment consists of rest, physical therapy, and NSAIDs. Refractory cases may be amenable to arthroscopic or open resection of the anterior tibiotalar fascicle with débridement of any adjacent synovitis and scar tissue.62
POSTERIOR ANKLE IMPINGEMENT
Posterior ankle impingement is often referred to as “os trigonum syndrome” since the posterior impingement is frequently associated with a prominent os trigonum. An os trigonum is an accessory ossicle representing the separated posterolateral tubercle of the talus. It is usually asymptomatic. However, in soccer players, pain can occur from impaction between the posterior tibial plafond and the os trigonum, or because of soft tissue compression between the 2 opposing osseous structures. The pain is due to repetitive microtrauma (ankle plantarflexion) or acute forced plantarflexion, which can present as an acute fracture of the os trigonum. Because soccer is a sport requiring both repetitive and extreme plantarflexion, it may predispose players to posterior ankle impingement (Figures 6A, 6B).62,66
Clinically, it can be very difficult to detect and diagnose because the affected structures lie deep and it can coexist with other disease processes (eg, peroneal tendinopathy, Achilles tendinopathy).62,66 Patients will complain of chronic deep posterior ankle pain that is worse with push-off activities (eg, jumping). On examination, patients will exhibit pain with palpation over the posterolateral process and with the crunch test. Lateral radiograph with the foot in plantar flexion will show the os trigonum impinged between the posterior tibial malleolus and the calcaneal tuberosity. An MRI will demonstrate the os trigonum as well as any associated inflammation and edema, while it can also demonstrate coexisting pathologies.
Initial treatment consists of rest, NSAIDs, and taping to prevent plantar flexion. Ultrasound-guided cortisone injection of the capsule and posterior bursa can be both therapeutic and diagnostic. A posterior injection can be used to temporize the symptoms so that the soccer player can make it through the season.
Surgical excision is saved for refractory cases, and this can be done either through an open posterolateral approach or arthroscopic techniques. Recently, Georgiannos and Bisbinas67 showed in an athletic population that endoscopic excision had both a lower complication rate and a quicker return to sports compared with the traditional open approach. Carreira and colleagues68 conducted a retrospective case series of 20 patients (mostly competitive athletes). They found that posterior ankle arthroscopy to address posterior impingement allowed for the maintenance or restoration of anatomic ROM of the ankle and hindfoot, ability to return to at least the previous level of activity, and improvement in objective assessment of pain relief and a higher level of function parameters.68
Continue to: TENDON PATHOLOGY
TENDON PATHOLOGY
SUPERIOR PERONEAL RETINACULUM INJURY
The superior peroneal retinaculum (SPR) forms the roof of the superior peroneal tunnel. The tunnel contains the peroneus brevis and longus tendons and is bordered by the retromalleolar groove of the fibula and the lower aspect of the posterior intramuscular septum of the leg.69,70 The SPR originates from the posterolateral ridge of the fibula and inserts onto the lateral calcaneus, and it is the primary restraint of the peroneal tendons within the retromalleolar sulcus.
Injury to the retinaculum results from both ankle dorsiflexion and inversion, and forceful reflex contraction of the peroneal muscles, which causes subluxation or dislocation of the contained tendons.69 A high level of suspicion is required regarding these injuries since the mechanism of injury is similar to that of a simple lateral ankle sprain. In the setting of retrofibular pain, snapping or popping sensations around the lateral malleolus, or chronic ankle instability that worsens on uneven surfaces, one must consider an injury to the SPR.69 Radiographs are not always diagnostic; however, occasionally on an internal rotation view, one may see a cortical avulsion off the distal tip of the lateral malleolus (“fleck sign”) indicating a rim fracture from an SPR injury (Figure 7). MRI is the best imaging modality to assess the peroneal tendons, as well as an SPR injury. Recently, ultrasound has grown in popularity and may be more useful, since it allows for dynamic evaluation of subluxating/dislocating tendons.69
Conservative management is often associated with poor outcomes, and surgery is indicated for all acute and chronic dislocations in athletes.71 Anatomic reconstruction of the SPR is the preferred surgical method.72 Peroneus brevis debulking and fibular groove deepening may also augment the retinaculum repair.73 van Dijk and colleagues in their systematic review showed that patients treated with both groove deepening and SPR repair have higher rates of return to the sport than patients treated with SPR repair alone.74
STRESS FRACTURES
FIFTH METATARSAL
Fifth metatarsal stress fractures usually occur secondary to lateral overload or avulsion of the peroneus brevis. The fifth metatarsal base can be susceptible to injury in a cavovarus foot. Non-operative treatment typically requires a longer period of immobilization (boot or cast) and necessitates a longer period of non–weight-bearing (anywhere between 6-12 weeks). Therefore, surgery is typically recommended in athletes or in the setting of a recurrent base of the fifth metatarsal fracture to expedite healing and return to play. Return to play is still not recommended until there is evidence of radiographic healing of the fracture. There are certain distinctions with fifth metatarsal stress fractures regarding location and healing rates that need to be taken into account.75,76 In particular, zone 2 injuries (Jones fractures) represent a vascular watershed area, making these fractures prone to nonunion with nonunion rates as high as 15% to 30%. Occasionally, the cavovarus deformity will require correction as well as a reduction in the risk of recurrence or nonunion. Surgical fixation most commonly consists of a single screw placed in an antegrade fashion.77 One must pay attention to screw size since smaller diameter screws (<4.5 mm) are associated with delayed union or nonunion. Moreover, screws that are too long will straighten the curved metatarsal shaft and can lead to fracture distraction or malreduction (Figures 8A, 8B).77
Patients have returned to competitive sports within 6 weeks; however, it should be noted that causes of failure were linked to early return and return to sports before a radiographic union can lead to failure of fixation. Ekstrand and van Dijk78 studied a large group of professional soccer players and found that out of 13,754 injuries, 0.5% (67) were fifth metatarsal fractures. Of note, they found that 45% of players had prodromal symptoms. Furthermore, after surgical treatment the fractures healed faster, compared with conservative treatment (75% vs 33%); however, there was no significant difference in lay-off days between both groups (80 vs 74 days).78 Matsuda and colleagues79 looked at 335 male collegiate soccer players, 29 of whom had a history of a fifth metatarsal stress fracture. They found that playing the midfield position and having an everted rearfoot and inverted forefoot alignment were associated with fifth metatarsal stress fractures.79 Saita and colleagues80 found that restricted hip internal rotation was associated with an increased risk of developing a Jones fracture in 162 professional football players. Finally, Fujitaka and colleagues81 looked at 273 male soccer players between 2005 and 2013. They found an association between weak toe-grip strength and fifth metatarsal fractures, suggesting that weak toe-grip may lead to an increase in the load applied onto the lateral side of the foot, resulting in a stress fracture.81
Continue to: NAVICULAR
NAVICULAR
Another common tarsal bone that sustains stress fractures is the navicular. It is not as common as calcaneal stress fractures in military recruits but can occur in the same type of population, as well as explosive athletics such as sprinters and soccer players. It commonly presents with an indistinct vague achy pain with activity that improves with rest, and pain at the dorsum of the midfoot or along the medial longitudinal arch with activity. It can easily go undiagnosed for quite some time given the difficulty in visualizing the navicular with plain radiographs. Clinically, it is difficult to make the diagnosis, and therefore advanced imaging is necessary when the injury is suspected. Both MRI and CT scans can be used to understand the extent of the injury (Figures 9A-9C). In non-displaced stress fractures, conservative non-operative treatment is the appropriate treatment modality with a brief period of immobilization and non–weight-bearing;82 however, operative treatment is also considered in elite athletes. In either case, return to play is discouraged until there is evidence of radiographic healing. When a displacement is noted, or there is a delay in diagnosis, then operative treatment is recommended.
CONCLUSION
Ankle injuries are very common in soccer and can result in decreased performance or significant loss of playing time. Treatment of acute injury generally follows a conservative route, with surgical intervention reserved for severe ruptures or osteochondral fracture of the ankle joint. Chronic ankle pathology resulting in mechanical or functional instability generally requires surgery to repair ligamentous damage and restore normal ankle kinematics. It is critical for the soccer player to receive appropriate rehabilitation prior to returning to play in order to reduce the risk for reinjury and further chronic instability. Prevention and early intervention of ankle injuries is key in preventing the long-term sequelae of ankle injuries, such as arthritis, in former soccer players.
1. Dvorak J, Junge A. Football injuries and physical symptoms. A review of the literature. Am J Sports Med. 2000;28(5 Suppl):S3-S9.
2. Chomiak J, Junge A, Peterson L, Dvorak J. Severe injuries in football players. Am J Sports Med. 2000;28(5 Suppl):S58-S68.
3. Cloke DJ, Ansell P, Avery P, Deehan D. Ankle injuries in football academies: a three-centre prospective study. Br J Sports Med. 2011;45(9):702-708. doi:10.1136/bjsm.2009.067900.
4. Cloke DJ, Spencer S, Hodson A, Deehan D. The epidemiology of ankle injuries occurring in English Football Association academies. Br J Sports Med. 2009;43(14):1119-1125. doi:10.1136/bjsm.2008.052050.
5. Dvorak J, Junge A, Derman W, Schwellnus M. Injuries and illnesses of football players during the 2010 FIFA World Cup. Br J Sports Med. 2011;45(8):626-630. doi:10.1136/bjsm.2010.079905.
6. Ekstrand J, Gillquist J. Soccer injuries and their mechanisms: a prospective study. Med Sci Sports Exerc. 1983;15(3):267-270.
7. Fousekis K, Tsepis E, Vagenas G. Intrinsic risk factors of noncontact ankle sprains in soccer: a prospective study on 100 professional players. Am J Sports Med. 2012;40(8):1842-1850. doi:10.1177/0363546512449602.
8. Gaulrapp H, Becker A, Walther M, Hess H. Injuries in women’s soccer: a 1-year all players prospective field study of the women’s Bundesliga (German premiere league). Clin J Sports Med. 2010;20(4):264-271. doi:10.1097/JSM.0b013e3181e78e33.
9. Morgan BE, Oberlander MA. An examination of injuries in major league soccer. The inaugural season. Am J Sports Med. 2001;29(4):426-430. doi:10.1177/03635465010290040701.
10. Jain N, Murray D, Kemp S, Calder J. Frequency and trends in foot and ankle injuries within an English Premier League Football Club using a new impact factor of injury to identify a focus for injury prevention. Foot Ankle Surg. 2014;20(4):237-240. doi:10.1016/j.fas.2014.05.004.
11. Moore KL, Dalley AF, Agur AMR. Clinically Oriented Anatomy. 6th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2010:xxix, 1134.
12. Thompson JC, Netter FH. Netter’s Concise Orthopaedic Anatomy. 2nd ed. Philadelphia, PA: Saunders Elsevier, 2010:x, 404.
13. Giza E, Mandelbaum B. Chronic footballer’s ankle. In: Football Traumatology. Springer Milan, 2006:333-351.
14. Garrick JG. The frequency of injury, mechanism of injury, and epidemiology of ankle sprains. Am J Sports Med. 1977:5(6):241-242. doi:10.1177/036354657700500606.
15. Agur AMR, Grant JCB. Grant’s Atlas of Anatomy. 13th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2011.
16. Renstrom PA, Konradsen L. Ankle ligament injuries. Br J Sports Med. 1997;31(1):11-20.
17. Chhabra A, Subhawong TK, Carrino JA. MR imaging of deltoid ligament pathologic findings and associated impingement syndromes. Radiographics. 2010;30(3):751-761. doi:10.1148/rg.303095756.
18. Hintermann B. Medial ankle instability. Foot Ankle Clin. 2003;8(4):723-738.
19. Woods C, Hawkins R, Hulse M, Hodson A. The Football Association Medical Research Programme: an audit of injuries in professional football: an analysis of ankle sprains. Br J Sports Med. 2003;37(3):233-238.
20. Thacker SB, Stroup DF, Branche CM, Gilchrist J, Goodman RA, Weitman EA. The prevention of ankle sprains in sports. A systematic review of the literature. Am J Sports Med. 1999;27(6):753-760. doi:10.1177/03635465990270061201.
21. Giza E, Fuller C, Junge A, Dvorak J. Mechanisms of foot and ankle injuries in soccer. Am J Sports Med. 2003;31(4):550-554. doi:10.1177/03635465030310041201.
22. Tucker AM. Common soccer injuries. Diagnosis, treatment and rehabilitation. Sports Med. 1997;23(1):21-32.
23. Lynch SA, Renstrom PA. Treatment of acute lateral ankle ligament rupture in the athlete. Conservative versus surgical treatment. Sports Med. 1999;27(1):61-71.
24. Chan KW, Ding BC, Mroczek KJ. Acute and chronic lateral ankle instability in the athlete. Bull NYU Hosp Jt Dis. 2011;69(1):17-26.
25. Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. 1992;21(4):384-390.
26. Bachmann LM, Kolb E, Koller MT, Steurer J, ter Riet G. Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ. 2003;326(7386):417. doi:10.1136/bmj.326.7386.417.
27. Balduini FC, Vegso JJ, Torg JS, Torg E. Management and rehabilitation of ligamentous injuries to the ankle. Sports Med. 1987;4(5):364-380.
28. Kerkhoffs GM, Rowe BH, Assendelft WJ, Kelly KD, Struijs PA, van Dijk CN. Immobilisation for acute ankle sprain. A systematic review. Arch Orthop Trauma Surg. 2001;121(8):462-471.
29. Konradsen L, Holmer P, Sondergaard L. Early mobilizing treatment for grade III ankle ligament injuries. Foot Ankle. 1991;12(2):69-73.
30. Eiff MP, Smith AT, Smith GE. Early mobilization versus immobilization in the treatment of lateral ankle sprains. Am J Sports Med. 1994;22(1):83-88. doi:10.1177/036354659402200115.
31. Shrier I. Treatment of lateral collateral ligament sprains of the ankle: a critical appraisal of the literature. Clin J Sport Med. 1995;5(3):187-195.
32. DiGiovanni BF, Partal G, Baumhauer JF. Acute ankle injury and chronic lateral instability in the athlete. Clin Sports Med. 2004;23(1):1-19, v. doi:10.1016/S0278-5919(03)00095-4.
33. Alt W, Lohrer H, Gollhofer A. Functional properties of adhesive ankle taping: neuromuscular and mechanical effects before and after exercise. Foot Ankle Int. 1999;20(4):238-245. doi:10.1177/107110079902000406.
34. Garrick JG, Requa RK. Role of external support in the prevention of ankle sprains. Med Sci Sports. 1973;5(3):200-203.
35. Sharpe SR, Knapik J, Jones B. Ankle braces effectively reduce recurrence of ankle sprains in female soccer players. J Athl Train. 1997;32(1):21-24.
36. Surve I, Schwellnus MP, Noakes T, Lombard C. A fivefold reduction in the incidence of recurrent ankle sprains in soccer players using the Sport-Stirrup orthosis. Am J Sports Med. 1994;22(5):601-606. doi:10.1177/036354659402200506.
37. Mohammadi F. Comparison of 3 preventive methods to reduce the recurrence of ankle inversion sprains in male soccer players. Am J Sports Med. 2007;35(6):922-926. doi:10.1177/0363546507299259.
38. Steffen K, Meeuwisse WH, Romiti M, et al. Evaluation of how different implementation strategies of an injury prevention programme (FIFA 11+) impact team adherence and injury risk in Canadian female youth football players: a cluster-randomised trial. Br J Sports Med. 2013;47(8):480-487. doi:10.1136/bjsports-2012-091887.
39. Steffen K, Emery CA, Romiti M, et al. High adherence to a neuromuscular injury prevention programme (FIFA 11+) improves functional balance and reduces injury risk in Canadian youth female football players: a cluster randomised trial. Br J Sports Med. 2013;47(12):794-802. doi: 10.1136/bjsports-2012-091886.
40. Junge A, Lamprecht M, Stamm H, et al. Countrywide campaign to prevent soccer injuries in Swiss amateur players. Am J Sports Med. 2011;39(1):57-63. doi:10.1177/0363546510377424.
41. Lin CF, Gross ML, Weinhold P. Ankle syndesmosis injuries: anatomy, biomechanics, mechanism of injury, and clinical guidelines for diagnosis and intervention. J Orthop Sports Phys Ther. 2006;36(6):372-384. doi:10.2519/jospt.2006.2195.
42. Lubberts B, D’Hooghe P, Bengtsson H, DiGiovanni CW, Calder J, Ekstrand J. Epidemiology and return to play following isolated syndesmotic injuries of the ankle: a prospective cohort study of 3677 male professional football players in the UEFA Elite Club Injury Study. Br J Sports Med. 2017. doi:10.1136/bjsports-2017-097710.
43. Harper MC, Keller TS. A radiographic evaluation of the tibiofibular syndesmosis. Foot Ankle. 1989;10(3):156-160.
44. Vogl TJ, Hochmuth K, Diebold T, et al. Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol. 1997;32(7):401-409.
45. Brown KW, Morrison WB, Schweitzer ME, Parellada JA, Nothnagel H. MRI findings associated with distal tibiofibular syndesmosis injury. AJR Am J Roentgenol. 2004;182(1):131-136. doi:10.2214/ajr.182.1.1820131.
46. Ogilvie-Harris DJ, Reed SC, Hedman TP. Disruption of the ankle syndesmosis: biomechanical study of the ligamentous restraints. Arthroscopy. 1994;10(5):558-560.
47. Boytim MJ, Fischer DA, Neumann L. Syndesmotic ankle sprains. Am J Sports Med. 1991;19(3):294-298. doi:10.1177/036354659101900315.
48. Hopkinson WJ, St Pierre P, Ryan JB, Wheeler JH. Syndesmosis sprains of the ankle. Foot Ankle. 1990;10(6):325-330. doi:10.1177/107110079001000607.
49. Del Buono A, Florio A, Boccanera MS, Maffulli N. Syndesmosis injuries of the ankle. Curr Rev Musculoskelet Med. 2013;6(4):313-319. doi:10.1007/s12178-013-9183-x.
50. Dattani R, Patnaik S, Kantak A, Srikanth B, Selvan TP. Injuries to the tibiofibular syndesmosis. J Bone Joint Surg Br. 2008;90(4):405-410. doi:10.1302/0301-620X.90B4.19750.
51. Schepers T. To retain or remove the syndesmotic screw: a review of literature. Arch Orthop Trauma Surg. 2011;131(7):879-883. doi:10.1007/s00402-010-1225-x.
52. Naqvi GA, Cunningham P, Lynch B, Galvin R, Awan N. Fixation of ankle syndesmotic injuries: comparison of tightrope fixation and syndesmotic screw fixation for accuracy of syndesmotic reduction. Am J Sports Med. 2012;40(12):2828-2835. doi:10.1177/0363546512461480.
53. Weening B, Bhandari M. Predictors of functional outcome following transsyndesmotic screw fixation of ankle fractures. J Orthop Trauma. 2005;19(2):102-108.
54. Colcuc C, Blank M, Stein T, et al. Lower complication rate and faster return to sports in patients with acute syndesmotic rupture treated with a new knotless suture button device. Knee Surg Sports Traumatol Arthrosc. 2017. doi:10.1007/s00167-017-4820-4823.
55. Savage-Elliott I, Ross KA, Smyth NA, Murawski CD, Kennedy JG. Osteochondral lesions of the talus: a current concepts review and evidence-based treatment paradigm. Foot Ankle Spec. 2014;7(5):414-422. doi:10.1177/1938640014543362.
56. Talusan PG, Milewski MD, Toy JO, Wall EJ. Osteochondritis dissecans of the talus: diagnosis and treatment in athletes. Clin Sports Med. 2014;33(2):267-284. doi:10.1016/j.csm.2014.01.003.
57. Murawski CD, Kennedy JG. Operative treatment of osteochondral lesions of the talus. J Bone Joint Surg Am. 2013;95(11):1045-1054. doi:10.2106/JBJS.L.00773.
58. Guney A, Akar M, Karaman I, Oner M, Guney B. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2384-2389. doi:10.1007/s00167-013-2784-5.
59. Hatic SO, Berlet GC. Particulated juvenile articular cartilage graft (DeNovo NT Graft) for treatment of osteochondral lesions of the talus. Foot Ankle Spec. 2010;3(6):361-364. doi:10.1177/1938640010388602.
60. van Eekeren IC, van Bergen CJ, Sierevelt IN, Reilingh ML, van Dijk CN. Return to sports after arthroscopic debridement and bone marrow stimulation of osteochondral talar defects: a 5- to 24-year follow-up study. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1311-1315. doi:10.1007/s00167-016-3992-6.
61. Tol JL, Slim E, van Soest AJ, van Dijk CN. The relationship of the kicking action in soccer and anterior ankle impingement syndrome. A biomechanical analysis. Am J Sports Med. 2002;30(1):45-50. doi:10.1177/03635465020300012101.
62. Sanders TG, Rathur SK. Impingement syndromes of the ankle. Magn Reson Imaging Clin N Am. 2008;16(1):29-38. doi:10.1016/j.mric.2008.02.005.
63. Ogilvie-Harris DJ, Gilbart MK, Chorney K. Chronic pain following ankle sprains in athletes: the role of arthroscopic surgery. Arthroscopy. 1997;13(5):564-574.
64. Robinson P, White LM, Salonen D, Ogilvie-Harris D. Anteromedial impingement of the ankle: using MR arthrography to assess the anteromedial recess. AJR Am J Roentgenol. 2002;178(3):601-604. doi:10.2214/ajr.178.3.1780601.
65. Mosier-La Clair SM, Monroe MT, Manoli A. Medial impingement syndrome of the anterior tibiotalar fascicle of the deltoid ligament on the talus. Foot Ankle Int. 2000;21(5):385-391.
66. Maquirriain J. Posterior ankle impingement syndrome. J Am Acad Orthop Surg. 2005;13(6):365-371.
67. Georgiannos D, Bisbinas I. Endoscopic versus open excision of os trigonum for the treatment of posterior ankle impingement syndrome in an athletic population: a randomized controlled study with 5-year follow-up. Am J Sports Med. 2017;45(6):1388-1394. doi:10.1177/0363546516682498.
68. Carreira DS, Vora AM, Hearne KL, Kozy J. Outcome of arthroscopic treatment of posterior impingement of the ankle. Foot Ankle Int. 2016;37(4):394-400. doi:10.1177/1071100715620857.
69. Roth JA, Taylor WC, Whalen J. Peroneal tendon subluxation: the other lateral ankle injury. Br J Sports Med. 2010;44(14):1047-1053. doi:10.1136/bjsm.2008.057182.
70. Athavale SA, Swathi, Vangara SV. Anatomy of the superior peroneal tunnel. J Bone Joint Surg Am. 2011;93(6):564-571. doi:10.2106/JBJS.17.00836.
71. Porter D, McCarroll J, Knapp E, Torma J. Peroneal tendon subluxation in athletes: fibular groove deepening and retinacular reconstruction. Foot Ankle Int. 2005;26(6):436-441.
72. Ferran NA, Oliva F, Maffulli N. Recurrent subluxation of the peroneal tendons. Sports Med. 2006;36(10):839-846. doi:10.1053/j.jfas.2010.02.007.
73. Saxena A, Ewen B. Peroneal subluxation: surgical results in 31 athletic patients. J Foot Ankle Surg. 2010;49(3):238-241.
74. van Dijk PA, Gianakos AL, Kerkhoffs GM, Kennedy JG. Return to sports and clinical outcomes in patients treated for peroneal tendon dislocation: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1155-1164. doi:10.1007/s00167-015-3833-z.
75. Lee KT, Park YU, Young KW, Kim JS, Kim JB. The plantar gap: another prognostic factor for fifth metatarsal stress fracture. Am J Sports Med. 2011;39(10):2206-2211. doi:10.1177/0363546511414856.
76. Torg JS. Fractures of the base of the fifth metatarsal distal to the tuberosity. Orthopedics. 1990;13:731-737.
77. Smith TO, Clark A, Hing CB. Interventions for treating proximal fifth metatarsal fractures in adults: a meta-analysis of the current evidence-base. Foot Ankle Surg. 2011;17(4):300-307. doi:10.1016/j.fas.2010.12.005.
78. Ekstrand J, van Dijk CN. Fifth metatarsal fractures among male professional footballers: a potential career-ending disease. Br J Sports Med. 2013;47(12):754-758.
79. Matsuda S, Fukubayashi T, Hirose N. Characteristics of the foot static alignment and the plantar pressure associated with fifth metatarsal stress fracture history in male soccer players: a case-control study. Sports Med Open. 2017;3(1):27.
80. Saita Y, Nagao M, Kawasaki T, et al. Range limitation in hip internal rotation and fifth metatarsal stress fractures (Jones fracture) in professional football players. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):1943-1949. doi:10.1007/s00167-017-4552-4.
81. Fujitaka K, Taniguchi A, Isomoto S, et al. Pathogenesis of fifth metatarsal fractures in college soccer players. Orthop J Sports Med. 2015;18;3(9):2325967115603654.
82. Torg J, Moyer J, Gaughan J, Boden B. Management of tarsal navicular stress fractures: conservative versus surgical treatment: a meta-analysis. Am J Sports Med. 2010;38(5):1048-1053.
83. Haytmanek CT, Williams BT, James EW, et al. Radiographic identification of the primary lateral ankle structures. Am J Sports Med. 2015;43(1):79-87. doi:10.1177/0363546514553778.
ABSTRACT
The ankle is one of the most commonly injured joints in soccer and represents a significant cost to the healthcare system. The ligaments that stabilize the ankle joint determine its biomechanics—alterations of which result from various soccer-related injuries. Acute sprains are among the most common injury in soccer players and are generally treated conservatively, with emphasis placed on secondary prevention to reduce the risk for future sprains and progression to chronic ankle instability. Repetitive ankle injuries in soccer players may cause chronic ankle instability, which includes both mechanical ligamentous laxity and functional changes. Chronic ankle pathology often requires surgery to repair ligamentous damage and remove soft-tissue or osseous impingement. Proper initial treatment, rehabilitation, and secondary prevention of ankle injuries can limit the amount of time lost from play and avoid negative long-term sequelae (eg, osteochondral lesions, arthritis). On the other hand, high ankle sprains portend a poorer prognosis and a longer recovery. These injuries will typically require surgical stabilization. Impingement-like syndromes of the ankle can undergo an initial trial of conservative treatment; when this fails, however, soccer players respond favorably to arthroscopic debridement of the lesions causing impingement. Finally, other pathologies (eg, stress fractures) are highly encouraged to be treated with surgical stabilization in elite soccer players.
Continue to: EPIDEMIOLOGY
EPIDEMIOLOGY
With roughly 200,000 professional and around 240 million amateur soccer players, soccer has been recognized as the most popular sport worldwide. Nevertheless, given its rising popularity in society, one must also consider the increasing incidence of injuries as a result. Elite soccer players sustain between 10 and 35 injuries per 1000 competitive playing hours.1 Approximately 80% are traumatic, and 20% are overuse injuries.2 Soccer injuries are more frequent with increasing age of the participants, whereas the incidence of injuries in preadolescent players is low. The incidence of injuries has been found to be higher during competition when compared with practice/training sessions, with some studies showing that 59% of injuries occurred during games.2 Amateur or recreational soccer players sustain fewer injuries than professional soccer players, as one would expect, given both the higher intensity of training and match schedule in professionals.
The ankle is one of the most commonly injured joints in soccer, with some studies suggesting it comprises one-fifth of all injuries sustained during soccer, which is only second to those of the knee.2 Ankle sprains specifically are quite a common occurrence in soccer.3-9 A recent study of an English premier league club showed that over a 4-season period, 20% of injuries were of the foot and ankle with a mean return to sport time of 54 days.10 Of all foot and ankle related injuries, ankle sprains are the most common, followed by bruises/contusions, and tendon lesions. Fractures are very rare (1%) in soccer, but when they do occur they impart a much more extended recovery. During the 2010 Fédération Internationale de Football Association (FIFA) World Cup, ankle sprains were among the most common injuries and approximately half lead to players missing training or competitive matches.5
ANATOMY
Knowledge of the biomechanics of both the foot and ankle joints is essential to understand soccer injuries. The ankle joint (talocrural articulation) consists of the distal ends of the tibia and fibula, which form the mortise, and the superior aspect of the talar dome.11 As a hinge joint, the ankle provides 20° of dorsiflexion and 50° of plantar flexion,12 with stability provided by the lateral, medial, and superior ligamentous complexes. The superior articular surface of the talus is narrower posteriorly, which creates a looser fit within the mortise during plantar flexion.11 This decreased stability could help explain why the most common injury in soccer involves a plantar flexion mechanism.13,14 Inferiorly, the talus articulates with the calcaneus to form the subtalar joint. It is at this site that the majority of both foot inversion and eversion occurs. The transverse tarsal joints (Chopart’s joints) separate the hindfoot from the midfoot. Movement of this joint depends on the relative alignment of its 2 articulations: the talonavicular and calcaneocuboid joints. During foot eversion, these 2 joints are parallel to each other allowing supple motion and aiding in shock absorption during the heel strike phase of the gait cycle. With foot inversion, the joints become nonparallel and thus lock the transverse tarsal joints providing a rigid lever needed for push-off.11,12
LATERAL LIGAMENTS
The ankle joint is stabilized laterally by a ligament complex consisting of 3 individual ligaments, all originating from the lateral malleolus: the anterior talofibular ligament (ATFL), the posterior talofibular ligament (PTFL), and the calcaneofibular ligament (CFL) (Figure 1).11,12,15 The ATFL is the primary restraint to inversion in plantar flexion, and it helps resist anterolateral translation of the talus in the mortise. However, it is the weakest and therefore the most frequently injured of the lateral ligaments. The PTFL plays only a supplementary role in ankle stability when the lateral ligament complex is intact. It is under the greatest strain in ankle dorsiflexion and acts to limit posterior talar displacement within the mortise as well as talar external rotation.13,16 The CFL is the primary restraint to inversion in the neutral or dorsiflexed position. It restrains subtalar inversion, thereby limiting talar tilt within the mortise.
DELTOID LIGAMENT
The deltoid ligament complex consists of 6 continuous adjacent superficial and deep ligaments that function synergistically to resist valgus and pronation forces, as well as external rotation of the talus in the mortise.11-13,17 The superficial layer crosses both ankle and subtalar joints. It originates from the anterior colliculus and fans out to insert into the navicular, neck of the talus, sustentaculum tali, and posteromedial talar tubercle. The tibiocalcaneal (sustentaculum tali) portion is the strongest component in the superficial layer and resists calcaneal eversion. The deep layer crosses the ankle joint only. It functions as the primary stabilizer of the medial ankle and prevents both lateral displacement and external rotation of the talus. It originates from the inferior and posterior aspects of the medial malleolus and inserts on the medial and posteromedial aspects of the talus.12,17,18
Continue to: SYNDESMOSIS
SYNDESMOSIS
The ankle syndesmosis, or inferior tibiofibular joint, is the distal articulation between the tibia and fibula. The syndesmosis contributes to ankle mortise integrity through its firm fixation of the lateral malleolus against the lateral surface of the talus. Ligaments comprising the ankle syndesmosis include the anterior inferior tibiofibular ligament (AITFL), the posterior inferior tibiofibular ligament (PITFL), the inferior transverse ligament, and the interosseous ligament (IOL).12
ANKLE SPRAINS
Ankle sprains are the most common pathology encountered amongst soccer players, representing from one-half to two-thirds of all ankle related injuries. Most sprains occur outside of player contact.
LATERAL ANKLE SPRAINS AND INSTABILITY
Injury to the lateral ligaments of the ankle represents 77% to 91% of all ankle sprains in soccer.6,19 The greatest risk factor for an ankle sprain in a soccer player is a history of prior sprain.20 Other risk factors include increasing age, player-to-player contact, condition of the pitch, weight-bearing status of the injured limb at the time of injury, and joint instability or laxity.21,22
The evaluation of an ankle sprain to determine its severity is best done after the acute phase, approximately 4 to 7 days after the initial injury when both pain and swelling have subsided.23 The anterior drawer (ATFL instability) and talar tilt (CFL instability) tests are useful in evaluating ankle instability in the delayed or chronic setting; however, both have been shown to have limited sensitivity and significant variability amongst different examiners.24
Clinical examination will direct further diagnostic tests including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT). The Ottawa ankle rules are generally helpful in determining whether plain X-rays are indicated in the acute setting.25,26 (Figure 2) According to these rules, ankle radiographs should be obtained if ankle pain is reported near the malleoli and 1 or more of the following is seen during examination: inability to bear weight immediately after injury and for 4 steps in the emergency department, and bony tenderness at the posterior edge or tip of the malleolus. Stress X-rays are generally not indicated in acute injuries but may be useful in chronic ankle instability cases.23
Continue to: Ankle sprains cover...
Ankle sprains cover a broad spectrum of injuries; therefore, a grading system was devised to aid in guiding treatment. Grade I (mild) sprains are those with minimal swelling and tenderness but have the ligaments still intact. Grade II (moderate) sprains occur when there are partial ligament tears associated with moderate pain, swelling, and tenderness. Finally, Grade III (severe) sprains are complete ligament tears with marked swelling, hemorrhage, tenderness, loss of function, and abnormal joint motion and instability.23, 24
Initial treatment for all ankle sprains is nonoperative and involves the RICE (rest, ice, compression, elevation) protocol with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during the acute phase (first 4-5 days) with a short period (no >2 weeks) of immobilization.27 Most authors agree that early mobilization followed by phased rehabilitation is warranted to minimize time away from sports.28-31 Prolonged immobilization (>2 weeks) has detrimental effects and may lead to a longer return to play.28-31 The rehabilitation protocol is divided into stages: (1) pain and edema control, (2) range of motion (ROM) and strengthening exercises, (3) soccer specific functional training, and (4) prophylactic intervention with balance and proprioception exercises. Surgical intervention is rarely indicated for acute ankle sprains. There are exceptions, however, such as when ankle sprains are associated with other injuries that require acute intervention (eg, fracture, osteochondral lesion). Surgery is indicated in the setting of chronic, recurrent mechanical instability. Anatomical repairs (modified Brostrom) seem to produce better outcomes than non-anatomical reconstructions (eg, Chrisman-Snook). Surgical outcomes are good, and most athletes are able to return to their pre-injury level of function.32
In athletes, prevention of recurrent sprains is key. Braces may help prevent ankle sprains and bracing has been shown to be superior to taping, as tape loses its restrictive properties within 20 to 30 minutes of initiating activity.33,34 Application of an orthosis (lace-up ankle orthosis) has been shown to reduce the incidence of ankle re-injury in soccer players with previous ankle sprains. Several studies have found minimal, if any, effect of orthoses on athletic performance.20,35,36 Low-profile braces for soccer have been developed which allow for minimal disruption of the player’s boot and space proximally to insert the shin guard. Another essential component of prevention is prophylactic intervention with balance and proprioceptive exercises. A study looking at first division men’s league football (soccer) players in Iran showed a significant decrease in re-injury rates with proprioceptive training.37 In 2003, FIFA introduced a comprehensive warm-up program (FIFA 11+), which has since been shown in several studies to decrease the risk of injury in amateur soccer players.38-40
MEDIAL ANKLE SPRAINS AND INSTABILITY
Soccer places an unusually high demand on both the medial foot and ankle structures when compared with other sports. For instance, striking the ball requires the player to abduct and externally rotate the foot, which preloads medial structures.9 Hintermann18 looked at 54 cases of medial ankle instability and found that injury commonly occurred during landing on an uneven surface, which applies to soccer players when landing after heading the ball or jumping over a tackle. Pronation with eversion and extreme rotational injuries are well known to cause deltoid ligament injury. However, complete rupture of the deltoid ligament is rare and is more often associated with ankle fractures.41 Due to its close proximity and similarly shared function in medial plantar arch stabilization with the tibiospring and spring ligaments, posterior tibialis tendon dysfunction is also frequently seen in medial ankle instability.17 After an acute injury, patients can present with a medial ankle hematoma and pain along the deltoid ligament. Although chronic insufficiency is diagnosed based on the feeling of “giving way,” pain in the medial gutter of the ankle and a valgus and pronation deformity of the foot can be corrected by activating the peroneus tertius muscle. Arthroscopy is the most specific way to confirm clinically suspected instability of the medial ankle; however, MRI can demonstrate loss of organized medial fibers (Figures 3A, 3B).18 Primary surgical repair of deltoid ligament tears yield good to excellent results and should be considered in the soccer player to prevent problems associated with chronic non-repaired tears such as instability, osteoarthritis, and impingement syndromes.18 After surgical repair, players will undergo extensive physical therapy that progresses to sport-specific exercises with the ultimate goal of returning to competitive play around 4-6 months post-operatively.
HIGH ANKLE SPRAINS (SYNDESMOSIS)
High ankle sprains are much less common than low ankle sprains; however, when they do occur they portend a lengthier rehabilitation and a poorer prognosis, especially if undiagnosed. Lubberts and colleagues42 studied the epidemiology of isolated syndesmotic injuries in professional football players. They pooled data from 15 consecutive seasons of European professional football between 2001 and 2016. They examined a total of 3677 players from 61 teams across 17 countries. There were 1320 ankle ligament injuries registered during 15 seasons, of which 94 (7%) were isolated syndesmotic injuries. The incidence of these injuries increased annually between 2001 and 2016. Injuries were 74% contact-related, and isolated syndesmotic injuries were followed by a mean of a 39-day absence.42 Moreover, football players may have an increased risk of syndesmotic sprains due to foot planting and cutting action.41
Continue to: These injuriesa are typically...
These injuries are typically identified with pain over the AITFL and interosseous membrane. Physical examination tests that help identify syndesmotic injuries include the squeeze test, external rotation test, and crossed-leg test.41 The diagnosis can be made on plain X-ray when there is clear diastasis between the distal tibia and fibula. Two critical measurements on plain films are made 1 cm above the tibial plafond and are used to evaluate the integrity of the syndesmosis: tibiofibular clear space >6 mm, and tibiofibular overlap <1 mm, which indicate disruption of the syndesmosis.43 More subtle injuries can be diagnosed with better sensitivity and specificity using MRI, which can also reveal secondary findings such as bone bruises, ATFL injury, osteochondral lesions, and tibiofibular incongruity.44,45 Arthroscopy is an invaluable diagnostic tool for syndesmotic injuries with a characteristic triad finding of PITFL scarring, disrupted interosseous ligament, and posterolateral tibial plafond chondral damage.46
Classification of the ligaments involved can aid in the selection of appropriate treatment. Grade I injuries involve AITFL tears. Grade IIa injuries involve AITFL and IOL tears. Grade IIb injuries include AITFL, PITFL, and IOL tears. Grade III injuries involve injury to all 3 ligaments, as well as a fibular fracture. Conservative treatment is recommended for Grades I and IIa, while surgical intervention is necessary for Grades IIb and III (Figures 4A, 4B). Compared with other ankle sprains, syndesmotic injuries typically require a more prolonged recovery/rehabilitation. Some studies suggest that these injuries require twice as long to heal.47 Hopkinson and colleagues48 reported a mean recovery time of 55 days following syndesmotic injuries in cadets at the United States Military Academy at West Point. Some surgeons advocate surgical intervention in professional athletes with mild sprains to expedite return to play.49
Surgery has been well established as necessary in more severe injuries where there is clear diastasis or instability of the syndesmosis. Traditionally, screws were used for surgical fixation; however, they often required a second surgery for subsequent removal. There is no general consensus on the optimal screw size, level of placement, or timing of removal.50,51 More recently, non-absorbable suture button fixation (eg, TightRope; Arthrex) has become more popular and provides certain advantages over screw fixation, such as avoiding the need for hardware removal. TightRope has been shown to provide more accurate stabilization of the syndesmosis as compared with screw fixation.52 Since malreduction is the most important indicator of poor long-term functional outcome, suture button fixation should be considered in the treatment of the football player.53 Finally, Colcuc and colleagues54 reported a lower complication rate and earlier return to sports in patients treated with knotless suture button devices compared with screw fixation.
OSTEOCHONDRAL LESIONS
Osteochondral lesions (OCLs) are cartilage-bone defects that are usually located in the talus. They can be caused by an acute traumatic event or repetitive microtrauma with no apparent history of trauma (eg, ankle instability). Acute OCLs can occur in soccer secondary to an ankle sprain or ankle fracture. Symptoms of OCLs include pain, swelling, and mechanical symptoms such as catching or locking, and on physical examination, one might see an effusion. The initial imaging modality of choice is radiographing; however, in ankle sprains with continued pain and swelling MRI may be indicated to rule out an underlying OCL. Missed acute lesions have a tendency not to heal and become chronic lesions, which can cause pain and playing disability. It is well established that chronic ankle instability is an important etiologic factor for OCLs. With the normal hydrostatic pressure within the ankle joint, synovial fluid gets pushed into cartilage/bone fissures, which can then lead to cystic degeneration of the subchondral bone.55-57
Surgical repair of an OCL is dependent on both the size and location of the lesion. Acute lesions can be managed by arthroscopic débridement, microfracture, or fixation of the lesion if enough bone remains attached to the chondral lesion. Return to play is based on development and maturation of fibrocartilage over the lesion (debridement/microfracture) or healing and incorporation of the new graft (chondral repair procedures). Meanwhile, chronic lesions can be managed in 1-stage (microfracture, osteochondral autograft transfer or 2-stage (autologous chondrocyte implantation [ACI]) procedures.56-57 Additional biologic healing augmentation with platelet-rich plasma has been described as well.58 Newer techniques in treating chronic talus OCLs, including ones that have failed to respond to bone marrow stimulation techniques, have been developed more recently such as the use of particulated juvenile articular cartilage allograft (DeNovo NT Natural Tissue Graft®; Zimmer Biomet).59 These newer techniques avoid the need for a 2-stage procedure, as is the case with ACI.
Continue to: Further studies are needed...
Further studies are needed to both investigate long-term outcomes and determine the superiority of the arthroscopic juvenile cartilage procedure compared with microfracture and other cartilage resurfacing procedures. When surgically treating OCLs, one must also restore normal ankle joint biomechanics for the lesion to heal. For instance, in the presence of ankle instability, ligament reconstruction must be performed. Also, one should also consider addressing any hindfoot malalignment with an osteotomy (calcaneus, supramalleolar). In a recent retrospective study, van Eekeren and colleagues60 showed that approximately 76% of patients were able to return to sports at long-term follow-up after arthroscopic débridement and bone marrow stimulation of talar OCLs. However, the activity level decreased at long-term follow-up and never attained the pre-injury level.60
ANKLE IMPINGEMENT
ANTERIOR ANKLE IMPINGEMENT (FOOTBALLER'S ANKLE)
Anterior ankle impingement is caused by anterior osteophytes on both the distal tibia and talar neck. It is thought to be related to repetitive microtrauma to the anteromedial aspect of the ankle from recurrent ball impact.61 It is very common amongst soccer players with some studies suggesting that 60% of soccer players have this syndrome. Ankle impingement is characterized by anterior pain with ankle dorsiflexion, decreased dorsiflexion, and swelling. It is primarily diagnosed with lateral ankle X-rays, which will show the osteophytes. An oblique anteromedial X-ray may increase detection of osteophytes (Figure 5). The early stages of anterior impingement can be treated successfully with injections and heel lifts. Treatment of lesions that fail to respond to conservative management involves arthroscopic or open excision of osteophytes. Most patients with no preexisting osteoarthritis treated arthroscopically will experience pain relief and return to full activity, though recurrent osteophyte formation has been noted at long-term follow-up.62
Anterior ankle impingement is most often caused by acute ankle sprains with an inversion type of mechanism.62 The subsequent reactive inflammation can cause fibrosis leading to distal fascicle enlargement of the AITFL. Impingement in the anterolateral gutter of this enlarged fascicle can also cause both chronic reactive synovitis and chondromalacia of the lateral talar dome.63 MRI can identify abnormal areas of pathology; however, 50% of cases are diagnosed based on clinical examination alone.63 Patients generally present with a history of anterolateral ankle pain and swelling with an occasional popping or snapping sensation.
Soccer players commonly develop anterior bony impingement due to repetitive loading of the anterior ankle from striking the ball. This repetition can lead to osteophyte formation of the anterior distal tibia and talar neck. After the osteophytes form, decreased dorsiflexion can occur due to a mechanical stop and inflammation of the interposed capsule.
The patient will exhibit tenderness to palpation along the anterolateral aspect of the ankle, with pain elicited at extreme passive dorsiflexion.62 Initially, an injection with local anesthetic and corticosteroid can serve both a diagnostic and therapeutic purpose; however, patients who fail conservative treatment can be treated with arthroscopy and resection of the involved scar tissue and osteophytes. The best results are seen in those patients with no concurrent intra-articular lesions or ankle osteoarthritis (Figure 5).62 When treated non-operatively, a player may return to play when pain resolves; however, if treated surgically with arthroscopic debridement/resection, a player must wait until his surgical scars have healed prior to attempting return to play.
Continue to: ANTEROMEDIAL ANKLE IMPINGEMENT
ANTEROMEDIAL ANKLE IMPINGEMENT
Anteromedial ankle impingement is a less common ankle impingement syndrome. It is associated with eversion injuries or following medial malleolar or talar fractures.64,65 Previous injury to the anterior tibiotalar fascicle of the deltoid complex leads to ligament thickening and subsequent impingement in the anteromedial corner of the talus. Adjacent fibrosis and synovitis are common consequences of impingement; however, osteophyte formation and chondral stripping along the anteromedial talus can also be seen. Patients typically complain of pain along the anteromedial joint line that is worse with activity, clicking or popping sensations, and painful, limited dorsiflexion. On examination, impingement can be detected through palpation over the anterior tibiotalar fascicle of the deltoid ligament and eversion or extreme passive dorsiflexion of the foot, all of which will elicit medial ankle tenderness.17,62 Initial treatment consists of rest, physical therapy, and NSAIDs. Refractory cases may be amenable to arthroscopic or open resection of the anterior tibiotalar fascicle with débridement of any adjacent synovitis and scar tissue.62
POSTERIOR ANKLE IMPINGEMENT
Posterior ankle impingement is often referred to as “os trigonum syndrome” since the posterior impingement is frequently associated with a prominent os trigonum. An os trigonum is an accessory ossicle representing the separated posterolateral tubercle of the talus. It is usually asymptomatic. However, in soccer players, pain can occur from impaction between the posterior tibial plafond and the os trigonum, or because of soft tissue compression between the 2 opposing osseous structures. The pain is due to repetitive microtrauma (ankle plantarflexion) or acute forced plantarflexion, which can present as an acute fracture of the os trigonum. Because soccer is a sport requiring both repetitive and extreme plantarflexion, it may predispose players to posterior ankle impingement (Figures 6A, 6B).62,66
Clinically, it can be very difficult to detect and diagnose because the affected structures lie deep and it can coexist with other disease processes (eg, peroneal tendinopathy, Achilles tendinopathy).62,66 Patients will complain of chronic deep posterior ankle pain that is worse with push-off activities (eg, jumping). On examination, patients will exhibit pain with palpation over the posterolateral process and with the crunch test. Lateral radiograph with the foot in plantar flexion will show the os trigonum impinged between the posterior tibial malleolus and the calcaneal tuberosity. An MRI will demonstrate the os trigonum as well as any associated inflammation and edema, while it can also demonstrate coexisting pathologies.
Initial treatment consists of rest, NSAIDs, and taping to prevent plantar flexion. Ultrasound-guided cortisone injection of the capsule and posterior bursa can be both therapeutic and diagnostic. A posterior injection can be used to temporize the symptoms so that the soccer player can make it through the season.
Surgical excision is saved for refractory cases, and this can be done either through an open posterolateral approach or arthroscopic techniques. Recently, Georgiannos and Bisbinas67 showed in an athletic population that endoscopic excision had both a lower complication rate and a quicker return to sports compared with the traditional open approach. Carreira and colleagues68 conducted a retrospective case series of 20 patients (mostly competitive athletes). They found that posterior ankle arthroscopy to address posterior impingement allowed for the maintenance or restoration of anatomic ROM of the ankle and hindfoot, ability to return to at least the previous level of activity, and improvement in objective assessment of pain relief and a higher level of function parameters.68
Continue to: TENDON PATHOLOGY
TENDON PATHOLOGY
SUPERIOR PERONEAL RETINACULUM INJURY
The superior peroneal retinaculum (SPR) forms the roof of the superior peroneal tunnel. The tunnel contains the peroneus brevis and longus tendons and is bordered by the retromalleolar groove of the fibula and the lower aspect of the posterior intramuscular septum of the leg.69,70 The SPR originates from the posterolateral ridge of the fibula and inserts onto the lateral calcaneus, and it is the primary restraint of the peroneal tendons within the retromalleolar sulcus.
Injury to the retinaculum results from both ankle dorsiflexion and inversion, and forceful reflex contraction of the peroneal muscles, which causes subluxation or dislocation of the contained tendons.69 A high level of suspicion is required regarding these injuries since the mechanism of injury is similar to that of a simple lateral ankle sprain. In the setting of retrofibular pain, snapping or popping sensations around the lateral malleolus, or chronic ankle instability that worsens on uneven surfaces, one must consider an injury to the SPR.69 Radiographs are not always diagnostic; however, occasionally on an internal rotation view, one may see a cortical avulsion off the distal tip of the lateral malleolus (“fleck sign”) indicating a rim fracture from an SPR injury (Figure 7). MRI is the best imaging modality to assess the peroneal tendons, as well as an SPR injury. Recently, ultrasound has grown in popularity and may be more useful, since it allows for dynamic evaluation of subluxating/dislocating tendons.69
Conservative management is often associated with poor outcomes, and surgery is indicated for all acute and chronic dislocations in athletes.71 Anatomic reconstruction of the SPR is the preferred surgical method.72 Peroneus brevis debulking and fibular groove deepening may also augment the retinaculum repair.73 van Dijk and colleagues in their systematic review showed that patients treated with both groove deepening and SPR repair have higher rates of return to the sport than patients treated with SPR repair alone.74
STRESS FRACTURES
FIFTH METATARSAL
Fifth metatarsal stress fractures usually occur secondary to lateral overload or avulsion of the peroneus brevis. The fifth metatarsal base can be susceptible to injury in a cavovarus foot. Non-operative treatment typically requires a longer period of immobilization (boot or cast) and necessitates a longer period of non–weight-bearing (anywhere between 6-12 weeks). Therefore, surgery is typically recommended in athletes or in the setting of a recurrent base of the fifth metatarsal fracture to expedite healing and return to play. Return to play is still not recommended until there is evidence of radiographic healing of the fracture. There are certain distinctions with fifth metatarsal stress fractures regarding location and healing rates that need to be taken into account.75,76 In particular, zone 2 injuries (Jones fractures) represent a vascular watershed area, making these fractures prone to nonunion with nonunion rates as high as 15% to 30%. Occasionally, the cavovarus deformity will require correction as well as a reduction in the risk of recurrence or nonunion. Surgical fixation most commonly consists of a single screw placed in an antegrade fashion.77 One must pay attention to screw size since smaller diameter screws (<4.5 mm) are associated with delayed union or nonunion. Moreover, screws that are too long will straighten the curved metatarsal shaft and can lead to fracture distraction or malreduction (Figures 8A, 8B).77
Patients have returned to competitive sports within 6 weeks; however, it should be noted that causes of failure were linked to early return and return to sports before a radiographic union can lead to failure of fixation. Ekstrand and van Dijk78 studied a large group of professional soccer players and found that out of 13,754 injuries, 0.5% (67) were fifth metatarsal fractures. Of note, they found that 45% of players had prodromal symptoms. Furthermore, after surgical treatment the fractures healed faster, compared with conservative treatment (75% vs 33%); however, there was no significant difference in lay-off days between both groups (80 vs 74 days).78 Matsuda and colleagues79 looked at 335 male collegiate soccer players, 29 of whom had a history of a fifth metatarsal stress fracture. They found that playing the midfield position and having an everted rearfoot and inverted forefoot alignment were associated with fifth metatarsal stress fractures.79 Saita and colleagues80 found that restricted hip internal rotation was associated with an increased risk of developing a Jones fracture in 162 professional football players. Finally, Fujitaka and colleagues81 looked at 273 male soccer players between 2005 and 2013. They found an association between weak toe-grip strength and fifth metatarsal fractures, suggesting that weak toe-grip may lead to an increase in the load applied onto the lateral side of the foot, resulting in a stress fracture.81
Continue to: NAVICULAR
NAVICULAR
Another common tarsal bone that sustains stress fractures is the navicular. It is not as common as calcaneal stress fractures in military recruits but can occur in the same type of population, as well as explosive athletics such as sprinters and soccer players. It commonly presents with an indistinct vague achy pain with activity that improves with rest, and pain at the dorsum of the midfoot or along the medial longitudinal arch with activity. It can easily go undiagnosed for quite some time given the difficulty in visualizing the navicular with plain radiographs. Clinically, it is difficult to make the diagnosis, and therefore advanced imaging is necessary when the injury is suspected. Both MRI and CT scans can be used to understand the extent of the injury (Figures 9A-9C). In non-displaced stress fractures, conservative non-operative treatment is the appropriate treatment modality with a brief period of immobilization and non–weight-bearing;82 however, operative treatment is also considered in elite athletes. In either case, return to play is discouraged until there is evidence of radiographic healing. When a displacement is noted, or there is a delay in diagnosis, then operative treatment is recommended.
CONCLUSION
Ankle injuries are very common in soccer and can result in decreased performance or significant loss of playing time. Treatment of acute injury generally follows a conservative route, with surgical intervention reserved for severe ruptures or osteochondral fracture of the ankle joint. Chronic ankle pathology resulting in mechanical or functional instability generally requires surgery to repair ligamentous damage and restore normal ankle kinematics. It is critical for the soccer player to receive appropriate rehabilitation prior to returning to play in order to reduce the risk for reinjury and further chronic instability. Prevention and early intervention of ankle injuries is key in preventing the long-term sequelae of ankle injuries, such as arthritis, in former soccer players.
ABSTRACT
The ankle is one of the most commonly injured joints in soccer and represents a significant cost to the healthcare system. The ligaments that stabilize the ankle joint determine its biomechanics—alterations of which result from various soccer-related injuries. Acute sprains are among the most common injury in soccer players and are generally treated conservatively, with emphasis placed on secondary prevention to reduce the risk for future sprains and progression to chronic ankle instability. Repetitive ankle injuries in soccer players may cause chronic ankle instability, which includes both mechanical ligamentous laxity and functional changes. Chronic ankle pathology often requires surgery to repair ligamentous damage and remove soft-tissue or osseous impingement. Proper initial treatment, rehabilitation, and secondary prevention of ankle injuries can limit the amount of time lost from play and avoid negative long-term sequelae (eg, osteochondral lesions, arthritis). On the other hand, high ankle sprains portend a poorer prognosis and a longer recovery. These injuries will typically require surgical stabilization. Impingement-like syndromes of the ankle can undergo an initial trial of conservative treatment; when this fails, however, soccer players respond favorably to arthroscopic debridement of the lesions causing impingement. Finally, other pathologies (eg, stress fractures) are highly encouraged to be treated with surgical stabilization in elite soccer players.
Continue to: EPIDEMIOLOGY
EPIDEMIOLOGY
With roughly 200,000 professional and around 240 million amateur soccer players, soccer has been recognized as the most popular sport worldwide. Nevertheless, given its rising popularity in society, one must also consider the increasing incidence of injuries as a result. Elite soccer players sustain between 10 and 35 injuries per 1000 competitive playing hours.1 Approximately 80% are traumatic, and 20% are overuse injuries.2 Soccer injuries are more frequent with increasing age of the participants, whereas the incidence of injuries in preadolescent players is low. The incidence of injuries has been found to be higher during competition when compared with practice/training sessions, with some studies showing that 59% of injuries occurred during games.2 Amateur or recreational soccer players sustain fewer injuries than professional soccer players, as one would expect, given both the higher intensity of training and match schedule in professionals.
The ankle is one of the most commonly injured joints in soccer, with some studies suggesting it comprises one-fifth of all injuries sustained during soccer, which is only second to those of the knee.2 Ankle sprains specifically are quite a common occurrence in soccer.3-9 A recent study of an English premier league club showed that over a 4-season period, 20% of injuries were of the foot and ankle with a mean return to sport time of 54 days.10 Of all foot and ankle related injuries, ankle sprains are the most common, followed by bruises/contusions, and tendon lesions. Fractures are very rare (1%) in soccer, but when they do occur they impart a much more extended recovery. During the 2010 Fédération Internationale de Football Association (FIFA) World Cup, ankle sprains were among the most common injuries and approximately half lead to players missing training or competitive matches.5
ANATOMY
Knowledge of the biomechanics of both the foot and ankle joints is essential to understand soccer injuries. The ankle joint (talocrural articulation) consists of the distal ends of the tibia and fibula, which form the mortise, and the superior aspect of the talar dome.11 As a hinge joint, the ankle provides 20° of dorsiflexion and 50° of plantar flexion,12 with stability provided by the lateral, medial, and superior ligamentous complexes. The superior articular surface of the talus is narrower posteriorly, which creates a looser fit within the mortise during plantar flexion.11 This decreased stability could help explain why the most common injury in soccer involves a plantar flexion mechanism.13,14 Inferiorly, the talus articulates with the calcaneus to form the subtalar joint. It is at this site that the majority of both foot inversion and eversion occurs. The transverse tarsal joints (Chopart’s joints) separate the hindfoot from the midfoot. Movement of this joint depends on the relative alignment of its 2 articulations: the talonavicular and calcaneocuboid joints. During foot eversion, these 2 joints are parallel to each other allowing supple motion and aiding in shock absorption during the heel strike phase of the gait cycle. With foot inversion, the joints become nonparallel and thus lock the transverse tarsal joints providing a rigid lever needed for push-off.11,12
LATERAL LIGAMENTS
The ankle joint is stabilized laterally by a ligament complex consisting of 3 individual ligaments, all originating from the lateral malleolus: the anterior talofibular ligament (ATFL), the posterior talofibular ligament (PTFL), and the calcaneofibular ligament (CFL) (Figure 1).11,12,15 The ATFL is the primary restraint to inversion in plantar flexion, and it helps resist anterolateral translation of the talus in the mortise. However, it is the weakest and therefore the most frequently injured of the lateral ligaments. The PTFL plays only a supplementary role in ankle stability when the lateral ligament complex is intact. It is under the greatest strain in ankle dorsiflexion and acts to limit posterior talar displacement within the mortise as well as talar external rotation.13,16 The CFL is the primary restraint to inversion in the neutral or dorsiflexed position. It restrains subtalar inversion, thereby limiting talar tilt within the mortise.
DELTOID LIGAMENT
The deltoid ligament complex consists of 6 continuous adjacent superficial and deep ligaments that function synergistically to resist valgus and pronation forces, as well as external rotation of the talus in the mortise.11-13,17 The superficial layer crosses both ankle and subtalar joints. It originates from the anterior colliculus and fans out to insert into the navicular, neck of the talus, sustentaculum tali, and posteromedial talar tubercle. The tibiocalcaneal (sustentaculum tali) portion is the strongest component in the superficial layer and resists calcaneal eversion. The deep layer crosses the ankle joint only. It functions as the primary stabilizer of the medial ankle and prevents both lateral displacement and external rotation of the talus. It originates from the inferior and posterior aspects of the medial malleolus and inserts on the medial and posteromedial aspects of the talus.12,17,18
Continue to: SYNDESMOSIS
SYNDESMOSIS
The ankle syndesmosis, or inferior tibiofibular joint, is the distal articulation between the tibia and fibula. The syndesmosis contributes to ankle mortise integrity through its firm fixation of the lateral malleolus against the lateral surface of the talus. Ligaments comprising the ankle syndesmosis include the anterior inferior tibiofibular ligament (AITFL), the posterior inferior tibiofibular ligament (PITFL), the inferior transverse ligament, and the interosseous ligament (IOL).12
ANKLE SPRAINS
Ankle sprains are the most common pathology encountered amongst soccer players, representing from one-half to two-thirds of all ankle related injuries. Most sprains occur outside of player contact.
LATERAL ANKLE SPRAINS AND INSTABILITY
Injury to the lateral ligaments of the ankle represents 77% to 91% of all ankle sprains in soccer.6,19 The greatest risk factor for an ankle sprain in a soccer player is a history of prior sprain.20 Other risk factors include increasing age, player-to-player contact, condition of the pitch, weight-bearing status of the injured limb at the time of injury, and joint instability or laxity.21,22
The evaluation of an ankle sprain to determine its severity is best done after the acute phase, approximately 4 to 7 days after the initial injury when both pain and swelling have subsided.23 The anterior drawer (ATFL instability) and talar tilt (CFL instability) tests are useful in evaluating ankle instability in the delayed or chronic setting; however, both have been shown to have limited sensitivity and significant variability amongst different examiners.24
Clinical examination will direct further diagnostic tests including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT). The Ottawa ankle rules are generally helpful in determining whether plain X-rays are indicated in the acute setting.25,26 (Figure 2) According to these rules, ankle radiographs should be obtained if ankle pain is reported near the malleoli and 1 or more of the following is seen during examination: inability to bear weight immediately after injury and for 4 steps in the emergency department, and bony tenderness at the posterior edge or tip of the malleolus. Stress X-rays are generally not indicated in acute injuries but may be useful in chronic ankle instability cases.23
Continue to: Ankle sprains cover...
Ankle sprains cover a broad spectrum of injuries; therefore, a grading system was devised to aid in guiding treatment. Grade I (mild) sprains are those with minimal swelling and tenderness but have the ligaments still intact. Grade II (moderate) sprains occur when there are partial ligament tears associated with moderate pain, swelling, and tenderness. Finally, Grade III (severe) sprains are complete ligament tears with marked swelling, hemorrhage, tenderness, loss of function, and abnormal joint motion and instability.23, 24
Initial treatment for all ankle sprains is nonoperative and involves the RICE (rest, ice, compression, elevation) protocol with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during the acute phase (first 4-5 days) with a short period (no >2 weeks) of immobilization.27 Most authors agree that early mobilization followed by phased rehabilitation is warranted to minimize time away from sports.28-31 Prolonged immobilization (>2 weeks) has detrimental effects and may lead to a longer return to play.28-31 The rehabilitation protocol is divided into stages: (1) pain and edema control, (2) range of motion (ROM) and strengthening exercises, (3) soccer specific functional training, and (4) prophylactic intervention with balance and proprioception exercises. Surgical intervention is rarely indicated for acute ankle sprains. There are exceptions, however, such as when ankle sprains are associated with other injuries that require acute intervention (eg, fracture, osteochondral lesion). Surgery is indicated in the setting of chronic, recurrent mechanical instability. Anatomical repairs (modified Brostrom) seem to produce better outcomes than non-anatomical reconstructions (eg, Chrisman-Snook). Surgical outcomes are good, and most athletes are able to return to their pre-injury level of function.32
In athletes, prevention of recurrent sprains is key. Braces may help prevent ankle sprains and bracing has been shown to be superior to taping, as tape loses its restrictive properties within 20 to 30 minutes of initiating activity.33,34 Application of an orthosis (lace-up ankle orthosis) has been shown to reduce the incidence of ankle re-injury in soccer players with previous ankle sprains. Several studies have found minimal, if any, effect of orthoses on athletic performance.20,35,36 Low-profile braces for soccer have been developed which allow for minimal disruption of the player’s boot and space proximally to insert the shin guard. Another essential component of prevention is prophylactic intervention with balance and proprioceptive exercises. A study looking at first division men’s league football (soccer) players in Iran showed a significant decrease in re-injury rates with proprioceptive training.37 In 2003, FIFA introduced a comprehensive warm-up program (FIFA 11+), which has since been shown in several studies to decrease the risk of injury in amateur soccer players.38-40
MEDIAL ANKLE SPRAINS AND INSTABILITY
Soccer places an unusually high demand on both the medial foot and ankle structures when compared with other sports. For instance, striking the ball requires the player to abduct and externally rotate the foot, which preloads medial structures.9 Hintermann18 looked at 54 cases of medial ankle instability and found that injury commonly occurred during landing on an uneven surface, which applies to soccer players when landing after heading the ball or jumping over a tackle. Pronation with eversion and extreme rotational injuries are well known to cause deltoid ligament injury. However, complete rupture of the deltoid ligament is rare and is more often associated with ankle fractures.41 Due to its close proximity and similarly shared function in medial plantar arch stabilization with the tibiospring and spring ligaments, posterior tibialis tendon dysfunction is also frequently seen in medial ankle instability.17 After an acute injury, patients can present with a medial ankle hematoma and pain along the deltoid ligament. Although chronic insufficiency is diagnosed based on the feeling of “giving way,” pain in the medial gutter of the ankle and a valgus and pronation deformity of the foot can be corrected by activating the peroneus tertius muscle. Arthroscopy is the most specific way to confirm clinically suspected instability of the medial ankle; however, MRI can demonstrate loss of organized medial fibers (Figures 3A, 3B).18 Primary surgical repair of deltoid ligament tears yield good to excellent results and should be considered in the soccer player to prevent problems associated with chronic non-repaired tears such as instability, osteoarthritis, and impingement syndromes.18 After surgical repair, players will undergo extensive physical therapy that progresses to sport-specific exercises with the ultimate goal of returning to competitive play around 4-6 months post-operatively.
HIGH ANKLE SPRAINS (SYNDESMOSIS)
High ankle sprains are much less common than low ankle sprains; however, when they do occur they portend a lengthier rehabilitation and a poorer prognosis, especially if undiagnosed. Lubberts and colleagues42 studied the epidemiology of isolated syndesmotic injuries in professional football players. They pooled data from 15 consecutive seasons of European professional football between 2001 and 2016. They examined a total of 3677 players from 61 teams across 17 countries. There were 1320 ankle ligament injuries registered during 15 seasons, of which 94 (7%) were isolated syndesmotic injuries. The incidence of these injuries increased annually between 2001 and 2016. Injuries were 74% contact-related, and isolated syndesmotic injuries were followed by a mean of a 39-day absence.42 Moreover, football players may have an increased risk of syndesmotic sprains due to foot planting and cutting action.41
Continue to: These injuriesa are typically...
These injuries are typically identified with pain over the AITFL and interosseous membrane. Physical examination tests that help identify syndesmotic injuries include the squeeze test, external rotation test, and crossed-leg test.41 The diagnosis can be made on plain X-ray when there is clear diastasis between the distal tibia and fibula. Two critical measurements on plain films are made 1 cm above the tibial plafond and are used to evaluate the integrity of the syndesmosis: tibiofibular clear space >6 mm, and tibiofibular overlap <1 mm, which indicate disruption of the syndesmosis.43 More subtle injuries can be diagnosed with better sensitivity and specificity using MRI, which can also reveal secondary findings such as bone bruises, ATFL injury, osteochondral lesions, and tibiofibular incongruity.44,45 Arthroscopy is an invaluable diagnostic tool for syndesmotic injuries with a characteristic triad finding of PITFL scarring, disrupted interosseous ligament, and posterolateral tibial plafond chondral damage.46
Classification of the ligaments involved can aid in the selection of appropriate treatment. Grade I injuries involve AITFL tears. Grade IIa injuries involve AITFL and IOL tears. Grade IIb injuries include AITFL, PITFL, and IOL tears. Grade III injuries involve injury to all 3 ligaments, as well as a fibular fracture. Conservative treatment is recommended for Grades I and IIa, while surgical intervention is necessary for Grades IIb and III (Figures 4A, 4B). Compared with other ankle sprains, syndesmotic injuries typically require a more prolonged recovery/rehabilitation. Some studies suggest that these injuries require twice as long to heal.47 Hopkinson and colleagues48 reported a mean recovery time of 55 days following syndesmotic injuries in cadets at the United States Military Academy at West Point. Some surgeons advocate surgical intervention in professional athletes with mild sprains to expedite return to play.49
Surgery has been well established as necessary in more severe injuries where there is clear diastasis or instability of the syndesmosis. Traditionally, screws were used for surgical fixation; however, they often required a second surgery for subsequent removal. There is no general consensus on the optimal screw size, level of placement, or timing of removal.50,51 More recently, non-absorbable suture button fixation (eg, TightRope; Arthrex) has become more popular and provides certain advantages over screw fixation, such as avoiding the need for hardware removal. TightRope has been shown to provide more accurate stabilization of the syndesmosis as compared with screw fixation.52 Since malreduction is the most important indicator of poor long-term functional outcome, suture button fixation should be considered in the treatment of the football player.53 Finally, Colcuc and colleagues54 reported a lower complication rate and earlier return to sports in patients treated with knotless suture button devices compared with screw fixation.
OSTEOCHONDRAL LESIONS
Osteochondral lesions (OCLs) are cartilage-bone defects that are usually located in the talus. They can be caused by an acute traumatic event or repetitive microtrauma with no apparent history of trauma (eg, ankle instability). Acute OCLs can occur in soccer secondary to an ankle sprain or ankle fracture. Symptoms of OCLs include pain, swelling, and mechanical symptoms such as catching or locking, and on physical examination, one might see an effusion. The initial imaging modality of choice is radiographing; however, in ankle sprains with continued pain and swelling MRI may be indicated to rule out an underlying OCL. Missed acute lesions have a tendency not to heal and become chronic lesions, which can cause pain and playing disability. It is well established that chronic ankle instability is an important etiologic factor for OCLs. With the normal hydrostatic pressure within the ankle joint, synovial fluid gets pushed into cartilage/bone fissures, which can then lead to cystic degeneration of the subchondral bone.55-57
Surgical repair of an OCL is dependent on both the size and location of the lesion. Acute lesions can be managed by arthroscopic débridement, microfracture, or fixation of the lesion if enough bone remains attached to the chondral lesion. Return to play is based on development and maturation of fibrocartilage over the lesion (debridement/microfracture) or healing and incorporation of the new graft (chondral repair procedures). Meanwhile, chronic lesions can be managed in 1-stage (microfracture, osteochondral autograft transfer or 2-stage (autologous chondrocyte implantation [ACI]) procedures.56-57 Additional biologic healing augmentation with platelet-rich plasma has been described as well.58 Newer techniques in treating chronic talus OCLs, including ones that have failed to respond to bone marrow stimulation techniques, have been developed more recently such as the use of particulated juvenile articular cartilage allograft (DeNovo NT Natural Tissue Graft®; Zimmer Biomet).59 These newer techniques avoid the need for a 2-stage procedure, as is the case with ACI.
Continue to: Further studies are needed...
Further studies are needed to both investigate long-term outcomes and determine the superiority of the arthroscopic juvenile cartilage procedure compared with microfracture and other cartilage resurfacing procedures. When surgically treating OCLs, one must also restore normal ankle joint biomechanics for the lesion to heal. For instance, in the presence of ankle instability, ligament reconstruction must be performed. Also, one should also consider addressing any hindfoot malalignment with an osteotomy (calcaneus, supramalleolar). In a recent retrospective study, van Eekeren and colleagues60 showed that approximately 76% of patients were able to return to sports at long-term follow-up after arthroscopic débridement and bone marrow stimulation of talar OCLs. However, the activity level decreased at long-term follow-up and never attained the pre-injury level.60
ANKLE IMPINGEMENT
ANTERIOR ANKLE IMPINGEMENT (FOOTBALLER'S ANKLE)
Anterior ankle impingement is caused by anterior osteophytes on both the distal tibia and talar neck. It is thought to be related to repetitive microtrauma to the anteromedial aspect of the ankle from recurrent ball impact.61 It is very common amongst soccer players with some studies suggesting that 60% of soccer players have this syndrome. Ankle impingement is characterized by anterior pain with ankle dorsiflexion, decreased dorsiflexion, and swelling. It is primarily diagnosed with lateral ankle X-rays, which will show the osteophytes. An oblique anteromedial X-ray may increase detection of osteophytes (Figure 5). The early stages of anterior impingement can be treated successfully with injections and heel lifts. Treatment of lesions that fail to respond to conservative management involves arthroscopic or open excision of osteophytes. Most patients with no preexisting osteoarthritis treated arthroscopically will experience pain relief and return to full activity, though recurrent osteophyte formation has been noted at long-term follow-up.62
Anterior ankle impingement is most often caused by acute ankle sprains with an inversion type of mechanism.62 The subsequent reactive inflammation can cause fibrosis leading to distal fascicle enlargement of the AITFL. Impingement in the anterolateral gutter of this enlarged fascicle can also cause both chronic reactive synovitis and chondromalacia of the lateral talar dome.63 MRI can identify abnormal areas of pathology; however, 50% of cases are diagnosed based on clinical examination alone.63 Patients generally present with a history of anterolateral ankle pain and swelling with an occasional popping or snapping sensation.
Soccer players commonly develop anterior bony impingement due to repetitive loading of the anterior ankle from striking the ball. This repetition can lead to osteophyte formation of the anterior distal tibia and talar neck. After the osteophytes form, decreased dorsiflexion can occur due to a mechanical stop and inflammation of the interposed capsule.
The patient will exhibit tenderness to palpation along the anterolateral aspect of the ankle, with pain elicited at extreme passive dorsiflexion.62 Initially, an injection with local anesthetic and corticosteroid can serve both a diagnostic and therapeutic purpose; however, patients who fail conservative treatment can be treated with arthroscopy and resection of the involved scar tissue and osteophytes. The best results are seen in those patients with no concurrent intra-articular lesions or ankle osteoarthritis (Figure 5).62 When treated non-operatively, a player may return to play when pain resolves; however, if treated surgically with arthroscopic debridement/resection, a player must wait until his surgical scars have healed prior to attempting return to play.
Continue to: ANTEROMEDIAL ANKLE IMPINGEMENT
ANTEROMEDIAL ANKLE IMPINGEMENT
Anteromedial ankle impingement is a less common ankle impingement syndrome. It is associated with eversion injuries or following medial malleolar or talar fractures.64,65 Previous injury to the anterior tibiotalar fascicle of the deltoid complex leads to ligament thickening and subsequent impingement in the anteromedial corner of the talus. Adjacent fibrosis and synovitis are common consequences of impingement; however, osteophyte formation and chondral stripping along the anteromedial talus can also be seen. Patients typically complain of pain along the anteromedial joint line that is worse with activity, clicking or popping sensations, and painful, limited dorsiflexion. On examination, impingement can be detected through palpation over the anterior tibiotalar fascicle of the deltoid ligament and eversion or extreme passive dorsiflexion of the foot, all of which will elicit medial ankle tenderness.17,62 Initial treatment consists of rest, physical therapy, and NSAIDs. Refractory cases may be amenable to arthroscopic or open resection of the anterior tibiotalar fascicle with débridement of any adjacent synovitis and scar tissue.62
POSTERIOR ANKLE IMPINGEMENT
Posterior ankle impingement is often referred to as “os trigonum syndrome” since the posterior impingement is frequently associated with a prominent os trigonum. An os trigonum is an accessory ossicle representing the separated posterolateral tubercle of the talus. It is usually asymptomatic. However, in soccer players, pain can occur from impaction between the posterior tibial plafond and the os trigonum, or because of soft tissue compression between the 2 opposing osseous structures. The pain is due to repetitive microtrauma (ankle plantarflexion) or acute forced plantarflexion, which can present as an acute fracture of the os trigonum. Because soccer is a sport requiring both repetitive and extreme plantarflexion, it may predispose players to posterior ankle impingement (Figures 6A, 6B).62,66
Clinically, it can be very difficult to detect and diagnose because the affected structures lie deep and it can coexist with other disease processes (eg, peroneal tendinopathy, Achilles tendinopathy).62,66 Patients will complain of chronic deep posterior ankle pain that is worse with push-off activities (eg, jumping). On examination, patients will exhibit pain with palpation over the posterolateral process and with the crunch test. Lateral radiograph with the foot in plantar flexion will show the os trigonum impinged between the posterior tibial malleolus and the calcaneal tuberosity. An MRI will demonstrate the os trigonum as well as any associated inflammation and edema, while it can also demonstrate coexisting pathologies.
Initial treatment consists of rest, NSAIDs, and taping to prevent plantar flexion. Ultrasound-guided cortisone injection of the capsule and posterior bursa can be both therapeutic and diagnostic. A posterior injection can be used to temporize the symptoms so that the soccer player can make it through the season.
Surgical excision is saved for refractory cases, and this can be done either through an open posterolateral approach or arthroscopic techniques. Recently, Georgiannos and Bisbinas67 showed in an athletic population that endoscopic excision had both a lower complication rate and a quicker return to sports compared with the traditional open approach. Carreira and colleagues68 conducted a retrospective case series of 20 patients (mostly competitive athletes). They found that posterior ankle arthroscopy to address posterior impingement allowed for the maintenance or restoration of anatomic ROM of the ankle and hindfoot, ability to return to at least the previous level of activity, and improvement in objective assessment of pain relief and a higher level of function parameters.68
Continue to: TENDON PATHOLOGY
TENDON PATHOLOGY
SUPERIOR PERONEAL RETINACULUM INJURY
The superior peroneal retinaculum (SPR) forms the roof of the superior peroneal tunnel. The tunnel contains the peroneus brevis and longus tendons and is bordered by the retromalleolar groove of the fibula and the lower aspect of the posterior intramuscular septum of the leg.69,70 The SPR originates from the posterolateral ridge of the fibula and inserts onto the lateral calcaneus, and it is the primary restraint of the peroneal tendons within the retromalleolar sulcus.
Injury to the retinaculum results from both ankle dorsiflexion and inversion, and forceful reflex contraction of the peroneal muscles, which causes subluxation or dislocation of the contained tendons.69 A high level of suspicion is required regarding these injuries since the mechanism of injury is similar to that of a simple lateral ankle sprain. In the setting of retrofibular pain, snapping or popping sensations around the lateral malleolus, or chronic ankle instability that worsens on uneven surfaces, one must consider an injury to the SPR.69 Radiographs are not always diagnostic; however, occasionally on an internal rotation view, one may see a cortical avulsion off the distal tip of the lateral malleolus (“fleck sign”) indicating a rim fracture from an SPR injury (Figure 7). MRI is the best imaging modality to assess the peroneal tendons, as well as an SPR injury. Recently, ultrasound has grown in popularity and may be more useful, since it allows for dynamic evaluation of subluxating/dislocating tendons.69
Conservative management is often associated with poor outcomes, and surgery is indicated for all acute and chronic dislocations in athletes.71 Anatomic reconstruction of the SPR is the preferred surgical method.72 Peroneus brevis debulking and fibular groove deepening may also augment the retinaculum repair.73 van Dijk and colleagues in their systematic review showed that patients treated with both groove deepening and SPR repair have higher rates of return to the sport than patients treated with SPR repair alone.74
STRESS FRACTURES
FIFTH METATARSAL
Fifth metatarsal stress fractures usually occur secondary to lateral overload or avulsion of the peroneus brevis. The fifth metatarsal base can be susceptible to injury in a cavovarus foot. Non-operative treatment typically requires a longer period of immobilization (boot or cast) and necessitates a longer period of non–weight-bearing (anywhere between 6-12 weeks). Therefore, surgery is typically recommended in athletes or in the setting of a recurrent base of the fifth metatarsal fracture to expedite healing and return to play. Return to play is still not recommended until there is evidence of radiographic healing of the fracture. There are certain distinctions with fifth metatarsal stress fractures regarding location and healing rates that need to be taken into account.75,76 In particular, zone 2 injuries (Jones fractures) represent a vascular watershed area, making these fractures prone to nonunion with nonunion rates as high as 15% to 30%. Occasionally, the cavovarus deformity will require correction as well as a reduction in the risk of recurrence or nonunion. Surgical fixation most commonly consists of a single screw placed in an antegrade fashion.77 One must pay attention to screw size since smaller diameter screws (<4.5 mm) are associated with delayed union or nonunion. Moreover, screws that are too long will straighten the curved metatarsal shaft and can lead to fracture distraction or malreduction (Figures 8A, 8B).77
Patients have returned to competitive sports within 6 weeks; however, it should be noted that causes of failure were linked to early return and return to sports before a radiographic union can lead to failure of fixation. Ekstrand and van Dijk78 studied a large group of professional soccer players and found that out of 13,754 injuries, 0.5% (67) were fifth metatarsal fractures. Of note, they found that 45% of players had prodromal symptoms. Furthermore, after surgical treatment the fractures healed faster, compared with conservative treatment (75% vs 33%); however, there was no significant difference in lay-off days between both groups (80 vs 74 days).78 Matsuda and colleagues79 looked at 335 male collegiate soccer players, 29 of whom had a history of a fifth metatarsal stress fracture. They found that playing the midfield position and having an everted rearfoot and inverted forefoot alignment were associated with fifth metatarsal stress fractures.79 Saita and colleagues80 found that restricted hip internal rotation was associated with an increased risk of developing a Jones fracture in 162 professional football players. Finally, Fujitaka and colleagues81 looked at 273 male soccer players between 2005 and 2013. They found an association between weak toe-grip strength and fifth metatarsal fractures, suggesting that weak toe-grip may lead to an increase in the load applied onto the lateral side of the foot, resulting in a stress fracture.81
Continue to: NAVICULAR
NAVICULAR
Another common tarsal bone that sustains stress fractures is the navicular. It is not as common as calcaneal stress fractures in military recruits but can occur in the same type of population, as well as explosive athletics such as sprinters and soccer players. It commonly presents with an indistinct vague achy pain with activity that improves with rest, and pain at the dorsum of the midfoot or along the medial longitudinal arch with activity. It can easily go undiagnosed for quite some time given the difficulty in visualizing the navicular with plain radiographs. Clinically, it is difficult to make the diagnosis, and therefore advanced imaging is necessary when the injury is suspected. Both MRI and CT scans can be used to understand the extent of the injury (Figures 9A-9C). In non-displaced stress fractures, conservative non-operative treatment is the appropriate treatment modality with a brief period of immobilization and non–weight-bearing;82 however, operative treatment is also considered in elite athletes. In either case, return to play is discouraged until there is evidence of radiographic healing. When a displacement is noted, or there is a delay in diagnosis, then operative treatment is recommended.
CONCLUSION
Ankle injuries are very common in soccer and can result in decreased performance or significant loss of playing time. Treatment of acute injury generally follows a conservative route, with surgical intervention reserved for severe ruptures or osteochondral fracture of the ankle joint. Chronic ankle pathology resulting in mechanical or functional instability generally requires surgery to repair ligamentous damage and restore normal ankle kinematics. It is critical for the soccer player to receive appropriate rehabilitation prior to returning to play in order to reduce the risk for reinjury and further chronic instability. Prevention and early intervention of ankle injuries is key in preventing the long-term sequelae of ankle injuries, such as arthritis, in former soccer players.
1. Dvorak J, Junge A. Football injuries and physical symptoms. A review of the literature. Am J Sports Med. 2000;28(5 Suppl):S3-S9.
2. Chomiak J, Junge A, Peterson L, Dvorak J. Severe injuries in football players. Am J Sports Med. 2000;28(5 Suppl):S58-S68.
3. Cloke DJ, Ansell P, Avery P, Deehan D. Ankle injuries in football academies: a three-centre prospective study. Br J Sports Med. 2011;45(9):702-708. doi:10.1136/bjsm.2009.067900.
4. Cloke DJ, Spencer S, Hodson A, Deehan D. The epidemiology of ankle injuries occurring in English Football Association academies. Br J Sports Med. 2009;43(14):1119-1125. doi:10.1136/bjsm.2008.052050.
5. Dvorak J, Junge A, Derman W, Schwellnus M. Injuries and illnesses of football players during the 2010 FIFA World Cup. Br J Sports Med. 2011;45(8):626-630. doi:10.1136/bjsm.2010.079905.
6. Ekstrand J, Gillquist J. Soccer injuries and their mechanisms: a prospective study. Med Sci Sports Exerc. 1983;15(3):267-270.
7. Fousekis K, Tsepis E, Vagenas G. Intrinsic risk factors of noncontact ankle sprains in soccer: a prospective study on 100 professional players. Am J Sports Med. 2012;40(8):1842-1850. doi:10.1177/0363546512449602.
8. Gaulrapp H, Becker A, Walther M, Hess H. Injuries in women’s soccer: a 1-year all players prospective field study of the women’s Bundesliga (German premiere league). Clin J Sports Med. 2010;20(4):264-271. doi:10.1097/JSM.0b013e3181e78e33.
9. Morgan BE, Oberlander MA. An examination of injuries in major league soccer. The inaugural season. Am J Sports Med. 2001;29(4):426-430. doi:10.1177/03635465010290040701.
10. Jain N, Murray D, Kemp S, Calder J. Frequency and trends in foot and ankle injuries within an English Premier League Football Club using a new impact factor of injury to identify a focus for injury prevention. Foot Ankle Surg. 2014;20(4):237-240. doi:10.1016/j.fas.2014.05.004.
11. Moore KL, Dalley AF, Agur AMR. Clinically Oriented Anatomy. 6th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2010:xxix, 1134.
12. Thompson JC, Netter FH. Netter’s Concise Orthopaedic Anatomy. 2nd ed. Philadelphia, PA: Saunders Elsevier, 2010:x, 404.
13. Giza E, Mandelbaum B. Chronic footballer’s ankle. In: Football Traumatology. Springer Milan, 2006:333-351.
14. Garrick JG. The frequency of injury, mechanism of injury, and epidemiology of ankle sprains. Am J Sports Med. 1977:5(6):241-242. doi:10.1177/036354657700500606.
15. Agur AMR, Grant JCB. Grant’s Atlas of Anatomy. 13th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2011.
16. Renstrom PA, Konradsen L. Ankle ligament injuries. Br J Sports Med. 1997;31(1):11-20.
17. Chhabra A, Subhawong TK, Carrino JA. MR imaging of deltoid ligament pathologic findings and associated impingement syndromes. Radiographics. 2010;30(3):751-761. doi:10.1148/rg.303095756.
18. Hintermann B. Medial ankle instability. Foot Ankle Clin. 2003;8(4):723-738.
19. Woods C, Hawkins R, Hulse M, Hodson A. The Football Association Medical Research Programme: an audit of injuries in professional football: an analysis of ankle sprains. Br J Sports Med. 2003;37(3):233-238.
20. Thacker SB, Stroup DF, Branche CM, Gilchrist J, Goodman RA, Weitman EA. The prevention of ankle sprains in sports. A systematic review of the literature. Am J Sports Med. 1999;27(6):753-760. doi:10.1177/03635465990270061201.
21. Giza E, Fuller C, Junge A, Dvorak J. Mechanisms of foot and ankle injuries in soccer. Am J Sports Med. 2003;31(4):550-554. doi:10.1177/03635465030310041201.
22. Tucker AM. Common soccer injuries. Diagnosis, treatment and rehabilitation. Sports Med. 1997;23(1):21-32.
23. Lynch SA, Renstrom PA. Treatment of acute lateral ankle ligament rupture in the athlete. Conservative versus surgical treatment. Sports Med. 1999;27(1):61-71.
24. Chan KW, Ding BC, Mroczek KJ. Acute and chronic lateral ankle instability in the athlete. Bull NYU Hosp Jt Dis. 2011;69(1):17-26.
25. Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. 1992;21(4):384-390.
26. Bachmann LM, Kolb E, Koller MT, Steurer J, ter Riet G. Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ. 2003;326(7386):417. doi:10.1136/bmj.326.7386.417.
27. Balduini FC, Vegso JJ, Torg JS, Torg E. Management and rehabilitation of ligamentous injuries to the ankle. Sports Med. 1987;4(5):364-380.
28. Kerkhoffs GM, Rowe BH, Assendelft WJ, Kelly KD, Struijs PA, van Dijk CN. Immobilisation for acute ankle sprain. A systematic review. Arch Orthop Trauma Surg. 2001;121(8):462-471.
29. Konradsen L, Holmer P, Sondergaard L. Early mobilizing treatment for grade III ankle ligament injuries. Foot Ankle. 1991;12(2):69-73.
30. Eiff MP, Smith AT, Smith GE. Early mobilization versus immobilization in the treatment of lateral ankle sprains. Am J Sports Med. 1994;22(1):83-88. doi:10.1177/036354659402200115.
31. Shrier I. Treatment of lateral collateral ligament sprains of the ankle: a critical appraisal of the literature. Clin J Sport Med. 1995;5(3):187-195.
32. DiGiovanni BF, Partal G, Baumhauer JF. Acute ankle injury and chronic lateral instability in the athlete. Clin Sports Med. 2004;23(1):1-19, v. doi:10.1016/S0278-5919(03)00095-4.
33. Alt W, Lohrer H, Gollhofer A. Functional properties of adhesive ankle taping: neuromuscular and mechanical effects before and after exercise. Foot Ankle Int. 1999;20(4):238-245. doi:10.1177/107110079902000406.
34. Garrick JG, Requa RK. Role of external support in the prevention of ankle sprains. Med Sci Sports. 1973;5(3):200-203.
35. Sharpe SR, Knapik J, Jones B. Ankle braces effectively reduce recurrence of ankle sprains in female soccer players. J Athl Train. 1997;32(1):21-24.
36. Surve I, Schwellnus MP, Noakes T, Lombard C. A fivefold reduction in the incidence of recurrent ankle sprains in soccer players using the Sport-Stirrup orthosis. Am J Sports Med. 1994;22(5):601-606. doi:10.1177/036354659402200506.
37. Mohammadi F. Comparison of 3 preventive methods to reduce the recurrence of ankle inversion sprains in male soccer players. Am J Sports Med. 2007;35(6):922-926. doi:10.1177/0363546507299259.
38. Steffen K, Meeuwisse WH, Romiti M, et al. Evaluation of how different implementation strategies of an injury prevention programme (FIFA 11+) impact team adherence and injury risk in Canadian female youth football players: a cluster-randomised trial. Br J Sports Med. 2013;47(8):480-487. doi:10.1136/bjsports-2012-091887.
39. Steffen K, Emery CA, Romiti M, et al. High adherence to a neuromuscular injury prevention programme (FIFA 11+) improves functional balance and reduces injury risk in Canadian youth female football players: a cluster randomised trial. Br J Sports Med. 2013;47(12):794-802. doi: 10.1136/bjsports-2012-091886.
40. Junge A, Lamprecht M, Stamm H, et al. Countrywide campaign to prevent soccer injuries in Swiss amateur players. Am J Sports Med. 2011;39(1):57-63. doi:10.1177/0363546510377424.
41. Lin CF, Gross ML, Weinhold P. Ankle syndesmosis injuries: anatomy, biomechanics, mechanism of injury, and clinical guidelines for diagnosis and intervention. J Orthop Sports Phys Ther. 2006;36(6):372-384. doi:10.2519/jospt.2006.2195.
42. Lubberts B, D’Hooghe P, Bengtsson H, DiGiovanni CW, Calder J, Ekstrand J. Epidemiology and return to play following isolated syndesmotic injuries of the ankle: a prospective cohort study of 3677 male professional football players in the UEFA Elite Club Injury Study. Br J Sports Med. 2017. doi:10.1136/bjsports-2017-097710.
43. Harper MC, Keller TS. A radiographic evaluation of the tibiofibular syndesmosis. Foot Ankle. 1989;10(3):156-160.
44. Vogl TJ, Hochmuth K, Diebold T, et al. Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol. 1997;32(7):401-409.
45. Brown KW, Morrison WB, Schweitzer ME, Parellada JA, Nothnagel H. MRI findings associated with distal tibiofibular syndesmosis injury. AJR Am J Roentgenol. 2004;182(1):131-136. doi:10.2214/ajr.182.1.1820131.
46. Ogilvie-Harris DJ, Reed SC, Hedman TP. Disruption of the ankle syndesmosis: biomechanical study of the ligamentous restraints. Arthroscopy. 1994;10(5):558-560.
47. Boytim MJ, Fischer DA, Neumann L. Syndesmotic ankle sprains. Am J Sports Med. 1991;19(3):294-298. doi:10.1177/036354659101900315.
48. Hopkinson WJ, St Pierre P, Ryan JB, Wheeler JH. Syndesmosis sprains of the ankle. Foot Ankle. 1990;10(6):325-330. doi:10.1177/107110079001000607.
49. Del Buono A, Florio A, Boccanera MS, Maffulli N. Syndesmosis injuries of the ankle. Curr Rev Musculoskelet Med. 2013;6(4):313-319. doi:10.1007/s12178-013-9183-x.
50. Dattani R, Patnaik S, Kantak A, Srikanth B, Selvan TP. Injuries to the tibiofibular syndesmosis. J Bone Joint Surg Br. 2008;90(4):405-410. doi:10.1302/0301-620X.90B4.19750.
51. Schepers T. To retain or remove the syndesmotic screw: a review of literature. Arch Orthop Trauma Surg. 2011;131(7):879-883. doi:10.1007/s00402-010-1225-x.
52. Naqvi GA, Cunningham P, Lynch B, Galvin R, Awan N. Fixation of ankle syndesmotic injuries: comparison of tightrope fixation and syndesmotic screw fixation for accuracy of syndesmotic reduction. Am J Sports Med. 2012;40(12):2828-2835. doi:10.1177/0363546512461480.
53. Weening B, Bhandari M. Predictors of functional outcome following transsyndesmotic screw fixation of ankle fractures. J Orthop Trauma. 2005;19(2):102-108.
54. Colcuc C, Blank M, Stein T, et al. Lower complication rate and faster return to sports in patients with acute syndesmotic rupture treated with a new knotless suture button device. Knee Surg Sports Traumatol Arthrosc. 2017. doi:10.1007/s00167-017-4820-4823.
55. Savage-Elliott I, Ross KA, Smyth NA, Murawski CD, Kennedy JG. Osteochondral lesions of the talus: a current concepts review and evidence-based treatment paradigm. Foot Ankle Spec. 2014;7(5):414-422. doi:10.1177/1938640014543362.
56. Talusan PG, Milewski MD, Toy JO, Wall EJ. Osteochondritis dissecans of the talus: diagnosis and treatment in athletes. Clin Sports Med. 2014;33(2):267-284. doi:10.1016/j.csm.2014.01.003.
57. Murawski CD, Kennedy JG. Operative treatment of osteochondral lesions of the talus. J Bone Joint Surg Am. 2013;95(11):1045-1054. doi:10.2106/JBJS.L.00773.
58. Guney A, Akar M, Karaman I, Oner M, Guney B. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2384-2389. doi:10.1007/s00167-013-2784-5.
59. Hatic SO, Berlet GC. Particulated juvenile articular cartilage graft (DeNovo NT Graft) for treatment of osteochondral lesions of the talus. Foot Ankle Spec. 2010;3(6):361-364. doi:10.1177/1938640010388602.
60. van Eekeren IC, van Bergen CJ, Sierevelt IN, Reilingh ML, van Dijk CN. Return to sports after arthroscopic debridement and bone marrow stimulation of osteochondral talar defects: a 5- to 24-year follow-up study. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1311-1315. doi:10.1007/s00167-016-3992-6.
61. Tol JL, Slim E, van Soest AJ, van Dijk CN. The relationship of the kicking action in soccer and anterior ankle impingement syndrome. A biomechanical analysis. Am J Sports Med. 2002;30(1):45-50. doi:10.1177/03635465020300012101.
62. Sanders TG, Rathur SK. Impingement syndromes of the ankle. Magn Reson Imaging Clin N Am. 2008;16(1):29-38. doi:10.1016/j.mric.2008.02.005.
63. Ogilvie-Harris DJ, Gilbart MK, Chorney K. Chronic pain following ankle sprains in athletes: the role of arthroscopic surgery. Arthroscopy. 1997;13(5):564-574.
64. Robinson P, White LM, Salonen D, Ogilvie-Harris D. Anteromedial impingement of the ankle: using MR arthrography to assess the anteromedial recess. AJR Am J Roentgenol. 2002;178(3):601-604. doi:10.2214/ajr.178.3.1780601.
65. Mosier-La Clair SM, Monroe MT, Manoli A. Medial impingement syndrome of the anterior tibiotalar fascicle of the deltoid ligament on the talus. Foot Ankle Int. 2000;21(5):385-391.
66. Maquirriain J. Posterior ankle impingement syndrome. J Am Acad Orthop Surg. 2005;13(6):365-371.
67. Georgiannos D, Bisbinas I. Endoscopic versus open excision of os trigonum for the treatment of posterior ankle impingement syndrome in an athletic population: a randomized controlled study with 5-year follow-up. Am J Sports Med. 2017;45(6):1388-1394. doi:10.1177/0363546516682498.
68. Carreira DS, Vora AM, Hearne KL, Kozy J. Outcome of arthroscopic treatment of posterior impingement of the ankle. Foot Ankle Int. 2016;37(4):394-400. doi:10.1177/1071100715620857.
69. Roth JA, Taylor WC, Whalen J. Peroneal tendon subluxation: the other lateral ankle injury. Br J Sports Med. 2010;44(14):1047-1053. doi:10.1136/bjsm.2008.057182.
70. Athavale SA, Swathi, Vangara SV. Anatomy of the superior peroneal tunnel. J Bone Joint Surg Am. 2011;93(6):564-571. doi:10.2106/JBJS.17.00836.
71. Porter D, McCarroll J, Knapp E, Torma J. Peroneal tendon subluxation in athletes: fibular groove deepening and retinacular reconstruction. Foot Ankle Int. 2005;26(6):436-441.
72. Ferran NA, Oliva F, Maffulli N. Recurrent subluxation of the peroneal tendons. Sports Med. 2006;36(10):839-846. doi:10.1053/j.jfas.2010.02.007.
73. Saxena A, Ewen B. Peroneal subluxation: surgical results in 31 athletic patients. J Foot Ankle Surg. 2010;49(3):238-241.
74. van Dijk PA, Gianakos AL, Kerkhoffs GM, Kennedy JG. Return to sports and clinical outcomes in patients treated for peroneal tendon dislocation: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1155-1164. doi:10.1007/s00167-015-3833-z.
75. Lee KT, Park YU, Young KW, Kim JS, Kim JB. The plantar gap: another prognostic factor for fifth metatarsal stress fracture. Am J Sports Med. 2011;39(10):2206-2211. doi:10.1177/0363546511414856.
76. Torg JS. Fractures of the base of the fifth metatarsal distal to the tuberosity. Orthopedics. 1990;13:731-737.
77. Smith TO, Clark A, Hing CB. Interventions for treating proximal fifth metatarsal fractures in adults: a meta-analysis of the current evidence-base. Foot Ankle Surg. 2011;17(4):300-307. doi:10.1016/j.fas.2010.12.005.
78. Ekstrand J, van Dijk CN. Fifth metatarsal fractures among male professional footballers: a potential career-ending disease. Br J Sports Med. 2013;47(12):754-758.
79. Matsuda S, Fukubayashi T, Hirose N. Characteristics of the foot static alignment and the plantar pressure associated with fifth metatarsal stress fracture history in male soccer players: a case-control study. Sports Med Open. 2017;3(1):27.
80. Saita Y, Nagao M, Kawasaki T, et al. Range limitation in hip internal rotation and fifth metatarsal stress fractures (Jones fracture) in professional football players. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):1943-1949. doi:10.1007/s00167-017-4552-4.
81. Fujitaka K, Taniguchi A, Isomoto S, et al. Pathogenesis of fifth metatarsal fractures in college soccer players. Orthop J Sports Med. 2015;18;3(9):2325967115603654.
82. Torg J, Moyer J, Gaughan J, Boden B. Management of tarsal navicular stress fractures: conservative versus surgical treatment: a meta-analysis. Am J Sports Med. 2010;38(5):1048-1053.
83. Haytmanek CT, Williams BT, James EW, et al. Radiographic identification of the primary lateral ankle structures. Am J Sports Med. 2015;43(1):79-87. doi:10.1177/0363546514553778.
1. Dvorak J, Junge A. Football injuries and physical symptoms. A review of the literature. Am J Sports Med. 2000;28(5 Suppl):S3-S9.
2. Chomiak J, Junge A, Peterson L, Dvorak J. Severe injuries in football players. Am J Sports Med. 2000;28(5 Suppl):S58-S68.
3. Cloke DJ, Ansell P, Avery P, Deehan D. Ankle injuries in football academies: a three-centre prospective study. Br J Sports Med. 2011;45(9):702-708. doi:10.1136/bjsm.2009.067900.
4. Cloke DJ, Spencer S, Hodson A, Deehan D. The epidemiology of ankle injuries occurring in English Football Association academies. Br J Sports Med. 2009;43(14):1119-1125. doi:10.1136/bjsm.2008.052050.
5. Dvorak J, Junge A, Derman W, Schwellnus M. Injuries and illnesses of football players during the 2010 FIFA World Cup. Br J Sports Med. 2011;45(8):626-630. doi:10.1136/bjsm.2010.079905.
6. Ekstrand J, Gillquist J. Soccer injuries and their mechanisms: a prospective study. Med Sci Sports Exerc. 1983;15(3):267-270.
7. Fousekis K, Tsepis E, Vagenas G. Intrinsic risk factors of noncontact ankle sprains in soccer: a prospective study on 100 professional players. Am J Sports Med. 2012;40(8):1842-1850. doi:10.1177/0363546512449602.
8. Gaulrapp H, Becker A, Walther M, Hess H. Injuries in women’s soccer: a 1-year all players prospective field study of the women’s Bundesliga (German premiere league). Clin J Sports Med. 2010;20(4):264-271. doi:10.1097/JSM.0b013e3181e78e33.
9. Morgan BE, Oberlander MA. An examination of injuries in major league soccer. The inaugural season. Am J Sports Med. 2001;29(4):426-430. doi:10.1177/03635465010290040701.
10. Jain N, Murray D, Kemp S, Calder J. Frequency and trends in foot and ankle injuries within an English Premier League Football Club using a new impact factor of injury to identify a focus for injury prevention. Foot Ankle Surg. 2014;20(4):237-240. doi:10.1016/j.fas.2014.05.004.
11. Moore KL, Dalley AF, Agur AMR. Clinically Oriented Anatomy. 6th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2010:xxix, 1134.
12. Thompson JC, Netter FH. Netter’s Concise Orthopaedic Anatomy. 2nd ed. Philadelphia, PA: Saunders Elsevier, 2010:x, 404.
13. Giza E, Mandelbaum B. Chronic footballer’s ankle. In: Football Traumatology. Springer Milan, 2006:333-351.
14. Garrick JG. The frequency of injury, mechanism of injury, and epidemiology of ankle sprains. Am J Sports Med. 1977:5(6):241-242. doi:10.1177/036354657700500606.
15. Agur AMR, Grant JCB. Grant’s Atlas of Anatomy. 13th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2011.
16. Renstrom PA, Konradsen L. Ankle ligament injuries. Br J Sports Med. 1997;31(1):11-20.
17. Chhabra A, Subhawong TK, Carrino JA. MR imaging of deltoid ligament pathologic findings and associated impingement syndromes. Radiographics. 2010;30(3):751-761. doi:10.1148/rg.303095756.
18. Hintermann B. Medial ankle instability. Foot Ankle Clin. 2003;8(4):723-738.
19. Woods C, Hawkins R, Hulse M, Hodson A. The Football Association Medical Research Programme: an audit of injuries in professional football: an analysis of ankle sprains. Br J Sports Med. 2003;37(3):233-238.
20. Thacker SB, Stroup DF, Branche CM, Gilchrist J, Goodman RA, Weitman EA. The prevention of ankle sprains in sports. A systematic review of the literature. Am J Sports Med. 1999;27(6):753-760. doi:10.1177/03635465990270061201.
21. Giza E, Fuller C, Junge A, Dvorak J. Mechanisms of foot and ankle injuries in soccer. Am J Sports Med. 2003;31(4):550-554. doi:10.1177/03635465030310041201.
22. Tucker AM. Common soccer injuries. Diagnosis, treatment and rehabilitation. Sports Med. 1997;23(1):21-32.
23. Lynch SA, Renstrom PA. Treatment of acute lateral ankle ligament rupture in the athlete. Conservative versus surgical treatment. Sports Med. 1999;27(1):61-71.
24. Chan KW, Ding BC, Mroczek KJ. Acute and chronic lateral ankle instability in the athlete. Bull NYU Hosp Jt Dis. 2011;69(1):17-26.
25. Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. 1992;21(4):384-390.
26. Bachmann LM, Kolb E, Koller MT, Steurer J, ter Riet G. Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ. 2003;326(7386):417. doi:10.1136/bmj.326.7386.417.
27. Balduini FC, Vegso JJ, Torg JS, Torg E. Management and rehabilitation of ligamentous injuries to the ankle. Sports Med. 1987;4(5):364-380.
28. Kerkhoffs GM, Rowe BH, Assendelft WJ, Kelly KD, Struijs PA, van Dijk CN. Immobilisation for acute ankle sprain. A systematic review. Arch Orthop Trauma Surg. 2001;121(8):462-471.
29. Konradsen L, Holmer P, Sondergaard L. Early mobilizing treatment for grade III ankle ligament injuries. Foot Ankle. 1991;12(2):69-73.
30. Eiff MP, Smith AT, Smith GE. Early mobilization versus immobilization in the treatment of lateral ankle sprains. Am J Sports Med. 1994;22(1):83-88. doi:10.1177/036354659402200115.
31. Shrier I. Treatment of lateral collateral ligament sprains of the ankle: a critical appraisal of the literature. Clin J Sport Med. 1995;5(3):187-195.
32. DiGiovanni BF, Partal G, Baumhauer JF. Acute ankle injury and chronic lateral instability in the athlete. Clin Sports Med. 2004;23(1):1-19, v. doi:10.1016/S0278-5919(03)00095-4.
33. Alt W, Lohrer H, Gollhofer A. Functional properties of adhesive ankle taping: neuromuscular and mechanical effects before and after exercise. Foot Ankle Int. 1999;20(4):238-245. doi:10.1177/107110079902000406.
34. Garrick JG, Requa RK. Role of external support in the prevention of ankle sprains. Med Sci Sports. 1973;5(3):200-203.
35. Sharpe SR, Knapik J, Jones B. Ankle braces effectively reduce recurrence of ankle sprains in female soccer players. J Athl Train. 1997;32(1):21-24.
36. Surve I, Schwellnus MP, Noakes T, Lombard C. A fivefold reduction in the incidence of recurrent ankle sprains in soccer players using the Sport-Stirrup orthosis. Am J Sports Med. 1994;22(5):601-606. doi:10.1177/036354659402200506.
37. Mohammadi F. Comparison of 3 preventive methods to reduce the recurrence of ankle inversion sprains in male soccer players. Am J Sports Med. 2007;35(6):922-926. doi:10.1177/0363546507299259.
38. Steffen K, Meeuwisse WH, Romiti M, et al. Evaluation of how different implementation strategies of an injury prevention programme (FIFA 11+) impact team adherence and injury risk in Canadian female youth football players: a cluster-randomised trial. Br J Sports Med. 2013;47(8):480-487. doi:10.1136/bjsports-2012-091887.
39. Steffen K, Emery CA, Romiti M, et al. High adherence to a neuromuscular injury prevention programme (FIFA 11+) improves functional balance and reduces injury risk in Canadian youth female football players: a cluster randomised trial. Br J Sports Med. 2013;47(12):794-802. doi: 10.1136/bjsports-2012-091886.
40. Junge A, Lamprecht M, Stamm H, et al. Countrywide campaign to prevent soccer injuries in Swiss amateur players. Am J Sports Med. 2011;39(1):57-63. doi:10.1177/0363546510377424.
41. Lin CF, Gross ML, Weinhold P. Ankle syndesmosis injuries: anatomy, biomechanics, mechanism of injury, and clinical guidelines for diagnosis and intervention. J Orthop Sports Phys Ther. 2006;36(6):372-384. doi:10.2519/jospt.2006.2195.
42. Lubberts B, D’Hooghe P, Bengtsson H, DiGiovanni CW, Calder J, Ekstrand J. Epidemiology and return to play following isolated syndesmotic injuries of the ankle: a prospective cohort study of 3677 male professional football players in the UEFA Elite Club Injury Study. Br J Sports Med. 2017. doi:10.1136/bjsports-2017-097710.
43. Harper MC, Keller TS. A radiographic evaluation of the tibiofibular syndesmosis. Foot Ankle. 1989;10(3):156-160.
44. Vogl TJ, Hochmuth K, Diebold T, et al. Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol. 1997;32(7):401-409.
45. Brown KW, Morrison WB, Schweitzer ME, Parellada JA, Nothnagel H. MRI findings associated with distal tibiofibular syndesmosis injury. AJR Am J Roentgenol. 2004;182(1):131-136. doi:10.2214/ajr.182.1.1820131.
46. Ogilvie-Harris DJ, Reed SC, Hedman TP. Disruption of the ankle syndesmosis: biomechanical study of the ligamentous restraints. Arthroscopy. 1994;10(5):558-560.
47. Boytim MJ, Fischer DA, Neumann L. Syndesmotic ankle sprains. Am J Sports Med. 1991;19(3):294-298. doi:10.1177/036354659101900315.
48. Hopkinson WJ, St Pierre P, Ryan JB, Wheeler JH. Syndesmosis sprains of the ankle. Foot Ankle. 1990;10(6):325-330. doi:10.1177/107110079001000607.
49. Del Buono A, Florio A, Boccanera MS, Maffulli N. Syndesmosis injuries of the ankle. Curr Rev Musculoskelet Med. 2013;6(4):313-319. doi:10.1007/s12178-013-9183-x.
50. Dattani R, Patnaik S, Kantak A, Srikanth B, Selvan TP. Injuries to the tibiofibular syndesmosis. J Bone Joint Surg Br. 2008;90(4):405-410. doi:10.1302/0301-620X.90B4.19750.
51. Schepers T. To retain or remove the syndesmotic screw: a review of literature. Arch Orthop Trauma Surg. 2011;131(7):879-883. doi:10.1007/s00402-010-1225-x.
52. Naqvi GA, Cunningham P, Lynch B, Galvin R, Awan N. Fixation of ankle syndesmotic injuries: comparison of tightrope fixation and syndesmotic screw fixation for accuracy of syndesmotic reduction. Am J Sports Med. 2012;40(12):2828-2835. doi:10.1177/0363546512461480.
53. Weening B, Bhandari M. Predictors of functional outcome following transsyndesmotic screw fixation of ankle fractures. J Orthop Trauma. 2005;19(2):102-108.
54. Colcuc C, Blank M, Stein T, et al. Lower complication rate and faster return to sports in patients with acute syndesmotic rupture treated with a new knotless suture button device. Knee Surg Sports Traumatol Arthrosc. 2017. doi:10.1007/s00167-017-4820-4823.
55. Savage-Elliott I, Ross KA, Smyth NA, Murawski CD, Kennedy JG. Osteochondral lesions of the talus: a current concepts review and evidence-based treatment paradigm. Foot Ankle Spec. 2014;7(5):414-422. doi:10.1177/1938640014543362.
56. Talusan PG, Milewski MD, Toy JO, Wall EJ. Osteochondritis dissecans of the talus: diagnosis and treatment in athletes. Clin Sports Med. 2014;33(2):267-284. doi:10.1016/j.csm.2014.01.003.
57. Murawski CD, Kennedy JG. Operative treatment of osteochondral lesions of the talus. J Bone Joint Surg Am. 2013;95(11):1045-1054. doi:10.2106/JBJS.L.00773.
58. Guney A, Akar M, Karaman I, Oner M, Guney B. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2384-2389. doi:10.1007/s00167-013-2784-5.
59. Hatic SO, Berlet GC. Particulated juvenile articular cartilage graft (DeNovo NT Graft) for treatment of osteochondral lesions of the talus. Foot Ankle Spec. 2010;3(6):361-364. doi:10.1177/1938640010388602.
60. van Eekeren IC, van Bergen CJ, Sierevelt IN, Reilingh ML, van Dijk CN. Return to sports after arthroscopic debridement and bone marrow stimulation of osteochondral talar defects: a 5- to 24-year follow-up study. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1311-1315. doi:10.1007/s00167-016-3992-6.
61. Tol JL, Slim E, van Soest AJ, van Dijk CN. The relationship of the kicking action in soccer and anterior ankle impingement syndrome. A biomechanical analysis. Am J Sports Med. 2002;30(1):45-50. doi:10.1177/03635465020300012101.
62. Sanders TG, Rathur SK. Impingement syndromes of the ankle. Magn Reson Imaging Clin N Am. 2008;16(1):29-38. doi:10.1016/j.mric.2008.02.005.
63. Ogilvie-Harris DJ, Gilbart MK, Chorney K. Chronic pain following ankle sprains in athletes: the role of arthroscopic surgery. Arthroscopy. 1997;13(5):564-574.
64. Robinson P, White LM, Salonen D, Ogilvie-Harris D. Anteromedial impingement of the ankle: using MR arthrography to assess the anteromedial recess. AJR Am J Roentgenol. 2002;178(3):601-604. doi:10.2214/ajr.178.3.1780601.
65. Mosier-La Clair SM, Monroe MT, Manoli A. Medial impingement syndrome of the anterior tibiotalar fascicle of the deltoid ligament on the talus. Foot Ankle Int. 2000;21(5):385-391.
66. Maquirriain J. Posterior ankle impingement syndrome. J Am Acad Orthop Surg. 2005;13(6):365-371.
67. Georgiannos D, Bisbinas I. Endoscopic versus open excision of os trigonum for the treatment of posterior ankle impingement syndrome in an athletic population: a randomized controlled study with 5-year follow-up. Am J Sports Med. 2017;45(6):1388-1394. doi:10.1177/0363546516682498.
68. Carreira DS, Vora AM, Hearne KL, Kozy J. Outcome of arthroscopic treatment of posterior impingement of the ankle. Foot Ankle Int. 2016;37(4):394-400. doi:10.1177/1071100715620857.
69. Roth JA, Taylor WC, Whalen J. Peroneal tendon subluxation: the other lateral ankle injury. Br J Sports Med. 2010;44(14):1047-1053. doi:10.1136/bjsm.2008.057182.
70. Athavale SA, Swathi, Vangara SV. Anatomy of the superior peroneal tunnel. J Bone Joint Surg Am. 2011;93(6):564-571. doi:10.2106/JBJS.17.00836.
71. Porter D, McCarroll J, Knapp E, Torma J. Peroneal tendon subluxation in athletes: fibular groove deepening and retinacular reconstruction. Foot Ankle Int. 2005;26(6):436-441.
72. Ferran NA, Oliva F, Maffulli N. Recurrent subluxation of the peroneal tendons. Sports Med. 2006;36(10):839-846. doi:10.1053/j.jfas.2010.02.007.
73. Saxena A, Ewen B. Peroneal subluxation: surgical results in 31 athletic patients. J Foot Ankle Surg. 2010;49(3):238-241.
74. van Dijk PA, Gianakos AL, Kerkhoffs GM, Kennedy JG. Return to sports and clinical outcomes in patients treated for peroneal tendon dislocation: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1155-1164. doi:10.1007/s00167-015-3833-z.
75. Lee KT, Park YU, Young KW, Kim JS, Kim JB. The plantar gap: another prognostic factor for fifth metatarsal stress fracture. Am J Sports Med. 2011;39(10):2206-2211. doi:10.1177/0363546511414856.
76. Torg JS. Fractures of the base of the fifth metatarsal distal to the tuberosity. Orthopedics. 1990;13:731-737.
77. Smith TO, Clark A, Hing CB. Interventions for treating proximal fifth metatarsal fractures in adults: a meta-analysis of the current evidence-base. Foot Ankle Surg. 2011;17(4):300-307. doi:10.1016/j.fas.2010.12.005.
78. Ekstrand J, van Dijk CN. Fifth metatarsal fractures among male professional footballers: a potential career-ending disease. Br J Sports Med. 2013;47(12):754-758.
79. Matsuda S, Fukubayashi T, Hirose N. Characteristics of the foot static alignment and the plantar pressure associated with fifth metatarsal stress fracture history in male soccer players: a case-control study. Sports Med Open. 2017;3(1):27.
80. Saita Y, Nagao M, Kawasaki T, et al. Range limitation in hip internal rotation and fifth metatarsal stress fractures (Jones fracture) in professional football players. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):1943-1949. doi:10.1007/s00167-017-4552-4.
81. Fujitaka K, Taniguchi A, Isomoto S, et al. Pathogenesis of fifth metatarsal fractures in college soccer players. Orthop J Sports Med. 2015;18;3(9):2325967115603654.
82. Torg J, Moyer J, Gaughan J, Boden B. Management of tarsal navicular stress fractures: conservative versus surgical treatment: a meta-analysis. Am J Sports Med. 2010;38(5):1048-1053.
83. Haytmanek CT, Williams BT, James EW, et al. Radiographic identification of the primary lateral ankle structures. Am J Sports Med. 2015;43(1):79-87. doi:10.1177/0363546514553778.
TAKE-HOME POINTS
- Soccer injuries of the foot and ankle are becoming more prevalent due to the ever-growing popularity of the sport.
- Low ankle sprains represent the majority of foot and ankle–related injuries due to soccer and most can be treated non-operatively, with an early mobilization protocol followed by a phased rehabilitation.
- High ankle sprains are less common than low ankle sprains; however, they require a lengthier rehabilitation and most of the time are treated surgically.
- Impingement-like syndromes are common among soccer players and can be due to repetitive microtrauma from recurrent ball impact. Most of these syndromes respond favorably to non-operative modalities.
- Stress fractures of the foot, although less common, often require surgical stabilization in soccer players.
Time to Stop Glucosamine and Chondroitin for Knee OA?
A 65-year-old man with moderately severe osteoarthritis (OA) of the knee presents to your office for his annual exam. During the medication review, the patient mentions he is using glucosamine and chondroitin for his knee pain, which was recommended by a family member. Should you tell the patient to continue taking the medication?
Knee OA is a common condition in the United States, affecting an estimated 12% of adults ages 60 and older and 16% of those ages 70 and older.2 The primary goals of OA therapy are to minimize pain and improve function. The American Academy of Orthopedic Surgeons (AAOS) and the American College of Rheumatology (ACR) agree that firstline treatment recommendations include aerobic exercise, resistance training, and weight loss.
Initial pharmacologic therapies include full-strength acetaminophen or oral/topical NSAIDs; the latter are also used if pain is unresponsive to acetaminophen.3,4 If initial therapy is inadequate to control pain, tramadol, other opioids, duloxetine, or intra-articular injections with corticosteroids or hyaluronate are alternatives.3,4 Total knee replacement may be indicated in moderate or severe knee OA with radiographic evidence.5 Vitamin D, lateral wedge insoles, and antioxidants are not currently recommended.6
Prior studies evaluating glucosamine and/or chondroitin have provided conflicting results regarding evidence on pain reduction, function, and quality of life. Therefore, guidelines on OA management do not recommend their use (AAOS, strong; ACR, conditional).3,4 However, consumption remains high, with 6.5 million US adults reporting use of glucosamine and/or chondroitin in the prior 30 days.7
A 2015 systematic review of 43 randomized trials evaluating oral chondroitin sulfate for OA of varying severity suggested there may be a significant decrease in short-term and long-term pain with doses ≥ 800 mg/d compared with placebo (level of evidence, low; risk for bias, high).8 However, no significant difference was noted in short- or long-term function, and the trials were highly heterogeneous.
Studies included in the 2015 systematic review found that glucosamine plus chondroitin did not have a significant effect on short- or long-term pain or physical function compared with placebo. Although glucosamine plus chondroitin led to significantly decreased pain compared with other medication, sensitivity analyses conducted for larger studies (N > 200) with adequate methods of blinding and allocation concealment found no difference in pain.8 There was no statistically significant difference in adverse events for glucosamine plus chondroitin vs placebo, based on data from three studies included in the review.8
This RCT from Roman-Blas et al evaluated chondroitin and glucosamine vs placebo in patients with more severe OA. The study was supported by Tedec-Meiji Farma (Madrid), maker of the combination of chondroitin plus glucosamine used in the study.1
Continue to: STUDY SUMMARY
STUDY SUMMARY
Chondroitin + glucosamine not better than placebo
This multicenter, randomized, double-blind, placebo-controlled trial was conducted in nine rheumatology referral centers and one orthopedic center in Spain. The trial evaluated the efficacy of chondroitin sulfate (1,200 mg) plus glucosamine sulfate (1,500 mg) (CS/GS) compared with placebo in 164 patients with Grade 2 or 3 knee OA and moderate-to-severe knee pain. OA grade was ascertained using the Kellgren-Lawrence scale, corresponding to osteophytes and either possible (Grade 2) or definite (Grade 3) joint space narrowing. Knee pain severity was defined by a self-reported global pain score of 40 to 80 mm on a 100-mm visual analog scale (VAS).
No significant difference was noted in group characteristics; average age in the CS/GS group was 67 and in the placebo group, 65. Exclusion criteria included BMI ≥ 35, concurrent arthritic conditions, and any coexisting chronic disease that would prevent successful completion of the trial.1
The primary endpoint was mean reduction in global pain score on a 0- to 100-mm VAS at six months. Secondary outcomes included mean reduction in total and subscale scores in pain and function on the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index (0–100-mm VAS for each) and the use of rescue medication.
Baseline global pain scores were 62 mm in both groups. Acetaminophen, up to 3 g/d, was the only allowed rescue medication. Clinic visits occurred at 4, 12, and 24 weeks. A statistically significant difference between groups was defined as P < .03.1
Results. In the intention-to-treat analysis at six months, patients in the placebo group had a greater reduction in pain than the CS/GC group (–20 mm vs –12 mm; P = .029). No other difference was noted between the placebo and CS/GS groups in the total or subscales of the WOMAC index, and no difference was noted in use of acetaminophen. More patients in the placebo group had at least a 50% improvement in pain or function compared with the CS/GS group (47.4% vs 27.5%; P = .01).
Continue to: In the CS/GS group...
In the CS/GS group, 31% did not complete the six-month treatment period, compared with 18% in the placebo group. More patients dropped out because of adverse effects (diarrhea, upper abdominal pain, and constipation) in the CS/GS group than the placebo group (33 vs 19; P = .018).1
WHAT’S NEW
Pharma-sponsored study finds treatment ineffective
The effectiveness of CS/GS for the treatment of knee OA has been in question for years, but this RCT is the first trial sponsored by a pharmaceutical company to evaluate CS/GS efficacy. This trial found evidence of a lack of efficacy. In patients with more severe OA of the knee, placebo was more effective than CS/GS, and CS/GS had significantly more adverse events. Therefore, it may be time to advise patients to stop taking their CS/GS supplement.
CAVEATS
Cannot generalize findings
The study compared only one medication dosing regimen using a combination of CS and GS. Whether either agent alone, or different dosing, would lead to the same outcome is unknown.
ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.
Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.
Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice (2018; 67[9]:566-568).
1. Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, et al. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69:77-85.
2. Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006;33:2271-2279.
3. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-474.
4. Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd ed. J Am Acad Orthop Surg. 2013;21:577-579.
5. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-1155.
6. Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97:523-526.
7. Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Rep. 2015;(79):1-16.
8. Singh JA, Noorbaloochi S, MacDonald R, et al. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;(1):CD005614.
A 65-year-old man with moderately severe osteoarthritis (OA) of the knee presents to your office for his annual exam. During the medication review, the patient mentions he is using glucosamine and chondroitin for his knee pain, which was recommended by a family member. Should you tell the patient to continue taking the medication?
Knee OA is a common condition in the United States, affecting an estimated 12% of adults ages 60 and older and 16% of those ages 70 and older.2 The primary goals of OA therapy are to minimize pain and improve function. The American Academy of Orthopedic Surgeons (AAOS) and the American College of Rheumatology (ACR) agree that firstline treatment recommendations include aerobic exercise, resistance training, and weight loss.
Initial pharmacologic therapies include full-strength acetaminophen or oral/topical NSAIDs; the latter are also used if pain is unresponsive to acetaminophen.3,4 If initial therapy is inadequate to control pain, tramadol, other opioids, duloxetine, or intra-articular injections with corticosteroids or hyaluronate are alternatives.3,4 Total knee replacement may be indicated in moderate or severe knee OA with radiographic evidence.5 Vitamin D, lateral wedge insoles, and antioxidants are not currently recommended.6
Prior studies evaluating glucosamine and/or chondroitin have provided conflicting results regarding evidence on pain reduction, function, and quality of life. Therefore, guidelines on OA management do not recommend their use (AAOS, strong; ACR, conditional).3,4 However, consumption remains high, with 6.5 million US adults reporting use of glucosamine and/or chondroitin in the prior 30 days.7
A 2015 systematic review of 43 randomized trials evaluating oral chondroitin sulfate for OA of varying severity suggested there may be a significant decrease in short-term and long-term pain with doses ≥ 800 mg/d compared with placebo (level of evidence, low; risk for bias, high).8 However, no significant difference was noted in short- or long-term function, and the trials were highly heterogeneous.
Studies included in the 2015 systematic review found that glucosamine plus chondroitin did not have a significant effect on short- or long-term pain or physical function compared with placebo. Although glucosamine plus chondroitin led to significantly decreased pain compared with other medication, sensitivity analyses conducted for larger studies (N > 200) with adequate methods of blinding and allocation concealment found no difference in pain.8 There was no statistically significant difference in adverse events for glucosamine plus chondroitin vs placebo, based on data from three studies included in the review.8
This RCT from Roman-Blas et al evaluated chondroitin and glucosamine vs placebo in patients with more severe OA. The study was supported by Tedec-Meiji Farma (Madrid), maker of the combination of chondroitin plus glucosamine used in the study.1
Continue to: STUDY SUMMARY
STUDY SUMMARY
Chondroitin + glucosamine not better than placebo
This multicenter, randomized, double-blind, placebo-controlled trial was conducted in nine rheumatology referral centers and one orthopedic center in Spain. The trial evaluated the efficacy of chondroitin sulfate (1,200 mg) plus glucosamine sulfate (1,500 mg) (CS/GS) compared with placebo in 164 patients with Grade 2 or 3 knee OA and moderate-to-severe knee pain. OA grade was ascertained using the Kellgren-Lawrence scale, corresponding to osteophytes and either possible (Grade 2) or definite (Grade 3) joint space narrowing. Knee pain severity was defined by a self-reported global pain score of 40 to 80 mm on a 100-mm visual analog scale (VAS).
No significant difference was noted in group characteristics; average age in the CS/GS group was 67 and in the placebo group, 65. Exclusion criteria included BMI ≥ 35, concurrent arthritic conditions, and any coexisting chronic disease that would prevent successful completion of the trial.1
The primary endpoint was mean reduction in global pain score on a 0- to 100-mm VAS at six months. Secondary outcomes included mean reduction in total and subscale scores in pain and function on the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index (0–100-mm VAS for each) and the use of rescue medication.
Baseline global pain scores were 62 mm in both groups. Acetaminophen, up to 3 g/d, was the only allowed rescue medication. Clinic visits occurred at 4, 12, and 24 weeks. A statistically significant difference between groups was defined as P < .03.1
Results. In the intention-to-treat analysis at six months, patients in the placebo group had a greater reduction in pain than the CS/GC group (–20 mm vs –12 mm; P = .029). No other difference was noted between the placebo and CS/GS groups in the total or subscales of the WOMAC index, and no difference was noted in use of acetaminophen. More patients in the placebo group had at least a 50% improvement in pain or function compared with the CS/GS group (47.4% vs 27.5%; P = .01).
Continue to: In the CS/GS group...
In the CS/GS group, 31% did not complete the six-month treatment period, compared with 18% in the placebo group. More patients dropped out because of adverse effects (diarrhea, upper abdominal pain, and constipation) in the CS/GS group than the placebo group (33 vs 19; P = .018).1
WHAT’S NEW
Pharma-sponsored study finds treatment ineffective
The effectiveness of CS/GS for the treatment of knee OA has been in question for years, but this RCT is the first trial sponsored by a pharmaceutical company to evaluate CS/GS efficacy. This trial found evidence of a lack of efficacy. In patients with more severe OA of the knee, placebo was more effective than CS/GS, and CS/GS had significantly more adverse events. Therefore, it may be time to advise patients to stop taking their CS/GS supplement.
CAVEATS
Cannot generalize findings
The study compared only one medication dosing regimen using a combination of CS and GS. Whether either agent alone, or different dosing, would lead to the same outcome is unknown.
ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.
Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.
Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice (2018; 67[9]:566-568).
A 65-year-old man with moderately severe osteoarthritis (OA) of the knee presents to your office for his annual exam. During the medication review, the patient mentions he is using glucosamine and chondroitin for his knee pain, which was recommended by a family member. Should you tell the patient to continue taking the medication?
Knee OA is a common condition in the United States, affecting an estimated 12% of adults ages 60 and older and 16% of those ages 70 and older.2 The primary goals of OA therapy are to minimize pain and improve function. The American Academy of Orthopedic Surgeons (AAOS) and the American College of Rheumatology (ACR) agree that firstline treatment recommendations include aerobic exercise, resistance training, and weight loss.
Initial pharmacologic therapies include full-strength acetaminophen or oral/topical NSAIDs; the latter are also used if pain is unresponsive to acetaminophen.3,4 If initial therapy is inadequate to control pain, tramadol, other opioids, duloxetine, or intra-articular injections with corticosteroids or hyaluronate are alternatives.3,4 Total knee replacement may be indicated in moderate or severe knee OA with radiographic evidence.5 Vitamin D, lateral wedge insoles, and antioxidants are not currently recommended.6
Prior studies evaluating glucosamine and/or chondroitin have provided conflicting results regarding evidence on pain reduction, function, and quality of life. Therefore, guidelines on OA management do not recommend their use (AAOS, strong; ACR, conditional).3,4 However, consumption remains high, with 6.5 million US adults reporting use of glucosamine and/or chondroitin in the prior 30 days.7
A 2015 systematic review of 43 randomized trials evaluating oral chondroitin sulfate for OA of varying severity suggested there may be a significant decrease in short-term and long-term pain with doses ≥ 800 mg/d compared with placebo (level of evidence, low; risk for bias, high).8 However, no significant difference was noted in short- or long-term function, and the trials were highly heterogeneous.
Studies included in the 2015 systematic review found that glucosamine plus chondroitin did not have a significant effect on short- or long-term pain or physical function compared with placebo. Although glucosamine plus chondroitin led to significantly decreased pain compared with other medication, sensitivity analyses conducted for larger studies (N > 200) with adequate methods of blinding and allocation concealment found no difference in pain.8 There was no statistically significant difference in adverse events for glucosamine plus chondroitin vs placebo, based on data from three studies included in the review.8
This RCT from Roman-Blas et al evaluated chondroitin and glucosamine vs placebo in patients with more severe OA. The study was supported by Tedec-Meiji Farma (Madrid), maker of the combination of chondroitin plus glucosamine used in the study.1
Continue to: STUDY SUMMARY
STUDY SUMMARY
Chondroitin + glucosamine not better than placebo
This multicenter, randomized, double-blind, placebo-controlled trial was conducted in nine rheumatology referral centers and one orthopedic center in Spain. The trial evaluated the efficacy of chondroitin sulfate (1,200 mg) plus glucosamine sulfate (1,500 mg) (CS/GS) compared with placebo in 164 patients with Grade 2 or 3 knee OA and moderate-to-severe knee pain. OA grade was ascertained using the Kellgren-Lawrence scale, corresponding to osteophytes and either possible (Grade 2) or definite (Grade 3) joint space narrowing. Knee pain severity was defined by a self-reported global pain score of 40 to 80 mm on a 100-mm visual analog scale (VAS).
No significant difference was noted in group characteristics; average age in the CS/GS group was 67 and in the placebo group, 65. Exclusion criteria included BMI ≥ 35, concurrent arthritic conditions, and any coexisting chronic disease that would prevent successful completion of the trial.1
The primary endpoint was mean reduction in global pain score on a 0- to 100-mm VAS at six months. Secondary outcomes included mean reduction in total and subscale scores in pain and function on the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index (0–100-mm VAS for each) and the use of rescue medication.
Baseline global pain scores were 62 mm in both groups. Acetaminophen, up to 3 g/d, was the only allowed rescue medication. Clinic visits occurred at 4, 12, and 24 weeks. A statistically significant difference between groups was defined as P < .03.1
Results. In the intention-to-treat analysis at six months, patients in the placebo group had a greater reduction in pain than the CS/GC group (–20 mm vs –12 mm; P = .029). No other difference was noted between the placebo and CS/GS groups in the total or subscales of the WOMAC index, and no difference was noted in use of acetaminophen. More patients in the placebo group had at least a 50% improvement in pain or function compared with the CS/GS group (47.4% vs 27.5%; P = .01).
Continue to: In the CS/GS group...
In the CS/GS group, 31% did not complete the six-month treatment period, compared with 18% in the placebo group. More patients dropped out because of adverse effects (diarrhea, upper abdominal pain, and constipation) in the CS/GS group than the placebo group (33 vs 19; P = .018).1
WHAT’S NEW
Pharma-sponsored study finds treatment ineffective
The effectiveness of CS/GS for the treatment of knee OA has been in question for years, but this RCT is the first trial sponsored by a pharmaceutical company to evaluate CS/GS efficacy. This trial found evidence of a lack of efficacy. In patients with more severe OA of the knee, placebo was more effective than CS/GS, and CS/GS had significantly more adverse events. Therefore, it may be time to advise patients to stop taking their CS/GS supplement.
CAVEATS
Cannot generalize findings
The study compared only one medication dosing regimen using a combination of CS and GS. Whether either agent alone, or different dosing, would lead to the same outcome is unknown.
ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.
Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.
Reprinted with permission from the Family Physicians Inquiries Network and The Journal of Family Practice (2018; 67[9]:566-568).
1. Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, et al. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69:77-85.
2. Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006;33:2271-2279.
3. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-474.
4. Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd ed. J Am Acad Orthop Surg. 2013;21:577-579.
5. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-1155.
6. Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97:523-526.
7. Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Rep. 2015;(79):1-16.
8. Singh JA, Noorbaloochi S, MacDonald R, et al. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;(1):CD005614.
1. Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, et al. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69:77-85.
2. Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006;33:2271-2279.
3. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-474.
4. Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd ed. J Am Acad Orthop Surg. 2013;21:577-579.
5. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-1155.
6. Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97:523-526.
7. Clarke TC, Black LI, Stussman BJ, et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Rep. 2015;(79):1-16.
8. Singh JA, Noorbaloochi S, MacDonald R, et al. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;(1):CD005614.
Use of Musculoskeletal Ultrasound and Regenerative Therapies in Soccer
ABSTRACT
Improvements in ultrasound technology have increased the popularity and use of ultrasound as a diagnostic and therapeutic modality for many soccer-related musculoskeletal (MSK) injuries. As a dynamic imaging modality, ultrasound offers increased accuracy and efficacy with minimally invasive procedures, such as guided injections, percutaneous tenotomy, and regenerative therapies, in the clinical setting. Emerging evidence indicates that regenerative therapies, such as platelet-rich-plasma (PRP), mesenchymal stem cells, and amniotic products, are a promising treatment for many MSK injuries and are gaining popularity among professional athletes. PRP is a safe treatment for a number of MSK conditions and has been included in the standard of care. However, conflicting evidence on return-to-play timeframes and efficacy in certain MSK conditions have led to inconsistent recommendations on indications for use, dose, and timing of treatment. Mesenchymal stem cell therapy, while promising, lacks high-level evidence of efficacy despite its increasing use among athletes. Currently, no data are available regarding the outcome of the use of amniotic products for the treatment of injuries in athletes. Furthermore, preparation of many regenerative therapies eclipses the concept of minimal manipulation and is subject to US Food and Drug Administration phase I to III trials. High-level research on regenerative medicine therapies should be continuously conducted to establish their clinical efficacy and safety data.
ULTRASOUND
Ultrasound (US) was first introduced for musculoskeletal (MSK) evaluation in 1957.1 Since then, US has gained increasing attention due to its ease of utilization in the clinical setting, repeatability, noninvasiveness, capability for contralateral comparison, lack of radiation exposure, and capability to provide real-time dynamic tissue assessment.1 Compared with magnetic resonance imaging or computed tomography, US presents limitations, including decreased resolution of certain tissues, limited field of view, limited penetration beyond osseous structures, incomplete evaluation of a joint or structure, and operator experience. However, advancements in technology, image resolution, and portability have improved the visualization of multiple anatomic structures and the accuracy of minimally invasive ultrasound-guided procedures at the point of care. The use of US for guided hip injections possibly decreases the cost relative to fluoroscopic guidance.2 Other studies have reported that US, as a result of its safety profile, has replaced fluoroscopy for certain procedures, such as barbotage of calcific tendinosis.3 US has been used for diagnostic purposes and guidance for therapeutic interventions, such as needle aspiration, diagnostic or therapeutic injection, needle tenotomy, tissue release, hydro-dissection, and biopsy.3 Given its expanding application, US has been increasingly used in the clinical setting, athletic training room, and sidelines of athletic events.
DIAGNOSTIC ULTRASOUND
An epidemiologic review of the National Collegiate Athletic Association (NCAA) men’s and women’s soccer injuries from 1988 to 2003 reported over 24,000 combined injuries. Over 70% of these injuries are MSK in nature and often affect the lower extremities.4,5 Ekstrand and colleagues6 also conducted an epidemiological review of muscle injuries among professional soccer players from 2001 to 2009. They found that 92% of all muscle injuries involved the lower extremities. The portability of US allows it to serve as an ideal modality for diagnostic evaluation of acute MSK injuries. Klauser and colleagues7 developed consensus based on the recommendations of the European Society of Musculoskeletal Radiology (ESSR) for the clinical indication of diagnostic ultrasound. A grading system was developed to describe the clinical utility of diagnostic US evaluation of MSK structures:
• Grade 0: Ultrasound is not indicated;
• Grade 1: Ultrasound is indicated if other imaging techniques are not appropriate;
• Grade 2: Ultrasound indication is equivalent to other imaging modalities;
• Grade 3: Ultrasound is the first-choice technique.
Henderson and colleagues8 conducted a review of 95 studies (12 systemic reviews and 83 diagnostic studies) that investigated the accuracy of diagnostic US imaging on soft tissue MSK injuries of the upper and lower extremities. They reported the sensitivity and specificity of the method for detection of over 40 hip, knee, ankle, and foot injuries and assigned corresponding grades based on diagnostic accuracy by using the same system developed by Klauser and colleagues.7,8 Common MSK injuries of the lower extremity and their corresponding ESSR grades are listed in the Table. This study demonstrated that diagnostic US is highly accurate for a number of soft tissue MSK injuries of the lower extremity and consistently matches the recommendation grades issued by Klauser and colleagues.7 In the hands of a skilled operator, US has become an increasingly popular and cost-effective modality for diagnosis and monitoring of acute muscle injuries and chronic tendinopathies among soccer athletes.
Table. Clinical Indication Grades for Diagnostic Ultrasound Evaluation of Common Lower Extremity Injuries7,8
Hip | Knee | Foot/Ankle |
Synovitis/Effusion: 3 | Quadricep tendinosis/tear: 3 | Anterior talofibular ligament injury: 3 |
Snapping hip (extra-articular): 3 | Patella tendinopathy: 3 | Calcaneofibular ligament injury: 3 |
Gluteal tendon tear: 3 | Pes anserine bursitis: 3 | Peroneal tendon tear/subluxation: 3 |
Meralgia paresthetica: 3 | Periarticular bursitis & ganglion: 3 | Posterior tibial tendinopathy: 3 |
Lateral femoral cutaneous nerve injury: 3 | Osgood-Schlatter & Sinding-Larsen: 3 | Plantaris tendon tear: 3 |
Femoral nerve injury: 3 | Synovitis/Effusion: 3 | Plantar fasciitis: 3 |
Sports hernia: 3 | Baker’s Cyst: 2-3 | Calcific tendonitis: 3 |
Morel-Lavallée lesions: 3 | MCL injury: 2 | Retrocalcaneal bursitis: 3 |
Muscle injury (high grade): 3 | IT band friction: 2 | Joint effusion: 3 |
Trochanteric bursitis: 2 | Medial patella plica syndrome: 2 | Ganglion cyst: 3 |
Proximal hamstring injury: 2 | Meniscal cyst: 2 | Retinacula pathology: 3 |
Sciatica: 1-2 | Common perineal neuropathy: 2 | Achilles tendinopathy: 2 |
Muscle injury (low grade): 1 | Distal hamstring tendon injury: 1-2 | Haglund disease: 2 |
Psoas tendon pathology: 1 | Intra-articular ganglion: 1 | Deltoid ligament injury: 2 |
Osteoarthritis: 0 | Hoffa’s fat pad syndrome: 1 | Plantar plate tear: 2 |
Labral tear: 0 | Loose bodies: 1 | Syndesmotic injury: 2 |
| LCL injury: 0-1 | Morton’s neuroma: 2 |
| Popliteal injury: 0-1 | Deltoid ligament injury: 1 |
| Plica syndrome: 0 | Spring ligament injury: 1 |
| Full/partial ACL tear: 0 | Anterolateral ankle impingement: 0 |
| PCL tear: 0 | Posterior talofibular ligament injury: 0 |
| Medial/lateral meniscus tear: 0 |
|
| Osteochondritis dissecans: 0 |
|
Abbreviations: ACL, anterior cruciate ligament; IT, iliotibial; LCL, lateral collateral ligament; MCL, medial collateral ligament; PCL, posterior cruciate ligament.
ULTRASOUND-GUIDED THERAPEUTIC PROCEDURES
The use of US at the point of care for needle guidance has led to its widespread application for therapeutic procedures, including injections and multiple regenerative therapies. Intra-articular US-guided injection and aspiration are common therapeutic interventions performed in the clinical setting. In a position statement of the American Medical Society for Sports Medicine, US-guided injections were found to be more accurate (SORT A evidence), effective (SORT B evidence), and cost effective (SORT B evidence) than landmark-guided injections.3 A recent meta-analysis conducted by Daniels and colleagues1 demonstrated the improved accuracy and efficacy of US-guided injections at the knee, ankle, and foot. Injections may serve a diagnostic purpose when anesthetics, such as lidocaine, are used in isolation, a therapeutic purpose, or both.
Continue to: Percutaneous tenotomy involve...
REGENERATIVE THERAPIES FOR MUSCULOSKELETAL CONDITIONS
PERCUTANEOUS TENOTOMY
Percutaneous tenotomy involves the introduction of a needle into damaged soft tissues, most often tendons (“needling”), in an effort to stimulate a healing response and resect the diseased tendon tissue. Although tenotomy was initially performed as an open or arthroscopic surgical technique, advances in US technology have led to improved sensitivity and specificity identifying areas of tendinous injury (hypervascularity, hypoechogenicity, and calcification); as such, the combination of these techniques has been used in the outpatient setting. New commercial models incorporate ultrasound guidance with needles or micro-resection probes for real-time débridement of damaged tissues. Percutaneous tenotomy has been described in the management of tendinopathy involving the rotator cuff, medial and lateral epicondyles, patellar and Achilles tendons, and plantar fascia.
Housner and colleagues9 evaluated the safety and short-term efficacy of US-guided needle tenotomy in 13 patients with chronic tendinosis of the patella, Achilles tendon, gluteus medius, iliotibial tract, hamstring, and rectus femoris. They reported no procedural complications and a significant decrease in pain scores at 4 and 12 weeks of follow-up.
Koh and colleagues10 conducted a prospective case series to evaluate the safety and efficacy of office-based, US-guided percutaneous tenotomy (using a commercial model) on 20 patients with chronic lateral epicondylitis. The authors reported no wound complications and significant improvement in pain scores at each follow-up period up to 1 year. Subsequent post-procedural US evaluation of injured tissues revealed evidence of healing (decreased tendon thickness, vascularity, and hypoechogenicity) in over half the cohort after 6 months compared with the baseline.11
Lee and colleagues12 evaluated the efficacy of US-guided needle tenotomy combined with platelet-rich plasma (PRP) injection on chronic recalcitrant gluteus medius tendinopathy. In this case series, 21 patients underwent PRP and “needling” through the hypoechoic regions of the injured tendon under direct US guidance. After a period of rest, all patients completed the structured rehabilitation protocol. After an average follow-up of 10 months, all patients displayed significant improvements in all outcome questionnaires and did not report any significant adverse events. The authors concluded that tenotomy combined with PRP is a safe and effective method for treatment for recalcitrant gluteus medius tendinopathy.
These studies indicate that US-guided percutaneous tenotomy, alone or in combination with regenerative therapies, such as PRP, is a safe and effective treatment option for various tendinopathies. However, while tenotomy appears safe with promising results and no reported major adverse events, the level of evidence remains low.
ORTHOBIOLOGICS
Orthobiologics are substances composed of biological materials that can be used to aid or even hasten the healing of bones, muscles, tendons, and ligaments. Orthobiologics may contain growth factors, which initiate or stimulate the body’s reparative process; matrix proteins, which serve as scaffolding for healing tissues; or stem cells, specifically adult stem cells, which are multipotent and can differentiate into several cell lines. Adult stem cells are categorized as hematopoietic, neural, epithelial, skin, and mesenchymal types. Mesenchymal stem cells (MSCs) are of particular interest in sports medicine applications because they secrete growth factors and cytokines with trophic, chemotactic, and immunosuppressive properties.13 MSCs are also multipotent and can differentiate into bones, muscles, cartilages, and tendons.14-17MSCs are readily isolated from many sources, including bone marrow, adipose tissues, synovial tissues, peripheral blood, skeletal muscles, umbilical cord blood, and placenta.13,14Several types of regenerative therapies used in orthopedic and sports medicine practice include PRP, stem cell therapy, and amniotic membrane/fluid preparations. While each therapy possesses the potential for promising results, the paucity of research and discrepancies among studies regarding the description of stem cell lines used limit the available evidence on the true clinical benefits of these regenerative therapies.
[HEAD 3] PLATELET-RICH PLASMA
PRP is an autologous product that has been used to stimulate biological factors and promote healing since the 1970s. Through the activation of platelets, PRP improves localized recruitment, proliferation, and differentiation of cells involved in tissue repair. Platelets, which are non-nucleated bodies located in peripheral blood, contain and release 3 groups of bioactive factors that enhance the healing process. Growth factors and cytokines released from alpha-granules play a role in cell proliferation, chemotaxis, cell differentiation, and angiogenesis. Bioactive factors, such as serotonin and histamine, released from dense granules, increase capillary permeability and improve cell recruitment and migration. Adhesion molecules also assist in cell migration and creation of an extracellular matrix, which acts as a scaffold for wound healing.18 Platelets are activated by mechanical trauma or contact with multiple activators, including Von Willebrand factor, collagen, thrombin, or calcium chloride. When activated, platelets release growth factors and cytokines, which create a pro-inflammatory environment that mediates the tissue repair process. After the procedure, the pro-inflammatory environment may result in patient discomfort, which can be managed with ice and acetaminophen. Use of nonsteroidal anti-inflammatory drugs may theoretically inhibit the inflammatory cascade induced by PRP, and they are avoided before and after the procedure, although evidence regarding necessary time frames is lacking.
Continue to: PRP consists of...
PRP consists of the fractionated liquid component of autologous whole blood, which contains increased concentrations of platelets and cytokines. Different methods and commercial preparations are available for collecting and preparing PRP. Variations in the amount of blood drawn, use of anticoagulants, presence or absence of an activating agent, number of centrifuge spins, and overall platelet and white blood cell concentrations lead to difficulty in evaluating and interpreting the available evidence regarding PRP therapy.
In vitro and animal studies demonstrated promising and safe results regarding the healing effect of PRP on injured soft tissues, such as tendons, ligaments, and muscles. In this regard, a number of studies have evaluated the effect of PRP on human MSK injuries. However, in addition to the above-mentioned variabilities in PRP, many of such studies lack standardization and randomization techniques and include a small number of patients only, thereby limiting the overall comparison and clinical application.
A landmark study conducted by Mishra and Pavelko19 concluded that PRP significantly reduced pain in patients with chronic elbow tendinosis. Similar findings were reported in high-level overhead athletes with ulnar collateral ligament insufficiency, which did not improve with conservative management.20 Fitzpatrick and colleagues21 found improvements in pain with the use of single PRP injection as treatment for chronic gluteal tendinopathy. PRP can effectively improve pain and recovery in chronic ligament and tendon injuries, such as lateral epicondylitis, patellar tendinopathy, and plantar fasciitis, when patients are unresponsive to traditional conservative management. The application of PRP to treat acute MSK injuries has produced mixed results. Hamid and colleagues22 conducted a level II randomized controlled trial to evaluate the effect of PRP combined with a rehabilitation program for treatment of grade 2 hamstring injuries on return-to-play compared with rehabilitation alone. Fourteen athletes were randomized into the study and control groups. Hamid and colleagues22 reported improved return-to-play in the study group compared with that in the control (26.7 and 42.5 days, respectively). This study also reported lower pain scores in the PRP group over time, but the difference was not statistically significant. Zanon and colleagues23 conducted a prospective study to evaluate return-to-play in professional soccer players with acute hamstring strains treated with PRP and a rehabilitation program. This study determined that athletes treated with PRP were “match fit,” meaning they would be available for match selection in an average of 36.8 days. However, Zanon and colleagues23 did not include a control group for comparison. Other studies reported that PRP treatment of acutely injured muscles and medial collateral ligaments of soccer and basketball players decreased their return-to-play interval.18 Reviews by Hamilton and colleagues24 and Pas and colleagues25 concluded that PRP treatment of acutely injured tissues with good blood supply (eg, hamstring muscles) did not improve pain or return-to-play compared with standardized rehabilitation protocols. Similarly, in a double-blinded placebo controlled trial, Reurink and colleagues26 evaluated return-to-play in 80 athletes with acute hamstring injuries treated with a rehabilitation program and either PRP or placebo. Reurink and colleagues26 found no difference in return-to-play (42 days for both groups), but the difference was not statistically significant. PRP has also been used intraoperatively and shows promising results in total knee arthroplasty, anterior cruciate ligament reconstruction, acute Achilles tendon repair, rotator cuff repair, and cartilage repair. However, many of these intraoperative studies are limited to animal models.
In 2009, the World Anti-Doping Agency (WADA) prohibited the use of PRP because it contains autologous growth factors and IGF-1, which could produce an anabolic effect. Recent studies have failed to demonstrate any athletic advantages of using PRP. WADA has since removed PRP from its prohibited list. PRP is also not prohibited by the US Anti-Doping Agency (USADA) and many major professional sporting leagues in the United States. However, care must be taken in reviewing the components of PRP because many commercially available products differ in PRP formulation. Since 2010, many team physicians have increasingly used PRP to treat a wide range of athletic injuries. A recent anonymous survey conducted by a team of physicians on PRP use in elite athletes revealed minimal complications but significant variability among physicians with regard to timing, belief in evidence, and formulation and dosing of PRP treatments. Many physicians did implicate athlete desire as the main indication for treatment.27
As an autologous treatment, PRP injection has no serious adverse effects beyond mild discomfort as a result of the procedure and pro-inflammatory state in the days following injection. Recent concerns regarding the potential of PRP treatment for heterotopic ossification have been reported, but published information is limited to case reports. PRP can improve pain and function in patients with chronic MSK injury. PRP appears to be a safe and effective alternative to surgery for patients with injury to poorly perfused tissue, which has not improved with conservative measures, such as rest, physical therapy, and anti-inflammatory medications. Care should be taken when treating athletes with PRP to establish regulations on doping by individual governing bodies.
Continue to: Use of stem...
STEM CELL THERAPY
Use of stem cell therapy is based on the properties of the proliferation and differentiation of multipoint MSC lines. These stem cells can theoretically regenerate injured tissues and influence repair through immunomodulation; paracrine activity through the release of bioactive agents, such as cytokines, trophic, and chemotactic molecules; and cell differentiation into various cell lineages.15,16,13,17 Orthopedic surgeons have used microfracture to recruit MSCs during cartilage repair procedures for over 20 years. This procedure draws multipotent MSCs to the injured site to induce chondrogenic proliferation and fibrocartilage repair.28
Adult MSCs provide a readily accessible autologous source of stem cells for regenerative therapies. MSCs can be isolated from a variety of tissues, including bone marrow, adipose tissues, synovia, human umbilical cord blood, and peripheral blood. The majority of stem cell therapies in the United States for sports medicine purposes are conducted using bone marrow aspirate concentrate (BMAC) and adipose tissues. The US Food and Drug Administration (FDA) allows the use of minimally manipulated autologous stem cells to be injected into the same patient on the same day. However, some studies reported that culturing stem cells or introducing products, such as collagenase to stem cells, can increase the stem cell concentration prior to injection. These processes constitute more than “minimal manipulation” and therefore would require drug trials prior to use in the United States.
Although MSCs can be readily obtained from a variety of tissue sources, the makeup of the cell concentrate differs. Bone marrow and adipose tissues are readily available sources of homogenous MSCs. Harvesting stem cells from adipose tissues provides a less invasive route of collection than from BMAC. Harvested BMAC and adipose tissues consist of heterogeneous cell populations that are composed of precursor and accessory cells, such as pericytes, endothelial cells, smooth muscle cells, fibroblasts, and macrophages in addition to MSCs.
Animal studies reported promising results when evaluating soft tissue lesions in small and large animal models.14,15 Although clinical and human evidence remains limited, the potential of MSCs for regenerative repair has led to a recent increase in the number of related clinical studies. Multiple systematic reviews have concluded that MSC therapy is safe for the treatment of osteoarthritis, cartilage lesions, and tendinopathies. Limited evidence is available regarding the safety of intramuscular use, and a theoretical concern arises on the development of heterotopic bone formation as a result of treatment.13,16 The efficacy of MSC therapy is difficult to determine due to the lack of standardization in stem cell populations, adjuvants (eg, PRP, hyaluronic acid, and scaffolding preparations), and delivery methods used.13,17
Similar to PRP, the increased use of MSC therapy among high-profile athletes has led to the promotion of these therapies as safe and effective despite limited evidence.29 Although MSC therapy is a promising and safe treatment option for patients with soft tissue injuries, the paucity in data and human studies limit its clinical use. Moreover, data of MSC efficacy is complicated because of the disparity between clinical studies regarding MSC collection method (many of which eclipse the “minimal manipulation” standard), description of isolated cell concentrates, dosage, method of delivery, use of adjuvants, and lack of randomization. Further studies using [standardized] methods are needed before establishing a true consensus on the safety and efficacy of MSC therapy.
AMNIOTIC MEMBRANE
The placenta is a source of MSCs, a collagen-rich extracellular matrix, and bioactive growth and regulatory factors. The capacity of the placenta to modulate biological activities and tissue formation is thought to provide a means of tissue repair and healing. The placenta consists of amniotic fluid, amniotic membrane (AM), chorionic membrane, and umbilical cord blood and tissues. Although MSCs have been isolated from each component of placental tissues, amniotic and chorionic membranes and umbilical cord tissues yield the highest concentration.
The majority of regenerative studies involving the placenta used AM alone or in combination with other placental tissues. AM is a metabolically active tissue that consists of an epithelial layer, a basement membrane, and a mesenchymal tissue layer. In addition to being a source of stem cells, AM synthesizes many growth factors, vasoactive peptides, and cytokines, which are capable of tissue regeneration. AM was initially used as a biological scaffold for the treatment of skin burns and wounds. Other intrinsic properties of AM include the provision of a matrix for cellular migration and proliferation, enhanced wound healing with reduced scar formation, antibacterial activity, and lastly, non-immunogenic and immunosuppressive properties. These inherent characteristics have spurred studies on the potential use of AM in sports medicine as a minimally invasive means to treat osteoarthritis and injuries of tendons, ligaments, muscles, fascia, and cartilages.
Continue to: Animal studies reported...
Animal studies reported positive results with the use of AM to treat osteoarthritis, cartilage defects, and tendon and ligament injuries. Few studies involving human participants also revealed favorable results with regard to the use of AM for the treatment of plantar fasciitis and osteoarthritis; however, these studies are industry-sponsored and employed small sample sizes. The unique mixture of a collagen-rich extracellular matrix, bioactive growth factors, and pluripotent stem cells may allow AM to become an effective treatment for MSK injuries. Although initial animal and human studies show promising results, variabilities regarding models (animal and human), pathologies, placental tissues, and methods of preparation, preservation, and delivery used limit the ability for comparison, analysis, and drawing of definitive conclusions. Thus far, no studies have evaluated the use of currently available AM products for the treatment of injuries sustained by soccer players.
Despite the current popularity of AM as regenerative therapy in academic research and potential use in clinical treatment in sports medicine, physicians should remain aware of the limited evidence available. Other barriers to research and use AM as a regenerative therapy include regulatory classifications based on the concept of “minimal manipulation” in biologic therapies. Minimally manipulated placental allografts are less regulated, less costly to study, and more easily commercialized. These products are not required to undergo FDA phase I to III trials prior to premarket approval. In 2000, the FDA position on all AM products falls into 2 categories. The first position states that AM that contains allogenic stem cells mixed with another drug that is micronized and/or cryopreserved is more than “minimally manipulated” and therefore categorized as “biologic” and would be subject to phase I to III trials. Dehydrated and decellularized AM, however, may meet the concept of minimal manipulation and is only approved by the FDA as a wound covering. Thus, any application of AM for the treatment of sports medicine pathology is not currently FDA-approved, considered off-label, not covered by insurance, and subject to out-of-pocket pay.30,31
CONCLUSION
With improvements in technology and portability, US has become an effective imaging modality for point-of-care evaluation, diagnosis, and continuous monitoring of many MSK injuries. Additionally, as a dynamic imaging modality, US allows for increased accuracy and efficacy when combined with minimally invasive procedures, such as diagnostic and therapeutic guided injections and percutaneous tenotomy, in the clinical setting; thereby decreasing the overall healthcare costs. PRP is proven to be a safe treatment for several MSK conditions, such as lateral epicondylitis, patellar tendonitis, and plantar fasciitis. Although PRP has been included in the standard of care in some areas, this technique may be predominantly athlete driven. Conflicting evidence with regard to return-to-play timeframes following PRP treatment for muscular injuries and poor evidence in conditions, such as Achilles tendonitis, have led to inconsistent indications for use, dose, and timing of treatment. Although early evidence of MSC therapy is promising, high-level evidence for MSC therapy is insufficient, despite its increased use among athletes. Thus far, no data are available regarding the outcomes of the use of amniotic products for the treatment of injuries among athletes. Furthermore, the preparation of amniotic products has many regulatory concerns. The authors advocate for continuous high-level research on regenerative medicine therapies to establish clinical efficacy and safety data.
1. Daniels E, Cole D, Jacobs B, Phillips S. Existing Evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576. doi:10.1177/2325967118756576.
2. Henne M, Centurion A, Rosas S, Youmans H, Osbahr D. Trends in utilization of image-guided hip joint injections. Unpublished. 2018.
3. Finnoff JT, Hall MM, Adams E, et al. American Medical Society for Sports Medicine position statement: Interventional musculoskeletal ultrasound in sports medicine. Clin J Sport Med. 2015;25:6-22. doi:10.1097/JSM.0000000000000175.
4. Agel J, Evans TA, Dick R, Putukian M, Marshal S. Descriptive epidemiology of collegiate men’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):270-277.
5. Dick R, Putukian M, Agel J, Evans T, Marshall S. Descriptive epidemiology of collegiate women’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):278-285.
6. Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011;39(6):1226-1232. doi:10.1177/0363546510395879.
7. Klauser A, Tagliafico A, Allen G, et al. Clinical indications for musculoskeletal ultrasound: A Delphi-based consensus paper of the European society of musculoskeletal radiology. Eur Radiol. 2012;22(5):1140-1148. doi:10.1007/s00330-011-2356-3.
8. Henderson R, Walker B, Young K. The accuracy of diagnostic ultrasound imaging for musculoskeletal soft tissue pathology of the extremities: a comprehensive review of the literature. Chiropr Man Therap. 2015;23(1):31. doi:10.1186/s12998-015-0076-5.
9. Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009;28(9):1187-1192. doi:10.7863/jum.2009.28.9.1187.
10. Koh J, Mohan PC, Howe TS, et al. Fasciotomy and surgical tenotomy for recalcitrant lateral elbow tendinopathy: early clinical experience with a novel device for minimally invasive percutaneous microresection. Am J Sports Med. 2013;41(3):636-644. doi:10.1177/0363546512470625.
11. Seng C, Mohan PC, Koh J, et al. Ultrasonic percutaneous tenotomy for recalcitrant lateral elbow tendinopathy: sustainability and sonographic progression at 3 years. Am J Sports Med. 2015;44(2):504-510. doi:10.1177/0363546515612758.
12. Lee J, Harrison J, Boachie-Adjei K, Vargas E, Moley P. Platelet-rich plasma injections with needle tenotomy for gluteus medius tendinopathy: A registry study with prospective follow-up. Orthop J Sports Med. 2016;4(11):2325967116671692. doi:10.1177/2325967116671692.
13. Osborne H, Anderson L, Burt P, Young M, Gerrard D. Australasian College of Sports Physicians-Position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med. 2016;50:1237-1244. doi:10.1136/bjsports-2015-095711.
14. Anderson J, Little D, Toth A, et al. Stem cell therapies for knee cartilage repair. The current status of preclinical and clinical studies. Am J Sports Med. 2013;42(9)2253-2261. doi:10.1177/0363546513508744.
15. Lee S, Kwon B, Lee Kyoungbun, Son Y, Chung S. Therapeutic mechanisms of human adipose-derived mesenchymal stem cells in a rat tendon injury model. Am J Sports Med. 2017;45(6):1429-1439. doi:10.1177/0363546517689874.
16. McIntyre J, Jones I, Han B, Vangsness C. Intra-articular mesenchymal stem cell therapy for the human joint. A systematic review. Am J Sports Med. 2017;0363546517735844. doi:10.1177/0363546517735844.
17. Pas HIMFL, Moen M, Haisma J, Winters M. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med. 2017;51:996-1002. doi:10.1136/bjsports-2016-096794.
18. Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272. doi:10.1177/0363546509349921.
19. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-1778. doi:10.1177/0363546506288850.
20. Dines J, Williams P, ElAttrache N, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop. 2016;45(4):296-300.
21. Fitzpatrick J, Bulsara M, O’Donnel J, McCrory P, Zheng M. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy. A randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid injection. Am J Sports Med. 2018;46(4)933-939. doi:10.1177/0363546517745525.
22. Hamid M, Ali M, Yusof A, George J, Lee L. Platelet-rich plasma injections for the treatment of hamstring injuries: A randomized controlled trial. Am J Sports Med. 2014;42(10):2410-2418. doi:10.1177/0363546514541540.
23. Zanon G, Combi F, Combi A, Perticarini L, Sammarchi L, Benazzo F. Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players. Joints. 2016;4(1):17-23. doi:10.11138/jts/2016.4.1.017.
24. Hamilton B, Tol JL, Almusa E, et al. Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomized controlled trial. Br J Sports Med. 2015;49:943-950. doi:10.1136/bjsports-2015-094603.
25. Pas HIMFL, Reurink G, Tol JL, Wier A, Winters M, Moen M. Efficacy of rehabilitation (lengthening) exercises, platelet-rich plasma injections, and other conservative interventions in acute hamstring injuries: an updated systematic review and meta-analysis. Br J Sports Med. 2015;49:1197-1205. doi:10.1136/bjsports-2015-094879.
26. Reurink G, Goudswaard G, Moen M, et al. Platelet-rich plasma injections in acute muscle injury. N Engl J Med. 2014;370:2546-2547. doi:10.1056/NEJMc1402340.
27. Kantrowitz D, Padaki A, Ahmad C, Lynch T. Defining platelet-rich plasma usage by team physicians in elite athletes. Orthop J Sports Med. 2018;6(4):2325967118767077. doi:10.1177/2325967118767077.
28. Mithoefer K, Peterson L, Zenobi-Wong M, Mandelbaum B. Cartilage issues in football-today’s problems and tomorrow’s solutions. Br J Sports Med. 2015;49(9):590-596. doi:1136/bjsports-2015-094772.
29. Matthews K, Cuchiara M. Regional regulatory insights: U.S. National Football League Athletes seeking unproven stem cell treatments. Stem Cells Dev. 2014;23(S1):60-64. doi:10.1089/scd.2014.0358.
30. McIntyre J, Jones I, Danilkovich A, Vangsness T. The placenta: applications in orthopaedic sports medicine. Am J Sports Med. 2018;46(1):234-247. doi:10.1177/0363546517697682.
31. Riboh J, Saltzman B, Yankee A, Cole BJ. Human amniotic membrane-derived products in sports medicine: Basic science, early results, and potential clinical applications. Am J Sports Med. 2015;44(9)2425-2434. doi:10.1177/0363546515612750.
ABSTRACT
Improvements in ultrasound technology have increased the popularity and use of ultrasound as a diagnostic and therapeutic modality for many soccer-related musculoskeletal (MSK) injuries. As a dynamic imaging modality, ultrasound offers increased accuracy and efficacy with minimally invasive procedures, such as guided injections, percutaneous tenotomy, and regenerative therapies, in the clinical setting. Emerging evidence indicates that regenerative therapies, such as platelet-rich-plasma (PRP), mesenchymal stem cells, and amniotic products, are a promising treatment for many MSK injuries and are gaining popularity among professional athletes. PRP is a safe treatment for a number of MSK conditions and has been included in the standard of care. However, conflicting evidence on return-to-play timeframes and efficacy in certain MSK conditions have led to inconsistent recommendations on indications for use, dose, and timing of treatment. Mesenchymal stem cell therapy, while promising, lacks high-level evidence of efficacy despite its increasing use among athletes. Currently, no data are available regarding the outcome of the use of amniotic products for the treatment of injuries in athletes. Furthermore, preparation of many regenerative therapies eclipses the concept of minimal manipulation and is subject to US Food and Drug Administration phase I to III trials. High-level research on regenerative medicine therapies should be continuously conducted to establish their clinical efficacy and safety data.
ULTRASOUND
Ultrasound (US) was first introduced for musculoskeletal (MSK) evaluation in 1957.1 Since then, US has gained increasing attention due to its ease of utilization in the clinical setting, repeatability, noninvasiveness, capability for contralateral comparison, lack of radiation exposure, and capability to provide real-time dynamic tissue assessment.1 Compared with magnetic resonance imaging or computed tomography, US presents limitations, including decreased resolution of certain tissues, limited field of view, limited penetration beyond osseous structures, incomplete evaluation of a joint or structure, and operator experience. However, advancements in technology, image resolution, and portability have improved the visualization of multiple anatomic structures and the accuracy of minimally invasive ultrasound-guided procedures at the point of care. The use of US for guided hip injections possibly decreases the cost relative to fluoroscopic guidance.2 Other studies have reported that US, as a result of its safety profile, has replaced fluoroscopy for certain procedures, such as barbotage of calcific tendinosis.3 US has been used for diagnostic purposes and guidance for therapeutic interventions, such as needle aspiration, diagnostic or therapeutic injection, needle tenotomy, tissue release, hydro-dissection, and biopsy.3 Given its expanding application, US has been increasingly used in the clinical setting, athletic training room, and sidelines of athletic events.
DIAGNOSTIC ULTRASOUND
An epidemiologic review of the National Collegiate Athletic Association (NCAA) men’s and women’s soccer injuries from 1988 to 2003 reported over 24,000 combined injuries. Over 70% of these injuries are MSK in nature and often affect the lower extremities.4,5 Ekstrand and colleagues6 also conducted an epidemiological review of muscle injuries among professional soccer players from 2001 to 2009. They found that 92% of all muscle injuries involved the lower extremities. The portability of US allows it to serve as an ideal modality for diagnostic evaluation of acute MSK injuries. Klauser and colleagues7 developed consensus based on the recommendations of the European Society of Musculoskeletal Radiology (ESSR) for the clinical indication of diagnostic ultrasound. A grading system was developed to describe the clinical utility of diagnostic US evaluation of MSK structures:
• Grade 0: Ultrasound is not indicated;
• Grade 1: Ultrasound is indicated if other imaging techniques are not appropriate;
• Grade 2: Ultrasound indication is equivalent to other imaging modalities;
• Grade 3: Ultrasound is the first-choice technique.
Henderson and colleagues8 conducted a review of 95 studies (12 systemic reviews and 83 diagnostic studies) that investigated the accuracy of diagnostic US imaging on soft tissue MSK injuries of the upper and lower extremities. They reported the sensitivity and specificity of the method for detection of over 40 hip, knee, ankle, and foot injuries and assigned corresponding grades based on diagnostic accuracy by using the same system developed by Klauser and colleagues.7,8 Common MSK injuries of the lower extremity and their corresponding ESSR grades are listed in the Table. This study demonstrated that diagnostic US is highly accurate for a number of soft tissue MSK injuries of the lower extremity and consistently matches the recommendation grades issued by Klauser and colleagues.7 In the hands of a skilled operator, US has become an increasingly popular and cost-effective modality for diagnosis and monitoring of acute muscle injuries and chronic tendinopathies among soccer athletes.
Table. Clinical Indication Grades for Diagnostic Ultrasound Evaluation of Common Lower Extremity Injuries7,8
Hip | Knee | Foot/Ankle |
Synovitis/Effusion: 3 | Quadricep tendinosis/tear: 3 | Anterior talofibular ligament injury: 3 |
Snapping hip (extra-articular): 3 | Patella tendinopathy: 3 | Calcaneofibular ligament injury: 3 |
Gluteal tendon tear: 3 | Pes anserine bursitis: 3 | Peroneal tendon tear/subluxation: 3 |
Meralgia paresthetica: 3 | Periarticular bursitis & ganglion: 3 | Posterior tibial tendinopathy: 3 |
Lateral femoral cutaneous nerve injury: 3 | Osgood-Schlatter & Sinding-Larsen: 3 | Plantaris tendon tear: 3 |
Femoral nerve injury: 3 | Synovitis/Effusion: 3 | Plantar fasciitis: 3 |
Sports hernia: 3 | Baker’s Cyst: 2-3 | Calcific tendonitis: 3 |
Morel-Lavallée lesions: 3 | MCL injury: 2 | Retrocalcaneal bursitis: 3 |
Muscle injury (high grade): 3 | IT band friction: 2 | Joint effusion: 3 |
Trochanteric bursitis: 2 | Medial patella plica syndrome: 2 | Ganglion cyst: 3 |
Proximal hamstring injury: 2 | Meniscal cyst: 2 | Retinacula pathology: 3 |
Sciatica: 1-2 | Common perineal neuropathy: 2 | Achilles tendinopathy: 2 |
Muscle injury (low grade): 1 | Distal hamstring tendon injury: 1-2 | Haglund disease: 2 |
Psoas tendon pathology: 1 | Intra-articular ganglion: 1 | Deltoid ligament injury: 2 |
Osteoarthritis: 0 | Hoffa’s fat pad syndrome: 1 | Plantar plate tear: 2 |
Labral tear: 0 | Loose bodies: 1 | Syndesmotic injury: 2 |
| LCL injury: 0-1 | Morton’s neuroma: 2 |
| Popliteal injury: 0-1 | Deltoid ligament injury: 1 |
| Plica syndrome: 0 | Spring ligament injury: 1 |
| Full/partial ACL tear: 0 | Anterolateral ankle impingement: 0 |
| PCL tear: 0 | Posterior talofibular ligament injury: 0 |
| Medial/lateral meniscus tear: 0 |
|
| Osteochondritis dissecans: 0 |
|
Abbreviations: ACL, anterior cruciate ligament; IT, iliotibial; LCL, lateral collateral ligament; MCL, medial collateral ligament; PCL, posterior cruciate ligament.
ULTRASOUND-GUIDED THERAPEUTIC PROCEDURES
The use of US at the point of care for needle guidance has led to its widespread application for therapeutic procedures, including injections and multiple regenerative therapies. Intra-articular US-guided injection and aspiration are common therapeutic interventions performed in the clinical setting. In a position statement of the American Medical Society for Sports Medicine, US-guided injections were found to be more accurate (SORT A evidence), effective (SORT B evidence), and cost effective (SORT B evidence) than landmark-guided injections.3 A recent meta-analysis conducted by Daniels and colleagues1 demonstrated the improved accuracy and efficacy of US-guided injections at the knee, ankle, and foot. Injections may serve a diagnostic purpose when anesthetics, such as lidocaine, are used in isolation, a therapeutic purpose, or both.
Continue to: Percutaneous tenotomy involve...
REGENERATIVE THERAPIES FOR MUSCULOSKELETAL CONDITIONS
PERCUTANEOUS TENOTOMY
Percutaneous tenotomy involves the introduction of a needle into damaged soft tissues, most often tendons (“needling”), in an effort to stimulate a healing response and resect the diseased tendon tissue. Although tenotomy was initially performed as an open or arthroscopic surgical technique, advances in US technology have led to improved sensitivity and specificity identifying areas of tendinous injury (hypervascularity, hypoechogenicity, and calcification); as such, the combination of these techniques has been used in the outpatient setting. New commercial models incorporate ultrasound guidance with needles or micro-resection probes for real-time débridement of damaged tissues. Percutaneous tenotomy has been described in the management of tendinopathy involving the rotator cuff, medial and lateral epicondyles, patellar and Achilles tendons, and plantar fascia.
Housner and colleagues9 evaluated the safety and short-term efficacy of US-guided needle tenotomy in 13 patients with chronic tendinosis of the patella, Achilles tendon, gluteus medius, iliotibial tract, hamstring, and rectus femoris. They reported no procedural complications and a significant decrease in pain scores at 4 and 12 weeks of follow-up.
Koh and colleagues10 conducted a prospective case series to evaluate the safety and efficacy of office-based, US-guided percutaneous tenotomy (using a commercial model) on 20 patients with chronic lateral epicondylitis. The authors reported no wound complications and significant improvement in pain scores at each follow-up period up to 1 year. Subsequent post-procedural US evaluation of injured tissues revealed evidence of healing (decreased tendon thickness, vascularity, and hypoechogenicity) in over half the cohort after 6 months compared with the baseline.11
Lee and colleagues12 evaluated the efficacy of US-guided needle tenotomy combined with platelet-rich plasma (PRP) injection on chronic recalcitrant gluteus medius tendinopathy. In this case series, 21 patients underwent PRP and “needling” through the hypoechoic regions of the injured tendon under direct US guidance. After a period of rest, all patients completed the structured rehabilitation protocol. After an average follow-up of 10 months, all patients displayed significant improvements in all outcome questionnaires and did not report any significant adverse events. The authors concluded that tenotomy combined with PRP is a safe and effective method for treatment for recalcitrant gluteus medius tendinopathy.
These studies indicate that US-guided percutaneous tenotomy, alone or in combination with regenerative therapies, such as PRP, is a safe and effective treatment option for various tendinopathies. However, while tenotomy appears safe with promising results and no reported major adverse events, the level of evidence remains low.
ORTHOBIOLOGICS
Orthobiologics are substances composed of biological materials that can be used to aid or even hasten the healing of bones, muscles, tendons, and ligaments. Orthobiologics may contain growth factors, which initiate or stimulate the body’s reparative process; matrix proteins, which serve as scaffolding for healing tissues; or stem cells, specifically adult stem cells, which are multipotent and can differentiate into several cell lines. Adult stem cells are categorized as hematopoietic, neural, epithelial, skin, and mesenchymal types. Mesenchymal stem cells (MSCs) are of particular interest in sports medicine applications because they secrete growth factors and cytokines with trophic, chemotactic, and immunosuppressive properties.13 MSCs are also multipotent and can differentiate into bones, muscles, cartilages, and tendons.14-17MSCs are readily isolated from many sources, including bone marrow, adipose tissues, synovial tissues, peripheral blood, skeletal muscles, umbilical cord blood, and placenta.13,14Several types of regenerative therapies used in orthopedic and sports medicine practice include PRP, stem cell therapy, and amniotic membrane/fluid preparations. While each therapy possesses the potential for promising results, the paucity of research and discrepancies among studies regarding the description of stem cell lines used limit the available evidence on the true clinical benefits of these regenerative therapies.
[HEAD 3] PLATELET-RICH PLASMA
PRP is an autologous product that has been used to stimulate biological factors and promote healing since the 1970s. Through the activation of platelets, PRP improves localized recruitment, proliferation, and differentiation of cells involved in tissue repair. Platelets, which are non-nucleated bodies located in peripheral blood, contain and release 3 groups of bioactive factors that enhance the healing process. Growth factors and cytokines released from alpha-granules play a role in cell proliferation, chemotaxis, cell differentiation, and angiogenesis. Bioactive factors, such as serotonin and histamine, released from dense granules, increase capillary permeability and improve cell recruitment and migration. Adhesion molecules also assist in cell migration and creation of an extracellular matrix, which acts as a scaffold for wound healing.18 Platelets are activated by mechanical trauma or contact with multiple activators, including Von Willebrand factor, collagen, thrombin, or calcium chloride. When activated, platelets release growth factors and cytokines, which create a pro-inflammatory environment that mediates the tissue repair process. After the procedure, the pro-inflammatory environment may result in patient discomfort, which can be managed with ice and acetaminophen. Use of nonsteroidal anti-inflammatory drugs may theoretically inhibit the inflammatory cascade induced by PRP, and they are avoided before and after the procedure, although evidence regarding necessary time frames is lacking.
Continue to: PRP consists of...
PRP consists of the fractionated liquid component of autologous whole blood, which contains increased concentrations of platelets and cytokines. Different methods and commercial preparations are available for collecting and preparing PRP. Variations in the amount of blood drawn, use of anticoagulants, presence or absence of an activating agent, number of centrifuge spins, and overall platelet and white blood cell concentrations lead to difficulty in evaluating and interpreting the available evidence regarding PRP therapy.
In vitro and animal studies demonstrated promising and safe results regarding the healing effect of PRP on injured soft tissues, such as tendons, ligaments, and muscles. In this regard, a number of studies have evaluated the effect of PRP on human MSK injuries. However, in addition to the above-mentioned variabilities in PRP, many of such studies lack standardization and randomization techniques and include a small number of patients only, thereby limiting the overall comparison and clinical application.
A landmark study conducted by Mishra and Pavelko19 concluded that PRP significantly reduced pain in patients with chronic elbow tendinosis. Similar findings were reported in high-level overhead athletes with ulnar collateral ligament insufficiency, which did not improve with conservative management.20 Fitzpatrick and colleagues21 found improvements in pain with the use of single PRP injection as treatment for chronic gluteal tendinopathy. PRP can effectively improve pain and recovery in chronic ligament and tendon injuries, such as lateral epicondylitis, patellar tendinopathy, and plantar fasciitis, when patients are unresponsive to traditional conservative management. The application of PRP to treat acute MSK injuries has produced mixed results. Hamid and colleagues22 conducted a level II randomized controlled trial to evaluate the effect of PRP combined with a rehabilitation program for treatment of grade 2 hamstring injuries on return-to-play compared with rehabilitation alone. Fourteen athletes were randomized into the study and control groups. Hamid and colleagues22 reported improved return-to-play in the study group compared with that in the control (26.7 and 42.5 days, respectively). This study also reported lower pain scores in the PRP group over time, but the difference was not statistically significant. Zanon and colleagues23 conducted a prospective study to evaluate return-to-play in professional soccer players with acute hamstring strains treated with PRP and a rehabilitation program. This study determined that athletes treated with PRP were “match fit,” meaning they would be available for match selection in an average of 36.8 days. However, Zanon and colleagues23 did not include a control group for comparison. Other studies reported that PRP treatment of acutely injured muscles and medial collateral ligaments of soccer and basketball players decreased their return-to-play interval.18 Reviews by Hamilton and colleagues24 and Pas and colleagues25 concluded that PRP treatment of acutely injured tissues with good blood supply (eg, hamstring muscles) did not improve pain or return-to-play compared with standardized rehabilitation protocols. Similarly, in a double-blinded placebo controlled trial, Reurink and colleagues26 evaluated return-to-play in 80 athletes with acute hamstring injuries treated with a rehabilitation program and either PRP or placebo. Reurink and colleagues26 found no difference in return-to-play (42 days for both groups), but the difference was not statistically significant. PRP has also been used intraoperatively and shows promising results in total knee arthroplasty, anterior cruciate ligament reconstruction, acute Achilles tendon repair, rotator cuff repair, and cartilage repair. However, many of these intraoperative studies are limited to animal models.
In 2009, the World Anti-Doping Agency (WADA) prohibited the use of PRP because it contains autologous growth factors and IGF-1, which could produce an anabolic effect. Recent studies have failed to demonstrate any athletic advantages of using PRP. WADA has since removed PRP from its prohibited list. PRP is also not prohibited by the US Anti-Doping Agency (USADA) and many major professional sporting leagues in the United States. However, care must be taken in reviewing the components of PRP because many commercially available products differ in PRP formulation. Since 2010, many team physicians have increasingly used PRP to treat a wide range of athletic injuries. A recent anonymous survey conducted by a team of physicians on PRP use in elite athletes revealed minimal complications but significant variability among physicians with regard to timing, belief in evidence, and formulation and dosing of PRP treatments. Many physicians did implicate athlete desire as the main indication for treatment.27
As an autologous treatment, PRP injection has no serious adverse effects beyond mild discomfort as a result of the procedure and pro-inflammatory state in the days following injection. Recent concerns regarding the potential of PRP treatment for heterotopic ossification have been reported, but published information is limited to case reports. PRP can improve pain and function in patients with chronic MSK injury. PRP appears to be a safe and effective alternative to surgery for patients with injury to poorly perfused tissue, which has not improved with conservative measures, such as rest, physical therapy, and anti-inflammatory medications. Care should be taken when treating athletes with PRP to establish regulations on doping by individual governing bodies.
Continue to: Use of stem...
STEM CELL THERAPY
Use of stem cell therapy is based on the properties of the proliferation and differentiation of multipoint MSC lines. These stem cells can theoretically regenerate injured tissues and influence repair through immunomodulation; paracrine activity through the release of bioactive agents, such as cytokines, trophic, and chemotactic molecules; and cell differentiation into various cell lineages.15,16,13,17 Orthopedic surgeons have used microfracture to recruit MSCs during cartilage repair procedures for over 20 years. This procedure draws multipotent MSCs to the injured site to induce chondrogenic proliferation and fibrocartilage repair.28
Adult MSCs provide a readily accessible autologous source of stem cells for regenerative therapies. MSCs can be isolated from a variety of tissues, including bone marrow, adipose tissues, synovia, human umbilical cord blood, and peripheral blood. The majority of stem cell therapies in the United States for sports medicine purposes are conducted using bone marrow aspirate concentrate (BMAC) and adipose tissues. The US Food and Drug Administration (FDA) allows the use of minimally manipulated autologous stem cells to be injected into the same patient on the same day. However, some studies reported that culturing stem cells or introducing products, such as collagenase to stem cells, can increase the stem cell concentration prior to injection. These processes constitute more than “minimal manipulation” and therefore would require drug trials prior to use in the United States.
Although MSCs can be readily obtained from a variety of tissue sources, the makeup of the cell concentrate differs. Bone marrow and adipose tissues are readily available sources of homogenous MSCs. Harvesting stem cells from adipose tissues provides a less invasive route of collection than from BMAC. Harvested BMAC and adipose tissues consist of heterogeneous cell populations that are composed of precursor and accessory cells, such as pericytes, endothelial cells, smooth muscle cells, fibroblasts, and macrophages in addition to MSCs.
Animal studies reported promising results when evaluating soft tissue lesions in small and large animal models.14,15 Although clinical and human evidence remains limited, the potential of MSCs for regenerative repair has led to a recent increase in the number of related clinical studies. Multiple systematic reviews have concluded that MSC therapy is safe for the treatment of osteoarthritis, cartilage lesions, and tendinopathies. Limited evidence is available regarding the safety of intramuscular use, and a theoretical concern arises on the development of heterotopic bone formation as a result of treatment.13,16 The efficacy of MSC therapy is difficult to determine due to the lack of standardization in stem cell populations, adjuvants (eg, PRP, hyaluronic acid, and scaffolding preparations), and delivery methods used.13,17
Similar to PRP, the increased use of MSC therapy among high-profile athletes has led to the promotion of these therapies as safe and effective despite limited evidence.29 Although MSC therapy is a promising and safe treatment option for patients with soft tissue injuries, the paucity in data and human studies limit its clinical use. Moreover, data of MSC efficacy is complicated because of the disparity between clinical studies regarding MSC collection method (many of which eclipse the “minimal manipulation” standard), description of isolated cell concentrates, dosage, method of delivery, use of adjuvants, and lack of randomization. Further studies using [standardized] methods are needed before establishing a true consensus on the safety and efficacy of MSC therapy.
AMNIOTIC MEMBRANE
The placenta is a source of MSCs, a collagen-rich extracellular matrix, and bioactive growth and regulatory factors. The capacity of the placenta to modulate biological activities and tissue formation is thought to provide a means of tissue repair and healing. The placenta consists of amniotic fluid, amniotic membrane (AM), chorionic membrane, and umbilical cord blood and tissues. Although MSCs have been isolated from each component of placental tissues, amniotic and chorionic membranes and umbilical cord tissues yield the highest concentration.
The majority of regenerative studies involving the placenta used AM alone or in combination with other placental tissues. AM is a metabolically active tissue that consists of an epithelial layer, a basement membrane, and a mesenchymal tissue layer. In addition to being a source of stem cells, AM synthesizes many growth factors, vasoactive peptides, and cytokines, which are capable of tissue regeneration. AM was initially used as a biological scaffold for the treatment of skin burns and wounds. Other intrinsic properties of AM include the provision of a matrix for cellular migration and proliferation, enhanced wound healing with reduced scar formation, antibacterial activity, and lastly, non-immunogenic and immunosuppressive properties. These inherent characteristics have spurred studies on the potential use of AM in sports medicine as a minimally invasive means to treat osteoarthritis and injuries of tendons, ligaments, muscles, fascia, and cartilages.
Continue to: Animal studies reported...
Animal studies reported positive results with the use of AM to treat osteoarthritis, cartilage defects, and tendon and ligament injuries. Few studies involving human participants also revealed favorable results with regard to the use of AM for the treatment of plantar fasciitis and osteoarthritis; however, these studies are industry-sponsored and employed small sample sizes. The unique mixture of a collagen-rich extracellular matrix, bioactive growth factors, and pluripotent stem cells may allow AM to become an effective treatment for MSK injuries. Although initial animal and human studies show promising results, variabilities regarding models (animal and human), pathologies, placental tissues, and methods of preparation, preservation, and delivery used limit the ability for comparison, analysis, and drawing of definitive conclusions. Thus far, no studies have evaluated the use of currently available AM products for the treatment of injuries sustained by soccer players.
Despite the current popularity of AM as regenerative therapy in academic research and potential use in clinical treatment in sports medicine, physicians should remain aware of the limited evidence available. Other barriers to research and use AM as a regenerative therapy include regulatory classifications based on the concept of “minimal manipulation” in biologic therapies. Minimally manipulated placental allografts are less regulated, less costly to study, and more easily commercialized. These products are not required to undergo FDA phase I to III trials prior to premarket approval. In 2000, the FDA position on all AM products falls into 2 categories. The first position states that AM that contains allogenic stem cells mixed with another drug that is micronized and/or cryopreserved is more than “minimally manipulated” and therefore categorized as “biologic” and would be subject to phase I to III trials. Dehydrated and decellularized AM, however, may meet the concept of minimal manipulation and is only approved by the FDA as a wound covering. Thus, any application of AM for the treatment of sports medicine pathology is not currently FDA-approved, considered off-label, not covered by insurance, and subject to out-of-pocket pay.30,31
CONCLUSION
With improvements in technology and portability, US has become an effective imaging modality for point-of-care evaluation, diagnosis, and continuous monitoring of many MSK injuries. Additionally, as a dynamic imaging modality, US allows for increased accuracy and efficacy when combined with minimally invasive procedures, such as diagnostic and therapeutic guided injections and percutaneous tenotomy, in the clinical setting; thereby decreasing the overall healthcare costs. PRP is proven to be a safe treatment for several MSK conditions, such as lateral epicondylitis, patellar tendonitis, and plantar fasciitis. Although PRP has been included in the standard of care in some areas, this technique may be predominantly athlete driven. Conflicting evidence with regard to return-to-play timeframes following PRP treatment for muscular injuries and poor evidence in conditions, such as Achilles tendonitis, have led to inconsistent indications for use, dose, and timing of treatment. Although early evidence of MSC therapy is promising, high-level evidence for MSC therapy is insufficient, despite its increased use among athletes. Thus far, no data are available regarding the outcomes of the use of amniotic products for the treatment of injuries among athletes. Furthermore, the preparation of amniotic products has many regulatory concerns. The authors advocate for continuous high-level research on regenerative medicine therapies to establish clinical efficacy and safety data.
ABSTRACT
Improvements in ultrasound technology have increased the popularity and use of ultrasound as a diagnostic and therapeutic modality for many soccer-related musculoskeletal (MSK) injuries. As a dynamic imaging modality, ultrasound offers increased accuracy and efficacy with minimally invasive procedures, such as guided injections, percutaneous tenotomy, and regenerative therapies, in the clinical setting. Emerging evidence indicates that regenerative therapies, such as platelet-rich-plasma (PRP), mesenchymal stem cells, and amniotic products, are a promising treatment for many MSK injuries and are gaining popularity among professional athletes. PRP is a safe treatment for a number of MSK conditions and has been included in the standard of care. However, conflicting evidence on return-to-play timeframes and efficacy in certain MSK conditions have led to inconsistent recommendations on indications for use, dose, and timing of treatment. Mesenchymal stem cell therapy, while promising, lacks high-level evidence of efficacy despite its increasing use among athletes. Currently, no data are available regarding the outcome of the use of amniotic products for the treatment of injuries in athletes. Furthermore, preparation of many regenerative therapies eclipses the concept of minimal manipulation and is subject to US Food and Drug Administration phase I to III trials. High-level research on regenerative medicine therapies should be continuously conducted to establish their clinical efficacy and safety data.
ULTRASOUND
Ultrasound (US) was first introduced for musculoskeletal (MSK) evaluation in 1957.1 Since then, US has gained increasing attention due to its ease of utilization in the clinical setting, repeatability, noninvasiveness, capability for contralateral comparison, lack of radiation exposure, and capability to provide real-time dynamic tissue assessment.1 Compared with magnetic resonance imaging or computed tomography, US presents limitations, including decreased resolution of certain tissues, limited field of view, limited penetration beyond osseous structures, incomplete evaluation of a joint or structure, and operator experience. However, advancements in technology, image resolution, and portability have improved the visualization of multiple anatomic structures and the accuracy of minimally invasive ultrasound-guided procedures at the point of care. The use of US for guided hip injections possibly decreases the cost relative to fluoroscopic guidance.2 Other studies have reported that US, as a result of its safety profile, has replaced fluoroscopy for certain procedures, such as barbotage of calcific tendinosis.3 US has been used for diagnostic purposes and guidance for therapeutic interventions, such as needle aspiration, diagnostic or therapeutic injection, needle tenotomy, tissue release, hydro-dissection, and biopsy.3 Given its expanding application, US has been increasingly used in the clinical setting, athletic training room, and sidelines of athletic events.
DIAGNOSTIC ULTRASOUND
An epidemiologic review of the National Collegiate Athletic Association (NCAA) men’s and women’s soccer injuries from 1988 to 2003 reported over 24,000 combined injuries. Over 70% of these injuries are MSK in nature and often affect the lower extremities.4,5 Ekstrand and colleagues6 also conducted an epidemiological review of muscle injuries among professional soccer players from 2001 to 2009. They found that 92% of all muscle injuries involved the lower extremities. The portability of US allows it to serve as an ideal modality for diagnostic evaluation of acute MSK injuries. Klauser and colleagues7 developed consensus based on the recommendations of the European Society of Musculoskeletal Radiology (ESSR) for the clinical indication of diagnostic ultrasound. A grading system was developed to describe the clinical utility of diagnostic US evaluation of MSK structures:
• Grade 0: Ultrasound is not indicated;
• Grade 1: Ultrasound is indicated if other imaging techniques are not appropriate;
• Grade 2: Ultrasound indication is equivalent to other imaging modalities;
• Grade 3: Ultrasound is the first-choice technique.
Henderson and colleagues8 conducted a review of 95 studies (12 systemic reviews and 83 diagnostic studies) that investigated the accuracy of diagnostic US imaging on soft tissue MSK injuries of the upper and lower extremities. They reported the sensitivity and specificity of the method for detection of over 40 hip, knee, ankle, and foot injuries and assigned corresponding grades based on diagnostic accuracy by using the same system developed by Klauser and colleagues.7,8 Common MSK injuries of the lower extremity and their corresponding ESSR grades are listed in the Table. This study demonstrated that diagnostic US is highly accurate for a number of soft tissue MSK injuries of the lower extremity and consistently matches the recommendation grades issued by Klauser and colleagues.7 In the hands of a skilled operator, US has become an increasingly popular and cost-effective modality for diagnosis and monitoring of acute muscle injuries and chronic tendinopathies among soccer athletes.
Table. Clinical Indication Grades for Diagnostic Ultrasound Evaluation of Common Lower Extremity Injuries7,8
Hip | Knee | Foot/Ankle |
Synovitis/Effusion: 3 | Quadricep tendinosis/tear: 3 | Anterior talofibular ligament injury: 3 |
Snapping hip (extra-articular): 3 | Patella tendinopathy: 3 | Calcaneofibular ligament injury: 3 |
Gluteal tendon tear: 3 | Pes anserine bursitis: 3 | Peroneal tendon tear/subluxation: 3 |
Meralgia paresthetica: 3 | Periarticular bursitis & ganglion: 3 | Posterior tibial tendinopathy: 3 |
Lateral femoral cutaneous nerve injury: 3 | Osgood-Schlatter & Sinding-Larsen: 3 | Plantaris tendon tear: 3 |
Femoral nerve injury: 3 | Synovitis/Effusion: 3 | Plantar fasciitis: 3 |
Sports hernia: 3 | Baker’s Cyst: 2-3 | Calcific tendonitis: 3 |
Morel-Lavallée lesions: 3 | MCL injury: 2 | Retrocalcaneal bursitis: 3 |
Muscle injury (high grade): 3 | IT band friction: 2 | Joint effusion: 3 |
Trochanteric bursitis: 2 | Medial patella plica syndrome: 2 | Ganglion cyst: 3 |
Proximal hamstring injury: 2 | Meniscal cyst: 2 | Retinacula pathology: 3 |
Sciatica: 1-2 | Common perineal neuropathy: 2 | Achilles tendinopathy: 2 |
Muscle injury (low grade): 1 | Distal hamstring tendon injury: 1-2 | Haglund disease: 2 |
Psoas tendon pathology: 1 | Intra-articular ganglion: 1 | Deltoid ligament injury: 2 |
Osteoarthritis: 0 | Hoffa’s fat pad syndrome: 1 | Plantar plate tear: 2 |
Labral tear: 0 | Loose bodies: 1 | Syndesmotic injury: 2 |
| LCL injury: 0-1 | Morton’s neuroma: 2 |
| Popliteal injury: 0-1 | Deltoid ligament injury: 1 |
| Plica syndrome: 0 | Spring ligament injury: 1 |
| Full/partial ACL tear: 0 | Anterolateral ankle impingement: 0 |
| PCL tear: 0 | Posterior talofibular ligament injury: 0 |
| Medial/lateral meniscus tear: 0 |
|
| Osteochondritis dissecans: 0 |
|
Abbreviations: ACL, anterior cruciate ligament; IT, iliotibial; LCL, lateral collateral ligament; MCL, medial collateral ligament; PCL, posterior cruciate ligament.
ULTRASOUND-GUIDED THERAPEUTIC PROCEDURES
The use of US at the point of care for needle guidance has led to its widespread application for therapeutic procedures, including injections and multiple regenerative therapies. Intra-articular US-guided injection and aspiration are common therapeutic interventions performed in the clinical setting. In a position statement of the American Medical Society for Sports Medicine, US-guided injections were found to be more accurate (SORT A evidence), effective (SORT B evidence), and cost effective (SORT B evidence) than landmark-guided injections.3 A recent meta-analysis conducted by Daniels and colleagues1 demonstrated the improved accuracy and efficacy of US-guided injections at the knee, ankle, and foot. Injections may serve a diagnostic purpose when anesthetics, such as lidocaine, are used in isolation, a therapeutic purpose, or both.
Continue to: Percutaneous tenotomy involve...
REGENERATIVE THERAPIES FOR MUSCULOSKELETAL CONDITIONS
PERCUTANEOUS TENOTOMY
Percutaneous tenotomy involves the introduction of a needle into damaged soft tissues, most often tendons (“needling”), in an effort to stimulate a healing response and resect the diseased tendon tissue. Although tenotomy was initially performed as an open or arthroscopic surgical technique, advances in US technology have led to improved sensitivity and specificity identifying areas of tendinous injury (hypervascularity, hypoechogenicity, and calcification); as such, the combination of these techniques has been used in the outpatient setting. New commercial models incorporate ultrasound guidance with needles or micro-resection probes for real-time débridement of damaged tissues. Percutaneous tenotomy has been described in the management of tendinopathy involving the rotator cuff, medial and lateral epicondyles, patellar and Achilles tendons, and plantar fascia.
Housner and colleagues9 evaluated the safety and short-term efficacy of US-guided needle tenotomy in 13 patients with chronic tendinosis of the patella, Achilles tendon, gluteus medius, iliotibial tract, hamstring, and rectus femoris. They reported no procedural complications and a significant decrease in pain scores at 4 and 12 weeks of follow-up.
Koh and colleagues10 conducted a prospective case series to evaluate the safety and efficacy of office-based, US-guided percutaneous tenotomy (using a commercial model) on 20 patients with chronic lateral epicondylitis. The authors reported no wound complications and significant improvement in pain scores at each follow-up period up to 1 year. Subsequent post-procedural US evaluation of injured tissues revealed evidence of healing (decreased tendon thickness, vascularity, and hypoechogenicity) in over half the cohort after 6 months compared with the baseline.11
Lee and colleagues12 evaluated the efficacy of US-guided needle tenotomy combined with platelet-rich plasma (PRP) injection on chronic recalcitrant gluteus medius tendinopathy. In this case series, 21 patients underwent PRP and “needling” through the hypoechoic regions of the injured tendon under direct US guidance. After a period of rest, all patients completed the structured rehabilitation protocol. After an average follow-up of 10 months, all patients displayed significant improvements in all outcome questionnaires and did not report any significant adverse events. The authors concluded that tenotomy combined with PRP is a safe and effective method for treatment for recalcitrant gluteus medius tendinopathy.
These studies indicate that US-guided percutaneous tenotomy, alone or in combination with regenerative therapies, such as PRP, is a safe and effective treatment option for various tendinopathies. However, while tenotomy appears safe with promising results and no reported major adverse events, the level of evidence remains low.
ORTHOBIOLOGICS
Orthobiologics are substances composed of biological materials that can be used to aid or even hasten the healing of bones, muscles, tendons, and ligaments. Orthobiologics may contain growth factors, which initiate or stimulate the body’s reparative process; matrix proteins, which serve as scaffolding for healing tissues; or stem cells, specifically adult stem cells, which are multipotent and can differentiate into several cell lines. Adult stem cells are categorized as hematopoietic, neural, epithelial, skin, and mesenchymal types. Mesenchymal stem cells (MSCs) are of particular interest in sports medicine applications because they secrete growth factors and cytokines with trophic, chemotactic, and immunosuppressive properties.13 MSCs are also multipotent and can differentiate into bones, muscles, cartilages, and tendons.14-17MSCs are readily isolated from many sources, including bone marrow, adipose tissues, synovial tissues, peripheral blood, skeletal muscles, umbilical cord blood, and placenta.13,14Several types of regenerative therapies used in orthopedic and sports medicine practice include PRP, stem cell therapy, and amniotic membrane/fluid preparations. While each therapy possesses the potential for promising results, the paucity of research and discrepancies among studies regarding the description of stem cell lines used limit the available evidence on the true clinical benefits of these regenerative therapies.
[HEAD 3] PLATELET-RICH PLASMA
PRP is an autologous product that has been used to stimulate biological factors and promote healing since the 1970s. Through the activation of platelets, PRP improves localized recruitment, proliferation, and differentiation of cells involved in tissue repair. Platelets, which are non-nucleated bodies located in peripheral blood, contain and release 3 groups of bioactive factors that enhance the healing process. Growth factors and cytokines released from alpha-granules play a role in cell proliferation, chemotaxis, cell differentiation, and angiogenesis. Bioactive factors, such as serotonin and histamine, released from dense granules, increase capillary permeability and improve cell recruitment and migration. Adhesion molecules also assist in cell migration and creation of an extracellular matrix, which acts as a scaffold for wound healing.18 Platelets are activated by mechanical trauma or contact with multiple activators, including Von Willebrand factor, collagen, thrombin, or calcium chloride. When activated, platelets release growth factors and cytokines, which create a pro-inflammatory environment that mediates the tissue repair process. After the procedure, the pro-inflammatory environment may result in patient discomfort, which can be managed with ice and acetaminophen. Use of nonsteroidal anti-inflammatory drugs may theoretically inhibit the inflammatory cascade induced by PRP, and they are avoided before and after the procedure, although evidence regarding necessary time frames is lacking.
Continue to: PRP consists of...
PRP consists of the fractionated liquid component of autologous whole blood, which contains increased concentrations of platelets and cytokines. Different methods and commercial preparations are available for collecting and preparing PRP. Variations in the amount of blood drawn, use of anticoagulants, presence or absence of an activating agent, number of centrifuge spins, and overall platelet and white blood cell concentrations lead to difficulty in evaluating and interpreting the available evidence regarding PRP therapy.
In vitro and animal studies demonstrated promising and safe results regarding the healing effect of PRP on injured soft tissues, such as tendons, ligaments, and muscles. In this regard, a number of studies have evaluated the effect of PRP on human MSK injuries. However, in addition to the above-mentioned variabilities in PRP, many of such studies lack standardization and randomization techniques and include a small number of patients only, thereby limiting the overall comparison and clinical application.
A landmark study conducted by Mishra and Pavelko19 concluded that PRP significantly reduced pain in patients with chronic elbow tendinosis. Similar findings were reported in high-level overhead athletes with ulnar collateral ligament insufficiency, which did not improve with conservative management.20 Fitzpatrick and colleagues21 found improvements in pain with the use of single PRP injection as treatment for chronic gluteal tendinopathy. PRP can effectively improve pain and recovery in chronic ligament and tendon injuries, such as lateral epicondylitis, patellar tendinopathy, and plantar fasciitis, when patients are unresponsive to traditional conservative management. The application of PRP to treat acute MSK injuries has produced mixed results. Hamid and colleagues22 conducted a level II randomized controlled trial to evaluate the effect of PRP combined with a rehabilitation program for treatment of grade 2 hamstring injuries on return-to-play compared with rehabilitation alone. Fourteen athletes were randomized into the study and control groups. Hamid and colleagues22 reported improved return-to-play in the study group compared with that in the control (26.7 and 42.5 days, respectively). This study also reported lower pain scores in the PRP group over time, but the difference was not statistically significant. Zanon and colleagues23 conducted a prospective study to evaluate return-to-play in professional soccer players with acute hamstring strains treated with PRP and a rehabilitation program. This study determined that athletes treated with PRP were “match fit,” meaning they would be available for match selection in an average of 36.8 days. However, Zanon and colleagues23 did not include a control group for comparison. Other studies reported that PRP treatment of acutely injured muscles and medial collateral ligaments of soccer and basketball players decreased their return-to-play interval.18 Reviews by Hamilton and colleagues24 and Pas and colleagues25 concluded that PRP treatment of acutely injured tissues with good blood supply (eg, hamstring muscles) did not improve pain or return-to-play compared with standardized rehabilitation protocols. Similarly, in a double-blinded placebo controlled trial, Reurink and colleagues26 evaluated return-to-play in 80 athletes with acute hamstring injuries treated with a rehabilitation program and either PRP or placebo. Reurink and colleagues26 found no difference in return-to-play (42 days for both groups), but the difference was not statistically significant. PRP has also been used intraoperatively and shows promising results in total knee arthroplasty, anterior cruciate ligament reconstruction, acute Achilles tendon repair, rotator cuff repair, and cartilage repair. However, many of these intraoperative studies are limited to animal models.
In 2009, the World Anti-Doping Agency (WADA) prohibited the use of PRP because it contains autologous growth factors and IGF-1, which could produce an anabolic effect. Recent studies have failed to demonstrate any athletic advantages of using PRP. WADA has since removed PRP from its prohibited list. PRP is also not prohibited by the US Anti-Doping Agency (USADA) and many major professional sporting leagues in the United States. However, care must be taken in reviewing the components of PRP because many commercially available products differ in PRP formulation. Since 2010, many team physicians have increasingly used PRP to treat a wide range of athletic injuries. A recent anonymous survey conducted by a team of physicians on PRP use in elite athletes revealed minimal complications but significant variability among physicians with regard to timing, belief in evidence, and formulation and dosing of PRP treatments. Many physicians did implicate athlete desire as the main indication for treatment.27
As an autologous treatment, PRP injection has no serious adverse effects beyond mild discomfort as a result of the procedure and pro-inflammatory state in the days following injection. Recent concerns regarding the potential of PRP treatment for heterotopic ossification have been reported, but published information is limited to case reports. PRP can improve pain and function in patients with chronic MSK injury. PRP appears to be a safe and effective alternative to surgery for patients with injury to poorly perfused tissue, which has not improved with conservative measures, such as rest, physical therapy, and anti-inflammatory medications. Care should be taken when treating athletes with PRP to establish regulations on doping by individual governing bodies.
Continue to: Use of stem...
STEM CELL THERAPY
Use of stem cell therapy is based on the properties of the proliferation and differentiation of multipoint MSC lines. These stem cells can theoretically regenerate injured tissues and influence repair through immunomodulation; paracrine activity through the release of bioactive agents, such as cytokines, trophic, and chemotactic molecules; and cell differentiation into various cell lineages.15,16,13,17 Orthopedic surgeons have used microfracture to recruit MSCs during cartilage repair procedures for over 20 years. This procedure draws multipotent MSCs to the injured site to induce chondrogenic proliferation and fibrocartilage repair.28
Adult MSCs provide a readily accessible autologous source of stem cells for regenerative therapies. MSCs can be isolated from a variety of tissues, including bone marrow, adipose tissues, synovia, human umbilical cord blood, and peripheral blood. The majority of stem cell therapies in the United States for sports medicine purposes are conducted using bone marrow aspirate concentrate (BMAC) and adipose tissues. The US Food and Drug Administration (FDA) allows the use of minimally manipulated autologous stem cells to be injected into the same patient on the same day. However, some studies reported that culturing stem cells or introducing products, such as collagenase to stem cells, can increase the stem cell concentration prior to injection. These processes constitute more than “minimal manipulation” and therefore would require drug trials prior to use in the United States.
Although MSCs can be readily obtained from a variety of tissue sources, the makeup of the cell concentrate differs. Bone marrow and adipose tissues are readily available sources of homogenous MSCs. Harvesting stem cells from adipose tissues provides a less invasive route of collection than from BMAC. Harvested BMAC and adipose tissues consist of heterogeneous cell populations that are composed of precursor and accessory cells, such as pericytes, endothelial cells, smooth muscle cells, fibroblasts, and macrophages in addition to MSCs.
Animal studies reported promising results when evaluating soft tissue lesions in small and large animal models.14,15 Although clinical and human evidence remains limited, the potential of MSCs for regenerative repair has led to a recent increase in the number of related clinical studies. Multiple systematic reviews have concluded that MSC therapy is safe for the treatment of osteoarthritis, cartilage lesions, and tendinopathies. Limited evidence is available regarding the safety of intramuscular use, and a theoretical concern arises on the development of heterotopic bone formation as a result of treatment.13,16 The efficacy of MSC therapy is difficult to determine due to the lack of standardization in stem cell populations, adjuvants (eg, PRP, hyaluronic acid, and scaffolding preparations), and delivery methods used.13,17
Similar to PRP, the increased use of MSC therapy among high-profile athletes has led to the promotion of these therapies as safe and effective despite limited evidence.29 Although MSC therapy is a promising and safe treatment option for patients with soft tissue injuries, the paucity in data and human studies limit its clinical use. Moreover, data of MSC efficacy is complicated because of the disparity between clinical studies regarding MSC collection method (many of which eclipse the “minimal manipulation” standard), description of isolated cell concentrates, dosage, method of delivery, use of adjuvants, and lack of randomization. Further studies using [standardized] methods are needed before establishing a true consensus on the safety and efficacy of MSC therapy.
AMNIOTIC MEMBRANE
The placenta is a source of MSCs, a collagen-rich extracellular matrix, and bioactive growth and regulatory factors. The capacity of the placenta to modulate biological activities and tissue formation is thought to provide a means of tissue repair and healing. The placenta consists of amniotic fluid, amniotic membrane (AM), chorionic membrane, and umbilical cord blood and tissues. Although MSCs have been isolated from each component of placental tissues, amniotic and chorionic membranes and umbilical cord tissues yield the highest concentration.
The majority of regenerative studies involving the placenta used AM alone or in combination with other placental tissues. AM is a metabolically active tissue that consists of an epithelial layer, a basement membrane, and a mesenchymal tissue layer. In addition to being a source of stem cells, AM synthesizes many growth factors, vasoactive peptides, and cytokines, which are capable of tissue regeneration. AM was initially used as a biological scaffold for the treatment of skin burns and wounds. Other intrinsic properties of AM include the provision of a matrix for cellular migration and proliferation, enhanced wound healing with reduced scar formation, antibacterial activity, and lastly, non-immunogenic and immunosuppressive properties. These inherent characteristics have spurred studies on the potential use of AM in sports medicine as a minimally invasive means to treat osteoarthritis and injuries of tendons, ligaments, muscles, fascia, and cartilages.
Continue to: Animal studies reported...
Animal studies reported positive results with the use of AM to treat osteoarthritis, cartilage defects, and tendon and ligament injuries. Few studies involving human participants also revealed favorable results with regard to the use of AM for the treatment of plantar fasciitis and osteoarthritis; however, these studies are industry-sponsored and employed small sample sizes. The unique mixture of a collagen-rich extracellular matrix, bioactive growth factors, and pluripotent stem cells may allow AM to become an effective treatment for MSK injuries. Although initial animal and human studies show promising results, variabilities regarding models (animal and human), pathologies, placental tissues, and methods of preparation, preservation, and delivery used limit the ability for comparison, analysis, and drawing of definitive conclusions. Thus far, no studies have evaluated the use of currently available AM products for the treatment of injuries sustained by soccer players.
Despite the current popularity of AM as regenerative therapy in academic research and potential use in clinical treatment in sports medicine, physicians should remain aware of the limited evidence available. Other barriers to research and use AM as a regenerative therapy include regulatory classifications based on the concept of “minimal manipulation” in biologic therapies. Minimally manipulated placental allografts are less regulated, less costly to study, and more easily commercialized. These products are not required to undergo FDA phase I to III trials prior to premarket approval. In 2000, the FDA position on all AM products falls into 2 categories. The first position states that AM that contains allogenic stem cells mixed with another drug that is micronized and/or cryopreserved is more than “minimally manipulated” and therefore categorized as “biologic” and would be subject to phase I to III trials. Dehydrated and decellularized AM, however, may meet the concept of minimal manipulation and is only approved by the FDA as a wound covering. Thus, any application of AM for the treatment of sports medicine pathology is not currently FDA-approved, considered off-label, not covered by insurance, and subject to out-of-pocket pay.30,31
CONCLUSION
With improvements in technology and portability, US has become an effective imaging modality for point-of-care evaluation, diagnosis, and continuous monitoring of many MSK injuries. Additionally, as a dynamic imaging modality, US allows for increased accuracy and efficacy when combined with minimally invasive procedures, such as diagnostic and therapeutic guided injections and percutaneous tenotomy, in the clinical setting; thereby decreasing the overall healthcare costs. PRP is proven to be a safe treatment for several MSK conditions, such as lateral epicondylitis, patellar tendonitis, and plantar fasciitis. Although PRP has been included in the standard of care in some areas, this technique may be predominantly athlete driven. Conflicting evidence with regard to return-to-play timeframes following PRP treatment for muscular injuries and poor evidence in conditions, such as Achilles tendonitis, have led to inconsistent indications for use, dose, and timing of treatment. Although early evidence of MSC therapy is promising, high-level evidence for MSC therapy is insufficient, despite its increased use among athletes. Thus far, no data are available regarding the outcomes of the use of amniotic products for the treatment of injuries among athletes. Furthermore, the preparation of amniotic products has many regulatory concerns. The authors advocate for continuous high-level research on regenerative medicine therapies to establish clinical efficacy and safety data.
1. Daniels E, Cole D, Jacobs B, Phillips S. Existing Evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576. doi:10.1177/2325967118756576.
2. Henne M, Centurion A, Rosas S, Youmans H, Osbahr D. Trends in utilization of image-guided hip joint injections. Unpublished. 2018.
3. Finnoff JT, Hall MM, Adams E, et al. American Medical Society for Sports Medicine position statement: Interventional musculoskeletal ultrasound in sports medicine. Clin J Sport Med. 2015;25:6-22. doi:10.1097/JSM.0000000000000175.
4. Agel J, Evans TA, Dick R, Putukian M, Marshal S. Descriptive epidemiology of collegiate men’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):270-277.
5. Dick R, Putukian M, Agel J, Evans T, Marshall S. Descriptive epidemiology of collegiate women’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):278-285.
6. Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011;39(6):1226-1232. doi:10.1177/0363546510395879.
7. Klauser A, Tagliafico A, Allen G, et al. Clinical indications for musculoskeletal ultrasound: A Delphi-based consensus paper of the European society of musculoskeletal radiology. Eur Radiol. 2012;22(5):1140-1148. doi:10.1007/s00330-011-2356-3.
8. Henderson R, Walker B, Young K. The accuracy of diagnostic ultrasound imaging for musculoskeletal soft tissue pathology of the extremities: a comprehensive review of the literature. Chiropr Man Therap. 2015;23(1):31. doi:10.1186/s12998-015-0076-5.
9. Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009;28(9):1187-1192. doi:10.7863/jum.2009.28.9.1187.
10. Koh J, Mohan PC, Howe TS, et al. Fasciotomy and surgical tenotomy for recalcitrant lateral elbow tendinopathy: early clinical experience with a novel device for minimally invasive percutaneous microresection. Am J Sports Med. 2013;41(3):636-644. doi:10.1177/0363546512470625.
11. Seng C, Mohan PC, Koh J, et al. Ultrasonic percutaneous tenotomy for recalcitrant lateral elbow tendinopathy: sustainability and sonographic progression at 3 years. Am J Sports Med. 2015;44(2):504-510. doi:10.1177/0363546515612758.
12. Lee J, Harrison J, Boachie-Adjei K, Vargas E, Moley P. Platelet-rich plasma injections with needle tenotomy for gluteus medius tendinopathy: A registry study with prospective follow-up. Orthop J Sports Med. 2016;4(11):2325967116671692. doi:10.1177/2325967116671692.
13. Osborne H, Anderson L, Burt P, Young M, Gerrard D. Australasian College of Sports Physicians-Position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med. 2016;50:1237-1244. doi:10.1136/bjsports-2015-095711.
14. Anderson J, Little D, Toth A, et al. Stem cell therapies for knee cartilage repair. The current status of preclinical and clinical studies. Am J Sports Med. 2013;42(9)2253-2261. doi:10.1177/0363546513508744.
15. Lee S, Kwon B, Lee Kyoungbun, Son Y, Chung S. Therapeutic mechanisms of human adipose-derived mesenchymal stem cells in a rat tendon injury model. Am J Sports Med. 2017;45(6):1429-1439. doi:10.1177/0363546517689874.
16. McIntyre J, Jones I, Han B, Vangsness C. Intra-articular mesenchymal stem cell therapy for the human joint. A systematic review. Am J Sports Med. 2017;0363546517735844. doi:10.1177/0363546517735844.
17. Pas HIMFL, Moen M, Haisma J, Winters M. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med. 2017;51:996-1002. doi:10.1136/bjsports-2016-096794.
18. Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272. doi:10.1177/0363546509349921.
19. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-1778. doi:10.1177/0363546506288850.
20. Dines J, Williams P, ElAttrache N, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop. 2016;45(4):296-300.
21. Fitzpatrick J, Bulsara M, O’Donnel J, McCrory P, Zheng M. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy. A randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid injection. Am J Sports Med. 2018;46(4)933-939. doi:10.1177/0363546517745525.
22. Hamid M, Ali M, Yusof A, George J, Lee L. Platelet-rich plasma injections for the treatment of hamstring injuries: A randomized controlled trial. Am J Sports Med. 2014;42(10):2410-2418. doi:10.1177/0363546514541540.
23. Zanon G, Combi F, Combi A, Perticarini L, Sammarchi L, Benazzo F. Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players. Joints. 2016;4(1):17-23. doi:10.11138/jts/2016.4.1.017.
24. Hamilton B, Tol JL, Almusa E, et al. Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomized controlled trial. Br J Sports Med. 2015;49:943-950. doi:10.1136/bjsports-2015-094603.
25. Pas HIMFL, Reurink G, Tol JL, Wier A, Winters M, Moen M. Efficacy of rehabilitation (lengthening) exercises, platelet-rich plasma injections, and other conservative interventions in acute hamstring injuries: an updated systematic review and meta-analysis. Br J Sports Med. 2015;49:1197-1205. doi:10.1136/bjsports-2015-094879.
26. Reurink G, Goudswaard G, Moen M, et al. Platelet-rich plasma injections in acute muscle injury. N Engl J Med. 2014;370:2546-2547. doi:10.1056/NEJMc1402340.
27. Kantrowitz D, Padaki A, Ahmad C, Lynch T. Defining platelet-rich plasma usage by team physicians in elite athletes. Orthop J Sports Med. 2018;6(4):2325967118767077. doi:10.1177/2325967118767077.
28. Mithoefer K, Peterson L, Zenobi-Wong M, Mandelbaum B. Cartilage issues in football-today’s problems and tomorrow’s solutions. Br J Sports Med. 2015;49(9):590-596. doi:1136/bjsports-2015-094772.
29. Matthews K, Cuchiara M. Regional regulatory insights: U.S. National Football League Athletes seeking unproven stem cell treatments. Stem Cells Dev. 2014;23(S1):60-64. doi:10.1089/scd.2014.0358.
30. McIntyre J, Jones I, Danilkovich A, Vangsness T. The placenta: applications in orthopaedic sports medicine. Am J Sports Med. 2018;46(1):234-247. doi:10.1177/0363546517697682.
31. Riboh J, Saltzman B, Yankee A, Cole BJ. Human amniotic membrane-derived products in sports medicine: Basic science, early results, and potential clinical applications. Am J Sports Med. 2015;44(9)2425-2434. doi:10.1177/0363546515612750.
1. Daniels E, Cole D, Jacobs B, Phillips S. Existing Evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576. doi:10.1177/2325967118756576.
2. Henne M, Centurion A, Rosas S, Youmans H, Osbahr D. Trends in utilization of image-guided hip joint injections. Unpublished. 2018.
3. Finnoff JT, Hall MM, Adams E, et al. American Medical Society for Sports Medicine position statement: Interventional musculoskeletal ultrasound in sports medicine. Clin J Sport Med. 2015;25:6-22. doi:10.1097/JSM.0000000000000175.
4. Agel J, Evans TA, Dick R, Putukian M, Marshal S. Descriptive epidemiology of collegiate men’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):270-277.
5. Dick R, Putukian M, Agel J, Evans T, Marshall S. Descriptive epidemiology of collegiate women’s soccer injuries: National Collegiate Athletic Association Injury Surveillance System, 1988-1989 through 2002-2003. J Athl Train. 2007;42(2):278-285.
6. Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011;39(6):1226-1232. doi:10.1177/0363546510395879.
7. Klauser A, Tagliafico A, Allen G, et al. Clinical indications for musculoskeletal ultrasound: A Delphi-based consensus paper of the European society of musculoskeletal radiology. Eur Radiol. 2012;22(5):1140-1148. doi:10.1007/s00330-011-2356-3.
8. Henderson R, Walker B, Young K. The accuracy of diagnostic ultrasound imaging for musculoskeletal soft tissue pathology of the extremities: a comprehensive review of the literature. Chiropr Man Therap. 2015;23(1):31. doi:10.1186/s12998-015-0076-5.
9. Housner JA, Jacobson JA, Misko R. Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. J Ultrasound Med. 2009;28(9):1187-1192. doi:10.7863/jum.2009.28.9.1187.
10. Koh J, Mohan PC, Howe TS, et al. Fasciotomy and surgical tenotomy for recalcitrant lateral elbow tendinopathy: early clinical experience with a novel device for minimally invasive percutaneous microresection. Am J Sports Med. 2013;41(3):636-644. doi:10.1177/0363546512470625.
11. Seng C, Mohan PC, Koh J, et al. Ultrasonic percutaneous tenotomy for recalcitrant lateral elbow tendinopathy: sustainability and sonographic progression at 3 years. Am J Sports Med. 2015;44(2):504-510. doi:10.1177/0363546515612758.
12. Lee J, Harrison J, Boachie-Adjei K, Vargas E, Moley P. Platelet-rich plasma injections with needle tenotomy for gluteus medius tendinopathy: A registry study with prospective follow-up. Orthop J Sports Med. 2016;4(11):2325967116671692. doi:10.1177/2325967116671692.
13. Osborne H, Anderson L, Burt P, Young M, Gerrard D. Australasian College of Sports Physicians-Position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med. 2016;50:1237-1244. doi:10.1136/bjsports-2015-095711.
14. Anderson J, Little D, Toth A, et al. Stem cell therapies for knee cartilage repair. The current status of preclinical and clinical studies. Am J Sports Med. 2013;42(9)2253-2261. doi:10.1177/0363546513508744.
15. Lee S, Kwon B, Lee Kyoungbun, Son Y, Chung S. Therapeutic mechanisms of human adipose-derived mesenchymal stem cells in a rat tendon injury model. Am J Sports Med. 2017;45(6):1429-1439. doi:10.1177/0363546517689874.
16. McIntyre J, Jones I, Han B, Vangsness C. Intra-articular mesenchymal stem cell therapy for the human joint. A systematic review. Am J Sports Med. 2017;0363546517735844. doi:10.1177/0363546517735844.
17. Pas HIMFL, Moen M, Haisma J, Winters M. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med. 2017;51:996-1002. doi:10.1136/bjsports-2016-096794.
18. Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272. doi:10.1177/0363546509349921.
19. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-1778. doi:10.1177/0363546506288850.
20. Dines J, Williams P, ElAttrache N, et al. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop. 2016;45(4):296-300.
21. Fitzpatrick J, Bulsara M, O’Donnel J, McCrory P, Zheng M. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy. A randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid injection. Am J Sports Med. 2018;46(4)933-939. doi:10.1177/0363546517745525.
22. Hamid M, Ali M, Yusof A, George J, Lee L. Platelet-rich plasma injections for the treatment of hamstring injuries: A randomized controlled trial. Am J Sports Med. 2014;42(10):2410-2418. doi:10.1177/0363546514541540.
23. Zanon G, Combi F, Combi A, Perticarini L, Sammarchi L, Benazzo F. Platelet-rich plasma in the treatment of acute hamstring injuries in professional football players. Joints. 2016;4(1):17-23. doi:10.11138/jts/2016.4.1.017.
24. Hamilton B, Tol JL, Almusa E, et al. Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomized controlled trial. Br J Sports Med. 2015;49:943-950. doi:10.1136/bjsports-2015-094603.
25. Pas HIMFL, Reurink G, Tol JL, Wier A, Winters M, Moen M. Efficacy of rehabilitation (lengthening) exercises, platelet-rich plasma injections, and other conservative interventions in acute hamstring injuries: an updated systematic review and meta-analysis. Br J Sports Med. 2015;49:1197-1205. doi:10.1136/bjsports-2015-094879.
26. Reurink G, Goudswaard G, Moen M, et al. Platelet-rich plasma injections in acute muscle injury. N Engl J Med. 2014;370:2546-2547. doi:10.1056/NEJMc1402340.
27. Kantrowitz D, Padaki A, Ahmad C, Lynch T. Defining platelet-rich plasma usage by team physicians in elite athletes. Orthop J Sports Med. 2018;6(4):2325967118767077. doi:10.1177/2325967118767077.
28. Mithoefer K, Peterson L, Zenobi-Wong M, Mandelbaum B. Cartilage issues in football-today’s problems and tomorrow’s solutions. Br J Sports Med. 2015;49(9):590-596. doi:1136/bjsports-2015-094772.
29. Matthews K, Cuchiara M. Regional regulatory insights: U.S. National Football League Athletes seeking unproven stem cell treatments. Stem Cells Dev. 2014;23(S1):60-64. doi:10.1089/scd.2014.0358.
30. McIntyre J, Jones I, Danilkovich A, Vangsness T. The placenta: applications in orthopaedic sports medicine. Am J Sports Med. 2018;46(1):234-247. doi:10.1177/0363546517697682.
31. Riboh J, Saltzman B, Yankee A, Cole BJ. Human amniotic membrane-derived products in sports medicine: Basic science, early results, and potential clinical applications. Am J Sports Med. 2015;44(9)2425-2434. doi:10.1177/0363546515612750.
TAKE-HOME POINTS
- Improvements in ultrasound technology have increased its use as a therapeutic and diagnostic modality.
- Ultrasound offers increased accuracy and efficacy with minimally invasive procedures.
- PRP is a safe and effective treatment for many musculoskeletal injuries, however return-to-play time frames limit its efficacy.
- While stem cell and amniotic products offer promising results, the paucity in data limits overall use.
- Care should be taken when discussing regenerative therapy as many products eclipse the concept of “minimal manipulation” and therefore require USFDA trials to establish safety data.
The PASTA Bridge – A Repair Technique for Partial Articular-Sided Rotator Cuff Tears: A Biomechanical Evaluation of Construct Strength
ABSTRACT
Partial articular-sided supraspinatus tendon avulsion (PASTA) tears are a common clinical problem that can require surgical intervention to reduce patient symptoms. Currently, no consensus has been reached regarding the optimal repair technique. The PASTA Bridge technique was developed by the senior author to address these types of lesions. A controlled laboratory study was performed comparing the PASTA Bridge with a standard transtendon rotator cuff repair to confirm its biomechanical efficacy. A 50% articular-sided partial tear of the supraspinatus tendon was created on 6 matched pairs of fresh-frozen cadaveric shoulders. For each matched pair, 1 humerus received a PASTA Bridge repair, whereas the contralateral side received a repair using a single suture anchor with a horizontal mattress suture. The ultimate load, yield load, and stiffness were determined from the load-displacement results for each sample. Video tracking software was used to determine the cyclic displacement of each sample at the articular margin and the repair site. Strain at the margin and repair site was then calculated using this collected data. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). No instance of failure was due to the PASTA Bridge construct itself. The results of this study have established that the PASTA Bridge is biomechanically equivalent to the transtendon repair technique. The PASTA Bridge is technically easy, percutaneous, reproducible, and is associated with fewer risks.
Continue to: Rotator cuff tests...
Rotator cuff tears can be classified as full-thickness or partial-thickness; the latter being further divided into the bursal surface, articular-sided, or intratendinous tears. A study analyzing the anatomical distribution of partial tears found that approximately 50% of those at the rotator cuff footprint were articular-sided and predominantly involved the supraspinatus tendon.1 These partial-thickness articular-sided supraspinatus tendon avulsion tears have been coined “PASTA lesions.” Current treatment recommendations suggest that a debridement, a transtendon technique, or a “takedown” method of completing a partial tear and performing a full-thickness repair be utilized for partial-thickness rotator cuff repairs.
The primary goal of a partial cuff repair is to reestablish the tendon footprint at the humeral head. It has been argued that the “takedown” method alters the normal footprint and presents tension complications that can result in poor outcomes.2-5 Also, if the full-thickness repair fails, the patient is left with a full-thickness tear that could be more disabling. The trans-tendon technique has proven to be superior in this sense, demonstrating an improvement in both footprint contact and healing potential.3-5 This article aims to evaluate the biomechanical effectiveness of a new PASTA lesion repair technique, the PASTA Bridge,6 when compared with a traditional transtendon suture anchor repair.
MATERIALS AND METHODS
BIOMECHANICAL OPERATIVE TECHNIQUE: PASTA BRIDGE REPAIR
A 17-gauge spinal needle was used to create a puncture in the supraspinatus tendon approximately 7.5 mm anterior to the centerline of the footprint and just medial to the simulated tear line. A 1.1-mm blunt Nitinol wire (Arthrex) was placed over the top of the spinal needle, and the spinal needle was removed. A 2.4-mm portal dilation instrument (Arthrex) was placed over the top of the 1.1 blunt wire (Arthrex) followed by the drill spear for the 2.4-mm BioComposite SutureTak (Arthrex). A pilot hole was created just medial to the simulated tear using the spear and a 1.8-mm drill followed by insertion of a 2.4-mm BioComposite SutureTak (Arthrex). This process was repeated approximately 5 mm posterior to the centerline of the footprint. A strand of suture from each anchor was tied in a manner similar to the “double pulley” method described by Lo and Burkhart.3 The opposing 2 limbs were tensioned to pull the knot taut over the repair site and fixed laterally with a 4.75-mm BioComposite SwiveLock (Arthrex) placed approximately 1 cm lateral to the greater tuberosity.
BIOMECHANICAL OPERATIVE TECHNIQUE: CONTROL (4.5-MM CORKSCREW FT GROUP)
A No. 11 scalpel was used to create a puncture in the tendon for a transtendon approach. A 4.5-mm titanium Corkscrew FT (Arthrex) was placed just medial to the beginning of the simulated tear. The No. 2 FiberWire (Arthrex) was passed anterior and posterior to the hole made for the transtendon approach. A horizontal mattress stitch was tied using a standard 2-handed knot technique.
BIOMECHANICAL ANALYSIS
The proximal humeri with intact supraspinatus tendons were removed from 6 matched pairs of fresh-frozen cadaver shoulders (3 males, 3 females; average age, 49 ± 12 years). The shaft of the humerus was potted in fiberglass resin. For each sample, a partial tear of the supraspinatus tendon was replicated by using a sharp blade to transect 50% of the medial side of the supraspinatus from the tuberosity.2,5 From each matched pair, 1 humerus was selected to receive a PASTA Bridge repair,6 and the contralateral repair was performed using one 4.5-mm titanium Corkscrew FT. Half of the samples of each repair were performed on the right humerus to avoid a mechanical bias. Each repair was performed by the same orthopedic surgeon.
Continue to: Biomechanical testing was...
Biomechanical testing was conducted using an INSTRON 8871 Axial Table Top Servo-hydraulic Testing System (INSTRON), with a 5 kN load cell attached to the crosshead. The system was calibrated using FastTrack software (AEC Software), and both the load and position controls were run through WaveMaker software (WaveMaker). Each sample was positioned on a fixed angle fixture and secured to the testing surface so that the direction of pull would be performed 45° to the humeral shaft. A custom fixture with inter-digitated brass clamps was attached to the crosshead, and dry ice was used to freeze the tendon to the clamp. The test setup can be seen in Figures 1A, 1B.
Each sample was pre-loaded to 10 N to remove slack from the system. Pre-loading was followed by cyclic loading between 10 N and 100 N,7-11 at 1 Hz, for 100 cycles. One-hundred cycles were chosen based on literature stating that the majority of the cyclic displacement occurs in the first 100 cycles.7-10 Post cycling, the samples were loaded to failure at a rate of 33 mm/sec.7-12 Load and position data were recorded at 500 Hz, and the mode of failure was noted for each sample.
Before loading, a soft-tissue marker was used to create individual marks on the supraspinatus in-line with the articular margin and lateral edge of the tuberosity (Figures 1A, 1B). The individual marks, a digital camera, and MaxTraq video tracking software (Innovision Systems) were used to calculate displacement and strain.
For each sample, the ultimate load, yield load, and stiffness were determined from the load-displacement results. Video tracking software was used to determine the cyclic displacement of each sample at both the articular margin (medial dots) and at the repair site. The strain at these 2 locations was calculated by dividing the cyclic displacement of the respective site by the distance between the site of interest and the lateral edge of the tuberosity (lateral marks) (ΔL/L). Paired t tests (α = 0.05) were used to determine if differences in ultimate load or strain between the 2 repairs were significant.
RESULTS
BIOMECHANICAL ANALYSIS
The results of the biomechanical testing are provided in the Table. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be needed to establish a significant difference for strain at the repair site. The modes of failure were mid-substance tendon tearing, the humeral head breaking, tearing at the musculotendinous junction, or the tendon tearing at the repair site. All 4 modes of failure occurred in at least 1 sample from both repair groups (Figures 2-4). Visual inspection of the samples post-testing revealed no damage to the anchors or sutures. A representative picture of the tendon tearing at the repair site can be seen in Figures 2A, 2B.
Continue to: The purpose of...
DISCUSSION
The purpose of this study was to evaluate the biomechanical strength of a new technique for PASTA repairs—the PASTA Bridge.6 After creation of a partial-thickness tear on a cadaveric model, we compared the PASTA Bridge technique6 with a standard transtendon suture anchor repair. We hypothesized that the PASTA Bridge would yield equivalent or better biomechanical properties including the ultimate load to failure and the degree of strain at different locations in the repair. Our results supported this hypothesis. The PASTA Bridge was biomechanically equivalent to transtendon repair.
For repairs of partial-thickness rotator cuff tears, 2 traditional techniques are transtendon repairs and the “takedown” method of completing a partial tear into a full tear with a subsequent repair.13 While clinical outcomes of the 2 methods suggest no superiority over the other,13 studies have demonstrated a biomechanical advantage with transtendon repairs. Repairs of PASTA lesions exhibit both lower strain and displacement of the repaired tendon compared with a full-thickness repair.2-5 Failure of the “takedown” method results in a full-thickness rotator cuff tear as opposed to a partial tear. This outcome can prove to be more debilitating for the patient. Furthermore, Mazzocca and colleagues5 illustrated that for partial tears >25% thickness, the cuff strain returned to the intact state once repaired.
Our data suggest that biomechanically the transtendon and the PASTA Bridge6 techniques were equivalent. While the ultimate load and strain at repair sites are comparable, the PASTA Bridge is percutaneous and presents significantly less risk of complications. The PASTA Bridge6 uses a medial row horizontal mattress with a lateral row fixation to recreate the rotator cuff footprint. It has been postulated that reestablishing a higher percentage of the footprint can aide in tendon-bone healing, having valuable implications for both biological and clinical outcomes of the patient.3,4,14 Greater contact at the tendon-bone interface may allow more fibers to participate in the healing process.14 In their analysis of rotator cuff repair, Apreleva and colleagues14 asserted that more laterally placed suture anchors may increase the repair-site area. The lateral anchors of the PASTA Bridge help not only to increase the footprint and thereby the healing potential of the repair but also assist in taking pressure off the medial row anchors.
In their report on double-row rotator cuff repair, Lo and Burkhart3 suggest that double-row fixation is superior to single-row repairs for a variety of reasons. Primarily, double-row techniques increase the number of points of fixation, which will secondarily reduce both the stress and load at each suture point.3 This effect improves the overall strength of the repair construct. Use of the lateral anchor of the PASTA Bridge6 allows the medial anchors to act as pivot points. Placing the stress laterally, the configuration allows for movement and strain distribution without sacrificing the integrity of the repair. In our analysis, failure occurred by the tendon tearing mid-substance, humeral head breaking, tendon tearing at the repair site, and tearing at the musculotendinous junction (Figures 2-4). There was no instance of failure due to the construct itself indicating that the 2.4-mm medial anchors are more than adequate for the PASTA Bridge.6 When visually inspecting the samples after failure, there was no damage to the anchors or sutures. This observation indicates that the PASTA Bridge construct is remarkably strong and capable of withstanding excessive forces.
There were some potential limitations of this study. The small sample size modified the potential for identifying significant differences between the groups. A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be required to determine a significant difference between the 2 repair groups in strain at the repair site. We did not test this many pairs because the data was so similar after 6 matched pairs that it did not warrant continuing further. Additional research should be done with larger sample populations to evaluate the biomechanical efficacy of this technique further.
CONCLUSION
The PASTA Bridge6 creates a strong construct for repair of articular-sided partial-thickness tears of the supraspinatus. The data suggest the PASTA Bridge6 is biomechanically equivalent to the gold standard transtendon suture anchor repair. The PASTA Bridge6 is technically sound, percutaneous, and presents less risk of complications. It does not require arthroscopic knot tying and carries only minimal risk of damage to residual tissues. In our analysis, there were no failures of the actual construct, asserting that the PASTA Bridge6 is a strong, durable repair. The PASTA Bridge6 should be strongly considered by surgeons treating PASTA lesions.
1. Schaeffeler C, Mueller D, Kirchhoff C, Wolf P, Rummeny EJ, Woertler K. Tears at the rotator cuff footprint: prevalence and imaging characteristics in 305 MR arthrograms of the shoulder. Eur Radiol. 2011;21:1477-1484. doi:10.1007/s00330-011-2066-x.
2. Gonzalez-Lomas G, Kippe MA, Brown GD, et al. In situ transtendon repair outperforms tear completion and repair for partial articular-sided supraspinatus tendon tears. J Shoulder Elbow Surg. 2008;17(5):722-728.
3. Lo IKY, Burkhart SS. Transtendon arthroscopic repair of partial-thickness, articular surface tears of the rotator cuff. Arthroscopy. 2004; 20(2):214-220. doi:10.1016/j.arthro.2003.11.042.
4. Mazzocca AD, Millett PJ, Guanche CA, Santangelo SA, Arciero RA. Arthroscopic single-row versus double-row suture anchor rotator cuff repair. Am J Sports Med. 2005;33(12):1861-1868.
5. Mazzocca AD, Rincon LM, O’Connor RW, et al. Intra-articular partial-thickness rotator cuff tears: analysis of injured and repaired strain behavior. Am J Sports Med. 2008;36(1):110-116. doi:10.1177/0363546507307502.
6. Hirahara AM, Andersen WJ. The PASTA bridge: a technique for the arthroscopic repair of PASTA lesions. Arthrosc Tech. In Press. Epub 2017 Sept 18.
7. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing and ultimate failure strength of biodegradable glenoid anchors. Arthroscopy. 2008; 24(2):224-228. doi:10.1016/j.arthro.2007.08.011.
8. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing of biodegradable suture anchors containing 2 high-strength sutures. Arthroscopy. 2007; 23(4):355-360. doi:10.1016/j.arthro.2006.12.009.
9. Barber FA, Feder SM, Burkhart SS, Ahrens J. The relationship of suture anchor failure and bone density to proximal humerus location: a cadaveric study. Arthroscopy. 1997;13(3):340-345. doi:10.1016/j.jbiomech.2009.12.007.
10. Barber FA, Herbert MA, Richards DP. Sutures and suture anchors: update 2003. Arthroscopy. 2003;19(9):985-990.
11. Burkhart SS, Johnson TC, Wirth MA, Athanasiou KA. Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy. 1997;13(2):172-176. doi:10.1016/S0749-8063(97)90151-1.
12. Hecker AT, Shea M, Hayhurst JO, Myers ER, Meeks LW, Hayes WC. Pull-out strength of suture anchors for rotator cuff and bankart lesion repairs. Am J Sports Med. 1993; 21(6):874-879.
13. Strauss EJ, Salata MJ, Kercher J, et al. The arthroscopic management of partial-thickness rotator cuff tears: a systematic review of the literature. Arthroscopy. 2011;27(4):568-580. doi:10.1016/j.arthro.2010.09.019.
14. Apreleva M, Özbaydar M, Fitzgibbons PG, Warner JJP. Rotator cuff tears: the effect of the reconstruction method on three-dimensional repair-site area. Arthroscopy. 2002;18(5):519-526. doi:10.1053/jars.2002.32930.
ABSTRACT
Partial articular-sided supraspinatus tendon avulsion (PASTA) tears are a common clinical problem that can require surgical intervention to reduce patient symptoms. Currently, no consensus has been reached regarding the optimal repair technique. The PASTA Bridge technique was developed by the senior author to address these types of lesions. A controlled laboratory study was performed comparing the PASTA Bridge with a standard transtendon rotator cuff repair to confirm its biomechanical efficacy. A 50% articular-sided partial tear of the supraspinatus tendon was created on 6 matched pairs of fresh-frozen cadaveric shoulders. For each matched pair, 1 humerus received a PASTA Bridge repair, whereas the contralateral side received a repair using a single suture anchor with a horizontal mattress suture. The ultimate load, yield load, and stiffness were determined from the load-displacement results for each sample. Video tracking software was used to determine the cyclic displacement of each sample at the articular margin and the repair site. Strain at the margin and repair site was then calculated using this collected data. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). No instance of failure was due to the PASTA Bridge construct itself. The results of this study have established that the PASTA Bridge is biomechanically equivalent to the transtendon repair technique. The PASTA Bridge is technically easy, percutaneous, reproducible, and is associated with fewer risks.
Continue to: Rotator cuff tests...
Rotator cuff tears can be classified as full-thickness or partial-thickness; the latter being further divided into the bursal surface, articular-sided, or intratendinous tears. A study analyzing the anatomical distribution of partial tears found that approximately 50% of those at the rotator cuff footprint were articular-sided and predominantly involved the supraspinatus tendon.1 These partial-thickness articular-sided supraspinatus tendon avulsion tears have been coined “PASTA lesions.” Current treatment recommendations suggest that a debridement, a transtendon technique, or a “takedown” method of completing a partial tear and performing a full-thickness repair be utilized for partial-thickness rotator cuff repairs.
The primary goal of a partial cuff repair is to reestablish the tendon footprint at the humeral head. It has been argued that the “takedown” method alters the normal footprint and presents tension complications that can result in poor outcomes.2-5 Also, if the full-thickness repair fails, the patient is left with a full-thickness tear that could be more disabling. The trans-tendon technique has proven to be superior in this sense, demonstrating an improvement in both footprint contact and healing potential.3-5 This article aims to evaluate the biomechanical effectiveness of a new PASTA lesion repair technique, the PASTA Bridge,6 when compared with a traditional transtendon suture anchor repair.
MATERIALS AND METHODS
BIOMECHANICAL OPERATIVE TECHNIQUE: PASTA BRIDGE REPAIR
A 17-gauge spinal needle was used to create a puncture in the supraspinatus tendon approximately 7.5 mm anterior to the centerline of the footprint and just medial to the simulated tear line. A 1.1-mm blunt Nitinol wire (Arthrex) was placed over the top of the spinal needle, and the spinal needle was removed. A 2.4-mm portal dilation instrument (Arthrex) was placed over the top of the 1.1 blunt wire (Arthrex) followed by the drill spear for the 2.4-mm BioComposite SutureTak (Arthrex). A pilot hole was created just medial to the simulated tear using the spear and a 1.8-mm drill followed by insertion of a 2.4-mm BioComposite SutureTak (Arthrex). This process was repeated approximately 5 mm posterior to the centerline of the footprint. A strand of suture from each anchor was tied in a manner similar to the “double pulley” method described by Lo and Burkhart.3 The opposing 2 limbs were tensioned to pull the knot taut over the repair site and fixed laterally with a 4.75-mm BioComposite SwiveLock (Arthrex) placed approximately 1 cm lateral to the greater tuberosity.
BIOMECHANICAL OPERATIVE TECHNIQUE: CONTROL (4.5-MM CORKSCREW FT GROUP)
A No. 11 scalpel was used to create a puncture in the tendon for a transtendon approach. A 4.5-mm titanium Corkscrew FT (Arthrex) was placed just medial to the beginning of the simulated tear. The No. 2 FiberWire (Arthrex) was passed anterior and posterior to the hole made for the transtendon approach. A horizontal mattress stitch was tied using a standard 2-handed knot technique.
BIOMECHANICAL ANALYSIS
The proximal humeri with intact supraspinatus tendons were removed from 6 matched pairs of fresh-frozen cadaver shoulders (3 males, 3 females; average age, 49 ± 12 years). The shaft of the humerus was potted in fiberglass resin. For each sample, a partial tear of the supraspinatus tendon was replicated by using a sharp blade to transect 50% of the medial side of the supraspinatus from the tuberosity.2,5 From each matched pair, 1 humerus was selected to receive a PASTA Bridge repair,6 and the contralateral repair was performed using one 4.5-mm titanium Corkscrew FT. Half of the samples of each repair were performed on the right humerus to avoid a mechanical bias. Each repair was performed by the same orthopedic surgeon.
Continue to: Biomechanical testing was...
Biomechanical testing was conducted using an INSTRON 8871 Axial Table Top Servo-hydraulic Testing System (INSTRON), with a 5 kN load cell attached to the crosshead. The system was calibrated using FastTrack software (AEC Software), and both the load and position controls were run through WaveMaker software (WaveMaker). Each sample was positioned on a fixed angle fixture and secured to the testing surface so that the direction of pull would be performed 45° to the humeral shaft. A custom fixture with inter-digitated brass clamps was attached to the crosshead, and dry ice was used to freeze the tendon to the clamp. The test setup can be seen in Figures 1A, 1B.
Each sample was pre-loaded to 10 N to remove slack from the system. Pre-loading was followed by cyclic loading between 10 N and 100 N,7-11 at 1 Hz, for 100 cycles. One-hundred cycles were chosen based on literature stating that the majority of the cyclic displacement occurs in the first 100 cycles.7-10 Post cycling, the samples were loaded to failure at a rate of 33 mm/sec.7-12 Load and position data were recorded at 500 Hz, and the mode of failure was noted for each sample.
Before loading, a soft-tissue marker was used to create individual marks on the supraspinatus in-line with the articular margin and lateral edge of the tuberosity (Figures 1A, 1B). The individual marks, a digital camera, and MaxTraq video tracking software (Innovision Systems) were used to calculate displacement and strain.
For each sample, the ultimate load, yield load, and stiffness were determined from the load-displacement results. Video tracking software was used to determine the cyclic displacement of each sample at both the articular margin (medial dots) and at the repair site. The strain at these 2 locations was calculated by dividing the cyclic displacement of the respective site by the distance between the site of interest and the lateral edge of the tuberosity (lateral marks) (ΔL/L). Paired t tests (α = 0.05) were used to determine if differences in ultimate load or strain between the 2 repairs were significant.
RESULTS
BIOMECHANICAL ANALYSIS
The results of the biomechanical testing are provided in the Table. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be needed to establish a significant difference for strain at the repair site. The modes of failure were mid-substance tendon tearing, the humeral head breaking, tearing at the musculotendinous junction, or the tendon tearing at the repair site. All 4 modes of failure occurred in at least 1 sample from both repair groups (Figures 2-4). Visual inspection of the samples post-testing revealed no damage to the anchors or sutures. A representative picture of the tendon tearing at the repair site can be seen in Figures 2A, 2B.
Continue to: The purpose of...
DISCUSSION
The purpose of this study was to evaluate the biomechanical strength of a new technique for PASTA repairs—the PASTA Bridge.6 After creation of a partial-thickness tear on a cadaveric model, we compared the PASTA Bridge technique6 with a standard transtendon suture anchor repair. We hypothesized that the PASTA Bridge would yield equivalent or better biomechanical properties including the ultimate load to failure and the degree of strain at different locations in the repair. Our results supported this hypothesis. The PASTA Bridge was biomechanically equivalent to transtendon repair.
For repairs of partial-thickness rotator cuff tears, 2 traditional techniques are transtendon repairs and the “takedown” method of completing a partial tear into a full tear with a subsequent repair.13 While clinical outcomes of the 2 methods suggest no superiority over the other,13 studies have demonstrated a biomechanical advantage with transtendon repairs. Repairs of PASTA lesions exhibit both lower strain and displacement of the repaired tendon compared with a full-thickness repair.2-5 Failure of the “takedown” method results in a full-thickness rotator cuff tear as opposed to a partial tear. This outcome can prove to be more debilitating for the patient. Furthermore, Mazzocca and colleagues5 illustrated that for partial tears >25% thickness, the cuff strain returned to the intact state once repaired.
Our data suggest that biomechanically the transtendon and the PASTA Bridge6 techniques were equivalent. While the ultimate load and strain at repair sites are comparable, the PASTA Bridge is percutaneous and presents significantly less risk of complications. The PASTA Bridge6 uses a medial row horizontal mattress with a lateral row fixation to recreate the rotator cuff footprint. It has been postulated that reestablishing a higher percentage of the footprint can aide in tendon-bone healing, having valuable implications for both biological and clinical outcomes of the patient.3,4,14 Greater contact at the tendon-bone interface may allow more fibers to participate in the healing process.14 In their analysis of rotator cuff repair, Apreleva and colleagues14 asserted that more laterally placed suture anchors may increase the repair-site area. The lateral anchors of the PASTA Bridge help not only to increase the footprint and thereby the healing potential of the repair but also assist in taking pressure off the medial row anchors.
In their report on double-row rotator cuff repair, Lo and Burkhart3 suggest that double-row fixation is superior to single-row repairs for a variety of reasons. Primarily, double-row techniques increase the number of points of fixation, which will secondarily reduce both the stress and load at each suture point.3 This effect improves the overall strength of the repair construct. Use of the lateral anchor of the PASTA Bridge6 allows the medial anchors to act as pivot points. Placing the stress laterally, the configuration allows for movement and strain distribution without sacrificing the integrity of the repair. In our analysis, failure occurred by the tendon tearing mid-substance, humeral head breaking, tendon tearing at the repair site, and tearing at the musculotendinous junction (Figures 2-4). There was no instance of failure due to the construct itself indicating that the 2.4-mm medial anchors are more than adequate for the PASTA Bridge.6 When visually inspecting the samples after failure, there was no damage to the anchors or sutures. This observation indicates that the PASTA Bridge construct is remarkably strong and capable of withstanding excessive forces.
There were some potential limitations of this study. The small sample size modified the potential for identifying significant differences between the groups. A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be required to determine a significant difference between the 2 repair groups in strain at the repair site. We did not test this many pairs because the data was so similar after 6 matched pairs that it did not warrant continuing further. Additional research should be done with larger sample populations to evaluate the biomechanical efficacy of this technique further.
CONCLUSION
The PASTA Bridge6 creates a strong construct for repair of articular-sided partial-thickness tears of the supraspinatus. The data suggest the PASTA Bridge6 is biomechanically equivalent to the gold standard transtendon suture anchor repair. The PASTA Bridge6 is technically sound, percutaneous, and presents less risk of complications. It does not require arthroscopic knot tying and carries only minimal risk of damage to residual tissues. In our analysis, there were no failures of the actual construct, asserting that the PASTA Bridge6 is a strong, durable repair. The PASTA Bridge6 should be strongly considered by surgeons treating PASTA lesions.
ABSTRACT
Partial articular-sided supraspinatus tendon avulsion (PASTA) tears are a common clinical problem that can require surgical intervention to reduce patient symptoms. Currently, no consensus has been reached regarding the optimal repair technique. The PASTA Bridge technique was developed by the senior author to address these types of lesions. A controlled laboratory study was performed comparing the PASTA Bridge with a standard transtendon rotator cuff repair to confirm its biomechanical efficacy. A 50% articular-sided partial tear of the supraspinatus tendon was created on 6 matched pairs of fresh-frozen cadaveric shoulders. For each matched pair, 1 humerus received a PASTA Bridge repair, whereas the contralateral side received a repair using a single suture anchor with a horizontal mattress suture. The ultimate load, yield load, and stiffness were determined from the load-displacement results for each sample. Video tracking software was used to determine the cyclic displacement of each sample at the articular margin and the repair site. Strain at the margin and repair site was then calculated using this collected data. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). No instance of failure was due to the PASTA Bridge construct itself. The results of this study have established that the PASTA Bridge is biomechanically equivalent to the transtendon repair technique. The PASTA Bridge is technically easy, percutaneous, reproducible, and is associated with fewer risks.
Continue to: Rotator cuff tests...
Rotator cuff tears can be classified as full-thickness or partial-thickness; the latter being further divided into the bursal surface, articular-sided, or intratendinous tears. A study analyzing the anatomical distribution of partial tears found that approximately 50% of those at the rotator cuff footprint were articular-sided and predominantly involved the supraspinatus tendon.1 These partial-thickness articular-sided supraspinatus tendon avulsion tears have been coined “PASTA lesions.” Current treatment recommendations suggest that a debridement, a transtendon technique, or a “takedown” method of completing a partial tear and performing a full-thickness repair be utilized for partial-thickness rotator cuff repairs.
The primary goal of a partial cuff repair is to reestablish the tendon footprint at the humeral head. It has been argued that the “takedown” method alters the normal footprint and presents tension complications that can result in poor outcomes.2-5 Also, if the full-thickness repair fails, the patient is left with a full-thickness tear that could be more disabling. The trans-tendon technique has proven to be superior in this sense, demonstrating an improvement in both footprint contact and healing potential.3-5 This article aims to evaluate the biomechanical effectiveness of a new PASTA lesion repair technique, the PASTA Bridge,6 when compared with a traditional transtendon suture anchor repair.
MATERIALS AND METHODS
BIOMECHANICAL OPERATIVE TECHNIQUE: PASTA BRIDGE REPAIR
A 17-gauge spinal needle was used to create a puncture in the supraspinatus tendon approximately 7.5 mm anterior to the centerline of the footprint and just medial to the simulated tear line. A 1.1-mm blunt Nitinol wire (Arthrex) was placed over the top of the spinal needle, and the spinal needle was removed. A 2.4-mm portal dilation instrument (Arthrex) was placed over the top of the 1.1 blunt wire (Arthrex) followed by the drill spear for the 2.4-mm BioComposite SutureTak (Arthrex). A pilot hole was created just medial to the simulated tear using the spear and a 1.8-mm drill followed by insertion of a 2.4-mm BioComposite SutureTak (Arthrex). This process was repeated approximately 5 mm posterior to the centerline of the footprint. A strand of suture from each anchor was tied in a manner similar to the “double pulley” method described by Lo and Burkhart.3 The opposing 2 limbs were tensioned to pull the knot taut over the repair site and fixed laterally with a 4.75-mm BioComposite SwiveLock (Arthrex) placed approximately 1 cm lateral to the greater tuberosity.
BIOMECHANICAL OPERATIVE TECHNIQUE: CONTROL (4.5-MM CORKSCREW FT GROUP)
A No. 11 scalpel was used to create a puncture in the tendon for a transtendon approach. A 4.5-mm titanium Corkscrew FT (Arthrex) was placed just medial to the beginning of the simulated tear. The No. 2 FiberWire (Arthrex) was passed anterior and posterior to the hole made for the transtendon approach. A horizontal mattress stitch was tied using a standard 2-handed knot technique.
BIOMECHANICAL ANALYSIS
The proximal humeri with intact supraspinatus tendons were removed from 6 matched pairs of fresh-frozen cadaver shoulders (3 males, 3 females; average age, 49 ± 12 years). The shaft of the humerus was potted in fiberglass resin. For each sample, a partial tear of the supraspinatus tendon was replicated by using a sharp blade to transect 50% of the medial side of the supraspinatus from the tuberosity.2,5 From each matched pair, 1 humerus was selected to receive a PASTA Bridge repair,6 and the contralateral repair was performed using one 4.5-mm titanium Corkscrew FT. Half of the samples of each repair were performed on the right humerus to avoid a mechanical bias. Each repair was performed by the same orthopedic surgeon.
Continue to: Biomechanical testing was...
Biomechanical testing was conducted using an INSTRON 8871 Axial Table Top Servo-hydraulic Testing System (INSTRON), with a 5 kN load cell attached to the crosshead. The system was calibrated using FastTrack software (AEC Software), and both the load and position controls were run through WaveMaker software (WaveMaker). Each sample was positioned on a fixed angle fixture and secured to the testing surface so that the direction of pull would be performed 45° to the humeral shaft. A custom fixture with inter-digitated brass clamps was attached to the crosshead, and dry ice was used to freeze the tendon to the clamp. The test setup can be seen in Figures 1A, 1B.
Each sample was pre-loaded to 10 N to remove slack from the system. Pre-loading was followed by cyclic loading between 10 N and 100 N,7-11 at 1 Hz, for 100 cycles. One-hundred cycles were chosen based on literature stating that the majority of the cyclic displacement occurs in the first 100 cycles.7-10 Post cycling, the samples were loaded to failure at a rate of 33 mm/sec.7-12 Load and position data were recorded at 500 Hz, and the mode of failure was noted for each sample.
Before loading, a soft-tissue marker was used to create individual marks on the supraspinatus in-line with the articular margin and lateral edge of the tuberosity (Figures 1A, 1B). The individual marks, a digital camera, and MaxTraq video tracking software (Innovision Systems) were used to calculate displacement and strain.
For each sample, the ultimate load, yield load, and stiffness were determined from the load-displacement results. Video tracking software was used to determine the cyclic displacement of each sample at both the articular margin (medial dots) and at the repair site. The strain at these 2 locations was calculated by dividing the cyclic displacement of the respective site by the distance between the site of interest and the lateral edge of the tuberosity (lateral marks) (ΔL/L). Paired t tests (α = 0.05) were used to determine if differences in ultimate load or strain between the 2 repairs were significant.
RESULTS
BIOMECHANICAL ANALYSIS
The results of the biomechanical testing are provided in the Table. There were no significant differences between the 2 repairs in ultimate load (P = .577), strain at the repair site (P = .355), or strain at the margin (P = .801). A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be needed to establish a significant difference for strain at the repair site. The modes of failure were mid-substance tendon tearing, the humeral head breaking, tearing at the musculotendinous junction, or the tendon tearing at the repair site. All 4 modes of failure occurred in at least 1 sample from both repair groups (Figures 2-4). Visual inspection of the samples post-testing revealed no damage to the anchors or sutures. A representative picture of the tendon tearing at the repair site can be seen in Figures 2A, 2B.
Continue to: The purpose of...
DISCUSSION
The purpose of this study was to evaluate the biomechanical strength of a new technique for PASTA repairs—the PASTA Bridge.6 After creation of a partial-thickness tear on a cadaveric model, we compared the PASTA Bridge technique6 with a standard transtendon suture anchor repair. We hypothesized that the PASTA Bridge would yield equivalent or better biomechanical properties including the ultimate load to failure and the degree of strain at different locations in the repair. Our results supported this hypothesis. The PASTA Bridge was biomechanically equivalent to transtendon repair.
For repairs of partial-thickness rotator cuff tears, 2 traditional techniques are transtendon repairs and the “takedown” method of completing a partial tear into a full tear with a subsequent repair.13 While clinical outcomes of the 2 methods suggest no superiority over the other,13 studies have demonstrated a biomechanical advantage with transtendon repairs. Repairs of PASTA lesions exhibit both lower strain and displacement of the repaired tendon compared with a full-thickness repair.2-5 Failure of the “takedown” method results in a full-thickness rotator cuff tear as opposed to a partial tear. This outcome can prove to be more debilitating for the patient. Furthermore, Mazzocca and colleagues5 illustrated that for partial tears >25% thickness, the cuff strain returned to the intact state once repaired.
Our data suggest that biomechanically the transtendon and the PASTA Bridge6 techniques were equivalent. While the ultimate load and strain at repair sites are comparable, the PASTA Bridge is percutaneous and presents significantly less risk of complications. The PASTA Bridge6 uses a medial row horizontal mattress with a lateral row fixation to recreate the rotator cuff footprint. It has been postulated that reestablishing a higher percentage of the footprint can aide in tendon-bone healing, having valuable implications for both biological and clinical outcomes of the patient.3,4,14 Greater contact at the tendon-bone interface may allow more fibers to participate in the healing process.14 In their analysis of rotator cuff repair, Apreleva and colleagues14 asserted that more laterally placed suture anchors may increase the repair-site area. The lateral anchors of the PASTA Bridge help not only to increase the footprint and thereby the healing potential of the repair but also assist in taking pressure off the medial row anchors.
In their report on double-row rotator cuff repair, Lo and Burkhart3 suggest that double-row fixation is superior to single-row repairs for a variety of reasons. Primarily, double-row techniques increase the number of points of fixation, which will secondarily reduce both the stress and load at each suture point.3 This effect improves the overall strength of the repair construct. Use of the lateral anchor of the PASTA Bridge6 allows the medial anchors to act as pivot points. Placing the stress laterally, the configuration allows for movement and strain distribution without sacrificing the integrity of the repair. In our analysis, failure occurred by the tendon tearing mid-substance, humeral head breaking, tendon tearing at the repair site, and tearing at the musculotendinous junction (Figures 2-4). There was no instance of failure due to the construct itself indicating that the 2.4-mm medial anchors are more than adequate for the PASTA Bridge.6 When visually inspecting the samples after failure, there was no damage to the anchors or sutures. This observation indicates that the PASTA Bridge construct is remarkably strong and capable of withstanding excessive forces.
There were some potential limitations of this study. The small sample size modified the potential for identifying significant differences between the groups. A post-hoc power analysis revealed that a sample size of at least 20 matched pairs would be required to determine a significant difference between the 2 repair groups in strain at the repair site. We did not test this many pairs because the data was so similar after 6 matched pairs that it did not warrant continuing further. Additional research should be done with larger sample populations to evaluate the biomechanical efficacy of this technique further.
CONCLUSION
The PASTA Bridge6 creates a strong construct for repair of articular-sided partial-thickness tears of the supraspinatus. The data suggest the PASTA Bridge6 is biomechanically equivalent to the gold standard transtendon suture anchor repair. The PASTA Bridge6 is technically sound, percutaneous, and presents less risk of complications. It does not require arthroscopic knot tying and carries only minimal risk of damage to residual tissues. In our analysis, there were no failures of the actual construct, asserting that the PASTA Bridge6 is a strong, durable repair. The PASTA Bridge6 should be strongly considered by surgeons treating PASTA lesions.
1. Schaeffeler C, Mueller D, Kirchhoff C, Wolf P, Rummeny EJ, Woertler K. Tears at the rotator cuff footprint: prevalence and imaging characteristics in 305 MR arthrograms of the shoulder. Eur Radiol. 2011;21:1477-1484. doi:10.1007/s00330-011-2066-x.
2. Gonzalez-Lomas G, Kippe MA, Brown GD, et al. In situ transtendon repair outperforms tear completion and repair for partial articular-sided supraspinatus tendon tears. J Shoulder Elbow Surg. 2008;17(5):722-728.
3. Lo IKY, Burkhart SS. Transtendon arthroscopic repair of partial-thickness, articular surface tears of the rotator cuff. Arthroscopy. 2004; 20(2):214-220. doi:10.1016/j.arthro.2003.11.042.
4. Mazzocca AD, Millett PJ, Guanche CA, Santangelo SA, Arciero RA. Arthroscopic single-row versus double-row suture anchor rotator cuff repair. Am J Sports Med. 2005;33(12):1861-1868.
5. Mazzocca AD, Rincon LM, O’Connor RW, et al. Intra-articular partial-thickness rotator cuff tears: analysis of injured and repaired strain behavior. Am J Sports Med. 2008;36(1):110-116. doi:10.1177/0363546507307502.
6. Hirahara AM, Andersen WJ. The PASTA bridge: a technique for the arthroscopic repair of PASTA lesions. Arthrosc Tech. In Press. Epub 2017 Sept 18.
7. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing and ultimate failure strength of biodegradable glenoid anchors. Arthroscopy. 2008; 24(2):224-228. doi:10.1016/j.arthro.2007.08.011.
8. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing of biodegradable suture anchors containing 2 high-strength sutures. Arthroscopy. 2007; 23(4):355-360. doi:10.1016/j.arthro.2006.12.009.
9. Barber FA, Feder SM, Burkhart SS, Ahrens J. The relationship of suture anchor failure and bone density to proximal humerus location: a cadaveric study. Arthroscopy. 1997;13(3):340-345. doi:10.1016/j.jbiomech.2009.12.007.
10. Barber FA, Herbert MA, Richards DP. Sutures and suture anchors: update 2003. Arthroscopy. 2003;19(9):985-990.
11. Burkhart SS, Johnson TC, Wirth MA, Athanasiou KA. Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy. 1997;13(2):172-176. doi:10.1016/S0749-8063(97)90151-1.
12. Hecker AT, Shea M, Hayhurst JO, Myers ER, Meeks LW, Hayes WC. Pull-out strength of suture anchors for rotator cuff and bankart lesion repairs. Am J Sports Med. 1993; 21(6):874-879.
13. Strauss EJ, Salata MJ, Kercher J, et al. The arthroscopic management of partial-thickness rotator cuff tears: a systematic review of the literature. Arthroscopy. 2011;27(4):568-580. doi:10.1016/j.arthro.2010.09.019.
14. Apreleva M, Özbaydar M, Fitzgibbons PG, Warner JJP. Rotator cuff tears: the effect of the reconstruction method on three-dimensional repair-site area. Arthroscopy. 2002;18(5):519-526. doi:10.1053/jars.2002.32930.
1. Schaeffeler C, Mueller D, Kirchhoff C, Wolf P, Rummeny EJ, Woertler K. Tears at the rotator cuff footprint: prevalence and imaging characteristics in 305 MR arthrograms of the shoulder. Eur Radiol. 2011;21:1477-1484. doi:10.1007/s00330-011-2066-x.
2. Gonzalez-Lomas G, Kippe MA, Brown GD, et al. In situ transtendon repair outperforms tear completion and repair for partial articular-sided supraspinatus tendon tears. J Shoulder Elbow Surg. 2008;17(5):722-728.
3. Lo IKY, Burkhart SS. Transtendon arthroscopic repair of partial-thickness, articular surface tears of the rotator cuff. Arthroscopy. 2004; 20(2):214-220. doi:10.1016/j.arthro.2003.11.042.
4. Mazzocca AD, Millett PJ, Guanche CA, Santangelo SA, Arciero RA. Arthroscopic single-row versus double-row suture anchor rotator cuff repair. Am J Sports Med. 2005;33(12):1861-1868.
5. Mazzocca AD, Rincon LM, O’Connor RW, et al. Intra-articular partial-thickness rotator cuff tears: analysis of injured and repaired strain behavior. Am J Sports Med. 2008;36(1):110-116. doi:10.1177/0363546507307502.
6. Hirahara AM, Andersen WJ. The PASTA bridge: a technique for the arthroscopic repair of PASTA lesions. Arthrosc Tech. In Press. Epub 2017 Sept 18.
7. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing and ultimate failure strength of biodegradable glenoid anchors. Arthroscopy. 2008; 24(2):224-228. doi:10.1016/j.arthro.2007.08.011.
8. Barber FA, Coons DA, Ruiz-Suarez M. Cyclic load testing of biodegradable suture anchors containing 2 high-strength sutures. Arthroscopy. 2007; 23(4):355-360. doi:10.1016/j.arthro.2006.12.009.
9. Barber FA, Feder SM, Burkhart SS, Ahrens J. The relationship of suture anchor failure and bone density to proximal humerus location: a cadaveric study. Arthroscopy. 1997;13(3):340-345. doi:10.1016/j.jbiomech.2009.12.007.
10. Barber FA, Herbert MA, Richards DP. Sutures and suture anchors: update 2003. Arthroscopy. 2003;19(9):985-990.
11. Burkhart SS, Johnson TC, Wirth MA, Athanasiou KA. Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy. 1997;13(2):172-176. doi:10.1016/S0749-8063(97)90151-1.
12. Hecker AT, Shea M, Hayhurst JO, Myers ER, Meeks LW, Hayes WC. Pull-out strength of suture anchors for rotator cuff and bankart lesion repairs. Am J Sports Med. 1993; 21(6):874-879.
13. Strauss EJ, Salata MJ, Kercher J, et al. The arthroscopic management of partial-thickness rotator cuff tears: a systematic review of the literature. Arthroscopy. 2011;27(4):568-580. doi:10.1016/j.arthro.2010.09.019.
14. Apreleva M, Özbaydar M, Fitzgibbons PG, Warner JJP. Rotator cuff tears: the effect of the reconstruction method on three-dimensional repair-site area. Arthroscopy. 2002;18(5):519-526. doi:10.1053/jars.2002.32930.
TAKE-HOME POINTS
- The PASTA Bridge is biomechanically equivalent to the gold-standard transtendon repair technique.
- The configuration is a double-row repair, increasing the number of fixation points.
- The lateral anchor of the PASTA Bridge assumes the stress of the repair, allowing the medial anchors to act as pivot points.
- The PASTA Bridge is strong and capable of withstanding excessive forces.
- The PASTA Bridge poses less risk of complication.
Patient Preferences in Office-Based Orthopedic Care: A Prospective Evaluation
ABSTRACT
Patient satisfaction has become a topic of interest within orthopedics as the landscape of provider reimbursement continues to evolve to reward value of care. Online internet physician rating sites are becoming increasingly popular ways for patients to subjectively express their provider experience. Understanding what patients value during their episode of care is important in the modern healthcare environment. The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. A prospective survey was electronically administered to 212 patients in an adult reconstruction clinic. One hundred ninety-six patients (92.5%) completed the survey. Demographic questions regarding age, sex, ethnicity, and prior adult reconstruction surgical history were obtained. When patients were asked how much time they would like the doctor to spend with them on a routine visit, the most common answer was 10 to 15 minutes (41.3%), with only 10.2% patients desiring >20 minutes. The majority of patients (83.1%) believe ≥30 minutes is too long to wait to see their surgeon. Less than half of patients (41.8%) stated that they would feel as though they were receiving below average care if seen only by a nurse practitioner or physician’s assistant at a postoperative visit. Patients reported no significant age, gender, or ethnicity preferences for their physician. Recommendations from friends or other physicians was the most common (66.4%) way for patients to find their physicians, while 12.2% utilized online rating sites during their search. Optimizing patient experiences in the office may include keeping wait times to <30 minutes and educating patients on the roles of physician extenders. More work needs to be done to further elucidate variables influencing the subjective patient experience with their orthopedic care.
Continue to: Patient satisfaction...
Patient satisfaction has become an important focus in the rapidly changing healthcare environment due to the significant impact it has on healthcare delivery, healthcare economics, assessment of the quality of care, development of patient-care models, and quality improvement initiatives.1-4 Historically, the quality of care was measured by objective metrics such as complication rates, range-of-motion, and the provider’s expert opinion on the outcome. While those metrics are still impactful variables when defining a successful outcome, the medical community is now increasingly recognizing the importance of patients’ perspectives when defining successful treatments. Patient satisfaction is now highly regarded by clinicians and the government when considering outcomes and is even being incorporated into determining the value of care. Under the Affordable Care Act, patients assumed a more active role in clinical decision-making as well as in creating quality and efficiency initiatives.5,6 By 2017, 2% of the United States government’s Medicare payments will be redistributed among hospitals and physicians based on their quality and efficiency metrics, which are largely determined by patients’ evaluations of care.7 As a result, there has been significant interest in identifying variables influencing patient satisfaction and subjective outcomes.8,9
Patient satisfaction is related to both the outcomes of care and the process of care. As first described by Donabedian,10patients may be satisfied with the successful outcome of their care, but dissatisfied with how they received their care. The process of care is complex and considers many aspects of healthcare delivery, including time, cost, healthcare provider interactions, and burdens faced. While patient satisfaction with outcomes and process of care are heavily related, they should be regarded separately. It is essential that providers understand what variables are important to patients with regards to how they experience healthcare and choose their provider, especially surrounding elective procedures such as hip and knee arthroplasty.11,12
Within orthopedic surgery, patient satisfaction scores are beginning to be incorporated as part of the standard-of-care quality metrics obtained along with patient-reported outcome measures (PROMs) at defined time points postoperatively. Furthermore, PROMs and patient satisfaction data are becoming an increasingly important component of medical decision-making.13-16 Several authors have reported that increased patient satisfaction is correlated with increased compliance, improved treatment outcomes across numerous medical settings, including orthopedics, decreased risk of litigation, and higher patient ratings of the quality of care.17,18 Various factors, including meeting of expectations, staff politeness, the communication skills of the surgeon, and waiting times, have been suggested to influence eventual patient satisfaction within the surgical literature.19-21 However, within orthopedic surgery there is a paucity of investigations evaluating how patients determine preferences and satisfaction with the process of care.
The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. The authors hypothesize that the majority of patients find their physicians through online rating sites or recommendations from family and friends. The authors believe that patients expect to be seen in <30 minutes and will be unsatisfied overall with the amount of time that they spend with their physician.
Continue to: METHODS...
METHODS
The senior author (BRL) and a research team created a 15-question survey to evaluate patient preferences regarding the demographic characteristics (eg, age, gender, ethnicity) of their physician, wait times in a waiting room, time spent with the physician, care received from physician extenders (eg, nurse practitioners, physician assistants), and how they learned of their physician (Appendix). An a priori power analysis was conducted to determine that approximately 200 patients were needed for inclusion.11,22 Following Institutional Review Board approval (ORA 15051104), the survey was administered to 212 patients in a single-surgeon, adult reconstruction clinic. The survey was digitally administered on a touch-screen tablet using an electronic independent third party survey center (SurveyMonkey Inc) devoid of any identifying data. The survey was offered to all patients >21 years of age who were English-speaking and in the common area as patients waiting to be seen, from June 2015 to March 2016. A research assistant approached patients in the waiting room and asked if they would like to participate in a short survey regarding what factors influence the patient-physician relationship from the patient’s perspective.
Appendix 1
- Do you wish to partake in this 3-minute survey?
- Have you had a prior knee or hip replacement?
- What is your age?
- 30-40 years
- 40-50 years
- 50-60 years
- 60-70 years
- 70-80 years
- 80+ years
- What is your gender?
- Which of the following best represents your racial or ethnic heritage?
- African American
- How much time would you like the doctor to spend talking to you on a routine visit?
- 0-5 minutes
- 5-10 minutes
- 10-15 minutes
- 15-20 minutes
- 20-30 minutes
- >30 minutes
- How long is too long to wait to see the doctor?
- 10 minutes
- 20 minutes
- 30 minutes
- 40 minutes
- 50 minutes
- An hour or more
- If you were to only see a physician’s assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care?
- Overall I am satisfied with the time the doctor spends with me.
- If you were to need a major surgery, would you want the physician to tell you what he or she would do if they were in your shoes?
- Would you prefer your doctor to be the same race/ethnicity as you?
- No
- No Preference
- Would you feel more comfortable with a male as opposed to a female orthopedic surgeon?
- Would you feel more comfortable with a female as opposed to a male orthopedic surgeon?
- What age would you like your physician to be?
- 25-35 years old
- 35-45 years old
- 45-55 years old
- 55-65 years old
- 65 years and older
- No preference
- How do you usually find your physician?
- Friends’ recommendations
- Healthcare provider’s recommendations
- Insurance plans
- Online research/ratings
- Other
Descriptive statistics were used to analyze subject demographics and survey responses. Chi-square analyses and multinomial logistic regressions were utilized to compare responses. All statistical analyses were conducted using SPSS version 24.0 software (SPSS Inc). Statistical significance was set at P < 0.05.
RESULTS
Of the 212 patients who were invited to participate, 196 patients (92.4%) agreed and completed the survey. Demographic and surgical history information can be found in Table 1. The majority of patients were female (62%) and above the age of 50 years (92.4%). Almost half (48.5%) of patients had a prior hip or knee replacement.
Table 1. Survey Respondent Demographics
| Number | Percent |
Age Range | ||
30-40 years | 4 | 2.0% |
40-50 years | 11 | 5.6% |
50-60 years | 47 | 24.0% |
60-70 years | 84 | 42.9% |
70-80 years | 41 | 20.9% |
>80 years | 9 | 4.6% |
Gender | ||
Male | 74 | 37.8% |
Female | 122 | 62.2% |
Ethnicity | ||
African American | 39 | 19.9% |
Asian | 3 | 1.5% |
Caucasian | 140 | 71.4% |
Hispanic | 10 | 5.1% |
Other | 4 | 2.0% |
Prior knee or hip replacement | ||
Yes | 95 | 48.5% |
No | 55 | 28.1% |
No Response | 46 | 23.5% |
When asked how long is too long to wait to see the doctor, 30 minutes (39.8%) was most commonly selected, followed by 40 minutes (24.5%) (Figure 1). When asked how much time patients would like the doctor to spend with them during an office visit, the majority (68.9%) selected either 10 to 15 minutes (41.3%) or 15 to 20 minutes (27.6%) (Figure 2). The majority of patients (92.3%) were satisfied with the amount of time the doctor spent with them. In addition, 94.9% of respondents would want their doctor to tell them what they would do if they were in the patient’s shoes when making decisions regarding their medical care (Table 2). Less than half of respondents (41.8%) believe that seeing a physician extender (eg, nurse practitioner or physician assistant) at a postoperative visit would result in a lower quality of care (Table 2).
Table 2. Responses to Survey Questions
If you were to only see a physician's assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care? | ||
Answer choices | Number | Percent |
No | 114 | 58.2% |
Yes | 82 | 41.8% |
If you were to need a major surgery would you want the physician to tell you what he or she would do if they were in your shoes? | ||
Answer choices | Number | Percent |
No | 10 | 5.1% |
Yes | 186 | 94.9% |
Would you prefer your doctor to be the same race/ethnicity as you? | ||
Answer choices | Number | Percent |
No | 29 | 14.8% |
Yes | 3 | 1.5% |
No Preference | 164 | 83.7% |
When asked if patients preferred a doctor of the same race/ethnicity, the vast majority (83.7%) had no preference (Table 2). There was no significant difference found between male and female respondents when asked if they would feel more comfortable with a male as opposed to a female orthopedic surgeon (P = .118) and vice versa (P = .604) (Table 3). Most patients preferred a physician between the ages of 45 and 55 years (39.3%), followed by 35 and 45 years (23.0%); however, this preference was not statistically significant (Table 4). Older patients were more likely to prefer younger physicians (odds ratio, 4.612 for 25-35 years of age; odds ratio, 1.328 for 35-45 years of age). Only 12.2% of patients reported online research/rating sites as the main resource utilized when selecting their physician (Figure 3). The majority (68.4%) reported that recommendations from either friends (35.2%) or healthcare providers (33.2%) were the main avenues through which they found their physicians.
Table 3. Overall Responses to Questions Regarding Male and Female Orthopedic Surgeonsa
Would you feel more comfortable with a male as opposed to a female orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 164 | 83.7% | 106 (86.9%) | 58 (78.4%) | 0.118 |
Yes | 32 | 16.3% | 16 (13.1%) | 16 (21.6%) |
|
Would you feel more comfortable with a female as opposed to a male orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 186 | 94.9% | 115 (94.3%) | 71 (95.9%) | 0.604 |
Yes | 10 | 5.1% | 7 (5.7%) | 3 (4.1%) |
|
aResponses were broken down by gender and compared utilizing a 2 x 2 chi-square analysis to test for significant differences in respondents’ gender preferences for their orthopedic surgeon.
Table 4. Patient Preferences Regarding Physician Age
What age would you like your physician to be? |
| 95% Confidence Interval | ||||
Answer Choices | Number or Responses | Percent | P value | Exp(β) | Lower Bound | Upper Bound |
25-35 years | 1 | 0.5% | 0.217 | 4.612 | 0.407 | 52.283 |
35-45 years | 45 | 23.0% | 0.161 | 1.328 | 0.893 | 1.975 |
45-55 years | 77 | 39.3% | 0.159 | 1.276 | 0.909 | 1.791 |
55-65 years | 9 | 4.6% | 0.483 | 1.302 | 0.624 | 2.717 |
≥65 years | 2 | 1.0% | 0.272 | 0.491 | 0.138 | 1.748 |
No preferencea | 62 | 31.6% | Reference | |||
aNo preference was used as the reference category for the answer choices, while the age bracket “>80 years” was used as the reference for the age of respondent variable.
Continue to: DISCUSSION...
DISCUSSION
The results of this study demonstrate that patients have several expectations and preferences with regards to the care they receive from physicians in the office. Patients prefer to wait <30 minutes before seeing their provider and desire only 10 to 20 minutes with their doctor. Patients do not have specific preferences with regards to the gender or ethnicity of their physician but would prefer a physician in the middle of their career, aged 45 to 55 years. Ultimately, patients do believe that seeing a physician at a postoperative visit is important, as just under half of patients thought that seeing a physician extender alone at a postoperative visit resulted in a lower quality of care.
While these results were obtained in a population specifically seeking the care of an orthopedic adult reconstruction surgeon, the results demonstrate that patients do not necessarily desire an unreasonable amount of time with their doctor. Patients simply want to be seen in a timely fashion and receive the full undivided attention of their doctor for approximately 20 minutes. Similarly, Patterson and colleagues22 found, in their series of 182 patients who presented to an orthopedic surgeon, that there was a significant correlation between time spent with the surgeon and overall patient satisfaction. Interestingly, the authors reported that patient satisfaction was not correlated with education level, sex, marital status, whether the patients were evaluated by a resident physician before seeing the attending surgeon, self-reported mental status, tobacco usage, the type of clinic visit, or the waiting time to see the surgeon (average, about 40 minutes for this cohort).22 Similarly, Teunis and colleagues23 reported an average 32-minute wait time in 81 patients presenting for care at an orthopedic hand clinic and demonstrated that a longer wait time was associated with decreased patient satisfaction. These results corroborate the findings of this study that a short wait time is important to patients when evaluating the process of care. Additionally, patients do not have unreasonable expectations with regards to the amount of time they would like to spend with the physician. A physician who has a clinic for 9 hours a day would thus be able to see 54 patients and still spend at least 10 minutes with each patient. The quality of the physician-patient interaction is likely more important than the actual amount of time spent; however, based on this study, patients do have certain expectations about how much time physicians should spend with them.
There were no significant sex, age, or ethnicity preferences in our specific patient cohort. However, a sizable percentage of respondents, 41.8%, believed that they were receiving inferior care if they only saw a physician extender at a routine follow-up visit. Many orthopedic surgeons rely on the care provided by physician extenders to enable them to see additional patients. Physician extenders are well trained to provide high-quality care, including at routine postoperative visits. The results of this study, that many patients believe physician extenders provide lower-quality care, may be a result of inadequate patient education regarding the extensive training and education physician extenders undergo. Physician extenders are qualified, licensed healthcare professionals who are playing increasingly important roles within orthopedics and medicine as a whole. As the demand for orthopedic surgeons to see more patients increases, so does the role of physician extenders. Future research is warranted into educating the public regarding the importance of these healthcare providers and the adequacy of their training.
While many practices now routinely obtain patient satisfaction scores, another modality through which patients can express their satisfaction and experiences with healthcare providers is through online internet physician rating sites (IPRS). These sites have exploded in number and popularity in recent years and, according to some studies, have a very real effect on provider selection.24 Interestingly, a low percentage of patients in this study utilized IPRS reviews to find their doctors. In a recent prospective survey study of 1000 consecutive patients presenting for care at the Mayo Clinic, Burkle and Keegan24 reported that 27% of patients would choose not to see a physician based on a negative IPRS review. Interestingly, only 1.0% of patients reported finding their doctor through advertising. Numerous authors have recently addressed advertising in orthopedic surgery, specifically direct-to-consumer marking, including the influence of physician self-promotion on patients.25,26 Specifically, Halawi and Barsoum26 discussed how direct-to-consumer marketing is commonly disseminated to the public through television and print advertisements, which are modalities more commonly utilized by older generations. However, many advertising agencies are moving toward internet-based advertising, especially through orthopedic group and individual surgeon websites for self-promoting advertisement, as approximately 75% of Americans use the internet for health-related information.25,27 The fact that many patients in this study did not utilize IPRS reviews or advertising (much of which is electronic) may be a result of the older, less internet-centric demographic that is often seen in an adult reconstruction clinic. Future research is warranted to determine what demographic of patients value IPRS reviews and how those reviews influence physician selection and the patient experience.
There are several limitations to this study. First, the majority of the surveyed population was Caucasian, and our results may not be equally reflective of diverse ethnic backgrounds. Second, the cohort size, while based on previous studies conducted in a similar fashion, may be underpowered to detect significant differences for 1 or more of these questions. In addition, having a question regarding the patient’s medical background or experiences may have provided further insight as to why patients selected the answers that they did. Furthermore, questions regarding the patient’s education level, religious background, and income brackets may have provided further context in which to evaluate their responses. These questions were omitted in an effort to keep the questionnaire at a length that would maximize enrollment and prevent survey fatigue. Future research is warranted to determine what patient-specific, injury/symptom-specific, and treatment-specific variables influence the subjective patient experience.
CONCLUSION
The vast majority of patients desire only 10 to 20 minutes with their doctor and are highly satisfied with the amount of time their surgeon spends with them. Patients reported no significant gender- or ethnicity-based preferences for their doctor. The majority of patients believe that a wait time exceeding 30 minutes is too long. A greater effort needs to be made to educate patients and the public about the significant and effective roles nurse practitioners and physician assistants can play within the healthcare system. While this cohort did not report notable utilization of IPRS reviews, it remains essential to understand what factors influence patients’ subjective experiences with their providers to ensure that patients achieve their desired outcomes, and report as such on these websites as they continue to gain popularity. Diminishing clinic wait times and understanding patient preferences may lead to a greater percentage of “satisfied” patients. While the majority of focus has been and will likely continue to be on improving patients’ satisfaction with their outcomes, more work needs to be done focusing specifically on the process through which outcomes are achieved.
1. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84–A(9):1560-1572.
2. Carr-Hill RA. The measurement of patient satisfaction. J Public Health Med. 1992;14(3):236-249.
3. Ross CK, Steward CA, Sinacore JM. A comparative study of seven measures of patient satisfaction. Med Care. 1995;33(4):392-406. doi:10.1097/00005650-199504000-00006.
4. Strasser S, Aharony L, Greenberger D. The patient satisfaction process: moving toward a comprehensive model. Med Care Rev. 1993;50(2):219-248. doi:10.1177/107755879305000205.
5. Bozic KJ. Orthopaedic healthcare worldwide: shared medical decision making in orthopaedics. Clin Orthop Relat Res. 2013;471(5):1412-1414. doi:10.1007/s11999-013-2838-5.
6. Youm J, Chenok KE, Belkora J, Chiu V, Bozic KJ. The emerging case for shared decision making in orthopaedics. Instr Course Lect. 2013;62:587-594. doi:10.2106/00004623-201210170-00011.
7. Blumenthal D, Abrams M, Nuzum R. The affordable CARE Act at 5 years. N Engl J Med. 2015;373(16):1580. doi:10.1056/NEJMc1510015.
8. Shirley ED, Sanders JO. Patient satisfaction: implications and predictors of success. J Bone Joint Surg Am. 2013;95(10):e69. doi:10.2106/JBJS.L.01048.
9. Morris BJ, Jahangir AA, Sethi MK. Patient satisfaction: an emerging health policy issue. AAOS Now Web site. http://www.aaos.org/AAOSNow/2013/Jun/advocacy/advocacy5/?ssopc=1. Published June 2013. Accessed November 19, 2016.
10. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743-1748. doi:10.1001/jama.260.12.1743.
11. Bozic KJ, Kaufman D, Chan VC, Caminiti S, Lewis C. Factors that influence provider selection for elective total joint arthroplasty. Clin Orthop Relat Res. 2013;471(6):1865-1872. doi:10.1007/s11999-012-2640-9.
12. Davies AR, Ware JE Jr. Involving consumers in quality of care assessment. Health Aff (Millwood). 1988;7(1):33-48.
13. Black N, Burke L, Forrest CB, et al. Patient-reported outcomes: pathways to better health, better services, and better societies. Qual Life Res. 2016;25(5):1103-1112. doi:10.1007/s11136-015-1168-3.
14. Gilbert A, Sebag-Montefiore D, Davidson S, Velikova G. Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecol Oncol. 2015;136(3):429-439. doi:10.1016/j.ygyno.2014.11.071.
15. Van Der Wees PJ, Nijhuis-Van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. Milbank Q. 2014;92(4):754-775. doi:10.1111/1468-0009.12091.
16. Franklin PD, Lewallen D, Bozic K, Hallstrom B, Jiranek W, Ayers DC. Implementation of patient-reported outcome measures in U.S. Total joint replacement registries: rationale, status, and plans. J Bone Joint Surg Am. 2014;96(Suppl 1):104-109. doi:10.2106/JBJS.N.00328.
17. Williams B. Patient satisfaction: a valid concept? Soc Sci Med. 1994;38(4):509-516. doi:10.1016/0277-9536(94)90247-X.
18. Hickson GB, Clayton EW, Entman SS, et al. Obstetricians' prior malpractice experience and patients' satisfaction with care. JAMA. 1994;272(20):1583-1587. doi:10.1001/jama.1994.03520200039032.
19. Larsson BW, Larsson G, Chantereau MW, von Holstein KS. International comparisons of patients' views on quality of care. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(1):62-73. doi:10.1108/09526860510576974.
20. McLafferty RB, Williams RG, Lambert AD, Dunnington GL. Surgeon communication behaviors that lead patients to not recommend the surgeon to family members or friends: analysis and impact. Surgery. 2006;140(4):616-624. doi:https://doi.org/10.1016/j.surg.2006.06.021.
21. Mira JJ, Tomás O, Virtudes-Pérez M, Nebot C, Rodríguez-Marín J. Predictors of patient satisfaction in surgery. Surgery. 2009;145(5):536-541. doi:10.1016/j.surg.2009.01.012.
22. Patterson BM, Eskildsen SM, Clement RC, et al. Patient satisfaction is associated with time with provider but not clinic wait time among orthopedic patients. Orthopedics. 2017;40(1):43-48. doi:10.3928/01477447-20161013-05.
23. Teunis T, Thornton ER, Jayakumar P, Ring D. Time seeing a hand surgeon is not associated With patient satisfaction. Clin Orthop Relat Res. 2015;473(7):2362-2368. doi:10.1007/s11999-014-4090-z.
24. Burkle CM, Keegan MT. Popularity of internet physician rating sites and their apparent influence on patients' choices of physicians. BMC Health Serv Res. 2015;15:416. doi:10.1186/s12913-015-1099-2.
25. Mohney S, Lee DJ, Elfar JC. The effect of orthopedic advertising and self-promotion on a naive population. Am J Orthop. 2016;45(4):E227-E232.
26. Halawi MJ, Barsoum WK. Direct-to-consumer marketing: implications for patient care and orthopedic education. Am J Orthop. 2016;45(6):E335-E336.
27. Mostaghimi A, Crotty BH, Landon BE. The availability and nature of physician information on the internet. J Gen Intern Med. 2010;25(11):1152-1156. doi:10.1007/s11606-010-1425-7.
ABSTRACT
Patient satisfaction has become a topic of interest within orthopedics as the landscape of provider reimbursement continues to evolve to reward value of care. Online internet physician rating sites are becoming increasingly popular ways for patients to subjectively express their provider experience. Understanding what patients value during their episode of care is important in the modern healthcare environment. The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. A prospective survey was electronically administered to 212 patients in an adult reconstruction clinic. One hundred ninety-six patients (92.5%) completed the survey. Demographic questions regarding age, sex, ethnicity, and prior adult reconstruction surgical history were obtained. When patients were asked how much time they would like the doctor to spend with them on a routine visit, the most common answer was 10 to 15 minutes (41.3%), with only 10.2% patients desiring >20 minutes. The majority of patients (83.1%) believe ≥30 minutes is too long to wait to see their surgeon. Less than half of patients (41.8%) stated that they would feel as though they were receiving below average care if seen only by a nurse practitioner or physician’s assistant at a postoperative visit. Patients reported no significant age, gender, or ethnicity preferences for their physician. Recommendations from friends or other physicians was the most common (66.4%) way for patients to find their physicians, while 12.2% utilized online rating sites during their search. Optimizing patient experiences in the office may include keeping wait times to <30 minutes and educating patients on the roles of physician extenders. More work needs to be done to further elucidate variables influencing the subjective patient experience with their orthopedic care.
Continue to: Patient satisfaction...
Patient satisfaction has become an important focus in the rapidly changing healthcare environment due to the significant impact it has on healthcare delivery, healthcare economics, assessment of the quality of care, development of patient-care models, and quality improvement initiatives.1-4 Historically, the quality of care was measured by objective metrics such as complication rates, range-of-motion, and the provider’s expert opinion on the outcome. While those metrics are still impactful variables when defining a successful outcome, the medical community is now increasingly recognizing the importance of patients’ perspectives when defining successful treatments. Patient satisfaction is now highly regarded by clinicians and the government when considering outcomes and is even being incorporated into determining the value of care. Under the Affordable Care Act, patients assumed a more active role in clinical decision-making as well as in creating quality and efficiency initiatives.5,6 By 2017, 2% of the United States government’s Medicare payments will be redistributed among hospitals and physicians based on their quality and efficiency metrics, which are largely determined by patients’ evaluations of care.7 As a result, there has been significant interest in identifying variables influencing patient satisfaction and subjective outcomes.8,9
Patient satisfaction is related to both the outcomes of care and the process of care. As first described by Donabedian,10patients may be satisfied with the successful outcome of their care, but dissatisfied with how they received their care. The process of care is complex and considers many aspects of healthcare delivery, including time, cost, healthcare provider interactions, and burdens faced. While patient satisfaction with outcomes and process of care are heavily related, they should be regarded separately. It is essential that providers understand what variables are important to patients with regards to how they experience healthcare and choose their provider, especially surrounding elective procedures such as hip and knee arthroplasty.11,12
Within orthopedic surgery, patient satisfaction scores are beginning to be incorporated as part of the standard-of-care quality metrics obtained along with patient-reported outcome measures (PROMs) at defined time points postoperatively. Furthermore, PROMs and patient satisfaction data are becoming an increasingly important component of medical decision-making.13-16 Several authors have reported that increased patient satisfaction is correlated with increased compliance, improved treatment outcomes across numerous medical settings, including orthopedics, decreased risk of litigation, and higher patient ratings of the quality of care.17,18 Various factors, including meeting of expectations, staff politeness, the communication skills of the surgeon, and waiting times, have been suggested to influence eventual patient satisfaction within the surgical literature.19-21 However, within orthopedic surgery there is a paucity of investigations evaluating how patients determine preferences and satisfaction with the process of care.
The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. The authors hypothesize that the majority of patients find their physicians through online rating sites or recommendations from family and friends. The authors believe that patients expect to be seen in <30 minutes and will be unsatisfied overall with the amount of time that they spend with their physician.
Continue to: METHODS...
METHODS
The senior author (BRL) and a research team created a 15-question survey to evaluate patient preferences regarding the demographic characteristics (eg, age, gender, ethnicity) of their physician, wait times in a waiting room, time spent with the physician, care received from physician extenders (eg, nurse practitioners, physician assistants), and how they learned of their physician (Appendix). An a priori power analysis was conducted to determine that approximately 200 patients were needed for inclusion.11,22 Following Institutional Review Board approval (ORA 15051104), the survey was administered to 212 patients in a single-surgeon, adult reconstruction clinic. The survey was digitally administered on a touch-screen tablet using an electronic independent third party survey center (SurveyMonkey Inc) devoid of any identifying data. The survey was offered to all patients >21 years of age who were English-speaking and in the common area as patients waiting to be seen, from June 2015 to March 2016. A research assistant approached patients in the waiting room and asked if they would like to participate in a short survey regarding what factors influence the patient-physician relationship from the patient’s perspective.
Appendix 1
- Do you wish to partake in this 3-minute survey?
- Have you had a prior knee or hip replacement?
- What is your age?
- 30-40 years
- 40-50 years
- 50-60 years
- 60-70 years
- 70-80 years
- 80+ years
- What is your gender?
- Which of the following best represents your racial or ethnic heritage?
- African American
- How much time would you like the doctor to spend talking to you on a routine visit?
- 0-5 minutes
- 5-10 minutes
- 10-15 minutes
- 15-20 minutes
- 20-30 minutes
- >30 minutes
- How long is too long to wait to see the doctor?
- 10 minutes
- 20 minutes
- 30 minutes
- 40 minutes
- 50 minutes
- An hour or more
- If you were to only see a physician’s assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care?
- Overall I am satisfied with the time the doctor spends with me.
- If you were to need a major surgery, would you want the physician to tell you what he or she would do if they were in your shoes?
- Would you prefer your doctor to be the same race/ethnicity as you?
- No
- No Preference
- Would you feel more comfortable with a male as opposed to a female orthopedic surgeon?
- Would you feel more comfortable with a female as opposed to a male orthopedic surgeon?
- What age would you like your physician to be?
- 25-35 years old
- 35-45 years old
- 45-55 years old
- 55-65 years old
- 65 years and older
- No preference
- How do you usually find your physician?
- Friends’ recommendations
- Healthcare provider’s recommendations
- Insurance plans
- Online research/ratings
- Other
Descriptive statistics were used to analyze subject demographics and survey responses. Chi-square analyses and multinomial logistic regressions were utilized to compare responses. All statistical analyses were conducted using SPSS version 24.0 software (SPSS Inc). Statistical significance was set at P < 0.05.
RESULTS
Of the 212 patients who were invited to participate, 196 patients (92.4%) agreed and completed the survey. Demographic and surgical history information can be found in Table 1. The majority of patients were female (62%) and above the age of 50 years (92.4%). Almost half (48.5%) of patients had a prior hip or knee replacement.
Table 1. Survey Respondent Demographics
| Number | Percent |
Age Range | ||
30-40 years | 4 | 2.0% |
40-50 years | 11 | 5.6% |
50-60 years | 47 | 24.0% |
60-70 years | 84 | 42.9% |
70-80 years | 41 | 20.9% |
>80 years | 9 | 4.6% |
Gender | ||
Male | 74 | 37.8% |
Female | 122 | 62.2% |
Ethnicity | ||
African American | 39 | 19.9% |
Asian | 3 | 1.5% |
Caucasian | 140 | 71.4% |
Hispanic | 10 | 5.1% |
Other | 4 | 2.0% |
Prior knee or hip replacement | ||
Yes | 95 | 48.5% |
No | 55 | 28.1% |
No Response | 46 | 23.5% |
When asked how long is too long to wait to see the doctor, 30 minutes (39.8%) was most commonly selected, followed by 40 minutes (24.5%) (Figure 1). When asked how much time patients would like the doctor to spend with them during an office visit, the majority (68.9%) selected either 10 to 15 minutes (41.3%) or 15 to 20 minutes (27.6%) (Figure 2). The majority of patients (92.3%) were satisfied with the amount of time the doctor spent with them. In addition, 94.9% of respondents would want their doctor to tell them what they would do if they were in the patient’s shoes when making decisions regarding their medical care (Table 2). Less than half of respondents (41.8%) believe that seeing a physician extender (eg, nurse practitioner or physician assistant) at a postoperative visit would result in a lower quality of care (Table 2).
Table 2. Responses to Survey Questions
If you were to only see a physician's assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care? | ||
Answer choices | Number | Percent |
No | 114 | 58.2% |
Yes | 82 | 41.8% |
If you were to need a major surgery would you want the physician to tell you what he or she would do if they were in your shoes? | ||
Answer choices | Number | Percent |
No | 10 | 5.1% |
Yes | 186 | 94.9% |
Would you prefer your doctor to be the same race/ethnicity as you? | ||
Answer choices | Number | Percent |
No | 29 | 14.8% |
Yes | 3 | 1.5% |
No Preference | 164 | 83.7% |
When asked if patients preferred a doctor of the same race/ethnicity, the vast majority (83.7%) had no preference (Table 2). There was no significant difference found between male and female respondents when asked if they would feel more comfortable with a male as opposed to a female orthopedic surgeon (P = .118) and vice versa (P = .604) (Table 3). Most patients preferred a physician between the ages of 45 and 55 years (39.3%), followed by 35 and 45 years (23.0%); however, this preference was not statistically significant (Table 4). Older patients were more likely to prefer younger physicians (odds ratio, 4.612 for 25-35 years of age; odds ratio, 1.328 for 35-45 years of age). Only 12.2% of patients reported online research/rating sites as the main resource utilized when selecting their physician (Figure 3). The majority (68.4%) reported that recommendations from either friends (35.2%) or healthcare providers (33.2%) were the main avenues through which they found their physicians.
Table 3. Overall Responses to Questions Regarding Male and Female Orthopedic Surgeonsa
Would you feel more comfortable with a male as opposed to a female orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 164 | 83.7% | 106 (86.9%) | 58 (78.4%) | 0.118 |
Yes | 32 | 16.3% | 16 (13.1%) | 16 (21.6%) |
|
Would you feel more comfortable with a female as opposed to a male orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 186 | 94.9% | 115 (94.3%) | 71 (95.9%) | 0.604 |
Yes | 10 | 5.1% | 7 (5.7%) | 3 (4.1%) |
|
aResponses were broken down by gender and compared utilizing a 2 x 2 chi-square analysis to test for significant differences in respondents’ gender preferences for their orthopedic surgeon.
Table 4. Patient Preferences Regarding Physician Age
What age would you like your physician to be? |
| 95% Confidence Interval | ||||
Answer Choices | Number or Responses | Percent | P value | Exp(β) | Lower Bound | Upper Bound |
25-35 years | 1 | 0.5% | 0.217 | 4.612 | 0.407 | 52.283 |
35-45 years | 45 | 23.0% | 0.161 | 1.328 | 0.893 | 1.975 |
45-55 years | 77 | 39.3% | 0.159 | 1.276 | 0.909 | 1.791 |
55-65 years | 9 | 4.6% | 0.483 | 1.302 | 0.624 | 2.717 |
≥65 years | 2 | 1.0% | 0.272 | 0.491 | 0.138 | 1.748 |
No preferencea | 62 | 31.6% | Reference | |||
aNo preference was used as the reference category for the answer choices, while the age bracket “>80 years” was used as the reference for the age of respondent variable.
Continue to: DISCUSSION...
DISCUSSION
The results of this study demonstrate that patients have several expectations and preferences with regards to the care they receive from physicians in the office. Patients prefer to wait <30 minutes before seeing their provider and desire only 10 to 20 minutes with their doctor. Patients do not have specific preferences with regards to the gender or ethnicity of their physician but would prefer a physician in the middle of their career, aged 45 to 55 years. Ultimately, patients do believe that seeing a physician at a postoperative visit is important, as just under half of patients thought that seeing a physician extender alone at a postoperative visit resulted in a lower quality of care.
While these results were obtained in a population specifically seeking the care of an orthopedic adult reconstruction surgeon, the results demonstrate that patients do not necessarily desire an unreasonable amount of time with their doctor. Patients simply want to be seen in a timely fashion and receive the full undivided attention of their doctor for approximately 20 minutes. Similarly, Patterson and colleagues22 found, in their series of 182 patients who presented to an orthopedic surgeon, that there was a significant correlation between time spent with the surgeon and overall patient satisfaction. Interestingly, the authors reported that patient satisfaction was not correlated with education level, sex, marital status, whether the patients were evaluated by a resident physician before seeing the attending surgeon, self-reported mental status, tobacco usage, the type of clinic visit, or the waiting time to see the surgeon (average, about 40 minutes for this cohort).22 Similarly, Teunis and colleagues23 reported an average 32-minute wait time in 81 patients presenting for care at an orthopedic hand clinic and demonstrated that a longer wait time was associated with decreased patient satisfaction. These results corroborate the findings of this study that a short wait time is important to patients when evaluating the process of care. Additionally, patients do not have unreasonable expectations with regards to the amount of time they would like to spend with the physician. A physician who has a clinic for 9 hours a day would thus be able to see 54 patients and still spend at least 10 minutes with each patient. The quality of the physician-patient interaction is likely more important than the actual amount of time spent; however, based on this study, patients do have certain expectations about how much time physicians should spend with them.
There were no significant sex, age, or ethnicity preferences in our specific patient cohort. However, a sizable percentage of respondents, 41.8%, believed that they were receiving inferior care if they only saw a physician extender at a routine follow-up visit. Many orthopedic surgeons rely on the care provided by physician extenders to enable them to see additional patients. Physician extenders are well trained to provide high-quality care, including at routine postoperative visits. The results of this study, that many patients believe physician extenders provide lower-quality care, may be a result of inadequate patient education regarding the extensive training and education physician extenders undergo. Physician extenders are qualified, licensed healthcare professionals who are playing increasingly important roles within orthopedics and medicine as a whole. As the demand for orthopedic surgeons to see more patients increases, so does the role of physician extenders. Future research is warranted into educating the public regarding the importance of these healthcare providers and the adequacy of their training.
While many practices now routinely obtain patient satisfaction scores, another modality through which patients can express their satisfaction and experiences with healthcare providers is through online internet physician rating sites (IPRS). These sites have exploded in number and popularity in recent years and, according to some studies, have a very real effect on provider selection.24 Interestingly, a low percentage of patients in this study utilized IPRS reviews to find their doctors. In a recent prospective survey study of 1000 consecutive patients presenting for care at the Mayo Clinic, Burkle and Keegan24 reported that 27% of patients would choose not to see a physician based on a negative IPRS review. Interestingly, only 1.0% of patients reported finding their doctor through advertising. Numerous authors have recently addressed advertising in orthopedic surgery, specifically direct-to-consumer marking, including the influence of physician self-promotion on patients.25,26 Specifically, Halawi and Barsoum26 discussed how direct-to-consumer marketing is commonly disseminated to the public through television and print advertisements, which are modalities more commonly utilized by older generations. However, many advertising agencies are moving toward internet-based advertising, especially through orthopedic group and individual surgeon websites for self-promoting advertisement, as approximately 75% of Americans use the internet for health-related information.25,27 The fact that many patients in this study did not utilize IPRS reviews or advertising (much of which is electronic) may be a result of the older, less internet-centric demographic that is often seen in an adult reconstruction clinic. Future research is warranted to determine what demographic of patients value IPRS reviews and how those reviews influence physician selection and the patient experience.
There are several limitations to this study. First, the majority of the surveyed population was Caucasian, and our results may not be equally reflective of diverse ethnic backgrounds. Second, the cohort size, while based on previous studies conducted in a similar fashion, may be underpowered to detect significant differences for 1 or more of these questions. In addition, having a question regarding the patient’s medical background or experiences may have provided further insight as to why patients selected the answers that they did. Furthermore, questions regarding the patient’s education level, religious background, and income brackets may have provided further context in which to evaluate their responses. These questions were omitted in an effort to keep the questionnaire at a length that would maximize enrollment and prevent survey fatigue. Future research is warranted to determine what patient-specific, injury/symptom-specific, and treatment-specific variables influence the subjective patient experience.
CONCLUSION
The vast majority of patients desire only 10 to 20 minutes with their doctor and are highly satisfied with the amount of time their surgeon spends with them. Patients reported no significant gender- or ethnicity-based preferences for their doctor. The majority of patients believe that a wait time exceeding 30 minutes is too long. A greater effort needs to be made to educate patients and the public about the significant and effective roles nurse practitioners and physician assistants can play within the healthcare system. While this cohort did not report notable utilization of IPRS reviews, it remains essential to understand what factors influence patients’ subjective experiences with their providers to ensure that patients achieve their desired outcomes, and report as such on these websites as they continue to gain popularity. Diminishing clinic wait times and understanding patient preferences may lead to a greater percentage of “satisfied” patients. While the majority of focus has been and will likely continue to be on improving patients’ satisfaction with their outcomes, more work needs to be done focusing specifically on the process through which outcomes are achieved.
ABSTRACT
Patient satisfaction has become a topic of interest within orthopedics as the landscape of provider reimbursement continues to evolve to reward value of care. Online internet physician rating sites are becoming increasingly popular ways for patients to subjectively express their provider experience. Understanding what patients value during their episode of care is important in the modern healthcare environment. The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. A prospective survey was electronically administered to 212 patients in an adult reconstruction clinic. One hundred ninety-six patients (92.5%) completed the survey. Demographic questions regarding age, sex, ethnicity, and prior adult reconstruction surgical history were obtained. When patients were asked how much time they would like the doctor to spend with them on a routine visit, the most common answer was 10 to 15 minutes (41.3%), with only 10.2% patients desiring >20 minutes. The majority of patients (83.1%) believe ≥30 minutes is too long to wait to see their surgeon. Less than half of patients (41.8%) stated that they would feel as though they were receiving below average care if seen only by a nurse practitioner or physician’s assistant at a postoperative visit. Patients reported no significant age, gender, or ethnicity preferences for their physician. Recommendations from friends or other physicians was the most common (66.4%) way for patients to find their physicians, while 12.2% utilized online rating sites during their search. Optimizing patient experiences in the office may include keeping wait times to <30 minutes and educating patients on the roles of physician extenders. More work needs to be done to further elucidate variables influencing the subjective patient experience with their orthopedic care.
Continue to: Patient satisfaction...
Patient satisfaction has become an important focus in the rapidly changing healthcare environment due to the significant impact it has on healthcare delivery, healthcare economics, assessment of the quality of care, development of patient-care models, and quality improvement initiatives.1-4 Historically, the quality of care was measured by objective metrics such as complication rates, range-of-motion, and the provider’s expert opinion on the outcome. While those metrics are still impactful variables when defining a successful outcome, the medical community is now increasingly recognizing the importance of patients’ perspectives when defining successful treatments. Patient satisfaction is now highly regarded by clinicians and the government when considering outcomes and is even being incorporated into determining the value of care. Under the Affordable Care Act, patients assumed a more active role in clinical decision-making as well as in creating quality and efficiency initiatives.5,6 By 2017, 2% of the United States government’s Medicare payments will be redistributed among hospitals and physicians based on their quality and efficiency metrics, which are largely determined by patients’ evaluations of care.7 As a result, there has been significant interest in identifying variables influencing patient satisfaction and subjective outcomes.8,9
Patient satisfaction is related to both the outcomes of care and the process of care. As first described by Donabedian,10patients may be satisfied with the successful outcome of their care, but dissatisfied with how they received their care. The process of care is complex and considers many aspects of healthcare delivery, including time, cost, healthcare provider interactions, and burdens faced. While patient satisfaction with outcomes and process of care are heavily related, they should be regarded separately. It is essential that providers understand what variables are important to patients with regards to how they experience healthcare and choose their provider, especially surrounding elective procedures such as hip and knee arthroplasty.11,12
Within orthopedic surgery, patient satisfaction scores are beginning to be incorporated as part of the standard-of-care quality metrics obtained along with patient-reported outcome measures (PROMs) at defined time points postoperatively. Furthermore, PROMs and patient satisfaction data are becoming an increasingly important component of medical decision-making.13-16 Several authors have reported that increased patient satisfaction is correlated with increased compliance, improved treatment outcomes across numerous medical settings, including orthopedics, decreased risk of litigation, and higher patient ratings of the quality of care.17,18 Various factors, including meeting of expectations, staff politeness, the communication skills of the surgeon, and waiting times, have been suggested to influence eventual patient satisfaction within the surgical literature.19-21 However, within orthopedic surgery there is a paucity of investigations evaluating how patients determine preferences and satisfaction with the process of care.
The purpose of this study is to determine what preferences, if any, patients have when selecting their physician and how they experience care in an outpatient orthopedic setting. The authors hypothesize that the majority of patients find their physicians through online rating sites or recommendations from family and friends. The authors believe that patients expect to be seen in <30 minutes and will be unsatisfied overall with the amount of time that they spend with their physician.
Continue to: METHODS...
METHODS
The senior author (BRL) and a research team created a 15-question survey to evaluate patient preferences regarding the demographic characteristics (eg, age, gender, ethnicity) of their physician, wait times in a waiting room, time spent with the physician, care received from physician extenders (eg, nurse practitioners, physician assistants), and how they learned of their physician (Appendix). An a priori power analysis was conducted to determine that approximately 200 patients were needed for inclusion.11,22 Following Institutional Review Board approval (ORA 15051104), the survey was administered to 212 patients in a single-surgeon, adult reconstruction clinic. The survey was digitally administered on a touch-screen tablet using an electronic independent third party survey center (SurveyMonkey Inc) devoid of any identifying data. The survey was offered to all patients >21 years of age who were English-speaking and in the common area as patients waiting to be seen, from June 2015 to March 2016. A research assistant approached patients in the waiting room and asked if they would like to participate in a short survey regarding what factors influence the patient-physician relationship from the patient’s perspective.
Appendix 1
- Do you wish to partake in this 3-minute survey?
- Have you had a prior knee or hip replacement?
- What is your age?
- 30-40 years
- 40-50 years
- 50-60 years
- 60-70 years
- 70-80 years
- 80+ years
- What is your gender?
- Which of the following best represents your racial or ethnic heritage?
- African American
- How much time would you like the doctor to spend talking to you on a routine visit?
- 0-5 minutes
- 5-10 minutes
- 10-15 minutes
- 15-20 minutes
- 20-30 minutes
- >30 minutes
- How long is too long to wait to see the doctor?
- 10 minutes
- 20 minutes
- 30 minutes
- 40 minutes
- 50 minutes
- An hour or more
- If you were to only see a physician’s assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care?
- Overall I am satisfied with the time the doctor spends with me.
- If you were to need a major surgery, would you want the physician to tell you what he or she would do if they were in your shoes?
- Would you prefer your doctor to be the same race/ethnicity as you?
- No
- No Preference
- Would you feel more comfortable with a male as opposed to a female orthopedic surgeon?
- Would you feel more comfortable with a female as opposed to a male orthopedic surgeon?
- What age would you like your physician to be?
- 25-35 years old
- 35-45 years old
- 45-55 years old
- 55-65 years old
- 65 years and older
- No preference
- How do you usually find your physician?
- Friends’ recommendations
- Healthcare provider’s recommendations
- Insurance plans
- Online research/ratings
- Other
Descriptive statistics were used to analyze subject demographics and survey responses. Chi-square analyses and multinomial logistic regressions were utilized to compare responses. All statistical analyses were conducted using SPSS version 24.0 software (SPSS Inc). Statistical significance was set at P < 0.05.
RESULTS
Of the 212 patients who were invited to participate, 196 patients (92.4%) agreed and completed the survey. Demographic and surgical history information can be found in Table 1. The majority of patients were female (62%) and above the age of 50 years (92.4%). Almost half (48.5%) of patients had a prior hip or knee replacement.
Table 1. Survey Respondent Demographics
| Number | Percent |
Age Range | ||
30-40 years | 4 | 2.0% |
40-50 years | 11 | 5.6% |
50-60 years | 47 | 24.0% |
60-70 years | 84 | 42.9% |
70-80 years | 41 | 20.9% |
>80 years | 9 | 4.6% |
Gender | ||
Male | 74 | 37.8% |
Female | 122 | 62.2% |
Ethnicity | ||
African American | 39 | 19.9% |
Asian | 3 | 1.5% |
Caucasian | 140 | 71.4% |
Hispanic | 10 | 5.1% |
Other | 4 | 2.0% |
Prior knee or hip replacement | ||
Yes | 95 | 48.5% |
No | 55 | 28.1% |
No Response | 46 | 23.5% |
When asked how long is too long to wait to see the doctor, 30 minutes (39.8%) was most commonly selected, followed by 40 minutes (24.5%) (Figure 1). When asked how much time patients would like the doctor to spend with them during an office visit, the majority (68.9%) selected either 10 to 15 minutes (41.3%) or 15 to 20 minutes (27.6%) (Figure 2). The majority of patients (92.3%) were satisfied with the amount of time the doctor spent with them. In addition, 94.9% of respondents would want their doctor to tell them what they would do if they were in the patient’s shoes when making decisions regarding their medical care (Table 2). Less than half of respondents (41.8%) believe that seeing a physician extender (eg, nurse practitioner or physician assistant) at a postoperative visit would result in a lower quality of care (Table 2).
Table 2. Responses to Survey Questions
If you were to only see a physician's assistant or nurse practitioner at your follow-up visit and not the doctor, would you feel like you were getting below average care? | ||
Answer choices | Number | Percent |
No | 114 | 58.2% |
Yes | 82 | 41.8% |
If you were to need a major surgery would you want the physician to tell you what he or she would do if they were in your shoes? | ||
Answer choices | Number | Percent |
No | 10 | 5.1% |
Yes | 186 | 94.9% |
Would you prefer your doctor to be the same race/ethnicity as you? | ||
Answer choices | Number | Percent |
No | 29 | 14.8% |
Yes | 3 | 1.5% |
No Preference | 164 | 83.7% |
When asked if patients preferred a doctor of the same race/ethnicity, the vast majority (83.7%) had no preference (Table 2). There was no significant difference found between male and female respondents when asked if they would feel more comfortable with a male as opposed to a female orthopedic surgeon (P = .118) and vice versa (P = .604) (Table 3). Most patients preferred a physician between the ages of 45 and 55 years (39.3%), followed by 35 and 45 years (23.0%); however, this preference was not statistically significant (Table 4). Older patients were more likely to prefer younger physicians (odds ratio, 4.612 for 25-35 years of age; odds ratio, 1.328 for 35-45 years of age). Only 12.2% of patients reported online research/rating sites as the main resource utilized when selecting their physician (Figure 3). The majority (68.4%) reported that recommendations from either friends (35.2%) or healthcare providers (33.2%) were the main avenues through which they found their physicians.
Table 3. Overall Responses to Questions Regarding Male and Female Orthopedic Surgeonsa
Would you feel more comfortable with a male as opposed to a female orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 164 | 83.7% | 106 (86.9%) | 58 (78.4%) | 0.118 |
Yes | 32 | 16.3% | 16 (13.1%) | 16 (21.6%) |
|
Would you feel more comfortable with a female as opposed to a male orthopedic surgeon? | |||||
Answer choices | Number | Percent | Female responses | Male responses | P value |
No | 186 | 94.9% | 115 (94.3%) | 71 (95.9%) | 0.604 |
Yes | 10 | 5.1% | 7 (5.7%) | 3 (4.1%) |
|
aResponses were broken down by gender and compared utilizing a 2 x 2 chi-square analysis to test for significant differences in respondents’ gender preferences for their orthopedic surgeon.
Table 4. Patient Preferences Regarding Physician Age
What age would you like your physician to be? |
| 95% Confidence Interval | ||||
Answer Choices | Number or Responses | Percent | P value | Exp(β) | Lower Bound | Upper Bound |
25-35 years | 1 | 0.5% | 0.217 | 4.612 | 0.407 | 52.283 |
35-45 years | 45 | 23.0% | 0.161 | 1.328 | 0.893 | 1.975 |
45-55 years | 77 | 39.3% | 0.159 | 1.276 | 0.909 | 1.791 |
55-65 years | 9 | 4.6% | 0.483 | 1.302 | 0.624 | 2.717 |
≥65 years | 2 | 1.0% | 0.272 | 0.491 | 0.138 | 1.748 |
No preferencea | 62 | 31.6% | Reference | |||
aNo preference was used as the reference category for the answer choices, while the age bracket “>80 years” was used as the reference for the age of respondent variable.
Continue to: DISCUSSION...
DISCUSSION
The results of this study demonstrate that patients have several expectations and preferences with regards to the care they receive from physicians in the office. Patients prefer to wait <30 minutes before seeing their provider and desire only 10 to 20 minutes with their doctor. Patients do not have specific preferences with regards to the gender or ethnicity of their physician but would prefer a physician in the middle of their career, aged 45 to 55 years. Ultimately, patients do believe that seeing a physician at a postoperative visit is important, as just under half of patients thought that seeing a physician extender alone at a postoperative visit resulted in a lower quality of care.
While these results were obtained in a population specifically seeking the care of an orthopedic adult reconstruction surgeon, the results demonstrate that patients do not necessarily desire an unreasonable amount of time with their doctor. Patients simply want to be seen in a timely fashion and receive the full undivided attention of their doctor for approximately 20 minutes. Similarly, Patterson and colleagues22 found, in their series of 182 patients who presented to an orthopedic surgeon, that there was a significant correlation between time spent with the surgeon and overall patient satisfaction. Interestingly, the authors reported that patient satisfaction was not correlated with education level, sex, marital status, whether the patients were evaluated by a resident physician before seeing the attending surgeon, self-reported mental status, tobacco usage, the type of clinic visit, or the waiting time to see the surgeon (average, about 40 minutes for this cohort).22 Similarly, Teunis and colleagues23 reported an average 32-minute wait time in 81 patients presenting for care at an orthopedic hand clinic and demonstrated that a longer wait time was associated with decreased patient satisfaction. These results corroborate the findings of this study that a short wait time is important to patients when evaluating the process of care. Additionally, patients do not have unreasonable expectations with regards to the amount of time they would like to spend with the physician. A physician who has a clinic for 9 hours a day would thus be able to see 54 patients and still spend at least 10 minutes with each patient. The quality of the physician-patient interaction is likely more important than the actual amount of time spent; however, based on this study, patients do have certain expectations about how much time physicians should spend with them.
There were no significant sex, age, or ethnicity preferences in our specific patient cohort. However, a sizable percentage of respondents, 41.8%, believed that they were receiving inferior care if they only saw a physician extender at a routine follow-up visit. Many orthopedic surgeons rely on the care provided by physician extenders to enable them to see additional patients. Physician extenders are well trained to provide high-quality care, including at routine postoperative visits. The results of this study, that many patients believe physician extenders provide lower-quality care, may be a result of inadequate patient education regarding the extensive training and education physician extenders undergo. Physician extenders are qualified, licensed healthcare professionals who are playing increasingly important roles within orthopedics and medicine as a whole. As the demand for orthopedic surgeons to see more patients increases, so does the role of physician extenders. Future research is warranted into educating the public regarding the importance of these healthcare providers and the adequacy of their training.
While many practices now routinely obtain patient satisfaction scores, another modality through which patients can express their satisfaction and experiences with healthcare providers is through online internet physician rating sites (IPRS). These sites have exploded in number and popularity in recent years and, according to some studies, have a very real effect on provider selection.24 Interestingly, a low percentage of patients in this study utilized IPRS reviews to find their doctors. In a recent prospective survey study of 1000 consecutive patients presenting for care at the Mayo Clinic, Burkle and Keegan24 reported that 27% of patients would choose not to see a physician based on a negative IPRS review. Interestingly, only 1.0% of patients reported finding their doctor through advertising. Numerous authors have recently addressed advertising in orthopedic surgery, specifically direct-to-consumer marking, including the influence of physician self-promotion on patients.25,26 Specifically, Halawi and Barsoum26 discussed how direct-to-consumer marketing is commonly disseminated to the public through television and print advertisements, which are modalities more commonly utilized by older generations. However, many advertising agencies are moving toward internet-based advertising, especially through orthopedic group and individual surgeon websites for self-promoting advertisement, as approximately 75% of Americans use the internet for health-related information.25,27 The fact that many patients in this study did not utilize IPRS reviews or advertising (much of which is electronic) may be a result of the older, less internet-centric demographic that is often seen in an adult reconstruction clinic. Future research is warranted to determine what demographic of patients value IPRS reviews and how those reviews influence physician selection and the patient experience.
There are several limitations to this study. First, the majority of the surveyed population was Caucasian, and our results may not be equally reflective of diverse ethnic backgrounds. Second, the cohort size, while based on previous studies conducted in a similar fashion, may be underpowered to detect significant differences for 1 or more of these questions. In addition, having a question regarding the patient’s medical background or experiences may have provided further insight as to why patients selected the answers that they did. Furthermore, questions regarding the patient’s education level, religious background, and income brackets may have provided further context in which to evaluate their responses. These questions were omitted in an effort to keep the questionnaire at a length that would maximize enrollment and prevent survey fatigue. Future research is warranted to determine what patient-specific, injury/symptom-specific, and treatment-specific variables influence the subjective patient experience.
CONCLUSION
The vast majority of patients desire only 10 to 20 minutes with their doctor and are highly satisfied with the amount of time their surgeon spends with them. Patients reported no significant gender- or ethnicity-based preferences for their doctor. The majority of patients believe that a wait time exceeding 30 minutes is too long. A greater effort needs to be made to educate patients and the public about the significant and effective roles nurse practitioners and physician assistants can play within the healthcare system. While this cohort did not report notable utilization of IPRS reviews, it remains essential to understand what factors influence patients’ subjective experiences with their providers to ensure that patients achieve their desired outcomes, and report as such on these websites as they continue to gain popularity. Diminishing clinic wait times and understanding patient preferences may lead to a greater percentage of “satisfied” patients. While the majority of focus has been and will likely continue to be on improving patients’ satisfaction with their outcomes, more work needs to be done focusing specifically on the process through which outcomes are achieved.
1. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84–A(9):1560-1572.
2. Carr-Hill RA. The measurement of patient satisfaction. J Public Health Med. 1992;14(3):236-249.
3. Ross CK, Steward CA, Sinacore JM. A comparative study of seven measures of patient satisfaction. Med Care. 1995;33(4):392-406. doi:10.1097/00005650-199504000-00006.
4. Strasser S, Aharony L, Greenberger D. The patient satisfaction process: moving toward a comprehensive model. Med Care Rev. 1993;50(2):219-248. doi:10.1177/107755879305000205.
5. Bozic KJ. Orthopaedic healthcare worldwide: shared medical decision making in orthopaedics. Clin Orthop Relat Res. 2013;471(5):1412-1414. doi:10.1007/s11999-013-2838-5.
6. Youm J, Chenok KE, Belkora J, Chiu V, Bozic KJ. The emerging case for shared decision making in orthopaedics. Instr Course Lect. 2013;62:587-594. doi:10.2106/00004623-201210170-00011.
7. Blumenthal D, Abrams M, Nuzum R. The affordable CARE Act at 5 years. N Engl J Med. 2015;373(16):1580. doi:10.1056/NEJMc1510015.
8. Shirley ED, Sanders JO. Patient satisfaction: implications and predictors of success. J Bone Joint Surg Am. 2013;95(10):e69. doi:10.2106/JBJS.L.01048.
9. Morris BJ, Jahangir AA, Sethi MK. Patient satisfaction: an emerging health policy issue. AAOS Now Web site. http://www.aaos.org/AAOSNow/2013/Jun/advocacy/advocacy5/?ssopc=1. Published June 2013. Accessed November 19, 2016.
10. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743-1748. doi:10.1001/jama.260.12.1743.
11. Bozic KJ, Kaufman D, Chan VC, Caminiti S, Lewis C. Factors that influence provider selection for elective total joint arthroplasty. Clin Orthop Relat Res. 2013;471(6):1865-1872. doi:10.1007/s11999-012-2640-9.
12. Davies AR, Ware JE Jr. Involving consumers in quality of care assessment. Health Aff (Millwood). 1988;7(1):33-48.
13. Black N, Burke L, Forrest CB, et al. Patient-reported outcomes: pathways to better health, better services, and better societies. Qual Life Res. 2016;25(5):1103-1112. doi:10.1007/s11136-015-1168-3.
14. Gilbert A, Sebag-Montefiore D, Davidson S, Velikova G. Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecol Oncol. 2015;136(3):429-439. doi:10.1016/j.ygyno.2014.11.071.
15. Van Der Wees PJ, Nijhuis-Van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. Milbank Q. 2014;92(4):754-775. doi:10.1111/1468-0009.12091.
16. Franklin PD, Lewallen D, Bozic K, Hallstrom B, Jiranek W, Ayers DC. Implementation of patient-reported outcome measures in U.S. Total joint replacement registries: rationale, status, and plans. J Bone Joint Surg Am. 2014;96(Suppl 1):104-109. doi:10.2106/JBJS.N.00328.
17. Williams B. Patient satisfaction: a valid concept? Soc Sci Med. 1994;38(4):509-516. doi:10.1016/0277-9536(94)90247-X.
18. Hickson GB, Clayton EW, Entman SS, et al. Obstetricians' prior malpractice experience and patients' satisfaction with care. JAMA. 1994;272(20):1583-1587. doi:10.1001/jama.1994.03520200039032.
19. Larsson BW, Larsson G, Chantereau MW, von Holstein KS. International comparisons of patients' views on quality of care. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(1):62-73. doi:10.1108/09526860510576974.
20. McLafferty RB, Williams RG, Lambert AD, Dunnington GL. Surgeon communication behaviors that lead patients to not recommend the surgeon to family members or friends: analysis and impact. Surgery. 2006;140(4):616-624. doi:https://doi.org/10.1016/j.surg.2006.06.021.
21. Mira JJ, Tomás O, Virtudes-Pérez M, Nebot C, Rodríguez-Marín J. Predictors of patient satisfaction in surgery. Surgery. 2009;145(5):536-541. doi:10.1016/j.surg.2009.01.012.
22. Patterson BM, Eskildsen SM, Clement RC, et al. Patient satisfaction is associated with time with provider but not clinic wait time among orthopedic patients. Orthopedics. 2017;40(1):43-48. doi:10.3928/01477447-20161013-05.
23. Teunis T, Thornton ER, Jayakumar P, Ring D. Time seeing a hand surgeon is not associated With patient satisfaction. Clin Orthop Relat Res. 2015;473(7):2362-2368. doi:10.1007/s11999-014-4090-z.
24. Burkle CM, Keegan MT. Popularity of internet physician rating sites and their apparent influence on patients' choices of physicians. BMC Health Serv Res. 2015;15:416. doi:10.1186/s12913-015-1099-2.
25. Mohney S, Lee DJ, Elfar JC. The effect of orthopedic advertising and self-promotion on a naive population. Am J Orthop. 2016;45(4):E227-E232.
26. Halawi MJ, Barsoum WK. Direct-to-consumer marketing: implications for patient care and orthopedic education. Am J Orthop. 2016;45(6):E335-E336.
27. Mostaghimi A, Crotty BH, Landon BE. The availability and nature of physician information on the internet. J Gen Intern Med. 2010;25(11):1152-1156. doi:10.1007/s11606-010-1425-7.
1. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84–A(9):1560-1572.
2. Carr-Hill RA. The measurement of patient satisfaction. J Public Health Med. 1992;14(3):236-249.
3. Ross CK, Steward CA, Sinacore JM. A comparative study of seven measures of patient satisfaction. Med Care. 1995;33(4):392-406. doi:10.1097/00005650-199504000-00006.
4. Strasser S, Aharony L, Greenberger D. The patient satisfaction process: moving toward a comprehensive model. Med Care Rev. 1993;50(2):219-248. doi:10.1177/107755879305000205.
5. Bozic KJ. Orthopaedic healthcare worldwide: shared medical decision making in orthopaedics. Clin Orthop Relat Res. 2013;471(5):1412-1414. doi:10.1007/s11999-013-2838-5.
6. Youm J, Chenok KE, Belkora J, Chiu V, Bozic KJ. The emerging case for shared decision making in orthopaedics. Instr Course Lect. 2013;62:587-594. doi:10.2106/00004623-201210170-00011.
7. Blumenthal D, Abrams M, Nuzum R. The affordable CARE Act at 5 years. N Engl J Med. 2015;373(16):1580. doi:10.1056/NEJMc1510015.
8. Shirley ED, Sanders JO. Patient satisfaction: implications and predictors of success. J Bone Joint Surg Am. 2013;95(10):e69. doi:10.2106/JBJS.L.01048.
9. Morris BJ, Jahangir AA, Sethi MK. Patient satisfaction: an emerging health policy issue. AAOS Now Web site. http://www.aaos.org/AAOSNow/2013/Jun/advocacy/advocacy5/?ssopc=1. Published June 2013. Accessed November 19, 2016.
10. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260(12):1743-1748. doi:10.1001/jama.260.12.1743.
11. Bozic KJ, Kaufman D, Chan VC, Caminiti S, Lewis C. Factors that influence provider selection for elective total joint arthroplasty. Clin Orthop Relat Res. 2013;471(6):1865-1872. doi:10.1007/s11999-012-2640-9.
12. Davies AR, Ware JE Jr. Involving consumers in quality of care assessment. Health Aff (Millwood). 1988;7(1):33-48.
13. Black N, Burke L, Forrest CB, et al. Patient-reported outcomes: pathways to better health, better services, and better societies. Qual Life Res. 2016;25(5):1103-1112. doi:10.1007/s11136-015-1168-3.
14. Gilbert A, Sebag-Montefiore D, Davidson S, Velikova G. Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecol Oncol. 2015;136(3):429-439. doi:10.1016/j.ygyno.2014.11.071.
15. Van Der Wees PJ, Nijhuis-Van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. Milbank Q. 2014;92(4):754-775. doi:10.1111/1468-0009.12091.
16. Franklin PD, Lewallen D, Bozic K, Hallstrom B, Jiranek W, Ayers DC. Implementation of patient-reported outcome measures in U.S. Total joint replacement registries: rationale, status, and plans. J Bone Joint Surg Am. 2014;96(Suppl 1):104-109. doi:10.2106/JBJS.N.00328.
17. Williams B. Patient satisfaction: a valid concept? Soc Sci Med. 1994;38(4):509-516. doi:10.1016/0277-9536(94)90247-X.
18. Hickson GB, Clayton EW, Entman SS, et al. Obstetricians' prior malpractice experience and patients' satisfaction with care. JAMA. 1994;272(20):1583-1587. doi:10.1001/jama.1994.03520200039032.
19. Larsson BW, Larsson G, Chantereau MW, von Holstein KS. International comparisons of patients' views on quality of care. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(1):62-73. doi:10.1108/09526860510576974.
20. McLafferty RB, Williams RG, Lambert AD, Dunnington GL. Surgeon communication behaviors that lead patients to not recommend the surgeon to family members or friends: analysis and impact. Surgery. 2006;140(4):616-624. doi:https://doi.org/10.1016/j.surg.2006.06.021.
21. Mira JJ, Tomás O, Virtudes-Pérez M, Nebot C, Rodríguez-Marín J. Predictors of patient satisfaction in surgery. Surgery. 2009;145(5):536-541. doi:10.1016/j.surg.2009.01.012.
22. Patterson BM, Eskildsen SM, Clement RC, et al. Patient satisfaction is associated with time with provider but not clinic wait time among orthopedic patients. Orthopedics. 2017;40(1):43-48. doi:10.3928/01477447-20161013-05.
23. Teunis T, Thornton ER, Jayakumar P, Ring D. Time seeing a hand surgeon is not associated With patient satisfaction. Clin Orthop Relat Res. 2015;473(7):2362-2368. doi:10.1007/s11999-014-4090-z.
24. Burkle CM, Keegan MT. Popularity of internet physician rating sites and their apparent influence on patients' choices of physicians. BMC Health Serv Res. 2015;15:416. doi:10.1186/s12913-015-1099-2.
25. Mohney S, Lee DJ, Elfar JC. The effect of orthopedic advertising and self-promotion on a naive population. Am J Orthop. 2016;45(4):E227-E232.
26. Halawi MJ, Barsoum WK. Direct-to-consumer marketing: implications for patient care and orthopedic education. Am J Orthop. 2016;45(6):E335-E336.
27. Mostaghimi A, Crotty BH, Landon BE. The availability and nature of physician information on the internet. J Gen Intern Med. 2010;25(11):1152-1156. doi:10.1007/s11606-010-1425-7.
TAKE-HOME POINTS
- The vast majority of patients desire only 10 to 20 minutes with their doctor and are highly satisfied with the amount of time their surgeon spends with them.
- Patients reported no significant gender- or ethnicity-based preferences for their doctor.
- The majority of patients believe that a wait time exceeding 30 minutes is too long.
- Nearly 42% of respondents felt they would be receiving below average medical care if seen only by a nurse practitioner or physician’s assistant at a postoperative appointment.
- Recommendations from friends is the most common way patients find their physicians.
Hip and Core Muscle Injuries in Soccer
ABSTRACT
Soccer is the most popular sport in the world and has the fourth highest number of sports injuries. Hip and groin injuries account for 14% of soccer injuries and can be difficult to recognize and treat as they often require a high level of suspicion and advanced imaging. Groin pain can be separated into 3 categories: (1) defined clinical entities for groin pain (adductor-related, iliopsoas-related, inguinal-related [sports hernias/athletic pubalgia], and pubic-related groin pain), (2) hip-related groin pain (hip morphologic abnormalities, labral tears, and chondral injuries), and (3) other causes of groin pain. Conservative approaches are typically the first line of treatment, but operative intervention has been reported to result in higher rates of return to sport in athletes with hip-related and inguinal-related groin pain injuries. In patients with concurrent hip-related and inguinal-related groin pain, the failure to recognize the relationship and treat both conditions may result in lower rates of return to sport. Preseason screening programs can identify high-risk athletes, who may benefit from a targeted prevention program. Further study on exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
Continue to: Each year, the global audience for soccer grows...
Each year, the global audience for soccer grows. Soccer has long surpassed all other sports as the most popular sport in the world, reaching 3.2 billion viewers during the 2014 World Cup.1 In the latest Fédération Internationale de Football Association (FIFA) Big Count survey, the organization estimated that 265 million people are actively involved in soccer, accounting for approximately 4% of the world’s population.2 Moreover, the number of people playing soccer increased by 9.5% within 6 years after the previous Big Count Survey.2 In the United States, soccer accounts for the fourth most common cause of sports injuries next to basketball, exercise, and football with approximately 228,000 injuries per year.3 The total cost of treatment related to worldwide soccer injuries tops $30 billion.4 The most common body parts injured are the thigh (25%), knee (18%), and hip and/or groin (14%).5
Hip and groin injuries in soccer players can be separated into 3 main categories based on the Doha Agreement:6 (1) defined clinical entities for groin pain, (2) hip-related groin pain, and (3) other causes of groin pain in athletes. Defined clinical entities include adductor-related, iliopsoas-related, inguinal-related (sports hernia/athletic pubalgia), and pubic-related groin pain; while hip-related groin pain includes hip morphologic abnormalities, labral tears, and chondral injuries. Included in other causes of groin pain are injuries not clinically defined. The Doha Agreement has acknowledged that not all causes of groin pain fit into the classification system including injuries of the rectus femoris, but they will be included under defined clinical entities for groin pain in this review. While they are not a cause of groin pain, proximal hamstring and gluteal and piriformis injuries are important causes of posterior and lateral hip pain in soccer players and will also be covered in the first section of this review.
DEFINED CLINICAL ENTITIES FOR GROIN PAIN IN SOCCER ATHLETES
ADDUCTOR-RELATED GROIN PAIN
Acute groin pain in soccer players is most commonly caused by muscle strain.7 Of the muscle strains, 66% involve the adductor longus, 25% the iliopsoas, and 23% the rectus femoris.7 The Doha Agreement defines adductor-related groin pain as adductor tenderness and pain on resisted adduction.6 Adductor longus strains in soccer players are typically noncontact injuries (62.5%) and most commonly the result of kicking (40%).7-9 Many athletes will remember a pop at the time of the original injury.9 The combination of history and physical examination is usually sufficient for diagnosis; however, magnetic resonance imaging (MRI) may be helpful in complicated situations with a reported 86% sensitivity and 89% specificity.10 The average playing time lost is 2 weeks.5 Management includes rest, anti-inflammatory medication, physical therapy with core strengthening, and avoidance of aggressive stretching. While partial and distal avulsions can heal with conservative measures, proximal osseous and retracted avulsions of the adductor longus can be treated surgically.11
Continue to: ILIOPSOAS-RELATED GROIN PAIN...
ILIOPSOAS-RELATED GROIN PAIN
Iliopsoas strains account for 25% of acute groin strains and typically result from an impact that causes eccentric overload while kicking the ball.7,12 Iliopsoas-related groin pain is defined by the Doha Agreement as groin pain that is reproducible with resisted hip flexion or hip flexor stretch.6 Iliopsoas strains respond well to conservative treatment such as rest, anti-inflammatory medication, and physical therapy. Rarely do these athletes become surgical candidates in the acute setting. Chronic cases of iliopsoas pathology occasionally require an arthroscopic intervention.
INGUINAL-RELATED GROIN PAIN
Inguinal-related groin pain is one of the most misleading diagnoses in sports because of its poorly defined and under-researched nature. The varying nomenclature of this entity illustrates the heterogeneity and includes sports hernia,9,13-15 athletic pubalgia,16 core muscle injury,17 athletic hernia,18 Gilmore’s groin,15 osteitis pubis,19 sportsman’s hernia,20,21 sportsmen’s groin,22 symphysis syndrome,23 and inguinal disruption.24 It is important to realize that in inguinal-related groin pain, regardless of the nomenclature, there is no true hernia present. The Doha Agreement has defined inguinal-related groin pain as “pain in the location of the inguinal region with associated tenderness of the inguinal canal,” which “is more likely if the pain is aggravated with resistance testing of the abdominal muscles or on Valsalva/cough/sneeze.”6 The condition is a painful soft tissue injury in the groin or inguinal area, involving a constellation of various anatomic areas including the abdominal musculature, sacroiliac joint, neural structures, pubic symphysis, adductors, and hip joint. This may account for up to 50% of chronic groin pain.25,26
One important theory in the development of inguinal-related groin pain is its relationship with femoroacetabular impingement (FAI). Cadaver studies demonstrate that cam deformities cause a 35% increase in motion at the pubic symphysis altering the biomechanics of the adductors and abdominal musculature and, with repetitive stress, may lead to tearing or attenuation of the transversalis fascia, rectus abdominis, internal obliques, and/or external obliques.12,27,28 Another prevailing theory of this is that the increased pubic stress causes weakness in the posterior portion of the inguinal canal, which then stretches and entraps the genitofemoral, ilioinguinal, lateral femoral cutaneous, or obturator nerves, ultimately causing pain.28,29
Physical examination findings include pain over the conjoined tendon, pubic tubercle/symphysis (present in 22% of patients), adductor origin (36%), and inguinal ring.25,30 Pain with resisted sit-ups is present in 46% of patients and pain with coughing/Valsalva is present in 10%.25,30,31 Selective injections can be a critical part of the evaluation to differentiate inguinal-related groin pain from FAI, osteitis pubis, and adductor strains while helping to determine the appropriate treatment.25,32 The role of advanced imaging is unclear as the clinical entity is still uncertain and the standard imaging findings have not been definitively established.33 However, several studies have reported MRI findings suggestive of inguinal-related groin pain. One of the more common MRI findings is the “secondary cleft sign,” which requires injecting a dye into the pubic symphysis.34 Several studies have shown that the radiographic dye extravasates preferentially into the side where the groin symptoms exist and are thought to be secondary to micro-tearing at the common attachment of the musculotendinous structures to the anterior pubis.34,35 However, it should be noted that the lack of imaging findings does not exclude the possibility of inguinal-related groin pathology.
Initial treatment consists of rest, anti-inflammatory medication, injections, and physical therapy with core strengthening.25 A study by Paajanen and colleagues36 suggested that early surgical intervention may be preferred over conservative management in a randomized trial comparing physical therapy, injections, anti-inflammatory medication, and rest vs an extraperitoneal laparoscopic mesh repair behind the pubic symphysis. In the conservative group, 20% of athletes returned to sport at 1 month, 27% at 3 months, and 50% at 12 months.36 In comparison, the surgical group had 67% return to sport at 1 month, 90% at 3 months, and 97% at 12 months.36 If surgical management is chosen, there are a variety of surgical options including laparoscopy, open or mini-open repairs of the abdominal musculature/fascia or pelvic floor with and without mesh, neurolysis, and adductor release. Muschawek and Berger37described a series of 129 patients that had an open-suture repair of the posterior wall of the inguinal canal with 67% of professional athletes returning to sport within 2 weeks and 83.7% of athletes returning to sport overall. The rates of return to play are consistently 80% to 100% without demonstrated superiority of one technique over another up to this point.30
Continue to: PUBIC-RELATED GROIN PAIN...
PUBIC-RELATED GROIN PAIN
Pubic-related groin pain is defined as tenderness to palpation over the pubic symphysis and adjacent bone.6 Osteitis pubis is a chronic overuse injury characterized by localized pain to the pubic symphysis and is believed to be caused by repetitive microtrauma from a dynamic rotation of the sacroiliac joint with suggested imbalances between the rectus abdominis and the adductor musculature.12,38 In soccer players, the condition may be related to the constant torsional stresses of kicking, running, or twisting.12 If performed, radiographs often show lytic areas of the pubic symphysis, widening of the symphysis, sclerosis, and cystic changes, while bone marrow edema may be present on MRI.38Management consists of rest, anti-inflammatory medication, and corticosteroid injections with gentle stretching once asymptomatic.12,39
RECTUS FEMORIS INJURIES
The most common injury to the rectus femoris is a strain as a result of an eccentric overload while a soccer player is hit trying to extend his or her leg to kick a ball.12 In pediatric soccer athletes, an avulsion of the anterior inferior iliac spine from the direct head of the rectus femoris is the second most common avulsion injury.40 Radiographs are diagnostic and can help determine treatment. Most avulsions are minimally displaced and can be treated conservatively, but surgical intervention should be considered for an avulsion >2 cm.12
PROXIMAL HAMSTRING INJURIES
Proximal hamstring injuries are important causes of acute posterior hip pain and are caused by an eccentric overload in hip flexion and knee extension.25 In soccer players, the typical mechanism is that the planted leg slipping on the playing turf creates a sudden violent flexion of the hip with the knee in an extended position. While relatively uncommon, when a significant avulsion occurs in a professional athlete, surgical intervention is often necessary. In general, these injuries may involve partial or full avulsions off the ischial tuberosity or separation of the bony apophysis in pediatric athletes. A physical examination in the acute setting typically demonstrates massive posterior thigh ecchymosis, a palpable defect, and/or weakness with knee flexion. Imaging is helpful to confirm the diagnosis and evaluate for surgical repair. Radiographs may show a bony avulsion, which is more commonly seen in pediatric apophyseal avulsions. MRI can be used to differentiate a complete tear (involving all 3 tendons) vs a partial tear and evaluate for retraction of the tendon distally. Complete and partial tears of 2 tendons with retraction of >2 cm should be surgically repaired.25 Partial tears without tendon retraction may be treated conservatively with rest, anti-inflammatory medication, and physical therapy and then followed later by a hamstring prevention program.25 We have found that biologic augmentation with platelet-rich plasma can help accelerate healing in partial thickness injuries; however, the evidence is conflicting.
GLUTEAL INJURIES
Chronic overuse injuries of the gluteal musculature are common causes of lateral hip pain. Abductor overuse caused by weakness in the gluteus medius with a normal tensor fascia lata can cause pain with sitting and side-lying.25Overuse of the gluteal muscles with muscular imbalances along with increased tension on the iliotibial band can lead to greater trochanteric pain syndrome.25 A physical examination may demonstrate tenderness over the greater trochanter bursa and positive flexion, abduction, and external rotation testing.25 Abductor overuse syndrome and greater trochanteric pain syndrome are best treated with anti-inflammatory medication and physical therapy to balance the core/pelvic musculature.41
PIRIFORMIS INJURIES
Piriformis syndrome is a compressive neuropathy of the sciatic nerve. The mechanism of injury in the athlete is through a minor trauma to the buttock or pelvis.25,42,43 Presenting symptoms include pain with sitting and internal rotation of the hip.12 Zeren and colleagues42 published the only study that includes 2 cases of bilateral piriformis syndrome in professional soccer players. The diagnosis was confirmed with electromyography that was negative at rest and positive when measured after running.42 The athletes exhausted conservative treatment with physical therapy, anti-inflammatory medications, injections, and rest and were treated with surgical decompression.42 Both players returned to professional soccer after 6 months and played for an average of 7 years.42
Continue to: HIP-RELATED GROIN PAIN IN SOCCER ATHLETES...
HIP-RELATED GROIN PAIN IN SOCCER ATHLETES
Hip-related groin pain has garnered more attention in the last several years after being a previously underdiagnosed entity. One study found that practitioners treated groin pain in athletes for 7 months on average before recognizing that the pathology was intra-articular.44 FAI, labral tears, and chondral injuries are the major intra-articular pathologies that cause groin pain in athletes and ultimately impaired performance.45,46
FEMOROACETABULAR IMPINGEMENT
FAI is caused by pincer-type, cam-type, or combined-type deformities. Pincer lesions are defined as an increased acetabular overhang, while cam lesions are described as an increased bone at the femoral head/neck junction. These deformities in isolation or in combination cause decreased hip motion and increased contact pressures between the anterolateral acetabulum and femoral head-neck junction, which may ultimately lead to labral tears, chondral lesions, and osteoarthritis.47 During hip flexion, cam deformities impact the anterolateral acetabulum, preferentially causing articular cartilage damage, while sparing the labrum.25 Conversely, pincer deformities cause repetitive microtrauma to the labrum, crushing it between the acetabular rim and femoral neck with secondary damage to the articular cartilage.25 Over time, the damage to the labrum and articular cartilage may lead to premature osteoarthritis, which occurs at a much younger age in the athletic population.48
We know from previous studies that soccer athletes have a high prevalence of morphologic abnormalities of the hip, most commonly FAI. Gerhardt and colleagues49 documented the prevalence of hip morphologic abnormalities in elite soccer players and found abnormalities in 72% of men and over 50% of women. It should be noted that this series looked at asymptomatic athletes; however, it has been shown that hip dysmorphia is a risk factor for hip and groin injuries and may provide an opportunity for injury prevention strategies.50
Physical examination findings in FAI include decreased hip internal rotation and pain with provocative testing. Wyss and colleagues51 measured hip internal rotation in athletes with and without FAI. They found that the athletes with FAI have an average of 4° of internal rotation compared with that of the non-FAI athletes with 28°.51 A worsening internal rotation deficit has been linked to increasing severity of the deformity and when <20° was correlated with joint damage.51 Provocative testing has a high sensitivity with a recent meta-analysis demonstrating the most sensitive tests to be the anterior impingement test (flexion-adduction-internal rotation) with 94% to 99% sensitivity and the flexion-internal rotation test with 96% sensitivity.52 While provocative tests are sensitive, there is no current consensus on physical examination findings that are specific in the diagnosis of FAI.6 Diagnosis is made with both positive physical examination and radiographic morphologic findings (alpha angle >55°).33 Advanced imaging with an MRI arthrogram can be helpful in diagnosing underlying injuries such as labral tears in athletes presenting with compatible symptoms.
Symptomatic patients are typically treated surgically through either open or arthroscopic procedures, which have favorable and comparable functional results, biomechanics, and return to sport.53 In soccer players, return to sport at the professional level after arthroscopic surgery was found to be 96%.54 Players returned to sport on average 9.2 months postoperatively and played an average of 70 games after surgery.54
Continue to: LABRAL TEARS...
LABRAL TEARS
Labral tears present with groin pain, limited hip range of motion, and symptoms of catching, locking, and instability.25Causes of labral tears include trauma, FAI, hip dysplasia, capsular laxity, and degeneration.55 Labral tears rarely occur in isolation and have a high association (87%) with morphologic abnormalities of the hip, most commonly FAI and occasionally dysplasia.56,57 Physical examination findings include positive anterior impingement tests (flexion-adduction-internal rotation) in athletes with anterior labral tears and, less commonly, positive flexion, abduction, and external rotation tests for athletes with lateral and posterolateral labral tears.57 Radiographic imaging is used to evaluate for concurrent morphologic abnormalities of the hip, and MRI arthrogram is used to confirm the diagnosis of a labral tear with a sensitivity of 76% to 91%.58 Initial treatment consists of conservative treatment, which includes rest, anti-inflammatory medication, activity modification, and physical therapy. In patient refractory to conservative treatment, arthroscopic surgery is effective with high rates of return to sport.59 It is important to note that when treating labral tears surgically, any morphologic abnormality needs to be addressed to prevent recurrence of the tear.
CHONDRAL INJURIES
Focal chondral lesions in the hip are commonly found in athletes with FAI and labral tears during arthroscopic evaluation.60 Full-thickness defects and unstable flaps in weight-bearing areas are indications for surgical intervention with microfracture.60 There are no studies examining the efficacy of microfracture in isolation; however, Locks and colleagues54 have demonstrated a 96% return to professional soccer after an arthroscopic treatment for FAI and found that severe chondral damage with microfracture did not lengthen the return to sport.
RELATIONSHIP BETWEEN INGUINAL-RELATED GROIN PAIN AND FEMOROACETABULAR IMPINGEMENT
The altered biomechanics and restricted range of motion in athletes with FAI cause an increase in compensatory motion at the pelvis and lumbosacral areas, which may contribute to the development of inguinal-related groin pain, bursitis, adductor, and gluteal dysfunction.25 In athletes with concurrent intra-articular hip pathology and inguinal-related groin pain, treating 1 condition in isolation will result in poor results. Larson and colleagues61 found that when only inguinal-related groin pain or FAI were addressed, return to sport was only 25% and 50%, respectively, while concurrent surgical treatment resulted in a return to sport of 89%.
DISCUSSION AND FUTURE DIRECTIONS
Groin injuries in soccer players can cause significant decreases in athletic performance, result in lost playing time, and may ultimately need a surgical intervention. Efforts are underway to determine the role and efficacy of identifying high-risk athletes that may benefit from targeted prevention strategies. Wyles and colleagues48 identified adolescent athletes with hip internal rotation of <10° and found at 5-year follow-up that 95% had abnormal MRI findings compared with 54% in the age-matched control group. Wollin and colleagues62 developed an in-season screening protocol using adductor strength reductions of 15%, adductor/abductor strength ratio <0.9, and hip and groin outcome scores <75 as indicators of at-risk individuals. By employing preseason and in-season screening protocols, we can identify high-risk athletes for further workup and close follow-up throughout the season. Pelvic radiographs in these high-risk athletes may help us determine the presence of abnormalities in hip morphology, which would place an athlete into a high-risk group where prevention strategies could then be employed. There are no data available to determine the most effective prevention strategy at this time. However, levels II and III evidence exists indicating that exercise programs may reduce the incidence of groin injuries.63 Additional strategies, like limiting adolescent playing time similar to strategies employed in baseball pitches with pitch counts, could potentially reduce the potential for injury. Further studies on preseason screening and in-season monitoring protocols, targeted exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
1. Kantar Media. 2014 FIFA World Cup Brazil television audience report. https://resources.fifa.com/mm/document/affederation/tv/02/74/55/57/2014f...(draft5)(issuedate14.12.15)_neutral.pdf. Accessed March 20, 2018.
2. Fédération Internationale de Football Association. FIFA Big Count. http://www.fifa.com/mm/document/fifafacts/bcoffsurv/emaga_9384_10704.pdf. Published July 2007. Accessed March 20, 2018.
3. United States Consumer Product Safety Commission. Neiss data highlights - 2015. https://www.cpsc.gov/s3fs-public/2015 Neiss data highlights.pdf. Accessed March 20, 2018.
4. Hassabi M, Mohammad-Javad Mortazavi S, Giti MR, Hassabi M, Mansournia MA, Shapouran S. Injury profile of a professional soccer team in the premier league of Iran. Asian J Sports Med. 2010;1(4):201-208.
5. Ekstrand J, Hagglund M, Walden M. Injury incidence and injury patterns in professional football: the UEFA injury study. Br J Sports Med. 2011;45(7):553-558.
6. Weir A, Brukner P, Delahunt E, et al. Doha agreement meeting on terminology and definitions in groin pain in athletes. Br J Sports Med. 2015;49(12):768-774.
7. Serner A, Tol JL, Jomaah N, et al. Diagnosis of acute groin injuries: a prospective study of 110 athletes. Am J Sports Med. 2015;43(8):1857-1864. doi:10.1177/0363546515585123.
8. Eckard TG, Padua DA, Dompier TP, Dalton SL, Thorborg K, Kerr ZY. Epidemiology of hip flexor and hip adductor strains in national collegiate athletic association athletes, 2009/2010-2014/2015. Am J Sports Med. 2017;45(12):2713-2722. doi:10.1177/0363546517716179.
9. Hopkins JN, Brown W, Lee CA. Sports hernia: definition, evaluation, and treatment. JBJS Rev. 2017;5(9):e6. doi:10.2106/JBJS.RVW.17.00022.
10. Omar IM, Zoga AC, Kavanagh EC, et al. Athletic pubalgia and "sports hernia": optimal MR imaging technique and findings. Radiographics. 2008;28(5):1415-1438. doi:10.1148/rg.285075217.
11. Vogt S, Ansah P, Imhoff AB. Complete osseous avulsion of the adductor longus muscle: acute repair with three Wberwire suture anchors. Arch Orthop Trauma Surg. 2007;127:613-615. doi:10.1007/s00402-007-0328-5.
12. Anderson K, Strickland SM, Warren R. Hip and groin injuries in athletes. Am J Sports Med. 2001;29(4):521-533. doi:10.1177/03635465010290042501.
13. Choi HR, Elattar O, Dills VD, Busconi B. Return to play after sports hernia surgery. Clin Sports Med. 2016;35(4):621-636. doi:10.1016/j.csm.2016.05.007.
14. Garvey JF, Hazard H. Sports hernia or groin disruption injury? Chronic athletic groin pain: a retrospective study of 100 patients with long-term follow-up. Hernia. 2014;18(6):815-823. doi:10.1007/s10029-013-1161-0.
15. Gilmore J. Groin pain in the soccer athlete: fact, fiction, and treatment. Clin Sports Med. 1998;17(4):787-793, vii. doi:10.1016/S0278-5919(05)70119-8.
16. Cohen B, Kleinhenz D, Schiller J, Tabaddor R. Understanding athletic pubalgia: a review. R I Med J. 2016;99(10):31-35.
17. Ross JR, Stone RM, Larson CM. Core muscle injury/sports hernia/athletic pubalgia, and femoroacetabular impingement. Sports Med Arthrosc Rev. 2015;23(4):213-220. doi:10.1097/JSA.0000000000000083.
18. Swan KG Jr, Wolcott M. The athletic hernia: a systematic review. Clin Orthop Relat Res. 2007;455:78-87. doi:10.1097/BLO.0b013e31802eb3ea.
19. Matikainen M, Hermunen H, Paajanen H. Athletic pubalgia in females: predictive value of MRI in outcomes of endoscopic surgery. Orthop J Sports Med. 2017;5(8):2325967117720171. doi:10.1177/2325967117720171.
20. Garvey JF, Read JW, Turner A. Sportsman hernia: what can we do? Hernia. 2010;14(1):17-25. doi:10.1007/s10029-009-0611-1.
21. Paksoy M, Sekmen U. Sportsman hernia; the review of current diagnosis and treatment modalities. Ulusal Cerrahi Derg. 2016;32(2):122-129. doi:10.5152/UCD.2015.3132.
22. Pokorny H, Resinger C, Fischer I, et al. Fast early recovery after transabdominal preperitoneal repair in athletes with sportsman's groin: a prospective clinical cohort study. J Laparoendosc Adv Surg Tech A. 2017;27(3):272-276. doi:10.1089/lap.2016.0188.
23. Biedert RM, Warnke K, Meyer S. Symphysis syndrome in athletes: surgical treatment for chronic lower abdominal, groin, and adductor pain in athletes. Clin J Sport Med. 2003;13(5):278-284.
24. Sheen AJ, Stephenson BM, Lloyd DM, et al. 'Treatment of the sportsman's groin': British Hernia Society's 2014 position statement based on the Manchester Consensus Conference. Br J Sports Med. 2014;48(14):1079-1087.
25. Miller M, Thompson S. DeLee & Drez's Orthopaedic Sports Medicine. 4th ed. Philadelphia, PA: Elsevier/Saunders; 2015.
26. Lovell G. The diagnosis of chronic groin pain in athletes: a review of 189 cases. J Sci Med Sport. 1995;27:76-79.
27. Dimitrakopoulou A, Schilders E. Sportsman's hernia? An ambiguous term. J Hip Preserv Surg. 2016;3(1):16-22. doi:10.1093/jhps/hnv083.
28. Strosberg DS, Ellis TJ, Renton DB. The role of femoroacetabular impingement in core muscle injury/athletic pubalgia: diagnosis and management. Front Surg. 2016;3:6. doi:10.3389/fsurg.2016.00006.
29. Muschaweck U, Berger LM. Sportsmen's groin-diagnostic approach and treatment with the minimal repair technique: a single-center uncontrolled clinical review. Sports Health. 2010;2(3):216-221. doi:10.1177/1941738110367623.
30. Larson CM. Sports hernia/athletic pubalgia: evaluation and management. Sports Health. 2014;6(2):139-144. doi:10.1177/1941738114523557.
31. Meyers WC, Foley DP, Garrett WE, Lohnes JH, Mandlebaum BR. Management of severe lower abdominal or inguinal pain in high-performance athletes. Am J Sports Med. 2000; 28(1):2-8. doi:10.1177/03635465000280011501.
32. Gerhardt MB, Mandelbaum BR, Hutchinson WB. Ancillary modalities in the treatment of athletic groin Pain: Local Anesthetics, Corticosteroids, and Orthobiologics. In: Diduch DR, Brunt LM, eds. Sports Hernia and Athletic Pubalgia: Diagnosis and Treatment. Boston, MA: Springer US; 2014:183-187.
33. Notzli HP, Wyss TF, Stoecklin CH, et al. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84(4):556-560.
34. Brennan D, O’Connell MJ, Ryan M, et al. Secondary cleft sign as a marker of injury in athletes with groin pain: MR image appearance and interpretation. Radiology. 2005;235(1):162-167. doi:10.1148/radiol.2351040045.
35. Byrne CA, Bowden DJ, Alkhayat A, Kavanagh EC, Eustace SJ. Sports-related groin pain secondary to symphysis pubis disorders: correlation between MRI findings and outcome after fluoroscopy-guided injection of steroid and local anesthetic. Am J Roentgenol. 2017;209(2):380-388. doi:10.2214/AJR.16.17578.
36. Paajanen H, Brinck T, Hermunen H, Airo I. Laparoscopic surgery for chronic groin pain in athletes is more effective than nonoperative treatment: a randomized clinical trial with magnetic resonance imaging of 60 patients with sportsman's hernia (athletic pubalgia). Surgery. 2011;150(1):99-107. doi:10.1016/j.surg.2011.02.016.
37. Muschaweck U, Berger L. Minimal repair technique of sportsmen's groin: an innovative open-suture repair to treat chronic inguinal pain. Hernia. 2010;14(1):27-33. doi:10.1007/s10029-009-0614-y.
38. Lynch TS, Bedi A, Larson CM. Athletic hip injuries. J Am Acad Orthop Surg. 2017;25(4):269-279. doi:10.5435/JAAOS-D-16-00171.
39. Holt MA, Keene JS, Graf BK, Helwig DC. Treatment of osteitis pubis in athletes. Results of corticosteroid injections. Am J Sports Med. 1995;23(5):601-606.doi:10.1177/036354659502300515.
40. Rossi F, Dragoni S. Acute avulsion fractures of the pelvis in adolescent competitive athletes: prevalence, location and sports distribution of 203 cases collected. Skeletal Radiol. 2001;30(3):127-131. doi: 10.1007/s002560000319.
41. Grumet RC, Frank RM, Slabaugh MA, Virkus WW, Bush-Joseph CA, Nho SJ. Lateral hip pain in an athletic population: differential diagnosis and treatment options. Sports Health. 2010;2(3):191-196. doi:10.1177/1941738110366829.
42. Zeren B, Canbek U, Oztekin HH, Imerci A, Akgun U. Bilateral piriformis syndrome in two elite soccer players: report of two cases. Orthop Traumatol Surg Res. 2015;101(8):987-990. doi:10.1016/j.otsr.2015.07.022.
43. Keskula DR, Tamburello M. Conservative management of piriformis syndrome. J Athl Train. 1992;27(2):102-110.
44. Byrd JW, Jones KS. Hip arthroscopy in athletes. Clin Sports Med. 2001;20(4):749-761.
45. Nepple JJ, Goljan P, Briggs KK, Garvey SE, Ryan M, Philippon MJ. Hip strength deficits in patients with symptomatic femoroacetabular impingement and labral tears. Arthroscopy.2015;31(11):2106-2111.
46. Mullins K, Hanlon M, Carton P. Differences in athletic performance between sportsmen with symptomatic femoroacetabular impingement and healthy controls. Clin J Sport Med.2018;28(4):370-376. doi:10.1097/JSM.0000000000000460.
47. Ganz R, Parvizi J, Beck M, Leunig M, Notzli H, Siebenrock KA. Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res. 2003;417:112-120. doi:10.1097/01.blo.0000096804.78689.c2.
48. Wyles CC, Norambuena GA, Howe BM, et al. Cam deformities and limited hip range of motion are associated with early osteoarthritic changes in adolescent athletes: a prospective matched cohort study. Am J Sports Med. 2017;45(13):3036-3043. doi:10.1177/0363546517719460 .
49. Gerhardt MB, Romero AA, Silvers HJ, Harris DJ, Watanabe D, Mandelbaum BR. The prevalence of radiographic hip abnormalities in elite soccer players. Am J Sports Med. 2012;40(3):584-588. doi:10.1177/0363546511432711.
50. Larson CM, Ross JR, Kuhn AW, et al. Radiographic hip anatomy correlates with range of motion and symptoms in national hockey league players. Am J Sports Med. 2017;45(7):1633-1639. doi:10.1177/0363546517692542.
51. Wyss TF, Clark JM, Weishaupt D, Notzli HP. Correlation between internal rotation and bony anatomy in the hip. Clin Orthop Relat Res. 2007;460:152-158. doi:10.1097/BLO.0b013e3180399430.
52. Reiman MP, Goode AP, Cook CE, Holmich P, Thorborg K. Diagnostic accuracy of clinical tests for the diagnosis of hip femoroacetabular impingement/labral tear: a systematic review with meta-analysis. Br J Sports Med. 2015;49:811. doi:10.1136/bjsports-2014-094302.
53. Papalia R, Del Buono A, Franceschi F, Marinozzi A, Maffulli N, Denaro V. Femoroacetabular impingement syndrome management: arthroscopy or open surgery? Int Orthop. 2012;36(5):903-914. doi:10.1007/s00264-011-1443-z.
54. Locks R, Utsunomiya H, Briggs KK, McNamara S, Chahla J, Philippon MJ. Return to play after hip arthroscopic surgery for femoroacetabular impingement in professional soccer players. Am J Sports Med. 2018;46(2):273-279. doi:10.1177/0363546517738741.
55. Kelly BT, Weiland DE, Schenker ML, Philippon MJ. Arthroscopic labral repair in the hip: surgical technique and review of the literature. Arthroscopy. 2005;21(12):1496-1504. doi:10.1016/j.arthro.2005.08.013.
56. Wenger DE, Kendell KR, Miner MR, Trousdale RT. Acetabular labral tears rarely occur in the absence of bony abnormalities. Clin Orthop Relat Res. 2004;426:145-150. doi:10.1097/01.blo.0000136903.01368.20.
57. Domb BG, Hartigan DE, Perets I. Decision making for labral treatment in the hip: repair versus débridement versus reconstruction. J Am Acad Orthop Surg. 2017;25(3):e53-e62. doi:10.5435/JAAOS-D-16-00144.
58. Frank JS, Gambacorta PL, Eisner EA. Hip pathology in the adolescent athlete. J Am Acad Orthop Surg. 2013;21(11):665-674. doi:10.5435/JAAOS-21-11-665.
59. Singh PJ, O'Donnell JM. The outcome of hip arthroscopy in Australian football league players: a review of 27 hips. Arthroscopy. 2010;26(6):743-749. doi:10.1016/j.arthro.2009.10.010.
60. Crawford K, Philippon MJ, Sekiya JK, Rodkey WG, Steadman JR. Microfracture of the hip in athletes. Clin Sports Med. 2006;25(2):327-335. doi:10.1016/j.csm.2005.12.004.
61. Larson CM, Pierce BR, Giveans MR. Treatment of athletes with symptomatic intra-articular hip pathology and athletic pubalgia/sports hernia: a case series. Arthroscopy.2011;27(6):768-775. doi:10.1016/j.arthro.2011.01.018.
62. Wollin M, Thorborg K, Welvaert M, Pizzari T. In-season monitoring of hip and groin strength, health and function in elite youth soccer: implementing an early detection and management strategy over two consecutive seasons. J Sci Med Sport. 2018;21(10):988. doi:10.1016/j.jsams.2018.03.004.
63. Charlton PC, Drew MK, Mentiplay BF, Grimaldi A, Clark RA. Exercise interventions for the prevention and treatment of groin pain and injury in athletes: a critical and systematic review. Sports Med. 2017;47:2011. doi:10.1007/s40279-017-0742-y.
ABSTRACT
Soccer is the most popular sport in the world and has the fourth highest number of sports injuries. Hip and groin injuries account for 14% of soccer injuries and can be difficult to recognize and treat as they often require a high level of suspicion and advanced imaging. Groin pain can be separated into 3 categories: (1) defined clinical entities for groin pain (adductor-related, iliopsoas-related, inguinal-related [sports hernias/athletic pubalgia], and pubic-related groin pain), (2) hip-related groin pain (hip morphologic abnormalities, labral tears, and chondral injuries), and (3) other causes of groin pain. Conservative approaches are typically the first line of treatment, but operative intervention has been reported to result in higher rates of return to sport in athletes with hip-related and inguinal-related groin pain injuries. In patients with concurrent hip-related and inguinal-related groin pain, the failure to recognize the relationship and treat both conditions may result in lower rates of return to sport. Preseason screening programs can identify high-risk athletes, who may benefit from a targeted prevention program. Further study on exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
Continue to: Each year, the global audience for soccer grows...
Each year, the global audience for soccer grows. Soccer has long surpassed all other sports as the most popular sport in the world, reaching 3.2 billion viewers during the 2014 World Cup.1 In the latest Fédération Internationale de Football Association (FIFA) Big Count survey, the organization estimated that 265 million people are actively involved in soccer, accounting for approximately 4% of the world’s population.2 Moreover, the number of people playing soccer increased by 9.5% within 6 years after the previous Big Count Survey.2 In the United States, soccer accounts for the fourth most common cause of sports injuries next to basketball, exercise, and football with approximately 228,000 injuries per year.3 The total cost of treatment related to worldwide soccer injuries tops $30 billion.4 The most common body parts injured are the thigh (25%), knee (18%), and hip and/or groin (14%).5
Hip and groin injuries in soccer players can be separated into 3 main categories based on the Doha Agreement:6 (1) defined clinical entities for groin pain, (2) hip-related groin pain, and (3) other causes of groin pain in athletes. Defined clinical entities include adductor-related, iliopsoas-related, inguinal-related (sports hernia/athletic pubalgia), and pubic-related groin pain; while hip-related groin pain includes hip morphologic abnormalities, labral tears, and chondral injuries. Included in other causes of groin pain are injuries not clinically defined. The Doha Agreement has acknowledged that not all causes of groin pain fit into the classification system including injuries of the rectus femoris, but they will be included under defined clinical entities for groin pain in this review. While they are not a cause of groin pain, proximal hamstring and gluteal and piriformis injuries are important causes of posterior and lateral hip pain in soccer players and will also be covered in the first section of this review.
DEFINED CLINICAL ENTITIES FOR GROIN PAIN IN SOCCER ATHLETES
ADDUCTOR-RELATED GROIN PAIN
Acute groin pain in soccer players is most commonly caused by muscle strain.7 Of the muscle strains, 66% involve the adductor longus, 25% the iliopsoas, and 23% the rectus femoris.7 The Doha Agreement defines adductor-related groin pain as adductor tenderness and pain on resisted adduction.6 Adductor longus strains in soccer players are typically noncontact injuries (62.5%) and most commonly the result of kicking (40%).7-9 Many athletes will remember a pop at the time of the original injury.9 The combination of history and physical examination is usually sufficient for diagnosis; however, magnetic resonance imaging (MRI) may be helpful in complicated situations with a reported 86% sensitivity and 89% specificity.10 The average playing time lost is 2 weeks.5 Management includes rest, anti-inflammatory medication, physical therapy with core strengthening, and avoidance of aggressive stretching. While partial and distal avulsions can heal with conservative measures, proximal osseous and retracted avulsions of the adductor longus can be treated surgically.11
Continue to: ILIOPSOAS-RELATED GROIN PAIN...
ILIOPSOAS-RELATED GROIN PAIN
Iliopsoas strains account for 25% of acute groin strains and typically result from an impact that causes eccentric overload while kicking the ball.7,12 Iliopsoas-related groin pain is defined by the Doha Agreement as groin pain that is reproducible with resisted hip flexion or hip flexor stretch.6 Iliopsoas strains respond well to conservative treatment such as rest, anti-inflammatory medication, and physical therapy. Rarely do these athletes become surgical candidates in the acute setting. Chronic cases of iliopsoas pathology occasionally require an arthroscopic intervention.
INGUINAL-RELATED GROIN PAIN
Inguinal-related groin pain is one of the most misleading diagnoses in sports because of its poorly defined and under-researched nature. The varying nomenclature of this entity illustrates the heterogeneity and includes sports hernia,9,13-15 athletic pubalgia,16 core muscle injury,17 athletic hernia,18 Gilmore’s groin,15 osteitis pubis,19 sportsman’s hernia,20,21 sportsmen’s groin,22 symphysis syndrome,23 and inguinal disruption.24 It is important to realize that in inguinal-related groin pain, regardless of the nomenclature, there is no true hernia present. The Doha Agreement has defined inguinal-related groin pain as “pain in the location of the inguinal region with associated tenderness of the inguinal canal,” which “is more likely if the pain is aggravated with resistance testing of the abdominal muscles or on Valsalva/cough/sneeze.”6 The condition is a painful soft tissue injury in the groin or inguinal area, involving a constellation of various anatomic areas including the abdominal musculature, sacroiliac joint, neural structures, pubic symphysis, adductors, and hip joint. This may account for up to 50% of chronic groin pain.25,26
One important theory in the development of inguinal-related groin pain is its relationship with femoroacetabular impingement (FAI). Cadaver studies demonstrate that cam deformities cause a 35% increase in motion at the pubic symphysis altering the biomechanics of the adductors and abdominal musculature and, with repetitive stress, may lead to tearing or attenuation of the transversalis fascia, rectus abdominis, internal obliques, and/or external obliques.12,27,28 Another prevailing theory of this is that the increased pubic stress causes weakness in the posterior portion of the inguinal canal, which then stretches and entraps the genitofemoral, ilioinguinal, lateral femoral cutaneous, or obturator nerves, ultimately causing pain.28,29
Physical examination findings include pain over the conjoined tendon, pubic tubercle/symphysis (present in 22% of patients), adductor origin (36%), and inguinal ring.25,30 Pain with resisted sit-ups is present in 46% of patients and pain with coughing/Valsalva is present in 10%.25,30,31 Selective injections can be a critical part of the evaluation to differentiate inguinal-related groin pain from FAI, osteitis pubis, and adductor strains while helping to determine the appropriate treatment.25,32 The role of advanced imaging is unclear as the clinical entity is still uncertain and the standard imaging findings have not been definitively established.33 However, several studies have reported MRI findings suggestive of inguinal-related groin pain. One of the more common MRI findings is the “secondary cleft sign,” which requires injecting a dye into the pubic symphysis.34 Several studies have shown that the radiographic dye extravasates preferentially into the side where the groin symptoms exist and are thought to be secondary to micro-tearing at the common attachment of the musculotendinous structures to the anterior pubis.34,35 However, it should be noted that the lack of imaging findings does not exclude the possibility of inguinal-related groin pathology.
Initial treatment consists of rest, anti-inflammatory medication, injections, and physical therapy with core strengthening.25 A study by Paajanen and colleagues36 suggested that early surgical intervention may be preferred over conservative management in a randomized trial comparing physical therapy, injections, anti-inflammatory medication, and rest vs an extraperitoneal laparoscopic mesh repair behind the pubic symphysis. In the conservative group, 20% of athletes returned to sport at 1 month, 27% at 3 months, and 50% at 12 months.36 In comparison, the surgical group had 67% return to sport at 1 month, 90% at 3 months, and 97% at 12 months.36 If surgical management is chosen, there are a variety of surgical options including laparoscopy, open or mini-open repairs of the abdominal musculature/fascia or pelvic floor with and without mesh, neurolysis, and adductor release. Muschawek and Berger37described a series of 129 patients that had an open-suture repair of the posterior wall of the inguinal canal with 67% of professional athletes returning to sport within 2 weeks and 83.7% of athletes returning to sport overall. The rates of return to play are consistently 80% to 100% without demonstrated superiority of one technique over another up to this point.30
Continue to: PUBIC-RELATED GROIN PAIN...
PUBIC-RELATED GROIN PAIN
Pubic-related groin pain is defined as tenderness to palpation over the pubic symphysis and adjacent bone.6 Osteitis pubis is a chronic overuse injury characterized by localized pain to the pubic symphysis and is believed to be caused by repetitive microtrauma from a dynamic rotation of the sacroiliac joint with suggested imbalances between the rectus abdominis and the adductor musculature.12,38 In soccer players, the condition may be related to the constant torsional stresses of kicking, running, or twisting.12 If performed, radiographs often show lytic areas of the pubic symphysis, widening of the symphysis, sclerosis, and cystic changes, while bone marrow edema may be present on MRI.38Management consists of rest, anti-inflammatory medication, and corticosteroid injections with gentle stretching once asymptomatic.12,39
RECTUS FEMORIS INJURIES
The most common injury to the rectus femoris is a strain as a result of an eccentric overload while a soccer player is hit trying to extend his or her leg to kick a ball.12 In pediatric soccer athletes, an avulsion of the anterior inferior iliac spine from the direct head of the rectus femoris is the second most common avulsion injury.40 Radiographs are diagnostic and can help determine treatment. Most avulsions are minimally displaced and can be treated conservatively, but surgical intervention should be considered for an avulsion >2 cm.12
PROXIMAL HAMSTRING INJURIES
Proximal hamstring injuries are important causes of acute posterior hip pain and are caused by an eccentric overload in hip flexion and knee extension.25 In soccer players, the typical mechanism is that the planted leg slipping on the playing turf creates a sudden violent flexion of the hip with the knee in an extended position. While relatively uncommon, when a significant avulsion occurs in a professional athlete, surgical intervention is often necessary. In general, these injuries may involve partial or full avulsions off the ischial tuberosity or separation of the bony apophysis in pediatric athletes. A physical examination in the acute setting typically demonstrates massive posterior thigh ecchymosis, a palpable defect, and/or weakness with knee flexion. Imaging is helpful to confirm the diagnosis and evaluate for surgical repair. Radiographs may show a bony avulsion, which is more commonly seen in pediatric apophyseal avulsions. MRI can be used to differentiate a complete tear (involving all 3 tendons) vs a partial tear and evaluate for retraction of the tendon distally. Complete and partial tears of 2 tendons with retraction of >2 cm should be surgically repaired.25 Partial tears without tendon retraction may be treated conservatively with rest, anti-inflammatory medication, and physical therapy and then followed later by a hamstring prevention program.25 We have found that biologic augmentation with platelet-rich plasma can help accelerate healing in partial thickness injuries; however, the evidence is conflicting.
GLUTEAL INJURIES
Chronic overuse injuries of the gluteal musculature are common causes of lateral hip pain. Abductor overuse caused by weakness in the gluteus medius with a normal tensor fascia lata can cause pain with sitting and side-lying.25Overuse of the gluteal muscles with muscular imbalances along with increased tension on the iliotibial band can lead to greater trochanteric pain syndrome.25 A physical examination may demonstrate tenderness over the greater trochanter bursa and positive flexion, abduction, and external rotation testing.25 Abductor overuse syndrome and greater trochanteric pain syndrome are best treated with anti-inflammatory medication and physical therapy to balance the core/pelvic musculature.41
PIRIFORMIS INJURIES
Piriformis syndrome is a compressive neuropathy of the sciatic nerve. The mechanism of injury in the athlete is through a minor trauma to the buttock or pelvis.25,42,43 Presenting symptoms include pain with sitting and internal rotation of the hip.12 Zeren and colleagues42 published the only study that includes 2 cases of bilateral piriformis syndrome in professional soccer players. The diagnosis was confirmed with electromyography that was negative at rest and positive when measured after running.42 The athletes exhausted conservative treatment with physical therapy, anti-inflammatory medications, injections, and rest and were treated with surgical decompression.42 Both players returned to professional soccer after 6 months and played for an average of 7 years.42
Continue to: HIP-RELATED GROIN PAIN IN SOCCER ATHLETES...
HIP-RELATED GROIN PAIN IN SOCCER ATHLETES
Hip-related groin pain has garnered more attention in the last several years after being a previously underdiagnosed entity. One study found that practitioners treated groin pain in athletes for 7 months on average before recognizing that the pathology was intra-articular.44 FAI, labral tears, and chondral injuries are the major intra-articular pathologies that cause groin pain in athletes and ultimately impaired performance.45,46
FEMOROACETABULAR IMPINGEMENT
FAI is caused by pincer-type, cam-type, or combined-type deformities. Pincer lesions are defined as an increased acetabular overhang, while cam lesions are described as an increased bone at the femoral head/neck junction. These deformities in isolation or in combination cause decreased hip motion and increased contact pressures between the anterolateral acetabulum and femoral head-neck junction, which may ultimately lead to labral tears, chondral lesions, and osteoarthritis.47 During hip flexion, cam deformities impact the anterolateral acetabulum, preferentially causing articular cartilage damage, while sparing the labrum.25 Conversely, pincer deformities cause repetitive microtrauma to the labrum, crushing it between the acetabular rim and femoral neck with secondary damage to the articular cartilage.25 Over time, the damage to the labrum and articular cartilage may lead to premature osteoarthritis, which occurs at a much younger age in the athletic population.48
We know from previous studies that soccer athletes have a high prevalence of morphologic abnormalities of the hip, most commonly FAI. Gerhardt and colleagues49 documented the prevalence of hip morphologic abnormalities in elite soccer players and found abnormalities in 72% of men and over 50% of women. It should be noted that this series looked at asymptomatic athletes; however, it has been shown that hip dysmorphia is a risk factor for hip and groin injuries and may provide an opportunity for injury prevention strategies.50
Physical examination findings in FAI include decreased hip internal rotation and pain with provocative testing. Wyss and colleagues51 measured hip internal rotation in athletes with and without FAI. They found that the athletes with FAI have an average of 4° of internal rotation compared with that of the non-FAI athletes with 28°.51 A worsening internal rotation deficit has been linked to increasing severity of the deformity and when <20° was correlated with joint damage.51 Provocative testing has a high sensitivity with a recent meta-analysis demonstrating the most sensitive tests to be the anterior impingement test (flexion-adduction-internal rotation) with 94% to 99% sensitivity and the flexion-internal rotation test with 96% sensitivity.52 While provocative tests are sensitive, there is no current consensus on physical examination findings that are specific in the diagnosis of FAI.6 Diagnosis is made with both positive physical examination and radiographic morphologic findings (alpha angle >55°).33 Advanced imaging with an MRI arthrogram can be helpful in diagnosing underlying injuries such as labral tears in athletes presenting with compatible symptoms.
Symptomatic patients are typically treated surgically through either open or arthroscopic procedures, which have favorable and comparable functional results, biomechanics, and return to sport.53 In soccer players, return to sport at the professional level after arthroscopic surgery was found to be 96%.54 Players returned to sport on average 9.2 months postoperatively and played an average of 70 games after surgery.54
Continue to: LABRAL TEARS...
LABRAL TEARS
Labral tears present with groin pain, limited hip range of motion, and symptoms of catching, locking, and instability.25Causes of labral tears include trauma, FAI, hip dysplasia, capsular laxity, and degeneration.55 Labral tears rarely occur in isolation and have a high association (87%) with morphologic abnormalities of the hip, most commonly FAI and occasionally dysplasia.56,57 Physical examination findings include positive anterior impingement tests (flexion-adduction-internal rotation) in athletes with anterior labral tears and, less commonly, positive flexion, abduction, and external rotation tests for athletes with lateral and posterolateral labral tears.57 Radiographic imaging is used to evaluate for concurrent morphologic abnormalities of the hip, and MRI arthrogram is used to confirm the diagnosis of a labral tear with a sensitivity of 76% to 91%.58 Initial treatment consists of conservative treatment, which includes rest, anti-inflammatory medication, activity modification, and physical therapy. In patient refractory to conservative treatment, arthroscopic surgery is effective with high rates of return to sport.59 It is important to note that when treating labral tears surgically, any morphologic abnormality needs to be addressed to prevent recurrence of the tear.
CHONDRAL INJURIES
Focal chondral lesions in the hip are commonly found in athletes with FAI and labral tears during arthroscopic evaluation.60 Full-thickness defects and unstable flaps in weight-bearing areas are indications for surgical intervention with microfracture.60 There are no studies examining the efficacy of microfracture in isolation; however, Locks and colleagues54 have demonstrated a 96% return to professional soccer after an arthroscopic treatment for FAI and found that severe chondral damage with microfracture did not lengthen the return to sport.
RELATIONSHIP BETWEEN INGUINAL-RELATED GROIN PAIN AND FEMOROACETABULAR IMPINGEMENT
The altered biomechanics and restricted range of motion in athletes with FAI cause an increase in compensatory motion at the pelvis and lumbosacral areas, which may contribute to the development of inguinal-related groin pain, bursitis, adductor, and gluteal dysfunction.25 In athletes with concurrent intra-articular hip pathology and inguinal-related groin pain, treating 1 condition in isolation will result in poor results. Larson and colleagues61 found that when only inguinal-related groin pain or FAI were addressed, return to sport was only 25% and 50%, respectively, while concurrent surgical treatment resulted in a return to sport of 89%.
DISCUSSION AND FUTURE DIRECTIONS
Groin injuries in soccer players can cause significant decreases in athletic performance, result in lost playing time, and may ultimately need a surgical intervention. Efforts are underway to determine the role and efficacy of identifying high-risk athletes that may benefit from targeted prevention strategies. Wyles and colleagues48 identified adolescent athletes with hip internal rotation of <10° and found at 5-year follow-up that 95% had abnormal MRI findings compared with 54% in the age-matched control group. Wollin and colleagues62 developed an in-season screening protocol using adductor strength reductions of 15%, adductor/abductor strength ratio <0.9, and hip and groin outcome scores <75 as indicators of at-risk individuals. By employing preseason and in-season screening protocols, we can identify high-risk athletes for further workup and close follow-up throughout the season. Pelvic radiographs in these high-risk athletes may help us determine the presence of abnormalities in hip morphology, which would place an athlete into a high-risk group where prevention strategies could then be employed. There are no data available to determine the most effective prevention strategy at this time. However, levels II and III evidence exists indicating that exercise programs may reduce the incidence of groin injuries.63 Additional strategies, like limiting adolescent playing time similar to strategies employed in baseball pitches with pitch counts, could potentially reduce the potential for injury. Further studies on preseason screening and in-season monitoring protocols, targeted exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
ABSTRACT
Soccer is the most popular sport in the world and has the fourth highest number of sports injuries. Hip and groin injuries account for 14% of soccer injuries and can be difficult to recognize and treat as they often require a high level of suspicion and advanced imaging. Groin pain can be separated into 3 categories: (1) defined clinical entities for groin pain (adductor-related, iliopsoas-related, inguinal-related [sports hernias/athletic pubalgia], and pubic-related groin pain), (2) hip-related groin pain (hip morphologic abnormalities, labral tears, and chondral injuries), and (3) other causes of groin pain. Conservative approaches are typically the first line of treatment, but operative intervention has been reported to result in higher rates of return to sport in athletes with hip-related and inguinal-related groin pain injuries. In patients with concurrent hip-related and inguinal-related groin pain, the failure to recognize the relationship and treat both conditions may result in lower rates of return to sport. Preseason screening programs can identify high-risk athletes, who may benefit from a targeted prevention program. Further study on exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
Continue to: Each year, the global audience for soccer grows...
Each year, the global audience for soccer grows. Soccer has long surpassed all other sports as the most popular sport in the world, reaching 3.2 billion viewers during the 2014 World Cup.1 In the latest Fédération Internationale de Football Association (FIFA) Big Count survey, the organization estimated that 265 million people are actively involved in soccer, accounting for approximately 4% of the world’s population.2 Moreover, the number of people playing soccer increased by 9.5% within 6 years after the previous Big Count Survey.2 In the United States, soccer accounts for the fourth most common cause of sports injuries next to basketball, exercise, and football with approximately 228,000 injuries per year.3 The total cost of treatment related to worldwide soccer injuries tops $30 billion.4 The most common body parts injured are the thigh (25%), knee (18%), and hip and/or groin (14%).5
Hip and groin injuries in soccer players can be separated into 3 main categories based on the Doha Agreement:6 (1) defined clinical entities for groin pain, (2) hip-related groin pain, and (3) other causes of groin pain in athletes. Defined clinical entities include adductor-related, iliopsoas-related, inguinal-related (sports hernia/athletic pubalgia), and pubic-related groin pain; while hip-related groin pain includes hip morphologic abnormalities, labral tears, and chondral injuries. Included in other causes of groin pain are injuries not clinically defined. The Doha Agreement has acknowledged that not all causes of groin pain fit into the classification system including injuries of the rectus femoris, but they will be included under defined clinical entities for groin pain in this review. While they are not a cause of groin pain, proximal hamstring and gluteal and piriformis injuries are important causes of posterior and lateral hip pain in soccer players and will also be covered in the first section of this review.
DEFINED CLINICAL ENTITIES FOR GROIN PAIN IN SOCCER ATHLETES
ADDUCTOR-RELATED GROIN PAIN
Acute groin pain in soccer players is most commonly caused by muscle strain.7 Of the muscle strains, 66% involve the adductor longus, 25% the iliopsoas, and 23% the rectus femoris.7 The Doha Agreement defines adductor-related groin pain as adductor tenderness and pain on resisted adduction.6 Adductor longus strains in soccer players are typically noncontact injuries (62.5%) and most commonly the result of kicking (40%).7-9 Many athletes will remember a pop at the time of the original injury.9 The combination of history and physical examination is usually sufficient for diagnosis; however, magnetic resonance imaging (MRI) may be helpful in complicated situations with a reported 86% sensitivity and 89% specificity.10 The average playing time lost is 2 weeks.5 Management includes rest, anti-inflammatory medication, physical therapy with core strengthening, and avoidance of aggressive stretching. While partial and distal avulsions can heal with conservative measures, proximal osseous and retracted avulsions of the adductor longus can be treated surgically.11
Continue to: ILIOPSOAS-RELATED GROIN PAIN...
ILIOPSOAS-RELATED GROIN PAIN
Iliopsoas strains account for 25% of acute groin strains and typically result from an impact that causes eccentric overload while kicking the ball.7,12 Iliopsoas-related groin pain is defined by the Doha Agreement as groin pain that is reproducible with resisted hip flexion or hip flexor stretch.6 Iliopsoas strains respond well to conservative treatment such as rest, anti-inflammatory medication, and physical therapy. Rarely do these athletes become surgical candidates in the acute setting. Chronic cases of iliopsoas pathology occasionally require an arthroscopic intervention.
INGUINAL-RELATED GROIN PAIN
Inguinal-related groin pain is one of the most misleading diagnoses in sports because of its poorly defined and under-researched nature. The varying nomenclature of this entity illustrates the heterogeneity and includes sports hernia,9,13-15 athletic pubalgia,16 core muscle injury,17 athletic hernia,18 Gilmore’s groin,15 osteitis pubis,19 sportsman’s hernia,20,21 sportsmen’s groin,22 symphysis syndrome,23 and inguinal disruption.24 It is important to realize that in inguinal-related groin pain, regardless of the nomenclature, there is no true hernia present. The Doha Agreement has defined inguinal-related groin pain as “pain in the location of the inguinal region with associated tenderness of the inguinal canal,” which “is more likely if the pain is aggravated with resistance testing of the abdominal muscles or on Valsalva/cough/sneeze.”6 The condition is a painful soft tissue injury in the groin or inguinal area, involving a constellation of various anatomic areas including the abdominal musculature, sacroiliac joint, neural structures, pubic symphysis, adductors, and hip joint. This may account for up to 50% of chronic groin pain.25,26
One important theory in the development of inguinal-related groin pain is its relationship with femoroacetabular impingement (FAI). Cadaver studies demonstrate that cam deformities cause a 35% increase in motion at the pubic symphysis altering the biomechanics of the adductors and abdominal musculature and, with repetitive stress, may lead to tearing or attenuation of the transversalis fascia, rectus abdominis, internal obliques, and/or external obliques.12,27,28 Another prevailing theory of this is that the increased pubic stress causes weakness in the posterior portion of the inguinal canal, which then stretches and entraps the genitofemoral, ilioinguinal, lateral femoral cutaneous, or obturator nerves, ultimately causing pain.28,29
Physical examination findings include pain over the conjoined tendon, pubic tubercle/symphysis (present in 22% of patients), adductor origin (36%), and inguinal ring.25,30 Pain with resisted sit-ups is present in 46% of patients and pain with coughing/Valsalva is present in 10%.25,30,31 Selective injections can be a critical part of the evaluation to differentiate inguinal-related groin pain from FAI, osteitis pubis, and adductor strains while helping to determine the appropriate treatment.25,32 The role of advanced imaging is unclear as the clinical entity is still uncertain and the standard imaging findings have not been definitively established.33 However, several studies have reported MRI findings suggestive of inguinal-related groin pain. One of the more common MRI findings is the “secondary cleft sign,” which requires injecting a dye into the pubic symphysis.34 Several studies have shown that the radiographic dye extravasates preferentially into the side where the groin symptoms exist and are thought to be secondary to micro-tearing at the common attachment of the musculotendinous structures to the anterior pubis.34,35 However, it should be noted that the lack of imaging findings does not exclude the possibility of inguinal-related groin pathology.
Initial treatment consists of rest, anti-inflammatory medication, injections, and physical therapy with core strengthening.25 A study by Paajanen and colleagues36 suggested that early surgical intervention may be preferred over conservative management in a randomized trial comparing physical therapy, injections, anti-inflammatory medication, and rest vs an extraperitoneal laparoscopic mesh repair behind the pubic symphysis. In the conservative group, 20% of athletes returned to sport at 1 month, 27% at 3 months, and 50% at 12 months.36 In comparison, the surgical group had 67% return to sport at 1 month, 90% at 3 months, and 97% at 12 months.36 If surgical management is chosen, there are a variety of surgical options including laparoscopy, open or mini-open repairs of the abdominal musculature/fascia or pelvic floor with and without mesh, neurolysis, and adductor release. Muschawek and Berger37described a series of 129 patients that had an open-suture repair of the posterior wall of the inguinal canal with 67% of professional athletes returning to sport within 2 weeks and 83.7% of athletes returning to sport overall. The rates of return to play are consistently 80% to 100% without demonstrated superiority of one technique over another up to this point.30
Continue to: PUBIC-RELATED GROIN PAIN...
PUBIC-RELATED GROIN PAIN
Pubic-related groin pain is defined as tenderness to palpation over the pubic symphysis and adjacent bone.6 Osteitis pubis is a chronic overuse injury characterized by localized pain to the pubic symphysis and is believed to be caused by repetitive microtrauma from a dynamic rotation of the sacroiliac joint with suggested imbalances between the rectus abdominis and the adductor musculature.12,38 In soccer players, the condition may be related to the constant torsional stresses of kicking, running, or twisting.12 If performed, radiographs often show lytic areas of the pubic symphysis, widening of the symphysis, sclerosis, and cystic changes, while bone marrow edema may be present on MRI.38Management consists of rest, anti-inflammatory medication, and corticosteroid injections with gentle stretching once asymptomatic.12,39
RECTUS FEMORIS INJURIES
The most common injury to the rectus femoris is a strain as a result of an eccentric overload while a soccer player is hit trying to extend his or her leg to kick a ball.12 In pediatric soccer athletes, an avulsion of the anterior inferior iliac spine from the direct head of the rectus femoris is the second most common avulsion injury.40 Radiographs are diagnostic and can help determine treatment. Most avulsions are minimally displaced and can be treated conservatively, but surgical intervention should be considered for an avulsion >2 cm.12
PROXIMAL HAMSTRING INJURIES
Proximal hamstring injuries are important causes of acute posterior hip pain and are caused by an eccentric overload in hip flexion and knee extension.25 In soccer players, the typical mechanism is that the planted leg slipping on the playing turf creates a sudden violent flexion of the hip with the knee in an extended position. While relatively uncommon, when a significant avulsion occurs in a professional athlete, surgical intervention is often necessary. In general, these injuries may involve partial or full avulsions off the ischial tuberosity or separation of the bony apophysis in pediatric athletes. A physical examination in the acute setting typically demonstrates massive posterior thigh ecchymosis, a palpable defect, and/or weakness with knee flexion. Imaging is helpful to confirm the diagnosis and evaluate for surgical repair. Radiographs may show a bony avulsion, which is more commonly seen in pediatric apophyseal avulsions. MRI can be used to differentiate a complete tear (involving all 3 tendons) vs a partial tear and evaluate for retraction of the tendon distally. Complete and partial tears of 2 tendons with retraction of >2 cm should be surgically repaired.25 Partial tears without tendon retraction may be treated conservatively with rest, anti-inflammatory medication, and physical therapy and then followed later by a hamstring prevention program.25 We have found that biologic augmentation with platelet-rich plasma can help accelerate healing in partial thickness injuries; however, the evidence is conflicting.
GLUTEAL INJURIES
Chronic overuse injuries of the gluteal musculature are common causes of lateral hip pain. Abductor overuse caused by weakness in the gluteus medius with a normal tensor fascia lata can cause pain with sitting and side-lying.25Overuse of the gluteal muscles with muscular imbalances along with increased tension on the iliotibial band can lead to greater trochanteric pain syndrome.25 A physical examination may demonstrate tenderness over the greater trochanter bursa and positive flexion, abduction, and external rotation testing.25 Abductor overuse syndrome and greater trochanteric pain syndrome are best treated with anti-inflammatory medication and physical therapy to balance the core/pelvic musculature.41
PIRIFORMIS INJURIES
Piriformis syndrome is a compressive neuropathy of the sciatic nerve. The mechanism of injury in the athlete is through a minor trauma to the buttock or pelvis.25,42,43 Presenting symptoms include pain with sitting and internal rotation of the hip.12 Zeren and colleagues42 published the only study that includes 2 cases of bilateral piriformis syndrome in professional soccer players. The diagnosis was confirmed with electromyography that was negative at rest and positive when measured after running.42 The athletes exhausted conservative treatment with physical therapy, anti-inflammatory medications, injections, and rest and were treated with surgical decompression.42 Both players returned to professional soccer after 6 months and played for an average of 7 years.42
Continue to: HIP-RELATED GROIN PAIN IN SOCCER ATHLETES...
HIP-RELATED GROIN PAIN IN SOCCER ATHLETES
Hip-related groin pain has garnered more attention in the last several years after being a previously underdiagnosed entity. One study found that practitioners treated groin pain in athletes for 7 months on average before recognizing that the pathology was intra-articular.44 FAI, labral tears, and chondral injuries are the major intra-articular pathologies that cause groin pain in athletes and ultimately impaired performance.45,46
FEMOROACETABULAR IMPINGEMENT
FAI is caused by pincer-type, cam-type, or combined-type deformities. Pincer lesions are defined as an increased acetabular overhang, while cam lesions are described as an increased bone at the femoral head/neck junction. These deformities in isolation or in combination cause decreased hip motion and increased contact pressures between the anterolateral acetabulum and femoral head-neck junction, which may ultimately lead to labral tears, chondral lesions, and osteoarthritis.47 During hip flexion, cam deformities impact the anterolateral acetabulum, preferentially causing articular cartilage damage, while sparing the labrum.25 Conversely, pincer deformities cause repetitive microtrauma to the labrum, crushing it between the acetabular rim and femoral neck with secondary damage to the articular cartilage.25 Over time, the damage to the labrum and articular cartilage may lead to premature osteoarthritis, which occurs at a much younger age in the athletic population.48
We know from previous studies that soccer athletes have a high prevalence of morphologic abnormalities of the hip, most commonly FAI. Gerhardt and colleagues49 documented the prevalence of hip morphologic abnormalities in elite soccer players and found abnormalities in 72% of men and over 50% of women. It should be noted that this series looked at asymptomatic athletes; however, it has been shown that hip dysmorphia is a risk factor for hip and groin injuries and may provide an opportunity for injury prevention strategies.50
Physical examination findings in FAI include decreased hip internal rotation and pain with provocative testing. Wyss and colleagues51 measured hip internal rotation in athletes with and without FAI. They found that the athletes with FAI have an average of 4° of internal rotation compared with that of the non-FAI athletes with 28°.51 A worsening internal rotation deficit has been linked to increasing severity of the deformity and when <20° was correlated with joint damage.51 Provocative testing has a high sensitivity with a recent meta-analysis demonstrating the most sensitive tests to be the anterior impingement test (flexion-adduction-internal rotation) with 94% to 99% sensitivity and the flexion-internal rotation test with 96% sensitivity.52 While provocative tests are sensitive, there is no current consensus on physical examination findings that are specific in the diagnosis of FAI.6 Diagnosis is made with both positive physical examination and radiographic morphologic findings (alpha angle >55°).33 Advanced imaging with an MRI arthrogram can be helpful in diagnosing underlying injuries such as labral tears in athletes presenting with compatible symptoms.
Symptomatic patients are typically treated surgically through either open or arthroscopic procedures, which have favorable and comparable functional results, biomechanics, and return to sport.53 In soccer players, return to sport at the professional level after arthroscopic surgery was found to be 96%.54 Players returned to sport on average 9.2 months postoperatively and played an average of 70 games after surgery.54
Continue to: LABRAL TEARS...
LABRAL TEARS
Labral tears present with groin pain, limited hip range of motion, and symptoms of catching, locking, and instability.25Causes of labral tears include trauma, FAI, hip dysplasia, capsular laxity, and degeneration.55 Labral tears rarely occur in isolation and have a high association (87%) with morphologic abnormalities of the hip, most commonly FAI and occasionally dysplasia.56,57 Physical examination findings include positive anterior impingement tests (flexion-adduction-internal rotation) in athletes with anterior labral tears and, less commonly, positive flexion, abduction, and external rotation tests for athletes with lateral and posterolateral labral tears.57 Radiographic imaging is used to evaluate for concurrent morphologic abnormalities of the hip, and MRI arthrogram is used to confirm the diagnosis of a labral tear with a sensitivity of 76% to 91%.58 Initial treatment consists of conservative treatment, which includes rest, anti-inflammatory medication, activity modification, and physical therapy. In patient refractory to conservative treatment, arthroscopic surgery is effective with high rates of return to sport.59 It is important to note that when treating labral tears surgically, any morphologic abnormality needs to be addressed to prevent recurrence of the tear.
CHONDRAL INJURIES
Focal chondral lesions in the hip are commonly found in athletes with FAI and labral tears during arthroscopic evaluation.60 Full-thickness defects and unstable flaps in weight-bearing areas are indications for surgical intervention with microfracture.60 There are no studies examining the efficacy of microfracture in isolation; however, Locks and colleagues54 have demonstrated a 96% return to professional soccer after an arthroscopic treatment for FAI and found that severe chondral damage with microfracture did not lengthen the return to sport.
RELATIONSHIP BETWEEN INGUINAL-RELATED GROIN PAIN AND FEMOROACETABULAR IMPINGEMENT
The altered biomechanics and restricted range of motion in athletes with FAI cause an increase in compensatory motion at the pelvis and lumbosacral areas, which may contribute to the development of inguinal-related groin pain, bursitis, adductor, and gluteal dysfunction.25 In athletes with concurrent intra-articular hip pathology and inguinal-related groin pain, treating 1 condition in isolation will result in poor results. Larson and colleagues61 found that when only inguinal-related groin pain or FAI were addressed, return to sport was only 25% and 50%, respectively, while concurrent surgical treatment resulted in a return to sport of 89%.
DISCUSSION AND FUTURE DIRECTIONS
Groin injuries in soccer players can cause significant decreases in athletic performance, result in lost playing time, and may ultimately need a surgical intervention. Efforts are underway to determine the role and efficacy of identifying high-risk athletes that may benefit from targeted prevention strategies. Wyles and colleagues48 identified adolescent athletes with hip internal rotation of <10° and found at 5-year follow-up that 95% had abnormal MRI findings compared with 54% in the age-matched control group. Wollin and colleagues62 developed an in-season screening protocol using adductor strength reductions of 15%, adductor/abductor strength ratio <0.9, and hip and groin outcome scores <75 as indicators of at-risk individuals. By employing preseason and in-season screening protocols, we can identify high-risk athletes for further workup and close follow-up throughout the season. Pelvic radiographs in these high-risk athletes may help us determine the presence of abnormalities in hip morphology, which would place an athlete into a high-risk group where prevention strategies could then be employed. There are no data available to determine the most effective prevention strategy at this time. However, levels II and III evidence exists indicating that exercise programs may reduce the incidence of groin injuries.63 Additional strategies, like limiting adolescent playing time similar to strategies employed in baseball pitches with pitch counts, could potentially reduce the potential for injury. Further studies on preseason screening and in-season monitoring protocols, targeted exercise therapy, early surgical intervention, and potential biologic intervention are needed to determine the most effective methods of preventing groin injuries in athletes.
1. Kantar Media. 2014 FIFA World Cup Brazil television audience report. https://resources.fifa.com/mm/document/affederation/tv/02/74/55/57/2014f...(draft5)(issuedate14.12.15)_neutral.pdf. Accessed March 20, 2018.
2. Fédération Internationale de Football Association. FIFA Big Count. http://www.fifa.com/mm/document/fifafacts/bcoffsurv/emaga_9384_10704.pdf. Published July 2007. Accessed March 20, 2018.
3. United States Consumer Product Safety Commission. Neiss data highlights - 2015. https://www.cpsc.gov/s3fs-public/2015 Neiss data highlights.pdf. Accessed March 20, 2018.
4. Hassabi M, Mohammad-Javad Mortazavi S, Giti MR, Hassabi M, Mansournia MA, Shapouran S. Injury profile of a professional soccer team in the premier league of Iran. Asian J Sports Med. 2010;1(4):201-208.
5. Ekstrand J, Hagglund M, Walden M. Injury incidence and injury patterns in professional football: the UEFA injury study. Br J Sports Med. 2011;45(7):553-558.
6. Weir A, Brukner P, Delahunt E, et al. Doha agreement meeting on terminology and definitions in groin pain in athletes. Br J Sports Med. 2015;49(12):768-774.
7. Serner A, Tol JL, Jomaah N, et al. Diagnosis of acute groin injuries: a prospective study of 110 athletes. Am J Sports Med. 2015;43(8):1857-1864. doi:10.1177/0363546515585123.
8. Eckard TG, Padua DA, Dompier TP, Dalton SL, Thorborg K, Kerr ZY. Epidemiology of hip flexor and hip adductor strains in national collegiate athletic association athletes, 2009/2010-2014/2015. Am J Sports Med. 2017;45(12):2713-2722. doi:10.1177/0363546517716179.
9. Hopkins JN, Brown W, Lee CA. Sports hernia: definition, evaluation, and treatment. JBJS Rev. 2017;5(9):e6. doi:10.2106/JBJS.RVW.17.00022.
10. Omar IM, Zoga AC, Kavanagh EC, et al. Athletic pubalgia and "sports hernia": optimal MR imaging technique and findings. Radiographics. 2008;28(5):1415-1438. doi:10.1148/rg.285075217.
11. Vogt S, Ansah P, Imhoff AB. Complete osseous avulsion of the adductor longus muscle: acute repair with three Wberwire suture anchors. Arch Orthop Trauma Surg. 2007;127:613-615. doi:10.1007/s00402-007-0328-5.
12. Anderson K, Strickland SM, Warren R. Hip and groin injuries in athletes. Am J Sports Med. 2001;29(4):521-533. doi:10.1177/03635465010290042501.
13. Choi HR, Elattar O, Dills VD, Busconi B. Return to play after sports hernia surgery. Clin Sports Med. 2016;35(4):621-636. doi:10.1016/j.csm.2016.05.007.
14. Garvey JF, Hazard H. Sports hernia or groin disruption injury? Chronic athletic groin pain: a retrospective study of 100 patients with long-term follow-up. Hernia. 2014;18(6):815-823. doi:10.1007/s10029-013-1161-0.
15. Gilmore J. Groin pain in the soccer athlete: fact, fiction, and treatment. Clin Sports Med. 1998;17(4):787-793, vii. doi:10.1016/S0278-5919(05)70119-8.
16. Cohen B, Kleinhenz D, Schiller J, Tabaddor R. Understanding athletic pubalgia: a review. R I Med J. 2016;99(10):31-35.
17. Ross JR, Stone RM, Larson CM. Core muscle injury/sports hernia/athletic pubalgia, and femoroacetabular impingement. Sports Med Arthrosc Rev. 2015;23(4):213-220. doi:10.1097/JSA.0000000000000083.
18. Swan KG Jr, Wolcott M. The athletic hernia: a systematic review. Clin Orthop Relat Res. 2007;455:78-87. doi:10.1097/BLO.0b013e31802eb3ea.
19. Matikainen M, Hermunen H, Paajanen H. Athletic pubalgia in females: predictive value of MRI in outcomes of endoscopic surgery. Orthop J Sports Med. 2017;5(8):2325967117720171. doi:10.1177/2325967117720171.
20. Garvey JF, Read JW, Turner A. Sportsman hernia: what can we do? Hernia. 2010;14(1):17-25. doi:10.1007/s10029-009-0611-1.
21. Paksoy M, Sekmen U. Sportsman hernia; the review of current diagnosis and treatment modalities. Ulusal Cerrahi Derg. 2016;32(2):122-129. doi:10.5152/UCD.2015.3132.
22. Pokorny H, Resinger C, Fischer I, et al. Fast early recovery after transabdominal preperitoneal repair in athletes with sportsman's groin: a prospective clinical cohort study. J Laparoendosc Adv Surg Tech A. 2017;27(3):272-276. doi:10.1089/lap.2016.0188.
23. Biedert RM, Warnke K, Meyer S. Symphysis syndrome in athletes: surgical treatment for chronic lower abdominal, groin, and adductor pain in athletes. Clin J Sport Med. 2003;13(5):278-284.
24. Sheen AJ, Stephenson BM, Lloyd DM, et al. 'Treatment of the sportsman's groin': British Hernia Society's 2014 position statement based on the Manchester Consensus Conference. Br J Sports Med. 2014;48(14):1079-1087.
25. Miller M, Thompson S. DeLee & Drez's Orthopaedic Sports Medicine. 4th ed. Philadelphia, PA: Elsevier/Saunders; 2015.
26. Lovell G. The diagnosis of chronic groin pain in athletes: a review of 189 cases. J Sci Med Sport. 1995;27:76-79.
27. Dimitrakopoulou A, Schilders E. Sportsman's hernia? An ambiguous term. J Hip Preserv Surg. 2016;3(1):16-22. doi:10.1093/jhps/hnv083.
28. Strosberg DS, Ellis TJ, Renton DB. The role of femoroacetabular impingement in core muscle injury/athletic pubalgia: diagnosis and management. Front Surg. 2016;3:6. doi:10.3389/fsurg.2016.00006.
29. Muschaweck U, Berger LM. Sportsmen's groin-diagnostic approach and treatment with the minimal repair technique: a single-center uncontrolled clinical review. Sports Health. 2010;2(3):216-221. doi:10.1177/1941738110367623.
30. Larson CM. Sports hernia/athletic pubalgia: evaluation and management. Sports Health. 2014;6(2):139-144. doi:10.1177/1941738114523557.
31. Meyers WC, Foley DP, Garrett WE, Lohnes JH, Mandlebaum BR. Management of severe lower abdominal or inguinal pain in high-performance athletes. Am J Sports Med. 2000; 28(1):2-8. doi:10.1177/03635465000280011501.
32. Gerhardt MB, Mandelbaum BR, Hutchinson WB. Ancillary modalities in the treatment of athletic groin Pain: Local Anesthetics, Corticosteroids, and Orthobiologics. In: Diduch DR, Brunt LM, eds. Sports Hernia and Athletic Pubalgia: Diagnosis and Treatment. Boston, MA: Springer US; 2014:183-187.
33. Notzli HP, Wyss TF, Stoecklin CH, et al. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84(4):556-560.
34. Brennan D, O’Connell MJ, Ryan M, et al. Secondary cleft sign as a marker of injury in athletes with groin pain: MR image appearance and interpretation. Radiology. 2005;235(1):162-167. doi:10.1148/radiol.2351040045.
35. Byrne CA, Bowden DJ, Alkhayat A, Kavanagh EC, Eustace SJ. Sports-related groin pain secondary to symphysis pubis disorders: correlation between MRI findings and outcome after fluoroscopy-guided injection of steroid and local anesthetic. Am J Roentgenol. 2017;209(2):380-388. doi:10.2214/AJR.16.17578.
36. Paajanen H, Brinck T, Hermunen H, Airo I. Laparoscopic surgery for chronic groin pain in athletes is more effective than nonoperative treatment: a randomized clinical trial with magnetic resonance imaging of 60 patients with sportsman's hernia (athletic pubalgia). Surgery. 2011;150(1):99-107. doi:10.1016/j.surg.2011.02.016.
37. Muschaweck U, Berger L. Minimal repair technique of sportsmen's groin: an innovative open-suture repair to treat chronic inguinal pain. Hernia. 2010;14(1):27-33. doi:10.1007/s10029-009-0614-y.
38. Lynch TS, Bedi A, Larson CM. Athletic hip injuries. J Am Acad Orthop Surg. 2017;25(4):269-279. doi:10.5435/JAAOS-D-16-00171.
39. Holt MA, Keene JS, Graf BK, Helwig DC. Treatment of osteitis pubis in athletes. Results of corticosteroid injections. Am J Sports Med. 1995;23(5):601-606.doi:10.1177/036354659502300515.
40. Rossi F, Dragoni S. Acute avulsion fractures of the pelvis in adolescent competitive athletes: prevalence, location and sports distribution of 203 cases collected. Skeletal Radiol. 2001;30(3):127-131. doi: 10.1007/s002560000319.
41. Grumet RC, Frank RM, Slabaugh MA, Virkus WW, Bush-Joseph CA, Nho SJ. Lateral hip pain in an athletic population: differential diagnosis and treatment options. Sports Health. 2010;2(3):191-196. doi:10.1177/1941738110366829.
42. Zeren B, Canbek U, Oztekin HH, Imerci A, Akgun U. Bilateral piriformis syndrome in two elite soccer players: report of two cases. Orthop Traumatol Surg Res. 2015;101(8):987-990. doi:10.1016/j.otsr.2015.07.022.
43. Keskula DR, Tamburello M. Conservative management of piriformis syndrome. J Athl Train. 1992;27(2):102-110.
44. Byrd JW, Jones KS. Hip arthroscopy in athletes. Clin Sports Med. 2001;20(4):749-761.
45. Nepple JJ, Goljan P, Briggs KK, Garvey SE, Ryan M, Philippon MJ. Hip strength deficits in patients with symptomatic femoroacetabular impingement and labral tears. Arthroscopy.2015;31(11):2106-2111.
46. Mullins K, Hanlon M, Carton P. Differences in athletic performance between sportsmen with symptomatic femoroacetabular impingement and healthy controls. Clin J Sport Med.2018;28(4):370-376. doi:10.1097/JSM.0000000000000460.
47. Ganz R, Parvizi J, Beck M, Leunig M, Notzli H, Siebenrock KA. Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res. 2003;417:112-120. doi:10.1097/01.blo.0000096804.78689.c2.
48. Wyles CC, Norambuena GA, Howe BM, et al. Cam deformities and limited hip range of motion are associated with early osteoarthritic changes in adolescent athletes: a prospective matched cohort study. Am J Sports Med. 2017;45(13):3036-3043. doi:10.1177/0363546517719460 .
49. Gerhardt MB, Romero AA, Silvers HJ, Harris DJ, Watanabe D, Mandelbaum BR. The prevalence of radiographic hip abnormalities in elite soccer players. Am J Sports Med. 2012;40(3):584-588. doi:10.1177/0363546511432711.
50. Larson CM, Ross JR, Kuhn AW, et al. Radiographic hip anatomy correlates with range of motion and symptoms in national hockey league players. Am J Sports Med. 2017;45(7):1633-1639. doi:10.1177/0363546517692542.
51. Wyss TF, Clark JM, Weishaupt D, Notzli HP. Correlation between internal rotation and bony anatomy in the hip. Clin Orthop Relat Res. 2007;460:152-158. doi:10.1097/BLO.0b013e3180399430.
52. Reiman MP, Goode AP, Cook CE, Holmich P, Thorborg K. Diagnostic accuracy of clinical tests for the diagnosis of hip femoroacetabular impingement/labral tear: a systematic review with meta-analysis. Br J Sports Med. 2015;49:811. doi:10.1136/bjsports-2014-094302.
53. Papalia R, Del Buono A, Franceschi F, Marinozzi A, Maffulli N, Denaro V. Femoroacetabular impingement syndrome management: arthroscopy or open surgery? Int Orthop. 2012;36(5):903-914. doi:10.1007/s00264-011-1443-z.
54. Locks R, Utsunomiya H, Briggs KK, McNamara S, Chahla J, Philippon MJ. Return to play after hip arthroscopic surgery for femoroacetabular impingement in professional soccer players. Am J Sports Med. 2018;46(2):273-279. doi:10.1177/0363546517738741.
55. Kelly BT, Weiland DE, Schenker ML, Philippon MJ. Arthroscopic labral repair in the hip: surgical technique and review of the literature. Arthroscopy. 2005;21(12):1496-1504. doi:10.1016/j.arthro.2005.08.013.
56. Wenger DE, Kendell KR, Miner MR, Trousdale RT. Acetabular labral tears rarely occur in the absence of bony abnormalities. Clin Orthop Relat Res. 2004;426:145-150. doi:10.1097/01.blo.0000136903.01368.20.
57. Domb BG, Hartigan DE, Perets I. Decision making for labral treatment in the hip: repair versus débridement versus reconstruction. J Am Acad Orthop Surg. 2017;25(3):e53-e62. doi:10.5435/JAAOS-D-16-00144.
58. Frank JS, Gambacorta PL, Eisner EA. Hip pathology in the adolescent athlete. J Am Acad Orthop Surg. 2013;21(11):665-674. doi:10.5435/JAAOS-21-11-665.
59. Singh PJ, O'Donnell JM. The outcome of hip arthroscopy in Australian football league players: a review of 27 hips. Arthroscopy. 2010;26(6):743-749. doi:10.1016/j.arthro.2009.10.010.
60. Crawford K, Philippon MJ, Sekiya JK, Rodkey WG, Steadman JR. Microfracture of the hip in athletes. Clin Sports Med. 2006;25(2):327-335. doi:10.1016/j.csm.2005.12.004.
61. Larson CM, Pierce BR, Giveans MR. Treatment of athletes with symptomatic intra-articular hip pathology and athletic pubalgia/sports hernia: a case series. Arthroscopy.2011;27(6):768-775. doi:10.1016/j.arthro.2011.01.018.
62. Wollin M, Thorborg K, Welvaert M, Pizzari T. In-season monitoring of hip and groin strength, health and function in elite youth soccer: implementing an early detection and management strategy over two consecutive seasons. J Sci Med Sport. 2018;21(10):988. doi:10.1016/j.jsams.2018.03.004.
63. Charlton PC, Drew MK, Mentiplay BF, Grimaldi A, Clark RA. Exercise interventions for the prevention and treatment of groin pain and injury in athletes: a critical and systematic review. Sports Med. 2017;47:2011. doi:10.1007/s40279-017-0742-y.
1. Kantar Media. 2014 FIFA World Cup Brazil television audience report. https://resources.fifa.com/mm/document/affederation/tv/02/74/55/57/2014f...(draft5)(issuedate14.12.15)_neutral.pdf. Accessed March 20, 2018.
2. Fédération Internationale de Football Association. FIFA Big Count. http://www.fifa.com/mm/document/fifafacts/bcoffsurv/emaga_9384_10704.pdf. Published July 2007. Accessed March 20, 2018.
3. United States Consumer Product Safety Commission. Neiss data highlights - 2015. https://www.cpsc.gov/s3fs-public/2015 Neiss data highlights.pdf. Accessed March 20, 2018.
4. Hassabi M, Mohammad-Javad Mortazavi S, Giti MR, Hassabi M, Mansournia MA, Shapouran S. Injury profile of a professional soccer team in the premier league of Iran. Asian J Sports Med. 2010;1(4):201-208.
5. Ekstrand J, Hagglund M, Walden M. Injury incidence and injury patterns in professional football: the UEFA injury study. Br J Sports Med. 2011;45(7):553-558.
6. Weir A, Brukner P, Delahunt E, et al. Doha agreement meeting on terminology and definitions in groin pain in athletes. Br J Sports Med. 2015;49(12):768-774.
7. Serner A, Tol JL, Jomaah N, et al. Diagnosis of acute groin injuries: a prospective study of 110 athletes. Am J Sports Med. 2015;43(8):1857-1864. doi:10.1177/0363546515585123.
8. Eckard TG, Padua DA, Dompier TP, Dalton SL, Thorborg K, Kerr ZY. Epidemiology of hip flexor and hip adductor strains in national collegiate athletic association athletes, 2009/2010-2014/2015. Am J Sports Med. 2017;45(12):2713-2722. doi:10.1177/0363546517716179.
9. Hopkins JN, Brown W, Lee CA. Sports hernia: definition, evaluation, and treatment. JBJS Rev. 2017;5(9):e6. doi:10.2106/JBJS.RVW.17.00022.
10. Omar IM, Zoga AC, Kavanagh EC, et al. Athletic pubalgia and "sports hernia": optimal MR imaging technique and findings. Radiographics. 2008;28(5):1415-1438. doi:10.1148/rg.285075217.
11. Vogt S, Ansah P, Imhoff AB. Complete osseous avulsion of the adductor longus muscle: acute repair with three Wberwire suture anchors. Arch Orthop Trauma Surg. 2007;127:613-615. doi:10.1007/s00402-007-0328-5.
12. Anderson K, Strickland SM, Warren R. Hip and groin injuries in athletes. Am J Sports Med. 2001;29(4):521-533. doi:10.1177/03635465010290042501.
13. Choi HR, Elattar O, Dills VD, Busconi B. Return to play after sports hernia surgery. Clin Sports Med. 2016;35(4):621-636. doi:10.1016/j.csm.2016.05.007.
14. Garvey JF, Hazard H. Sports hernia or groin disruption injury? Chronic athletic groin pain: a retrospective study of 100 patients with long-term follow-up. Hernia. 2014;18(6):815-823. doi:10.1007/s10029-013-1161-0.
15. Gilmore J. Groin pain in the soccer athlete: fact, fiction, and treatment. Clin Sports Med. 1998;17(4):787-793, vii. doi:10.1016/S0278-5919(05)70119-8.
16. Cohen B, Kleinhenz D, Schiller J, Tabaddor R. Understanding athletic pubalgia: a review. R I Med J. 2016;99(10):31-35.
17. Ross JR, Stone RM, Larson CM. Core muscle injury/sports hernia/athletic pubalgia, and femoroacetabular impingement. Sports Med Arthrosc Rev. 2015;23(4):213-220. doi:10.1097/JSA.0000000000000083.
18. Swan KG Jr, Wolcott M. The athletic hernia: a systematic review. Clin Orthop Relat Res. 2007;455:78-87. doi:10.1097/BLO.0b013e31802eb3ea.
19. Matikainen M, Hermunen H, Paajanen H. Athletic pubalgia in females: predictive value of MRI in outcomes of endoscopic surgery. Orthop J Sports Med. 2017;5(8):2325967117720171. doi:10.1177/2325967117720171.
20. Garvey JF, Read JW, Turner A. Sportsman hernia: what can we do? Hernia. 2010;14(1):17-25. doi:10.1007/s10029-009-0611-1.
21. Paksoy M, Sekmen U. Sportsman hernia; the review of current diagnosis and treatment modalities. Ulusal Cerrahi Derg. 2016;32(2):122-129. doi:10.5152/UCD.2015.3132.
22. Pokorny H, Resinger C, Fischer I, et al. Fast early recovery after transabdominal preperitoneal repair in athletes with sportsman's groin: a prospective clinical cohort study. J Laparoendosc Adv Surg Tech A. 2017;27(3):272-276. doi:10.1089/lap.2016.0188.
23. Biedert RM, Warnke K, Meyer S. Symphysis syndrome in athletes: surgical treatment for chronic lower abdominal, groin, and adductor pain in athletes. Clin J Sport Med. 2003;13(5):278-284.
24. Sheen AJ, Stephenson BM, Lloyd DM, et al. 'Treatment of the sportsman's groin': British Hernia Society's 2014 position statement based on the Manchester Consensus Conference. Br J Sports Med. 2014;48(14):1079-1087.
25. Miller M, Thompson S. DeLee & Drez's Orthopaedic Sports Medicine. 4th ed. Philadelphia, PA: Elsevier/Saunders; 2015.
26. Lovell G. The diagnosis of chronic groin pain in athletes: a review of 189 cases. J Sci Med Sport. 1995;27:76-79.
27. Dimitrakopoulou A, Schilders E. Sportsman's hernia? An ambiguous term. J Hip Preserv Surg. 2016;3(1):16-22. doi:10.1093/jhps/hnv083.
28. Strosberg DS, Ellis TJ, Renton DB. The role of femoroacetabular impingement in core muscle injury/athletic pubalgia: diagnosis and management. Front Surg. 2016;3:6. doi:10.3389/fsurg.2016.00006.
29. Muschaweck U, Berger LM. Sportsmen's groin-diagnostic approach and treatment with the minimal repair technique: a single-center uncontrolled clinical review. Sports Health. 2010;2(3):216-221. doi:10.1177/1941738110367623.
30. Larson CM. Sports hernia/athletic pubalgia: evaluation and management. Sports Health. 2014;6(2):139-144. doi:10.1177/1941738114523557.
31. Meyers WC, Foley DP, Garrett WE, Lohnes JH, Mandlebaum BR. Management of severe lower abdominal or inguinal pain in high-performance athletes. Am J Sports Med. 2000; 28(1):2-8. doi:10.1177/03635465000280011501.
32. Gerhardt MB, Mandelbaum BR, Hutchinson WB. Ancillary modalities in the treatment of athletic groin Pain: Local Anesthetics, Corticosteroids, and Orthobiologics. In: Diduch DR, Brunt LM, eds. Sports Hernia and Athletic Pubalgia: Diagnosis and Treatment. Boston, MA: Springer US; 2014:183-187.
33. Notzli HP, Wyss TF, Stoecklin CH, et al. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84(4):556-560.
34. Brennan D, O’Connell MJ, Ryan M, et al. Secondary cleft sign as a marker of injury in athletes with groin pain: MR image appearance and interpretation. Radiology. 2005;235(1):162-167. doi:10.1148/radiol.2351040045.
35. Byrne CA, Bowden DJ, Alkhayat A, Kavanagh EC, Eustace SJ. Sports-related groin pain secondary to symphysis pubis disorders: correlation between MRI findings and outcome after fluoroscopy-guided injection of steroid and local anesthetic. Am J Roentgenol. 2017;209(2):380-388. doi:10.2214/AJR.16.17578.
36. Paajanen H, Brinck T, Hermunen H, Airo I. Laparoscopic surgery for chronic groin pain in athletes is more effective than nonoperative treatment: a randomized clinical trial with magnetic resonance imaging of 60 patients with sportsman's hernia (athletic pubalgia). Surgery. 2011;150(1):99-107. doi:10.1016/j.surg.2011.02.016.
37. Muschaweck U, Berger L. Minimal repair technique of sportsmen's groin: an innovative open-suture repair to treat chronic inguinal pain. Hernia. 2010;14(1):27-33. doi:10.1007/s10029-009-0614-y.
38. Lynch TS, Bedi A, Larson CM. Athletic hip injuries. J Am Acad Orthop Surg. 2017;25(4):269-279. doi:10.5435/JAAOS-D-16-00171.
39. Holt MA, Keene JS, Graf BK, Helwig DC. Treatment of osteitis pubis in athletes. Results of corticosteroid injections. Am J Sports Med. 1995;23(5):601-606.doi:10.1177/036354659502300515.
40. Rossi F, Dragoni S. Acute avulsion fractures of the pelvis in adolescent competitive athletes: prevalence, location and sports distribution of 203 cases collected. Skeletal Radiol. 2001;30(3):127-131. doi: 10.1007/s002560000319.
41. Grumet RC, Frank RM, Slabaugh MA, Virkus WW, Bush-Joseph CA, Nho SJ. Lateral hip pain in an athletic population: differential diagnosis and treatment options. Sports Health. 2010;2(3):191-196. doi:10.1177/1941738110366829.
42. Zeren B, Canbek U, Oztekin HH, Imerci A, Akgun U. Bilateral piriformis syndrome in two elite soccer players: report of two cases. Orthop Traumatol Surg Res. 2015;101(8):987-990. doi:10.1016/j.otsr.2015.07.022.
43. Keskula DR, Tamburello M. Conservative management of piriformis syndrome. J Athl Train. 1992;27(2):102-110.
44. Byrd JW, Jones KS. Hip arthroscopy in athletes. Clin Sports Med. 2001;20(4):749-761.
45. Nepple JJ, Goljan P, Briggs KK, Garvey SE, Ryan M, Philippon MJ. Hip strength deficits in patients with symptomatic femoroacetabular impingement and labral tears. Arthroscopy.2015;31(11):2106-2111.
46. Mullins K, Hanlon M, Carton P. Differences in athletic performance between sportsmen with symptomatic femoroacetabular impingement and healthy controls. Clin J Sport Med.2018;28(4):370-376. doi:10.1097/JSM.0000000000000460.
47. Ganz R, Parvizi J, Beck M, Leunig M, Notzli H, Siebenrock KA. Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res. 2003;417:112-120. doi:10.1097/01.blo.0000096804.78689.c2.
48. Wyles CC, Norambuena GA, Howe BM, et al. Cam deformities and limited hip range of motion are associated with early osteoarthritic changes in adolescent athletes: a prospective matched cohort study. Am J Sports Med. 2017;45(13):3036-3043. doi:10.1177/0363546517719460 .
49. Gerhardt MB, Romero AA, Silvers HJ, Harris DJ, Watanabe D, Mandelbaum BR. The prevalence of radiographic hip abnormalities in elite soccer players. Am J Sports Med. 2012;40(3):584-588. doi:10.1177/0363546511432711.
50. Larson CM, Ross JR, Kuhn AW, et al. Radiographic hip anatomy correlates with range of motion and symptoms in national hockey league players. Am J Sports Med. 2017;45(7):1633-1639. doi:10.1177/0363546517692542.
51. Wyss TF, Clark JM, Weishaupt D, Notzli HP. Correlation between internal rotation and bony anatomy in the hip. Clin Orthop Relat Res. 2007;460:152-158. doi:10.1097/BLO.0b013e3180399430.
52. Reiman MP, Goode AP, Cook CE, Holmich P, Thorborg K. Diagnostic accuracy of clinical tests for the diagnosis of hip femoroacetabular impingement/labral tear: a systematic review with meta-analysis. Br J Sports Med. 2015;49:811. doi:10.1136/bjsports-2014-094302.
53. Papalia R, Del Buono A, Franceschi F, Marinozzi A, Maffulli N, Denaro V. Femoroacetabular impingement syndrome management: arthroscopy or open surgery? Int Orthop. 2012;36(5):903-914. doi:10.1007/s00264-011-1443-z.
54. Locks R, Utsunomiya H, Briggs KK, McNamara S, Chahla J, Philippon MJ. Return to play after hip arthroscopic surgery for femoroacetabular impingement in professional soccer players. Am J Sports Med. 2018;46(2):273-279. doi:10.1177/0363546517738741.
55. Kelly BT, Weiland DE, Schenker ML, Philippon MJ. Arthroscopic labral repair in the hip: surgical technique and review of the literature. Arthroscopy. 2005;21(12):1496-1504. doi:10.1016/j.arthro.2005.08.013.
56. Wenger DE, Kendell KR, Miner MR, Trousdale RT. Acetabular labral tears rarely occur in the absence of bony abnormalities. Clin Orthop Relat Res. 2004;426:145-150. doi:10.1097/01.blo.0000136903.01368.20.
57. Domb BG, Hartigan DE, Perets I. Decision making for labral treatment in the hip: repair versus débridement versus reconstruction. J Am Acad Orthop Surg. 2017;25(3):e53-e62. doi:10.5435/JAAOS-D-16-00144.
58. Frank JS, Gambacorta PL, Eisner EA. Hip pathology in the adolescent athlete. J Am Acad Orthop Surg. 2013;21(11):665-674. doi:10.5435/JAAOS-21-11-665.
59. Singh PJ, O'Donnell JM. The outcome of hip arthroscopy in Australian football league players: a review of 27 hips. Arthroscopy. 2010;26(6):743-749. doi:10.1016/j.arthro.2009.10.010.
60. Crawford K, Philippon MJ, Sekiya JK, Rodkey WG, Steadman JR. Microfracture of the hip in athletes. Clin Sports Med. 2006;25(2):327-335. doi:10.1016/j.csm.2005.12.004.
61. Larson CM, Pierce BR, Giveans MR. Treatment of athletes with symptomatic intra-articular hip pathology and athletic pubalgia/sports hernia: a case series. Arthroscopy.2011;27(6):768-775. doi:10.1016/j.arthro.2011.01.018.
62. Wollin M, Thorborg K, Welvaert M, Pizzari T. In-season monitoring of hip and groin strength, health and function in elite youth soccer: implementing an early detection and management strategy over two consecutive seasons. J Sci Med Sport. 2018;21(10):988. doi:10.1016/j.jsams.2018.03.004.
63. Charlton PC, Drew MK, Mentiplay BF, Grimaldi A, Clark RA. Exercise interventions for the prevention and treatment of groin pain and injury in athletes: a critical and systematic review. Sports Med. 2017;47:2011. doi:10.1007/s40279-017-0742-y.
TAKE-HOME POINTS
- Groin injuries in soccer players can cause significant decreases in athletic performance, result in lost playing time, and may ultimately need surgical intervention.
- Groin pain can be separated into 3 categories: (1) defined clinical entities for groin pain (adductor-related, iliopsoas-related, inguinal-related [sports hernias/athletic pubalgia], and pubic-related groin pain), (2) hip-related groin pain (hip morphologic abnormalities, labral tears, and chondral injuries), and (3) other causes of groin pain.
- Acute groin pain in soccer players is most commonly caused by muscle strain involving the adductor longus, the iliopsoas or the rectus femoris.
- Inguinal-related groin pain is a common cause of chronic groin pain and typically is the most challenging to treat with a complex pathophysiology and a high association with femoroacetabular impingement.
- Hip-related groin pain (femoroacetabular impingement, labral tears, and chondral injuries) usually respond well to surgical intervention and has high rates of return to sport.